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SUMMARY AND CONCLUSIONS OF THE FINDINGS IN THE PRESENT 
THESIS 
Summary
The present thesis has drawn on a wide range of studies employing a variety of 
methodologies, aiming to explore the importance of hody composition and morphology 
in relation to health and disease in adults, with a principle consideration of the need for 
health promotion. To achieve these aims, a series of hypotheses were postulated and a 
number of research questions were asked, followed by hypothesis testing and data 
analyses to gain new understanding, and to establish firmly the associations o f body 
morphology with health and disease.
Recognising the limited success in reversing the increasing trends in overweight has 
prompted the need to design new strategies in promoting public awareness of the risk of 
ill health associated with overweight and central fat distribution. These studies were 
carried out in this context to develop simple methods for assessing body composition, to 
enable health professionals and general public to assess and identify people with 
increasing health risks associated with overweight and increased intra-abdominal fat 
accumulation. The use of body mass index is established hut is too complex for lay use, 
and does not take accoimt of fat distribution as an indicator of ill health. Waist 
circumference was explored since it reflects both fatness and central fat distribution. It 
was shown that height correlated weakly or not at all with waist circumference. Analysis 
of magnetic resonance imaging and computerised tomography data showed that height 
correlated weakly with intra-abdominal fat and had limited influence on the strong 
relationship between waist circumference and intra-abdominal fat. Thus waist 
circumference could be used as an index of adiposity and health risk without the need of 
incorporating height to create complex ratios (height adjustment). New equations 
employing simple anthropometric variables including a single measurement of waist 
circumference have been derived and cross-validated in an independent Dutch 
population. These equations were found to be valid for assessing total hody fatness.
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Cut-offs of waist circumference were derived to identify people with high body mass 
index (overweight) or with high waist to hip ratio (central fat distribution): Action Level 
1 (94 cm in men, 80 cm in women) identifies those with body mass index above 25 
kg/m^ or waist to hip ratio above 0.95 in men or above 0.80 in women. Action Level 2 
(102 cm in men, 88 cm in women) identifies those with body mass index above 30 
kg/m^ or waist to hip ratio above 0.95 in men or above 0.80 in women. Receiver 
operating characteristic (ROC) analysis showed that Action Level 1 was close to the 
optimal (at the point where sensitivity equals specificity) value for identifying people 
with cardiovascular risk factors, including hypertension, hypercholesterolaemia or low 
high density lipoprotein (HDL) cholesterol.
Excessive accumulation of the metabolically active intra-abdominal fat is associated 
with metabolic disorders. Magnetic resonance imaging and computerised tomography 
studies conducted in Aberdeen and The Netherlands have shown that waist 
circumference is closely related to intra-ahdominal fat. Epidemiological studies in the 
present thesis showed that large waist circumference was associated with poor quality of 
life and a cluster of metabolic disorders and symptoms of clironic diseases including 
non-insulin-dependent diabetes mellitus (NIDDM), respiratory symptoms, low back 
pain, and high blood pressure, high total plasma cholesterol and low HDL cholesterol.
In our cross-sectional study, low hip circumference was related to NIDDM 
independently of waist (abdominal fat), suggested that reduced muscle mass (i.e. 
reduced postural, mainly type 1 muscle fibres) may be a consequence of NIDDM.
Analysis of data from a weight reduction follow-up study of free living women showed 
that moderate reduction (5-10 cm) of waist circumference was associated with 85% 
chance of improving at least one of the major cardiovascular risk factors in overweight 
women who had not been selected for high cardiovascular risk.
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Features of metabolic syndrome including insulin resistance, NIDDM, Cushing’s 
syndrome, hypertension, and increased intra-ahdominal fat accumulation have 
previously been found to associate with increased type 2b, glycolytic, white muscle 
fibres. Athletes who specialise in power sports tend to have higher proportions of type 
2b muscle fibres than those who specialise in endurance sports who tend to have greater 
proportion of oxidative, type 1 muscle fibres. A retrospective study of former physical 
trainees was carried out to test the hypothesis that those with a natural ability in power 
sports (a presumed marker of type 2 muscle fibre predominance) might have increased 
risks of cardiovascular disorders compared to those with a natural ability in endurance 
sports (a marker of type 1 muscle fibre predominance). It was found that compared to 
men who had a natural ability in endurance sports, those who had a natural ability in 
power sports were more likely to report the development of cardiovascular disorders.
Epidemiological studies of Barker and colleagues have produced compelling evidence 
for the associations between small birth weight (presumed to reflect failure in early 
growth) with health risks tlirough metabolic diseases (coronary heart disease, stroke, 
non-insulin dependent diabetes mellitus) in later life. The diseases under question are 
those associated with the ‘metabolic syndrome’ linked by insulin resistance and with 
central fat distribution. Our previous studies and that of Law et al have foimd women 
and men who had small birth weights had increased abdominal fat deposition, indicated 
by large waist circumference or high waist to hip ratio. Amongst the same women from 
our previous study, low birth weight also tended to relate to elevated blood pressure and 
heart rate. The ‘thrifty phenotype’ and ‘programming’ hypotheses were assessed as ways 
to explain possible influences of early nutrition on the development of visceral organ 
morphology and function to relate to health in later life. It is surprising that little is 
known about the development and function of the musculoskeletal system, which is the 
biggest and arguably most expendable organ of all, in relation to metabolic disorders in 
adulthood. In the present thesis, birth weight was found to correlate negatively with 
cardiovascular disorders and had an additive effect with natural ability in power sports. 
Compared to men who had a natural ability in endurance sports and above median birth
X
weight, those with a natural ability in power sports and below median birth weight were 
more likely to develop CHD and/or risk factors (age, current body mass index, and 
lifestyle factors adjusted odds ratio = 10.5, 95% confidence interval: 1.9 to 59.5), 
compared to men in the endurance group with above median birth weight.
Skeletal structure based on measured body dimensions including height, lower leg 
length and demi-arm span was studied to investigate the influences from age and gender, 
and as marker for adaptation to the effects of early growth development, to relate to 
coronary heart disease and predisposing risk factors. Analysis of variance with 
adjustments for age, social class and smoking showed that in men, short height, lower 
leg length or demi-arm span was associated with hypercholesterolaemia, and long lower 
leg length was associated with diabetes mellitus. In women, short height or lower leg 
length was associated with coronary heart disease. High ratio of lower leg lengthiheight 
or lower leg length:demi-arm span was associated with diabetes mellitus in ruen. In 
women, high ratio of demi-arm span:height or low ratio of lower leg length:demi-arm 
span was associated with coronary heart disease.
A specially made tape measure, the ‘Waist Watcher’, was developed based on Action 
Level cut-offs to provide guidelines for target waist circumference. As part of a health 
promotion directed at general public, a prospective study was designed to assess the 
usefrilness of the Waist Watcher for weight management in 600 men and women. 
Baseline data were available for analysis of the accuiacy of self-reported body weight, 
height, and waist circumference in 101 men and 62 women. Classifications using waist 
Action Level 1 or Action Level 2 by the investigator were used as the reference method. 
Using the ‘Waist Watcher’ with different colour bands based on the Action Level, and 
photographic instructions to assess waist size, subjects classified themselves into correct 
categories according to Action Level 1 with sensitivities of 100% and 94.3%, and 
specificities of 95.0% and 96.3%, and according to Action Level 2 with sensitivities of 
97.1% and 100%, and specificities of 100% for both sexes. Only 2% of the sample 
misclassified themselves into the wiong categories of waist circumference Action
XI
Levels. The findings suggest that the Waist Watcher tape measure and photographic 
instructions can be used by the general public to assess their own waist circmnference, 
alerting those who need weight management and screening for cardiovascular risk 
factors, and providing a target of desirable range of waist circumference.
Conclusions
1. New equations for men and women using simple anthropometric variables including 
a single measurement of waist circumference have been developed and cross­
validated. These equations are rohust in predicting body fatness with little error or 
bias from extremes of fat distribution and age. A single measurement of waist 
circumference provides a convenient way to assess body fatness in epidemiology 
and clinical situation.
2. Cut-offs of waist circumference at Action Level 1 (94 cm in men and 80 cm in 
women) and Action Level 2 (102 cm in men and 88 cm in women) have been 
derived to identify men and women at risk of overweight or central fat distribution. 
These Action Levels are useful in alerting public awareness of health risks 
associated with overweight and intra-abdominal fat accumulation.
3. Waist circumference Action Level 1 in men and in women is close to the optimal 
cut-offs from ROC analysis for identifying hypertension, hypercholesterolaemia or 
low HDL cholesterol.
4. Height has very limited influence on waist circumference as an index of adiposity, 
and can be neglected for practical applications.
5. Lai'ger waist circmnference associates with increased risks o f chr onic diseases and 
symptoms, cardiovascular risk factors and poor quality of life. Those with large 
waist circmnference should take action in lifestyle modification and weight 
management to prevent further weight gain, and should be urged to lose weight.
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6. Reduced hip circumference (i.e. reduced postural, mainly type 1 muscle fibres) was 
related to NIDDM independently of waist circumference (abdominal fat).
7. A moderate reduction of waist of 5-10 cm may he a useful guideline for achieving
realistic targets in weight management and improving cardiovascular risks.
8. Short stature and limb lengths, and also altered skeletal proportions, which may 
reflect interrupted growth, are associated with several metabolic disorders. Skeletal 
disproportion associates with diabetes mellitus in men and CHD in women.
9. Men with natural ability in power sports are more likely in later life to develop
CHD and/or predisposing risk factors than those with a natural ability in endurance
sports, suggesting that muscle fibre composition may play important roles in 
cardiovascular disorders. Low birth weight has an independent additive effect on 
these disorders.
10. Waist circumference measmed using the ‘Waist Watcher’ tape measure by subjects 
agrees to within (95% confidence interval limits of agreement) 6.5 cm in men and 
5.3 cm in women. Using the ‘Waist Watcher’ tape measure, subjects self-classify 
their waist circumference according to Action Level 1 (<94 cm in men, <80 cm in 
women) or Action Level 2 (>102 cm in men, >88 cm in women) with sensitivities 
and specificities above 94%. ‘Waist Watcher’ tape measure provides a valuable tool 
for screening health risks associated with intra-abdominal fat accumulation, in 
health promotion directed at the general public.
11. The findings of the present thesis contribute new Imowledge in the aetiology of 
diseases, and also they provide an opportimity to use morphological markers of 
musculoskeletal development and body composition so that those who are at risk 
could be targeted better by health promotion directed at the general public.
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1.1 introduction
The associations of overweight and fat distribution with metabolic complications are 
well established (Bjdrntorp, 1992), but the causal links remain unclear. Genetic and 
enviromnental factors and their interactions have long been considered as the main 
determinants of body fatness and fat distribution (Bouchard, 1990). Recent evidence 
emerged from studies of Barker and colleagues (1992) suggests that early malnutrition 
could result in irreversible damage to vital organs in order to sustain the development of 
the nervous system, ‘programming’ such subjects to greater susceptibility to metabolic 
disorders in certain enviromnent, which could persist through to adult life. Early 
nutrition could thus be important in the development of body morphology and health, 
acting with genetic and environmental factors.
Studies of muscle composition have shown type 2b muscle fibres were associated with 
features of metabolic syndrome, including non-insulin-dependent diabetes mellitus 
(NIDDM) (Marin et al, 1994), decreased insulin sensitivity (Lillioja et al, 1987), 
Cushing’s syndrome (Rebuffé-Scrive et al, 1988), raised insulin and glucose 
concentrations (Krotkiewski et al, 1990), and increased intra-abdominal fat 
accumulation (Seidell et al, 1989a). All these studies found increased type 2h muscle 
fibres were associated with central fat distribution.
This chapter is a literatuie review which aims firstly to review existing studies on the 
development of overweight and fat distribution, skeletal structure, and muscle 
morphology, secondly to review the relationships between early nutrition and health in 
later life, and thirdly to seek evidence of early growth in relation to hody morphology, 
including weight, skeletal structure (height and limb lengths), and muscle composition.
1.2 Body fat, overweight and fat distribution: an overview
1.2.1 What is overweight?
Overweight implies an excessive fat storage in an expanded adipose tissue mass. There 
are many methods of measuring body fat, ranging from simple antlu'opometric to
complex computerised scamiing techniques. This issue will he considered in Chapter 3. 
Because of the ease of the measurements, body mass over the of height squaie (kg/m^), 
known as the Quetelet index (Quetelet, 1869) or body mass index (BMI), is a useful 
method for assessing the degree of overweight in epidemiological studies. BMI is now 
almost universally accepted as the measiue of body fatness, the range 20-25 is 
considered as desirable. These figures were derived from the relationships between BMI 
and mortality rates (Royal College of Physicians, 1991). Garrow (1981) further defined 
the ranges between 25-30 and 30-40 to indicate different grades of overweight.
In Western societies, the rising prevalence of overweight adults, whose BMI exceeds 30 
kg/m^, has now reached 15-20% (Gregory et al, 1990; Kuczmai'ski et al, 1994; Beimett 
et al, 1995; Seidell, 1995a). Overweight clearly relates to premature death (Lew and 
Garfmkle, 1989) and a cluster of morbidity such as NIDDM, cardiovascular disease 
(CVD), and certain cancers. Quality of life in such persons is surprisingly less 
established, in view of their increased risk of disability (Stewart et al, 1983; Launer et 
al, 1994). Overweight is now increasingly accepted as a disease per se, imposing 
enormous burdens on health care resources (Colditz, 1992; Office of Health Economics, 
1994; German Society for Obesity Research, 1995; Institute of Medicine, 1995; Levy et 
al, 1996; Seidell, 1995b; Sjostrom et al, 1995; Wolf and Colditz, 1996).
1.2.2 What causes overweight?
Weight gain (i.e. fat gain) occurs when energy intake exceeds energy expenditure. The 
energy balance cycle (Figure 1.2.1) consists of many variable components. Energy 
intake normally in the form of ingested foods, is influenced by appetite, i.e. palatability 
of the food, sight and smell, which are controlled by the satiety/hunger centre located in 
the hypothalamus. In Western societies, food supply is not a limiting factor, but some 
40% of all people consciously limit their food intake to control weight. Basal metabolic 
rate is the largest component of energy expenditure (-75%), influenced mainly by the 
proportion of lean body mass. Physical activity occupies on average about 15%, and 
thermo genesis about 10% of energy expenditure, foods, especially carbohydrate increase
thermo genesis tlii'ough dietary induced thermogenesis. Weight change results from 
changes in one or a combination of these components, which involves many factors in 
humans, making the task of identifying the aetiology of overweight extremely difficult. 
Genetics, environment, behaviour and medical conditions are some of major influencing 
factors. Although the presence of unlimited food, without the need for physical exertion 
to obtain it, promotes obesity, not everyone becomes overweight under those conditions. 
Differences between individuals in their tendency to weight gain are ultimately genetic, 
and genetic mechanisms may in principle operate through appetite, tluough power of 
restraint, or tlii’ough metabolic mechanisms. The genetic basis of most obesity in 
humans is polygenic, but some potential major genetic factors are the subject o f current 
research elsewhere. Recent epidemiological evidence suggests that early nutrition may 
play an important role in the development of overweight (Barker, 1992). This issue will 
be addressed in later sections of this chapter.
Obesity appears to run in families, though whether this reflects a genetic effect or is the 
consequence of a common family environment is unclear. Garn and Clark (1976) 
showed that the likelihood that a child will be obese is 40-50% if one parent is obese and 
70-80% if  both are ohese. Stunkard et al (1986) compared the similarities between 
related individuals who were exposed to different enviromnent and non-related 
individuals living together. They studied 540 Danish adult adoptees and both their 
biological and adopted parents. BMI of adopted children was observed to continue to 
resemble their biological parents, particularly for mothers and daughters, but there was 
no significant relationship with the adoptive parents.
Bouchard et al (1985) studied 917 subjects aged 8-26 years from more than 400 families 
to examine the roles of genetic and environmental influences on obesity and fat 
distribution. The sample included 80 pairs of adopted siblings, 95 pairs of cousins, 370 
pairs of biological siblings, 69 pairs of dizygotic twins and 87 pairs of monozygotic 
twins. Increasing similarity in fatness and fat distribution was observed between 
siblings, dizygotic and monozygotic twins, but none was detected between adopted
siblings. The greater heritahility between dizygotic twins than between siblings must be 
reflecting environmental factors, since their gene similarity (50%) is the same as in 
siblings, on the other hand, differences in intra-uterine growth of twins - even 
monozygotic twins, are well described, and this could affect later growth. Significant 
genetic (#fects were found for BMI, subcutaneous fat, fat distribution, body density and 
fat free mass. Similarities found between children and parents and between adoptive 
children and foster parents indicate an influence of enviromnental factors. Intraclass 
correlations for BMI and skinfold thicknesses were almost identical in the biological and 
adoptive families, but extremity/trunlc ratio and the proportion of total fat mass in 
subcutaneous sites were more closely correlated in natural than adoptive relations.
Further studies by Bouchard’s group (1988) used a path analysis technique in 1698 
French Canadians, including adoptive, biological, and twin relations to determine 
genetic and non-genetic familial influences. They found genetic transmission explained 
5-30% of total variance for total body fat and fat distribution, and familial environment 
explained transmission of 10-30%. The ratio of subcutaneous fat from six skinfold 
thicknesses to fat mass from underwater weighing explained 40% of total variance 
transmissible between generations, from which 25% was accounted for by genetic and 
15% by environmental factors, indicating fat distribution is accounted for by a large 
genetic component. Studies of overfeeding in twins by Foehlman et al (1986) and 
Bouchard et al (1990) suggest interactions between genetic and enviromnental factors in 
developing overweight.
1.2.3 Body fat distribution
Over the last ten years, fat patterning research in relation to health has re-emerged forty 
yeai’s since it was first suggested by Jean Vague (1947 & 1949). People with central fat 
distribution tend to have large proportion of body fat situated at the abdominal regions, 
accompanied hy a relative increase in fat mass deposited within the abdomen (Ashwell 
et al, 1985; Seidell et al, 1988). Increased abdominal fat has been observed to relate to 
high risk of developing ill health, acting independently from obesity.
People with central fat distribution in both sexes tend to have a distinct body shape, said 
to resemble that of an apple (Figure 1.2.2), a physical characteristic of men, so termed 
‘android’ by Vague, and tend to associate with metabolic abnormalities and chronic 
diseases (Vague, 1956; Kissebah et al, 1982; Lapidus et al, 1984; Larsson et al, 1984; 
Ohlson et al, 1985). There is also evidence suggesting central fat distribution is related 
to increased proportion of fast glycolytic muscle fibres (Krotkiewski et al, 1990), 
another masculine characteristic (Simoneau and Bouchard, 1989), and these people have 
been observed to have poor endurance but not poor strength in physical performance 
(Seidell et al, 1989a).
1.2.4 Regional fat cell metabolism
Studies of abdominal subcutaneous fat cells in subjects with central fat distribution 
showed a change in morphology with significant increase in eell volume, accompanied 
by an increase in androgenic/oestrogenic activity (Rebuffé-Scrive and Bjorntorp, 1985). 
Higher rate of basal and adrenaline-stimulated lipolysis was observed and these cells 
showed diminished sensitivity to antilipolytic action of insulin (Kissebah et al, 1986) 
and more responsive to lipolytic effect of catecholamines (Lafontan et al, 1985).
Increased central fat deposition relates specifically to an increase in intra-abdominal fat 
area on single computerised tomography (CT) scans (Ashwell et al, 1985; Seidell et al, 
1988). This intra-abdominal (visceral) adipose tissue which includes the omental fat 
mass, has been observed to have much greater lipolytic capacity than subcutaneous fat, 
and contains a similar concentration of the imier mitochondrial membrane uncoupling 
protein (32 Kd) to that in perirenal and periadrenal fat masses (Lean and Trayhurn, 
1987). This protein has been considered unique to the functionally distinct brown 
adipose tissue found in internal fat masses in humans, and its mRNA is detectable in 
insignificant amounts in subcutaneous fat (Riquier et al, 1984). More recently a variant 
uncoupling protein-2 has been identified in white adipose tissue.
Regulation of lipolysis probably depends on both insulin and catecholamines. Omental 
fat cells have been shown to be even less sensitive than abdominal subcutaneous fat cells 
to the antilipolytic effect of insulin (Bolinder et al, 1983). An increased lipolytic 
responsiveness to catecholamines was also observed in these cells. This may be related 
to a less pronounced adrenergic receptor response and a decrease in the ratio of 
receptor sites on these cell membrane (Lafontan et al, 1985). Changes in response to 
insulin and catecholamines may have effects on the increased mobilisation of free fatty 
acids (FFA) that drain at high levels directly into the portal vein (Rebuffé-Scrive and 
Bjorntorp, 1985), this may influence the insulin clearance by the liver (Smith, 1985). 
Diminished extraction and removal of insulin could be the result o f direct influence by 
androgens (Kissebah et al, 1982). Increased hepatic exposure to FFA reduces hepatic 
clearance of insulin that may lead to increased posthepatic insulin delivery and 
hyperinsulinaemia (Bjorntorp, 1991).
The associations between increased intra-abdominal fat mass and metabolic disorders, 
NIDDM and CVD may be explained if an increase in plasma FFA flux is indeed a 
feature of central fat deposition, which may evoke and/or exacerbate the metabolic 
disorders. FFA may inhibit peripheral glucose metabolism and reduce insulin sensitivity. 
This reduction correlated inversely with the amount of glucose metabolised by 
peripheral tissues. (Randle et al, 1963; Randle et al, 1964). Increased FFA probably 
contributes to insulin resistance more than to hyperinsulinaemia, and to eventual 
exhaustion of P-cells of the pancreas (DeFronzo, 1988). Increased hepatic availability of 
FFA could stimulate hepatic FFA estérification and increase synthesis of very low 
density lipoprotein, thus increasing plasma triglyceride concentration, leading to raised 
small dense LDL, which is highly atherogenic (Austin et al, 1990; Griffin et al, 1994). 
FFA may inhibit cholesterol esterifying capacity and thus decrease the acquisition of 
cholesterol by high density lipoprotein particle.
1.2.5 Methods of measuring body fat
Underwater weighing is the conventional ‘reference standard’ (Figure 1.2.3) for a two- 
compartment model, which measures body density from which fat and lean mass content 
are estimated assuming standard figures for density of these components (Siri, 1961). 
Other robust methods include the total body potassium method measuring intracellular 
fluid by detecting the natiual radioactive isotope (Boddy et al, 1972), and 
measurement of the total body water by dilution of a deuterium labelled water dose 
(Schoeller et al, 1980). The principles for these techniques are described in detail 
elsewhere (Brodie, 1980; Garrow, 1983; Shephard, 1991). More complicated multi­
compartment models of body composition including bone mass are under development.
For routine clinical and epidemiological use, simpler and cheaper antlnopometric 
measuiements have been used to predict body composition in relation to body density by 
imderwater weighing. Various combinations of anthropometric measurements have been 
used as independent variables. Shephard (1991) reviewed the extensive literature and 
found few truly practical antlnopometric approaches to predict body density or fat 
content. The most widely used method, that of Durnin and Womersley (1974) used the 
log 1 0 sum of four skinfolds measured at biceps, triceps, subscapular and suprailiac sites 
(Figure 1.2.4). Jackson and his colleagues (Jackson and Pollock, 1978; Jackson et al, 
1980) used the sum of tlrree or seven skinfolds in combination with waist and forearm 
circumferences or gluteal circumference, and age for generalised regression equations. 
These approaches have not been subjected to systematic validation in separate samples 
or populations. Recently, Deurenberg et al (1991) suggested that BMI with age and sex 
can predict body density with an accuracy similar to that of skinfold methods in a large 
sample of Dutch population. McNeill et al (1991) observed skinfold method to be as 
good as bio electrical impedance, body water dilution, and better than counting 
methods relating to underwater weighing in normal weight and overweight women. 
Reilly et al (1994) found the skinfold method (Durnin and Womersley, 1974) to 
underestimate body fat in small sample (#= 16) of 70 year old women.
1.2.6 Assessment of body fat distribution
The re-emergence of fat patterning studies was further advanced by the invention of the 
CT scanner. This approach enables scientists to ‘view directly’ the fat masses distributed 
over different sites in the body, and relate them to metabolic variables (Seidell et al, 
1989b). Due to a radiation exposure of 2 mSieverts/exposure (annual permitted exposure 
to X-rays in Britain is 5 mSieverts), X-ray CT use is limited in vivo. Only small numbers 
of volunteers have been studied by a few centres, with limited number of scans made. 
Abdominal (intra-abdominal and subcutaneous) fat areas calculated from CT scans were 
used to validate anthropometric indices of fat distribution such as ratios waist to hip 
(Ashwell et al, 1985) or waist to thigh (Seidell et al, 1988), and various body diameters 
(van der Kooy et al, 1993), and in a variety of clinical conditions (Lean, 1986).
Fat volumes estimated by thi'ee dimension reconstruction from adjacent scans may 
provide a more meaningfiil pictiue of fat distribution than cross-sectional areas. The use 
of magnetic resonance imaging (MRl) (Figure 1.2.5) is safer than CT scanning, thus 
more images can be made to calculate fat volumes in human subjects, and the procedure 
may be repeated on the same subject for observations of changes in body composition 
and fat distribution. McNeill et al (1991) showed a good agreement between total body 
fat calculated from the sum of fat volumes obtained by MRI and the established 
underwater weighing method in women. Sohlstrom et al (1993) used an MRI machine 
with low magnetic field strength (0.02 Tesla), and observed similarly good agreement 
with underwater weighing teclinique for estimating total body fat in Swedish women. 
Abate et al (1994) compared subcutaneous and intra-abdominal fat volumes estimated 
by MRI (0.35 Tesla), and the actual fat volumes dissected from three human cadavers, 
ineluding two males and a female showed the two methods only differed slightly (mean 
difference = 0.08 kg; 95% confidence interval = 0.01 to 0.15 kg). Potentially, MRI could 
be used as the ‘reference method’ for measuring body fat distribution and for validating 
anthropometric measures including waist and hip circumferences (Figure 1.2.6).
1.2.1 Legends of figures in chapter 1.2 
Figure 1.2.1. The energy balance cycle (page 11).
Figure 1.2.2. Silhouette photographs showing variation in body fat distribution in men 
(a & b) and in women (c & d). Subjects have similar body mass index, but the male (b) 
and female (d) patients with non-insulin dependent diabetes mellitus have higher waist 
to hip ratio, indicating a more centralised fat distribution (page 12).
Figure 1.2.3. Measuring total body density by underwater weighing to estimate body 
composition (page 13).
Figure 1.2.4. Common sites for measuring subcutaneous skinfold thicknesses to predict 
total body fat by underwater weighing (page 14).
Figure 1.2.5. Magnetic resonance imaging (MRI) machine for scanning body tissues 
(page 15).
Figure 1.2.6. Measuring body fat distribution using antlu'opometry according to the 
World Health Organisation (1995) standaid recommendation. Waist circumference 
between the lowest rib margin and top of the lateral iliac crest (a), and maximum hip 
circumference at the greater trochanters (b) (page 16).
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Figure 1.2.1. The energy balance cycle.
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Figure 1.2.2. Silhouette photographs showing variation in human body fat distribution.
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Figure 1.2.3. Measuring total body density by underwater weighing.
13
Figure 1.2.4. Measuring skinfold thicknesses using skinfold calipers.
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iFigure 1.2.5. Magnetic resonance imaging (MRI) machine for scanning body tissues.
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Figure 1.2.6. Assessing body fat distribution from body circumferences.
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1,3 Skeletal structure
1.3.1 A global view of the trends in height changes over time
Average height varies between countries, races, areas, and social classes etc. Like body 
weight or body fatness, genetic and environmental factors are thought to be the main 
determinants, but their relative contributions are not apparent. There exists a wide range 
of adult heights in various parts of Africa. Just 200 years ago, Norwegian men who are 
now amongst the tallest in the world were only as tall as the Buslimen’s present height 
(Eveleth and Tamier, 1976). Martorell and Habicht (1986) found that although there 
were height differences amongst the tallest boys in high social class from different 
countries, height differences between social classes within a country were much wider, 
particularly in countries where there is a huge gap between the rich and the poor. In 
India, the height gap between classes in the nineteen-eighties was similar to that existed 
in Britain over 150 years ago (Floud et al, 1990), reflected in the military recruits at 
Sandhurst (high social class) and Marine Society (low social class from the London 
Slums). Height differences between social classes have been narrowing steadily in 
Britain, but the gap is wider than that of many European countries. In general, there has 
been steady trends towards height increase over the past 100 yeai's in developed 
countries (Floud, 1990).
1.3.2 Nutritional status and height
Malnutrition or nutrition depletion through infection affects height growth during early 
development. Martorell and Habicht (1986) have shown that the length of children up to 
2 months old hom  developing countries is near' the 50th percentile of the growth chail, 
but begins to fall after that. Explanations for this trend may be that at the early stage, the 
child receives enough energy and anti-infective property from breast milk, but growth 
begins to fail if it continues to breast feed since energy from breast milk cannot 
adequately provide the growing child, or if the child begins to wean, there is a higher 
chance of contact with infected substances. Nutrition and health care clearly help infants 
grow better in developing countries.
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There is no direct evidence for height as a marker of nutritional status, but historical 
evidence has provided remarkable parallel trends in changes in height with various 
factors that can influence nutritional status. For example, the rapid gain in height of 
English working-class children coincides with the steep rises in life expectancy in 
England, wages, and consumers’ expenditure, all occurred around the same time at about 
1820-1850 (Floud et al, 1990).
1.3.3 Height and health
Height has long been used as an indicator of health. Army and police recruits must 
achieve a certain height for selection. Taller slaves were bought at a higher price as they 
were thought be stronger, thus more productive (Fogel, 1986). Subjects of short stature 
have been shown to have increased risk of premature death (Waaler, 1984), particularly 
in younger age groups, indicated by steeper gradients. Similar to body mass index 
(Andrés et al, 1985), the differences in mortality rates become less marked between 
groups in the elderly. A study of Fogel et al (1986) has shown that Union Army (United 
States) rejection rates due to poor health were higher in shorter subjects.
1.3.4 Limb lengths in relation to height
Whilst different body proportions exist between adults of different races (Reeves et al, 
1996), and that it has been suggested that growth failure in utero at different periods of 
pregnancy may result in altered body morphology (Bai'ker, 1994), evidence has 
indicated that improved standards of living with adequate nutrition has brought the body 
proportions of Japanese children nearer to the reference standards of the British (Tanner 
et al, 1982). Increase in height, or specifically leg length reflects improvement in health 
and growth (Tamier et al, 1982).
Early growth is clearly affected by imder feeding in experimental animals (McCance, 
1968). Disproportionate growth, e.g. longer or shorter legs than expected for height 
occurs with delayed puberty (Tanner, 1971), but associations with metabolic disorders 
are not described.
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1.4 Muscle morphology and function
1.4.1 Characteristics of muscie fibres
The primary function of the skeletal muscles is performing contractions. The muscle is 
not homogeneous. All human skeletal muscles have a mixture of muscle fibres. 
Different muscles contain different types of fibres in vaiying proportions, serving a wide 
range of demands. The content o f different fibre types associates closely with the speed, 
intensity, duration and types of contractions.
In terms of the speed of contractions, human muscle fibres are classified as type 1 (slow 
twitch), and type 2 (fast twitch). Based on histologic profile, type 2 (fast twitch) fibres 
are further subdivided into at least 2 different types, 2a and 2b (Brooke and Kaiser, 
1970). Based on their dynamic and metabolic behaviour, type 1 muscle fibres are known 
as slow oxidative, type 2a as fast oxidative-glycolytic and type 2b as fast glycolytic. 
Other muscle fibres have also been identified. Type 2c are thought to be transitional 
fibres between type 1 and 2. There may be ‘dormant’ stem cells which may function as 
replacement for damaged fibres (Jones and Round, 1990).
Type 1 muscle fibres have high oxidative capacity, with high mitochondrial and 
capillary densities and are red in appearance. Their major substrates are circulating FFA 
and intra-muscular glycogen, being utilised by the oxidative phosphorylation pathway. 
Type I muscle fibres are highly fatigue resistant at slow speed of contraction, such as 
postural maintenance during habitual activity.
In contrast to type 1, type 2b muscle fibres have low respiratory capacity and high 
glycolytic enzyme activity. They have low mitochondrial and capillary densities and 
appear white. The main substrate is muscle glycogen, used anaerobically (not dependent 
on oxygen) by the glycolytic pathway producing lactic acid. These muscle fibres can 
contract rapidly with very high power output for explosive activity, but they fatigue 
easily with an associated accumulation of lactic acid.
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Type 2a fibres are intermediate between type 1 and type 2b muscle fibres. They are high 
in both glycolytic and oxidative enzyme activities. These muscle fibres can perform fast 
contractions and relatively fatigue resistant, using glycogen as their main substrate with 
moderate amount of FFA.
There is a hierarchical recruitment of muscle fibres according to functional demands 
(Henneman, 1965). Type 1 muscle fibres are recruited at both low and high speed of 
contraction, whereas type 2 muscle fibres are relatively inactive at low speed and 
recruited when type 1 muscle fibres are fatigued or at high speed of contraction, such as 
in sudden bursts of action, and high workload.
The choice for fuel utilisation mainly depends on energy demands. More glycogen is 
used with increasing rate and intensity of workload, as energy is converted much faster 
from glycogen than FFA. Endurance training can have a glycogen sparing effect by 
increasing the capacity for FFA oxidation for a given workload. Other factors could also 
affect substrate preference include diet composition, substrate availability, and hormonal 
and enzymatic activities (Âstrand and Rodahl, 1986).
1.4.2 Muscle morphology: nature or nurture ?
On average, healthy subjects have about half and half of slow and fast twitch fibres in 
the commonly biopsied vastus lateralis, deltoid and gastronemius muscles, but the range 
of type 1 muscle fibres varies from 10% to 90% between individuals (Saltin and 
Gollnick, 1983). Athletes who specialise in ‘aerobic’ sports, such as marathon runners, 
tend to have high proportion of slow twitch (type 1) muscle fibres, while those who 
specialise in anaerobic sports, such as 100 m sprinters or weight lifters, tend to have 
high proportion of fast twitch (type 2a and 2b) muscle fibres (Âstrand and Rodalil, 1986; 
Fox et al, 1988).
It is unclear whether the difference of muscle composition between athletes engaging in 
different types of sport is primarily due to genetic or training effects. Howald (1982)
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suggested self selection for sports activities may exist in early life. Young people with 
predominant type 1 muscle fibres may be more physiologically suited, and so attracted 
to endurance sports, while those with higher type 2 fast twitch fibres prefer sprinting 
events. Komi et al (1977) showed monozygotic twins have more similar proportion of 
slow twitch type 1 muscle fibres than dizygotic twins in the vastus lateralis, with 
estimated heritability of 99.5% in males and 92.2% in females. Trained athletes 
including cyclists, canoeists, rumiers, weight lifters had similar proportion of muscle 
fibres in the vastus lateralis (leg) as the deltoid (upper body), whereas enzyme activities 
were higher in muscles associated with frequent use (Gollnick et al, 1972).
Studies of physical training have shown conflicting results as to whether training can 
have an effect on muscle fibres transformation (Andersen and Henriksson, 1977, Saltin 
et al, 1968). Endurance training is associated with increased aerobic capacity of the 
muscle, such as increased capillary (Andersen and Heniiksson, 1977) and mitochondrial 
proliferation, accompanied by increased oxidative enzyme activities (Heniiksson and 
Reitman, 1977). These results do suggest some capacity towards a greater functional 
similarity to type 1 muscle fibres.
Decreased physical demands tend to shift muscles towards type 2 muscle fibre 
characteristics. Animals with spinal cord section, where the muscles are inactive and 
relieved from all neural influence, have most of their type 1 muscle fibres transformed to 
type 2b (Salmons and Vrbova, 1969). Paraplegic patients have high proportion of type 2 
muscle fibres (almost 100%) in their paralysed lower limbs, whereas their unaffected 
upper limbs have similar proportions of fibre types to healthy subjects (Grimby et al, 
1978). Detraining in an Olympic cross country skier due to injuries decreased his type 1 
muscle fibres from 81% to 57% (cited by Howald, 1982). Similarly, Howald (1982) 
reported a decrease in type 1 muscle fibres from 73% to 69%, and an increase in type 2 
muscle fibres in a long distance runner who reduced his training intensity due to health 
problems for 6 months, from 100 km/week to 40 km/week. Wlien the intensity increased 
to 110 km/week, type 1 muscle fibres increased to 77% with a corresponding decrease in
2 1
type 2 muscle fibres. Patients who had knee surgery also reduced their type 1 muscle 
fibres in just 5 weeks (Haggmark et al, 1981).
1.4.3 Electrical stimulation and muscle morphology
Almost by chance, Buller et al (1960) discovered that when the nerves of fast twitch, 
white muscle (flexor digitorum longus) and slow twitch red muscle (soleus) of cats were 
crossed over, after a period of time, the speed of contraction of the fast twitch white 
muscle became slower and this muscle became red in appearance resembling that of the 
slow twitch red muscle. Similarly, the slow twitch red muscle fibres became faster and 
whiter. These workers ruled out the influence of neural impulse, and postulated that the 
transformation was induced by a chemical substance from the supplying nerve.
Severing of the tendon (tenotomy) of the slow twitch soleus muscle from the bone 
Vrobova (1963) or immobilising the limbs (Fischbach and Robbins, 1969) has the effect 
of increasing the speed of contraction of the slow twitch soleus muscle. The change to 
fast speed could be prevented by low frequency electrical stimulation (5 or 10 Hz), but 
not by higher frequencies (20 or 40 Hz) within 3 weeks (Salmons and Vrobova, 1969). 
Later, it was shown in rabbits that after cross innervation, the slow twitch red muscle 
(soleus) which was supplied by the nerve originally from the fast twitch white muscle 
(extensor digitorum longus) acquired the physiological and biochemical characteristics 
similar to the fast twitch white muscle, and this transformation could be prevented by 
electrical stimulation to the supplying nerve at low frequency (10 Hz) in 8 weeks 
(Salmons and Sréter, 1976). These observations demonstrated that muscle 
transformation was probably independent of any chemical substance released from the 
serving nerve suggested by Buller et al (1960), and that muscle fibre characteristics are 
greatly influenced by the patterns of neural impulse and duration of stimulation. The 
transformation is reversible, Sréter et al (1975) have shown the initial rabbit fast twitch 
white muscles became red slow twitch muscles as a result of low frequency electrical 
stimulation, regained their former characteristics when the stimulus was removed.
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1.4.4 Ageing and muscle morphology
Histological evidence of muscle specimens from the elderly at autopsy often shows 
areas of fibre type grouping, i.e. the whole fascicle containing only type 1 muscle fibres 
(Jones and Round, 1990), suggesting that all adjacent fibres are re-imieiwated by one 
type of motor neuron, and the there is probably an increase in size of the motor unit (an 
increase in the number of fibres innervated by each nerve). As a consequence, fine motor 
control in the elderly is diminished, resulting in shaking of the hands and fingers etc.
1.4.5 Muscle morphology and metabolic disorders
Bonen et al {\9S \) have shown predominant type 1, slow twitch red muscle (soleus) of 
rats are more sensitive to insulin than white, fast twitch muscles (plantaris and extensor 
digitorum longus). Single animal type 1 muscle fibres are more sensitive to insulin than 
type 2 muscle fibres (Bisenburg, 1983; Hom and Goodlier, 1984). In non-diabetic men, 
increased proportion of type 1 muscle fibres and capillary density aie associated with 
higher insulin sensitivity (Lillioja et al, 1987).
Before puberty, boys and girls (6 years old) have been shown to have higher proportion 
of type 1 muscle fibres than adults (Bell et al, 1980). Men tend to have higher 
proportion of type 2 muscle fibres than women (Simoneau et al, 1989). Wade et al 
(1990) have observed that compared to leaner subjects, overweight subjects have lower 
proportion of type 1 muscle fibres and they oxidised less FFA during aerobic exercise. 
Subjects with central fat distribution and those with NIDDM have been shown to 
associate with increased proportion of fast twitch type 2 white fibres and decreased 
capillary density (Lillioja et al, 1987; Marin et al, 1994). Holmang and co-workers have 
shown strong relationships between different hormones and muscle morphology and 
function. Excess cortisol (Holmang et al, 1992a) and testosterone (Holmang et al, 
1992b) in female rats have been shown to shift the muscle towards type 2 muscle fibres 
and reduce capillary density with diminished sensitivity to insulin. Rats made 
hyperinsulinaemic by implantation of osmotic mini-pump increased the proportion of 
type 2 muscle fibres in 7 days, but in contrast to cortisol and testosterone, capillary
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density and insulin sensitivity were increased in all fibre types (Holmang et al, 1993). 
These workers suggested that capillary density (blood supply) is important for 
determining insulin sensitivity, and that muscle composition may be a consequence 
rather than a cause of hyperinsulinaemia. In humans, hyperinsulinaemia have also been 
observed to strongly associate with increased capillary density in all muscle fibres, 
especially around type 2b muscle fibres (Eriksson et al, 1994) in prediabetic men: These 
subjects had impaired glucose tolerance and after 15 yeai's, developed NIDDM. 
Oestrogen causes a decrease in rat muscle fibre diameter (Suzuki et al, 1985). Lithell et 
al (1981) have observed high correlations between serum insulin {r = 0.87, P <0.001) 
and blood glucose (r = 0.51, P  <0,05) with muscle fibres area/capillary ratio.
Physical activity can protect against development of NIDDM (Manson et al, 1991), 
cardiovascular disease (Morris et al, 1953a & b; Faffenbager et al, 1970), and increase 
life expectancy of IDDM (Moy et al, 1993). NIDDM has an important genetic 
component. The muscle fibre type of children of NIDDM parents has not been examined 
previously. However NIDDM is associated with a relative lack of exercise, which itself 
may favour a shift of metabolic activity towards type 2 muscle fibres.
Cross-sectional studies have found associations between type 2b muscle fibres and 
features of metabolic syndrome X (Lillioja et al, 1987; Lillioja & Bogardus, 1988; 
Rebuffé-Scrive et al, 1988; Krotkiewski et al, 1990; Marin et al, 1994).
1 A. 8 Other effects on muscle morphology
Increased oxygen supply to muscle is probably a feature of endurance training, 
associated with type 1 muscle fibre predominance. It seems possible that hypoxia, e.g. 
smoking, vascular disease, and sleep apnea could lead to an adaptive response of the 
muscle towards characteristics of type 2, glycolytic muscle fibres.
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1.5 Evidence linking early malnutrition and altered body morphology
Barker and colleague’s studies centred on the relationships between early development 
and metabolic disorders in later life. Although Barker (1994) mentioned the importance 
of the skeletal muscle and body morphology in describing the ‘tlorifty phenotype’ and 
‘programming’ hypotheses, it is surprising that there has been only one published study 
on body fat distribution in relation to early growth in men by Barker’s group (Law et al, 
1992), we have since performed similar studies on women (Han, 1994; Han et al, 
1995a).
We have found only one study by Barker’s group on skeletal structure (height) in 
relation to early growth and metabolic diseases (Barker et al, 1990). Development of 
stature has previous been examined in detail by many studies, notably those of Tamier 
(1989). Floud et al (1990) have gathered a huge amount of historical evidence of the 
influence of nutrition on height development.
1.5.1 Birth weight and body fat distribution
In a large retrospective study of men born in Hertfordshire {n = 845) and Preston (n ^  
239), Law et al (1992) have shown the men’s current waist to hip ratio significantly (P 
<0.05) increased with low birth weight, and low birth weight relative to placental 
weight, adjusted for BMI. We have performed similar analysis on 46 women and shown 
that low birth weight was associated with large waist circumference (Han et al, 1995a), 
indicating increased intra-abdominal fat mass deposition (Flan et al, 1995b). In the same 
study of the women, low birth weight was also associated with a tendency for elevated 
blood pressure and heart rate, indicating poor cardiovascular function (Han et al, 1996a). 
Valdez et al {\99 \)  found an inverse relationship between birth weight and the ratio of 
sub scapular' to triceps skinfold thickness rather than with waist to hips ratio.
1.5.2 Early nutrition and the development of body stature
The main factors affecting height growth have been identified as low social class, lower 
birth order, low mother’s height, lai’ge numher of siblings, low birth weight, young
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mother (<25 years), and heavy smoking mother during pregnancy (Floud et al, 1990). 
Amongst these factors, birth weight appears to have a big influence on height. Martorell 
and Habicht (1986) have emphasised the limiting factor of early growth in the 
development of body statur e as, “After early childhood, it is rare for the rate of growth 
to be fast enough for children to regain the centile position in height which they had in 
early infancy, and this period of restricted growth therefore leaves a permanent legacy: 
(1) growth impairment during the first few years of life largely determines the small 
stature exhibited by adults from developing countries; and (2) with a malnourished 
population, those who exliibit a greater degree of stunting as young children are those 
who are the shortest as adults.”
Boyd OrT (1928) was probably the first to note the importairce of early nutrition on body 
development. Children aged between 5-14 years were given milk or biscuits of the same 
calories in addition to their school diet. After seven months, those who received either 
fresh or skimmed milk grew 20% taller than control group (without supplements), while 
those who had biscuits as supplements did not differ from control group. This study 
showed the importance of protein in body development of children, which led to 
subsequent guidelines for growth improvement in children (FAO/WHO/UNU, 1985).
1.6 Relationships between early nutrition and health in later life
So far in the review, only genetic and environmental factors have been considered as 
determinants of body morphology and diseases. The past ten years saw Barker and 
colleagues (1992 & 1994) produce a host of evidence showing striking relationships 
between poor early growth and metabolic disorders in later life. Two hypotheses, the 
Tlirifty phenotype’ and ‘programming’, were used to describe these relationships to 
suggest that early exposure to adverse conditions, including fetal malnutrition as 
reflected by low birth weight, or perinatal nutrition depletion (infection), as reflected by 
infant weight and mortality rates at the time the subjects were born, may predispose 
subjects to higher susceptibility to develop chronic diseases including bronchitis, 
ischaemic heart disease and NIDDM.
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1.6.1 The 'thrifty phenotype’ hypothesis
In describing the associations between body size at birth and impaired glucose tolerance 
in later life, Barker has suggested that, poor nutrition in fetal and early life is 
detrimental to the development and fiinction of the (3 cells of the islets of Langerhans, 
and changes in tissues, primarily muscle, which respond to insulin production or in the 
sensitivity of the tissues to it disposes to the development of NIDDM; adult influences, 
including obesity, ageing, and physical inactivity, determine the time of onset and 
severity of the disease.
According to the ‘tlirifty phenotype’ hypothesis, NIDDM is the outcome of the 
undernourished fetus and infant having developing with some reduction in size and/or 
function o f vital organs, including the endocrine pancreas. For as long as the individual 
remains undernourished, its limited glucose-insulin metabolism is adequate. A move to 
over- or good nutrition with expansion of adipose tissue mass, however, exposes the 
deficiencies in (3 cell function, and tissue sensitivity to insulin action, impaired 
carbohydrate tolerance and diabetes results.”
1.6.2 The ‘programming’ hypothesis
Lucas (1991) proposed the ‘programming’ hypothesis to suggest that a stimulus or insult 
at a critical period of development has lasting or lifelong significance, has led to 
Barker’s (1994) arguments that, “...undernutrition in utero and during infancy 
permanently changes the body’s structure, physiology, and metabolism, and leads to 
coronary heart disease and stroke in adult life. Four underlying principles of the 
‘programming’ were established based on animal studies. First, undernutrition in eai'ly 
life has permanent effects. Second, undernutrition has different effects at different times 
in early life. Third, rapidly growing fetuses and neonates are more vulnerable to 
undernutrition. Fourth, the permanent effects of undernutrition include reduced cell 
numbers, altered organ structure, and resetting of hormonal axes.”
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2.1 Aims, hypotheses and selection of research questions
The present thesis aimed to achieve four major objectives in the study of components of 
body morphology (adiposity, skeletal structure, muscle composition) and related 
metabolic disorders.
1. Firstly to develop simple scientifically valid and practical methods for assessing 
specific components of body morphology.
2. Secondly to establish the relationships between measures of body morphology and a 
range of metabolic disorders and ill health.
3. Thirdly to study some determinants of body morphology and related metabolic 
disorders.
4. Subsequently, the findings on the implications of altered body morphology on 
health risks were applied towards health promotion, to devise elements for strategies 
directed at general public.
• The following hypotheses and research questions were postulated and tested to 
achieve the main objectives listed above.
2.1.1 Development of simple and practical methods for assessing body 
morphology
Existing evidence prior to the present thesis
The current increasing trends in prevalence of overweight and the lack progress 
prevention and treatment of this ‘disease’ are probably due both to the lack of public 
awareness of health risks associated with overweight, and the lack of readily available 
methods for health professionals to assess both body composition and adverse fat 
distribution, combined with unattainable and inappropriate targets for management.
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Hypothesis
A novel simple anthi'opometric measure can be validated for identifying those with 
excess fat or adverse fat distribution.
Research questions
Are existing methods of measuring body morphology satisfactory in terms of accuracy 
and practicality?
Can a better novel method be derived to reflect central fat and total adiposity?
2.1.2 Relationships between body morphology and metabolic disorders
Existing evidence prior to the present thesis
Waist circumference is amongst a variety of different antlnopometric indicators o f intra­
abdominal fat. Excessive intra-abdominal fat accumulation is associated with increased 
metabolic risks. Body composition studies using scanning teclmique have identified the 
waist circumference as its proxy.
Hypothesis
Waist circumference identifies those at increased health risk.
Research question
How well does waist circumference relate to metabolic disorders compared to the 
existing methods of body mass index and waist to hip ratio?
2.1.3 Some determinants of body morphology and metabolic disorders
Existing evidence prior to the present thesis
Animal studies have shown diet imbalance during early growth can affect skeletal 
structure.
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Cross-sectional studies have found associations between type 2b muscle fibres and 
features of metabolic syndrome X. Athletes who are specialised in power sports tend to 
have type 2b muscle fibre predominance. Further, according to the ‘tlnifty phenotype' 
hypothesis used to explain the relationships between early growth and metabolic 
disorders, muscle morphology may also be affected by early growth. It is possible that 
there may be many more hierarchical steps to sustain growth of more vital organs, e.g. 
the nervous system, visceral organs and musculoskeletal system in that order. In the 
present studies, it is hypothesised that the musculoskeletal system may be one of the first 
body organs to be ‘sacrificed’.
Hypotheses
People with limb lengths longer or shorter than expected, which may reflect interrupted 
early growth, are more at risk of metabolic disorders in later life.
People with a natural ability in power sports (a presumed marker of type 2 muscle 
fibres) more likely to develop metabolic disorders than those with a natural ability in 
endui’ance sports (a presumed marker for type 1 muscle fibres) in later life, and low birth 
weight influences their relationship.
Research questions
Does disproportionate stature (limb lengths relative to height) associate with health 
hazards?
Is the musculoskeletal system affected by low birth weight, contributing to altered body 
functional capacity in adult life?
Do individuals with declared natural ability in power sports suffer higher rate of 
coronary heart disease?
31
2.1.4 Implications of altered body morphology on health risks appiied towards 
health promotion
Existing evidence prior to the present thesis
Failure to check increase in obesity urges the need for the use of the simple 
measurement of waist circumference for assessing health risk, directed at the general 
population.
Hypothesis
Self measurement of waist circumference is a robust guide to the need for weight 
management.
Research questions
Is self-reported waist circumference reliable?
Does a patent ‘Waist Watcher’ tape measure improve self-measurement?
2.2 Rationale for selection of study designs and methods for the 
present thesis
To be able to address the hypotheses satisfactorily in the present thesis, a wide range of 
multi-disciplinary approaches was employed, including cross-sectional and longitudinal 
laboratory based studies of physical measures, epidemiological studies of 
antlu'opometric and biochemical variables, and retrospective questioimaire studies based 
on reported information. Details of methodologies will be described in each chapter.
To answer all the research questions, a large database was needed, which was not 
available locally. The epidemiological studies were made possible tlirough international 
collaboration with the ongoing MORGEN (Bilthoven, The Netherlands) and WHO 
MONICA (Glasgow, Scotland) projects. The study of waist reduction and 
cardiovascular risk factors employed data collected in the Aberdeen follow up study of 
weight loss (Lean et al, 1997). In all these cases, raw data had been collected by
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collaborating researchers, but the analysis were novel and originated from the need to 
answer hypotheses in the present thesis.
The hypothesis that those with predominant type 2b muscle fibre proportions might be 
more likely to develop metabolic disorders could not be tested directly, as it would 
require muscle biopsies and a long term follow up. Instead, a retrospective study was 
designed using natural ability in sporting performance as presumed marker for muscle 
composition, relying on the findings of associations of type 1 and type 2 muscle fibre 
predominance with endurance and power athletes respectively (Âstrand and Rodahl, 
1986), to relate to cardiovascular disorders. The subjects recruitment was conducted in 
collaboration with the Army School of Physical Training (Aldershot, England) in order 
to maintain anonymity of the former soldiers.
In a cross-sectional study, 1189 subjects were recruited specifically in Glasgow, to 
investigate the associations of altered body proportion in adults (used as presumed 
makers for the effects of poor nutrition at different time of early intra-uterine growth) to 
relate to coronary heart disease and predisposing risk factors.
2.3 Statistical considerations for experimental designs in research
Starting a research study requires cai'eful plans in experimental design to recognise and 
minimise potential error and bias, in order to infer correctly and interpret the results with 
confidence. This section addresses some of the fundamental considerations for the 
development of protocols for scientific studies, and then relates these issues to the work 
in the present thesis.
2.3.1. Measurement error
The reason for recruiting more than one subject in experiments is that there will be 
differences between individuals for any measurable characteristic, or response to an 
intervention, and all measurements have a range of error attached. Measurement error 
can be minimised by increasing precision to reduce random error, which includes
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sampling error. The primary way to reduce random errors is by increasing sample size. 
Another way of minimising random error is by increasing validity to reduce systematic 
error: inferences to actual subjects in the study (internal validity) and to subjects outside 
the study (external validity). With respect to internal validity, selection bias, information 
bias and confounding play a role.
Subject selection
Methods of subject recruitment depend on the questions asked to test the hypothesis 
raised, and the distribution and variability of variable of interest. In practice, we are 
normally limited to subjects who are easily available to us. This may have an effect on 
the outcome of the experiment. The lower the variability between the subjects is, the 
better chance we have of detecting a ti'eatment difference if it exists. Although it is 
helpful to restrict to a paiticular subset for uniformity, it may lead to difficulties, for 
example a treatment may be effective in one group, but not in others. When human 
subjects are involved, study design becomes important for ethical reasons to avoid 
wasting time, resources and goodwill in projects based on inappropriate aims or 
methods.
Random Sampling
Random sampling is required to ensure the subjects ai*e representative of the population, 
to eliminate biases such as volunteer bias. There are several methods for sampling 
including the simple random sampling from a table of random sampling numbers (Fisher 
and Yates, 1974) which will be representative provided it is large enough. Stratified 
random sampling in sections of populations uses identifiable categories such as age, sex, 
race, geographic area, demographic and lifestyle factors, to ensure that the sample 
represents these aspects within the general population.
It has to be recognised that volunteer subjects may have some unusual qualities such that 
they are not entirely representative of the general population.
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Sample size
The larger the sample size, the closer it reflects the ‘true’ population (Kline, 1954), but 
limits must be set in most laboratory based experiments due to the time and the costs. 
Excessive sample sizes also expose unnecessary numbers of subjects to the research and 
thus become unethical. To obtain a minimum sample size for a study, the statistical 
power must be set, and the number calculated for determining the differences that the 
study aims to detect or exclude. This calculation requires some estimate o f the 
variability in measurement of the variable of interest, either tlirough experience or pilot 
tests. The sample size therefore depends on the standard error of the variable to be 
estimated including biological variability, measurement error and random errors (Kahn 
and Sempos, 1989). In human studies, the size of the sample recruited must allow for the 
potential rates of response and drop out. In practice, original research often addresses 
topics where in formation necessary for a formal power estimation is not available, and 
reasonable assumption have to be made.
Controls
Controls are required to eliminate the influence of as many confounding factors as 
possible. A common method used in cross-sectional research is matched pair control. 
For intervention studies, treatment and control group recruited from the same population 
should be randomly allocated. A cross-over design is often used in longitudinal studies 
being highly economical in numbers of subjects, but parallel control method avoids the 
need for a washout period and carry-over effects, and it also reduces problems related to 
subject fatigue. Studies using controls allow better assessment of the effectiveness of 
treatment on the variable of interest. There are several ways of designing controls. One 
way is just not to give the treatment to the control subjects, the other is to give them a 
placebo treatment (e.g. a dummy pill) so that the ‘placebo effects’, in which the potential 
response from the physical appearance or taste etc. of taking the pill, can be eliminated, 
and so the ‘true effect’ of the treatment can be obtained.
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An internal control group, e.g. bottom tertile of a variable can be used as the reference 
group to look for explanatory factors in a high tertile group. To avoid bias from post hoc 
stratification of the sample, this type of analysis needs to be plaimed in advance.
Repeatability, accuracy and precision
The results of a study must be reproducible within reasonable limits of errors. Factors 
within this are that the method of measurements should be accui'ate and precise. The 
accuracy of a method is a function of its ability to yield results that are close to the true 
value. An accurate result provides specific and unbiased results. The precision of a 
method is related to its ability to provide the same result every time. A precise method 
yields small ‘spread’ of observed repeated measurements made on one specimen. A 
precise (highly repeatable) method is not necessarily accurate (close to the true 
measurement). To assess the validity, the results must be tested in an independent 
sample, and cross-validated to assess for potential biological bias. The Bland and 
Altman (1986) method offers a useful way to compare two methods by assessing 
accui'acy and bias.
2.3.2 Sensitivity, specificity, and predictive values
A  good method used to screen subjects with a particular health risk would ideally have 
high sensitivity and specificity. High sensitivity conectly identifies most people with the 
disease, and high specificity correctly identifies most people without the disease. 
Because no test is perfect, and the distributions of sensitivity and specificity normally 
overlap each other in disease and non-disease populations, the two tests cannot both 
reach 100% at a single point. Receiver operating characteristic (ROC) analysis can be 
used to identify the level where maximum mean value of sensitivity plus specificity 
occurs. The level can be defined based on the trade-offs between misclassification and 
resources etc, A screening test should be cheap and simple, relatively non-invasive, 
provides acceptable sensitivity and specificity, used where screening has practical value. 
Values of positive prediction (percentage of positive results that are true positive) and 
negative prediction (percentage of negative results that are true negative) test results aie
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used to assess the diagnostic value of the results of the tests. A test with high sensitivity 
may yield low positive prediction if the prevalence of the disease of interest is low.
2.4 Study designs in the present thesis
Cross-sectional population survey
In the MORGEN study, a stratified random sampling method was used to recruit 
subjects, by sampling randomly from civil registries from Amsterdam, Maastricht, and 
Doetinchem. To obtain similar numbers of subjects at each age, the recruitment was 
stratified by sex and five year age group. The numbers were planned to be analysed by 
tertiles, but not large enough to be divided by quintiles for most outcome variables. 
Longitudinal follow up is underway, but was not available for analysis in the present 
thesis. When the prevalence of outcome variable increases, analysis in smaller groups 
(e.g. quintiles) will be possible.
In the body composition studies, an opportunistic approach was used to select volunteers 
to match the general population profile (Gregory et al, 1990; Bennett et al, 1995) in 
terms of age, sex, height, weight and fat distribution. Using this approach, the risks of 
bias from a non-randomised recruitment are reduced when the range and distribution of 
variables of interest match those in a random sample.
Retrospective follow up study
In the study of early natural sporting ability in relation to metabolic disorders in later life 
in former British soldiers, subjects were selected as a population of interest because of 
their probable relative homogeneity in terms of health, fitness, dietary and other lifestyle 
behaviours at the same age. Subjects were surveyed using postal questionnaires to 
determine to recalled determinants. The numbers of subjects recruited were based on a 
pilot study to determine the response rate and the incidence of the disease of interest. It 
was considered that recall bias in birth weight, medical history, and natural ability in 
sport type would be unlikely to confound analysis by explanatory variables of interest.
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Diet intervention
A  randomised cross-over design was used in a study of overweight volunteers in the 
study of waist reduction and improvement in cardiovascular risk factors. All subjects 
were treated with moderately low calorie diets, with one group receiving high, and the 
other low proportion of energy from cai'bohydrate for tlii'ee months. Each subject group 
receiving the alternative diet for a second tliree month period. The numbers of subjects 
and statistical power to detect the differences were determined prior to the trial. The 
main sources of bias may come from the volunteers’ self interest in weight loss studies 
and expectation of the diets.
Follow up study
In the study of the effectiveness of the Waist Watcher tape measure in weight 
management, one group of subjects received the tape and dietary and exercise 
recommendations, and the other, serving as control, received nothing. Subjects were 
recruited by stratified random sampling from a random sample of 1800 subjects who 
participated in the MONICA 4 project one year previously, based on age, sex, and waist 
circumference. Quota sampling method was used in order to assign approximately equal 
number in each cell.
2.5 Statistical methods applied in data analyses in the present thesis
In the present thesis, a variety of statistical methods were employed to analyse the data, 
with the aid of computer software including SPSS (Version 6, Chicago, USA) and SAS 
(version 6.1, Cary, USA). Specific statistical handling is described in each section.
Data summary and presentation
Information of data collected was examined by calculating numbers from the data 
(statistics). There were three types of data; qualitative data, e.g. sex, discrete quantitative 
data, e.g. number of people in a household, and continuous quantitative data, e.g. 
weight. Data were summarised to examine the frequency distributions. The average of 
the sample was presented as mean, and the measures of dispersion were presented as
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standard deviation and range. The summary extracted from the data were presented in 
the form of tables and graphs to convey information.
Measures o f  association
The present thesis used (multiple) linear regression, for continuous dependent variables, 
and (multiple) logistic regression analyses, for dichotomous dependent variables, to 
determine the associations between variables, presented as regression coefficients and 
odds ratios, respectively. Standard error and 95% confidence interval of the samples 
were calculated to determine the precision of the estimates of the populations from 
which they were drawn. Analyses of residuals from multiple linear regression were used 
to determine the relative contribution of individual variables which correlated closely to 
each other, e.g. body mass index, waist circumference and hip circumference.
Comparing data
Differences between groups were compared using chi-square tests, and t-tests. Where 
two methods of measurements were being compared, an adopted Bland and Altman
(1986) method was used to estimate the magnitude of errors and biases at extreme ends 
of measurements, and to examine systematic differences between methods. These 
differences were plotted against factors such as age and other biological measurements 
to examine possible bias.
Sensitivity and specificity, and predictive values
The sensitivities and specificities were calculated to evaluate the performance of the test 
methods to identify the number of subjects with health risks, and those without a risk. 
The positive and negative prediction values were calculated to assess the results of the 
tests. Analyses of receiver operating characteristics (ROC) were performed to determine 
an ‘optimal’ cut-off point that identified the maximum numbers of those with risk 
(sensitivity) and the maximum numbers of those without a risk (specificity).
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3.1
PREDICTING BODY COMPOSITION BY BODY DENSITY FROM 
SIMPLE ANTHROPOMETRIC MEASUREMENTS
This section has been peer reviewed and has been published as
Lean MEJ, Han TS. Deurenberg P. Predicting body composition by 
densitometry from simple anthropometric measurements. American Journai of 
Clinical Nutrition 1996; 63:4-14.
41
ABSTRACT
New equations have been developed to predict body fat (percent BF) calculated from 
body density measured by underwater weighing from simple anthropometric 
measurements, using stepwise multiple regression analysis in 63 men and 84 women. 
Logio sum of 4 skinfold tliicknesses explained 80.1% (SE = 3.8) of variance of percent 
BF in men and 76.4% (SE = 4.6) in women. Alternative equations using limb lengths 
instead of height may be valuable for epidemiological and clinical work, with particular 
advantages for the very overweight and the chair- or bed-bound for whom no previous 
predictive equations existed. Five equations combining triceps skinfold thickness with 
other antlrropometric measurements explained >80% (men) and 77% (women) of 
vai'iance. The most powerful prediction was from waist circumference and triceps 
skinfold thickness, which explained 86.6% (SE = 3.2) of variance of percent BF in men 
and 79.0% (SE = 4.0) in women. Percent BF for men = 0.353 x waist (cm) + 0.756 
triceps (mm) + 0.235 x age (years) - 26.4; for women = 0.232 x waist (cm) + 0.657 x 
triceps (mm) + 0.215 x age (years) - 5.5. The equations were tested in a sepai'ately 
studied validation sample of 146 men and 238 women aged 18-83 years. Skinfold 
thickness measurements continued to give good predictions of mean body density, but 
with significant bias at extremes of body fat and of age. The most robust prediction with 
least bias was from waist circumference adjusted for age. Percent BF for men = 0.567 x 
waist (cm) + 0.101 x age (year’s) - 31.8; and for women = 0.439 x waist (cm) + 0.221 x 
age (years) - 9.4.
Keywords: antliropometry, body composition, body mass index, fat distribution
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INTRODUCTION
Many techniques have been developed to assess body composition in humans. Direct 
measui'ement by chemical analysis, either by macroscopic dissection or by lipid 
extraction is of limited value as it cannot be done in vivo. The conventional standard is 
underwater weighing (UWW) for a two-compartment model, which measures body 
density from which fat and lean mass content are estimated assuming standard figures 
for density of these components (Siri, 1961). Other robust methods include the total 
body potassium method, measuring intracellular fluid by detecting the natural 
radioactive isotope (Boddy et al, 1972), and measurement of the total body water by 
dilution of a deuterium-labelled water dose (Schoeller, 1980). The principles for these 
techniques are described in detail by Brodie (1980), Garrow (1983), Gibson (1990) and 
Shephard (1991). More complicated multi-compailment models of body composition 
including bone mass are under development.
For routine clinical and epidemiological use, simpler and cheaper anthropometric 
measurements have been used to predict body composition in relation to body density by 
UWW. Various combinations of antliropometric measurements have been used as 
independent variables. Shephard (1991) reviewed the extensive literature and found few 
truly practical anthi'opometric approaches to predict hody density or fat content. The 
most widely used method, that o f Durnin and Womersley (1974) used the log sum of 
four skinfold thicknesses to develop regression equations for males and females of 
different age groups. Jackson and Pollock (1978) and Jackson et al (1980) used the sum 
of three or seven skinfold thiclmesses in combination with waist and forearm 
circumferences or gluteal circumference and age for generalised regression equations. 
These approaches have not been subjected to systematic validation in separate samples 
or populations. Recently, Deurenberg et al (1991) suggested that body mass index 
(BMI) with age and sex can predict body density with an accuracy similar to that of 
skinfold methods in a large sample of Dutch population. McNeill et al (1991) observed 
skinfold-thiclmess method to be as good as bioelectrical impedance, body water dilution, 
and better than counting methods relating to UWW in lean and overweight groups
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of women. Reilly et al (1994) found the skinfold-thickness method to underestimate 
body fat in small sample (« = 16) of 65-79 year old women.
The present study was designed to develop regression equations from different 
combinations of simple anthi'opometric measurements, age, and sex to obtain the best 
equations to predict body density from UWW. Recognising possible errors from the 
influence of fat distribution on prediction of body composition (Lean and Mann, 1991) 
from the conventional skinfold-thickness method of Durnin and Womersley (1974), we 
included waist and hip circumferential measurements, because waist (Han et al, 1995a; 
Pouliot et al, 1994; Ross et al, 1992; Ross et al, 1993; Seidell et al, 1989) or waist to hip 
ratio (Han et al, 1995a; Pouliot et al, 1994) has been found to correlate with the ratio of 
visceral to subcutaneous fat. Alternative methods were considered for very obese 
subjects, i.e. BMI >37 kg/m^, whose skinfold thicknesses exceed the size of the calipers, 
or where the use of skinfolds is inconvenient or unacceptable, and arm span and lower 
leg length were considered for subjects whose height cannot he measured. The equations 
developed were then tested in a validation study employing a large data set obtained in a 
different population.
METHODS
1. Determination study (Glasgow)
Subjects and recruitment
Ethical approval was obtained from Glasgow Royal Infirmary’s Ethical Committee. 
Healthy adult white volunteers (63 men and 84 women) were recruited from Greater 
Glasgow area by local advertisement. Volunteers with known diabetes were not 
included. Physical characteristics of subjects are shown in Table 3.1.1. Subjects were 
recruited to provide an even distribution by age (Figure 3.1.1), but not selected for any 
other criteria.
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Measurements of subjects were made in the morning after overnight fasting, with an 
empty bladder, wearing a swimsuit. All measurements were made by the same 
investigator in every subject, thus n = 147, or 63 for men, 84 for women in all analyses.
Densitometry by underwater weighing
A metal chair was suspended in a hydrotherapy pool, attached to a strain gauge 
(Mecmesin Ltd, Horsham, England) with a ±20-kg range, and sensitivity to 0.01 kg. 
Subjects sat in the chair, with water up to their necks, holding the arm-rests of the chair 
and with their feet on a bar attached to the chair. Their noses were sealed by a nose clip. 
In full expiration, subjects gently lowered their head under water. Weight was recorded 
using a pen recorder that was calibrated with known weights.
Residual lung volume
The residual lung volume was measuied simultaneously with UWW by the tliree-breath- 
nitrogen technique modified from Womersley (1974). Four 6-litre anaesthetic bags 
(Olnneda pic, Hatfield, UK) were filled with a known volume of 100% oxygen 
measuied by a dry rolling seal spirometer (PK Morgan, Kent, UK), about 3 litres for 
women and 4 litres for men (Wilmore et al, 1980). On raising their heads from under 
water, a 3 5-ml mouth piece connected to an anaesthetic bag was inserted into the 
subject’s mouth. Subjects then breathed in and out deeply tlnee times. After the last 
complete expiration, the bag was sealed and the gas mix obtained was immediately 
analysed for oxygen (Polarographic, PK Morgan, Kent, United Kingdom) and carbon 
dioxide (Infra-red, PK Morgan, Kent, UK) content. Nitrogen content (%N) of the gas 
mix was calculated from differences in oxygen (%0 2 ) and carbon dioxide (%C0 2 ): 
(% A  = 100% - % 0 i -  %COi) . Residual volmne (RV) was calculated as:
80% -  N%
where V is the initial volume of 100% oxygen in the gas bag, 0.035 / is the volume of 
the dead space in the mouth piece, with nitrogen content of the alveoli air before the test
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assumed to be 80%, and a correction factor (F) was included for standard temperature
and pressure in dry condition (STPD):
273 + Th P  aim — PsF  -  ----------- X--------------------- ,273 + Tg P  atm — Pa
where Tb and Tg are the temperature of body (37 °C) and gas in the spirometer 
respectively, Patm is atmospheric pressure, Pa and P s  are saturated vapour pressure of 
water in the lungs (assumed to be 47.1 mmHg) and spirometer (assumed to be 18.63 
mmHg) respectively (Womersley, 1974).
Subjects were first allowed to practise the teclmiques for holding breath, bending down 
and up, and breathing to the mouth-piece adequately outside the pool. They also 
practised in the water to familiarise themselves with the environment. Finally, 
measurements were made after allowing the water to become absolutely calm. The 
temperature of the pool was kept at exactly 36.5 °C throughout the studies.
Anthropometry
Height was measured with the subject standing, back to stadiometer, in bare feet. The 
head was adjusted so that the Frankfurt plane (the line from the auditory meatus to the 
lower border of the eye orbit) was horizontal. Feet were kept parallel with the heels 
together. The subject was encouraged to stretch upwards by applying gentle pressure at 
the mastoid processes (Gibson, 1990). The moving arm of the stadiometer was lowered 
to touch the top of the head and height was measured to the nearest 1 mm.
Arm span was measured from the distance between the tips of the longest fingers in each 
hand, with arms stretched horizontally while in standing position and with the back 
against a wall. Lower leg length was taken from the mean of the two legs. The subject 
sat in a chair, with bare feet, and lower legs vertical and parallel. Lower leg length was 
measured as the distance between the floor and the top of the patella.
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Weight was measured to the nearest 0.05 kg by a beam balance, which was calibrated 
daily using ten 8 kg test weights. Waist, hip, thigh, and mid-upper arm circumferences 
(MUAC) and skinfold thicknesses were made with subjects standing, with intended sites 
marked on the skin, except hip and thigh circumferences. A flexible steel tape was used 
(Holtain Ltd, Crymych, UK). All measurements were made twice, and the mean was 
used in regression equations. Waist circumference was measured midway between the 
lateral lower ribs and iliac crests (WHO, 1989). Subjects were asked not to tuck the 
stomach in, and the measurement was taken in gentle expiration. Their clothes were 
loosened around the waist area. Hip circumference was taken at the widest part over the 
trochanters. Feet were kept 25 to 30 cm apart, (WHO, 1989). Thigh circumference was 
measured for both legs 2 cm below the gluteal fold, with the weight on the non­
measured leg, i.e. the leg being measured relaxed. The average of the two legs was used 
in regression equations.
MU AC was measured on the right arm at the midpoint between the tip of the acromion 
and the tip of olecranon, elbow bent at 90°. Four skinfold thicknesses were measured 
according to the protocol described by Durnin and Womersley (1974). All 
measurements were made on the right side of the body with calipers (Holtain Ltd, 
Crymych, UK). Biceps and triceps skinfold thicknesses were taken at the midpoint {see 
MU AC) of the upper arm. Subscapular skinfold thickness was measured with subject’s 
shoulders relaxed. The measurement of supra-iliac skinfold thickness was taken with the 
subject breathing gently. In some obese subjects whose skinfold thiclcness exceeded the 
range of the calipers (50 mm), an estimate was made with a ruler.
Statistics
Data were analysed using the MINITAB statistical programme (Clecom, Birmingham, 
UK). Linear regression equations were developed using stepwise multiple regression 
analysis. Body density by UWW was used as the dependent (response) variable, 
anthropometric measurements and age used as independent (explanatory) variables for 
men and women separately.
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Measurements of UWW and residual lung volume were made three times for each 
subject, and twice for body circumferences and the mean taken. The experiment was 
repeated if the CV for the repeated measurements was >1%. The SD of repeated 
measurements on the same subject was calculated by the equation given by Bland
(1987): SD = (xi -  y j  where xi and yt are pairs of measurements for i = 1
to n. The CV was calculated as SD/overall mean.
2. Validation study (Wageningen)
Data were made available from earlier studies by Deurenberg et al (1991) from 146 men 
and 238 women, including body density measured by UWW with residual volume 
estimated by simultaneous helium dilution; waist and hip circumferences; biceps; 
triceps; subscapular and suprailiac skinfold thicknesses; weight; height, age; and sex. 
Anthropométrie measurements used the same protocols as in the present study except 
that skinfold-thickness measurements were made on the left. This sample was used as an 
independent population to test the validity of the equations derived from the Glasgow 
determination study. Measurements of arm span, lower leg length, and MU AC were not 
available in the validation sample. Skinfold-thickness measurements were available in 
143 men and 236 women.
Statistics
The Bland and Altman analysis (Bland and Altman, 1986) used to assess the mean and 
95% CIs of errors of body fat prediction as the difference in percent body fat estimated 
by regression equations from percent body fat measured by the reference UWW method.
RESULTS
1. Determination study
Details of subjects and the antlnopometric data are given as mean ±SD in Table 3.1.1. 
Sixty-three males aged 17-65 years and 84 females aged 18-64 years were studied under
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standard fasting conditions, with even distributions over wide ranges of weight, BMI, 
waist circumference, waist to hip ratio, skinfold thicknesses and body density. The mean 
height, weight and BMI were similar to average figures in the British adult population 
(Gregory e /a/, 1990).
Diurnal variations were studied for certain measurements made in the morning fasting 
and then in late afternoon for weight in 15 men, mean age 25 (range 20 to 46 yeai's) and 
35 women, mean age 25 (range 21 to 35) years, and height of 65 men, mean age 42.3 
yeai's (range: 16.8-65.4) and 69 women, mean age 43.1 years (range: 22.3-70.7), On 
average, there was a significant increase in body weight, mean +0.26 kg (95% Cl: 0.16 
to 0.35, P < 0.05) and a decrease in height, mean -0.8 cm (95% Cl: -1.0 to -0.6, P < 
0.001) in the afternoon compared with the morning. These effects are compounded in 
estimates of BMI so on average, BMI (weight/height^) would increase by 0.3 kg/m^ 
(1.2%) during the day. The CVs for repeated measurements of UWW, and waist and hip 
circumferences were 0.16%, 0.44% and 0.20% respectively.
Figure 3.1.1a shows the age distribution, separately for men and women, in relation to 
body density. In general, body density decreased with increasing age. Females had 
consistently lower body density than males at a given age.
A plot between body density and waist circumference (Figure 3.1.1b) demonstrates an 
almost linear relationship (men: r = -0.88 and women: r  = -0.79). Both men and women 
showed approximately the same gradient, with lower intercept in females. For a given 
waist circumference, the women tended to be less dense (fatter) than men, reflecting the 
greater central (visceral) fat deposition in men. Waist to hip ratio gave good prediction 
in men, but no better than waist circumference alone.
A plot between body density and triceps skinfold thickness (Figure 3.1.1c) shows the 
regression lines for males and females almost shared an identical intercept and slope, 
suggesting triceps skinfold thickness reflects proportionally the same amount of fat for
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the two sexes. Men tended to be leaner with smaller triceps skinfold thickness (10.9 ±4.6 
mm) than women (19.1 ±5.4 mm).
Linear regression: single variables
Table 3.1.2 shows the 17 significant (P < 0.001) correlations between body density and 
single antliropometric variables for men and women. Body density correlated most 
closely with waist circumference in both sexes (r = -0.88 in men and -0.79 in women). 
Thigh circumference correlated only moderately with body density, slightly higher in 
women (r = -0.58) than in men (r = -0.53). Correlation coefficients between body 
density and individual skinfolds ranged from -0.61 to -0.76 in men and from -0.66 to - 
0.77 in women. The sum of four skinfold thicknesses correlated with body density more 
closely than single or combinations of two or tlnee skinfolds in men (r = -0.772) but not 
in women (r = -0.763). A search was made for a better nonlinear relation (quadratic or 
logarithmic transformation), but no improvement in or SE was found, except for the 
relation with skinfold thicknesses. As in the study of Durnin and Womersley (1974) 
logarithmic transformation of the sum of four skinfold thicknesses increased the 
correlations significantly (P < 0.05) with body density in both men (r = -0.81) and 
women (r = -0.78).
Stepwise multiple regression analysis
When all 20 anthropometric measurements or selected ratios (Table 3.1.2) were 
considered separately for each sex as possible explanatory variables, the best prediction 
(highest r^) of body density for men was Waist circumference + Triceps skinfold 
thickness + Age. This equation accoimted for 86.6% of variance of body density. The 
best prediction of body density in women was from BMI + Triceps skinfold thickness + 
Age, explaining 80.2% of variance, but this equation was only slightly better than other 
simple equations, which included Waist circumference + Triceps SF + Age (r^ = 79.0%). 
Other antlu’opometric variables combining with triceps skinfold thickness also gave 
good prediction of body density explaining >76.0% of variance (Table 3.1.3). Log]o
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sum of four skinfold thicknesses (log^oZ^SF) gave a similar power of prediction of body 
density in the present study (men: r ' = 80.1 %; women: = 76.4%) to the published
equations (highest revalue of 81%) of Durnin and Womersley (1974).
Figures 3.1.2a-d show the relationships between the observed body density and 
predicted body density from some selected anthi’opometric variables. Tables 3.1.4 and 
3.1.5 contain six pairs of regression equations (numbers 1-6) validated in the 
Wageningen study to predict body density and equivalent percent body fat estimated 
from Siri’s equation (1961): Percent body fat = (4.95/body density - 4.5) x 100%.
For subjects whose height camiot be measured, arm span and lower leg length were 
considered as alternatives. Height correlated with arm span (men: r -  0.76 and women: r 
^  0.81) and lower leg length (r ^  0.85 for both men and women). These variables gave 
prediction of body fat as good as other commonly used variables (Table 3.1.3). 
Equations 7-12 incorporating these variables which could not be validated in the 
Wageningen validation study.
2. Validation study
Subjects in the validation sample had wider range of ages (18-83 years) than the 
determination study. Both samples had similar BMIs but the validation sample was 
fatter and had higher waist circumference and waist to hip ratio, indicating an 
accumulation of abdominal fat mass associated with older subjects in this sample (Table 
3.1.6).
Percentage body fat was predicted by equations 1-6 derived from the determination 
study, and by that of Durnin and Womersley (1974) for comparison. The prediction 
enors of each equation were calculated from the difference between predicted body fat 
and body fat measured by UWW.
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Table 3.1.7 shows the mean body fat of the Wageningen validation sample predicted by 
equations derived from the Glasgow determination study correlated highly (r >0.82; P 
<0.001) with body fat by UWW. The mean difference (prediction errors) with its SE and 
SD for each of the derived equations and those of Durnin and Womersley (1974) were 
similar, ranging from 4 to 5% of body weight, i.e., 95% Cl limits for errors of 8 to 10% 
of body weight about the mean errors. Body fat prediction from triceps skinfold 
thickness in men gave the worst SD of 6.6% of body weight (95% Cl limits of eiTor: 
13% of body weight). Although the mean errors of all equations were close to zero, 
almost all equations had significant positive or negative slopes for a plot of errors 
relative to body fat measuied by the reference UWW method. This indicates systematic 
errors or bias in predicting body fat in individuals at extreme ends of body fat spectrum 
(Table 3.1.8). Densitometry makes an assumption the fat free mass has a constant 
density of about 1.1 kg/1 (Siri, 1961); error in the reference method may relate to the 
possibility that the density of fat free mass is lower than this in the obese subjects, and 
higher than this in the very thin subjects because of different relative contribution of the 
organs (Shephard, 1991).
Using waist circumference alone, adjusted for age, gave equally good prediction of body 
fat, with similar SE and SD to other equations using more than one variable or 
measurement, including the Durnin and Womersley equations (Figures 3.1.3a-j^. The 
mean enors were close to zero in both men (-0.95 % of body weight) and women (-0.93 
% of body weight), with a negative slope of errors almost identical to those found using 
Durnin and Womersley equations for men (Figure 3.1.3c). The slope was less steep for 
women (Figure 3.1.31) indicating that body fat is less likely to be underestimated in 
fatter subjects using the waist circumference equations than those from Durnin and 
Womersley.
All equations containing triceps-skinfold measurement, including those from Dmnin and 
Womersley had significant positive or negative slopes for a plot of enors in predicting 
body fat against age (Table 3.1.9). Negative slopes were observed for predicting errors
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with increasing age by Durnin and Womersley (1974) equations, but there was no 
systematic bias in percent body fat prediction with age using waist equations in both 
sexes (Figures 3.1.4a & b). The mean and 95% CIs of errors of percent body fat 
prediction in different age groups are presented in Table 3.1.10 showed that the 
skinfold-thickness method (Durnin and Womersley, 1974) gave good prediction of 
percent body fat in younger subjects (age <60 years), but underestimated percent body 
fat of subjects aged 60-83 years up to 15% of body weight, whereas the waist 
circumference equations from the present study continued to give good prediction of 
percent body fat in 60 -83 years.
DISCUSSION
The present study has examined all the simple antliropometric measures currently in use, 
in predicting body density to estimate percentage body fat. The numbers of subjects (63 
men and 84 women) studied met the minimal number (n = 50) for generating prediction 
equations, recommended by Katch (1985), and allowed power of prediction at least 
equal power to those currently employed. The age distribution of subjects permits 
confidence over a wide range of ages. The validation sample had been studied under 
similar rigorous conditions, but by other observers and in an entirely different white 
population.
The equations from the present study were derived from a healthy white population 
broadly representative of the UK adult population, including very few athletes or 
unusually thin individuals. Barata et al (1993) recently found the equation of Jackson 
and Pollock (1978) better than those of Durnin and Womersley (1974) for athletes. 
Caution should be exercised when applying the equations to other population groups, or 
to subgroups with unusual physical chai’acteristics.
Stepwise multiple regression analysis for the combination of single measurements found 
waist circumference and triceps skinfold thickness, together with age, to provide the best 
prediction (highest r^) of body density, explaining 86.6% and 79% of variance in men
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and women, respectively, in the population from which the equations were derived. This 
equation applied less well in the validation study, which probably reflects differences 
between observers in triceps skinfold-thickness measurements. The prediction of body 
density from waist measurement alone, corrected for age (Table 3.1.3), is remarkably 
good (men: = 77.8%; women: = 70.4%). Age adjusted BMI also showed good
prediction of body density(men: = 67.0%; women: = 74.5%). Thus, for
epidemiological work, both waist circumference and BMI may be useful simple 
measurements. Several other combinations of body circumferences and skinfold 
thicknesses (biceps, triceps, subscapulai*, suprailiac) also gave good correlation with 
body density, but no better than the combination of waist circumference and triceps 
skinfold thickness. Age and triceps skinfold thickness combined with BMI, the ratios of 
body mass to arm span or body mass lower leg length gave similar prediction power for 
body density in both sexes. The classical equation of Durnin and Womersley (1974) 
using log^oZ^SF still gives a useful prediction, but BMI (with age and sex corrections) 
also demonstrated high predictive value ( /  ^  80.0%; not shown in tables) for body 
density, confirming previous observations from Deurenberg et al (1991). Equations with 
BMI + Triceps skinfold thickness gave better predictions of body density (men: -
84.5%; women: = 80.2%) than did logioZ^SF. The best four equations obtained from
stepwise multiple regression analysis in the Glasgow determination study, which all 
included triceps skinfold thickness measurement and either waist circumference or body 
mass, were significantly more powerful (P < 0.05) than log^qE^SF prediction equations 
in the population used to derive them.
A major advantage of waist circumference and triceps skinfold-thickness methods lies in 
their practical use (Tables 3.1.4 and 3.1.5). The four skinfold method requires a little 
practice to be reproducible, and may present some difficulties when subjects are clothed, 
or when skinfold thickness exceeds 50 mm (the limit of the calipers). This eliminates 
mainly obese subjects. With BMI above 37 kg/m^, subscapular and supra-iliac skinfolds 
usually exceed 50 mm and can only be roughly estimated.
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The equations based on Waist circumference + Triceps skinfold thickness offer another 
advantage over skinfold only methods by taking account of body fat distribution. For 
example, people with heart disease and with non insulin dependent diabetes mellitus 
have exaggerated central (visceral) fat distribution (Bjorntorp, 1985). In subjects with 
the highest quartile of waist to hip ratio including subjects with diabetes, we have found 
that equations using waist circumference are significantly better than methods based on 
subcutaneous skinfold thicknesses or BMI (Han and Lean, 1994). Waist circumference 
reflects intra-abdominal fat, as distinct from the subcutaneous fat which is reflected in 
triceps measurement, although both reflect total fat as well. Magnetic resonance imaging 
(Han et al, 1995a; Ross et al, 1992; Ross et al, 1993) and computerised tomograhy 
studies (Pouliot et al, 1994; Seidell et al, 1989) showed that waist circumference 
correlated with fat fi'om all sites, including intra-abdominal fat (r range 0.73-0.94; P < 
0.001) and total body fat (r >0.94; P < 0.001) in both men and women, although triceps 
skinfold thickness correlated highly with subcutaneous fat (r range 0.69-0.89; P < 0.05) 
and poorly with intra-abdominal fat {r ~  0.39; P = not significant) in both men and 
women.
Equations using the simple measurement of waist circumference and age proved to be 
remarkably robust for body fat prediction, as good as the existing method of combining 
4 skinfolds in men and better in fatter women where the Dm'nin and Womersley 
systematically imderestimates body fat. Figures 3.1,3c & f  suggest some bias in 
predicting body fat with increasing body fatness. Measurement of residual lung volume 
by helium in Wageningen and nitrogen in Glasgow were the only méthodologie 
difference, but this does not readily explain any bias. An alternative explanation for the 
bias could be the difference in body fat distribution in the Dutch population, possibly 
related to physical activity, smoking, and alcohol consumption. These equations based 
on waist circumference (Tables 3.1.4a and 3.1.5a; equation 1) are also applicable to 
older subjects without the systematic underestimation of body fat shown by the four­
skinfold method. This bias may indicate altered density in lean body mass with age
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(Reilly et al, 1994), but there is little independent evidence for altered lean body mass in 
elderly people. Altered body fat distribution with aging is a more plausible explanation, 
which is taken into account by the waist circumference method.
Waist measurement is the a highly practical method and its percentage measurement 
error is low due to its large circumference. Only a flexible tape is required, with minimal 
training to use bony landmarks. The only drawback would be in the very obese (BMI 
>45 kg/m^) when a large apron of abdominal fat would invalidate waist measurement. 
Wlien waist circumference and skinfold measureiuents are not available, BMI from body 
mass and height could be used as alternative method to predict body fat. The bias could 
be from one of the UWW protocols. The Glasgow method was tested against the earlier 
Durnin and Womersley tank as its replacement, showing no difference between the two 
methods on the same subjects. The Wageningen has been well established and has been 
used in many published studies (Deui'enberg et al, 1991). Because of their distance from 
one another, the Glasgow and Wageningen UWW methods cannot be compared directly.
Alternatives to BMI were developed using the ratios of body mass over arm span in 
kg/cm or lower leg length in kg/cm. These indices were analysed with other single 
antliropometric variables adjusted for age and sex. The best equations obtained were for 
the ratios of body mass to arm span (r^ = 80.0%), and body mass to lower leg length {r" 
= 79.3%). There was no significant difference when various powers were applied to 
variables. Triceps skinfold thickness was added to these equations (sepamte sexes) 
resulting in similar’ improvement for the prediction of body density as other multiple 
regression equations, for the ratios of body mass to arm span, /  ^  84.4% (men) and 
79.9% (women) and body mass to lower leg length, r" -  83.5% (men) and 79.3% 
(women). These equations may be of value for the elderly, chair-bound and bedridden 
subjects, and use of lower leg length instead of height may occasionally be helpful 
clinically and in field work. To keep errors to a minimmn in routine use, training of 
observers is urged, even for simple procedures.
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CONCLUSIONS
The twelve equations for each sex group (Tables 3.1.4 and 3.1.5) use simple 
anthropometric measurements to predict body composition. All equations, except mid­
upper arm circumference in men, gave acceptable accuracy and low error of prediction 
(Table 3.1.3), and thus can be used for clinical and epidemiological purposes. The time, 
equipment, and skill required for these measurements vaiy. An equation using waist 
circumference adjusted for age, as well as giving a prediction with low error and 
freedom &om bias with age or fatness, is also amongst the most convenient and avoids 
errors associated with altered fat distribution. Log sum of four skinfold thicknesses still 
gives very acceptable prediction of body composition, but with some underestimation in 
elderly subjects and in fat women, and BMI can be used satisfactorily when these 
measures are unavailable. The most powerful prediction of body fat, from waist 
circumference and triceps skinfold thickness performed less well in a validation sample, 
and is probably dependent on individual technique of triceps skinfold thickness 
measuiement. For the elderly, chair-bound and those with amputations, arm span or 
lower leg length can be used instead of height.
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Table 3,1.1. Chaincteristics of men and women in the determination study.
Men {n = 63) Women {n = 84)
Mean SD Range Mean SD Range
Age (years) 40.1 13.1 16.8-65.4 39.9 14.1 18.0-64.3
Height (m) 1.75 0.06 1.61-1.87 1.62 0.06 1.43-1.78
Weight (kg) 76.5 13.1 58.8-128.4 65.4 11.9 46.1-97.3
Body mass index (kg/m^) 24.9 4.3 18.9-41.2 24.9 4.3 18.3-37.7
Waist circumference (cm) 88.1 12.5 68.7-129.1 78.3 11.8 60.4-116.1
Hip circumference (cm) 98.0 6.8 87.6-125.5 101.2 9.3 83.8-133.0
Thigh circumference (cm) 55.3 5.1 45.8-70.2 56.6 4.6 49.2-69.9
MUAC (cm) 31.3 3.1 25.9-41.4 29.5 3.8 23.4-43.8
Waist to hip ratio 0.90 0.08 0.77-1.11 0.77 0.08 0.62-0.99
Lower leg length (cm) 53.6 2.2 48.3-57.9 49.6 2.9 40.4-57.6
Armspan (m) 1.76 0.07 1.60-1.90 1.61 0.08 1.40-1.78
Triceps skinfold (mm) 10.9 4.6 3.9-22.7 19.1 5.4 6.1-32.4
E^skinfold (mm) 51.2 25.7 19.7-161.9 63.2 24.2 23.4-126.1
Body density (kg/1) 1.049 0.023 1.003-1.087 1.024 0.020 0.987-1.061
Body fat (% of body weight) 22.3 8.9 5.2-43.7 33.75 8.7 16.4-51.7
MUAC = mid-upper arm circumference; Z^skinfbid = sum o f biceps, triceps, subscapular and supra-iliac 
skinfolds.
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Table 3.1.2. CoiTelation coefficients between body density and anthropometric 
measurements.
Men (« = 63) Women {n = 84)
Age -0.572*** -0.687***
Height 0.104 0.182
Weight -0.713*** -0.691***
Body mass index -0.755*** -0.781***
Waist circumference -0.878*** -0.790***
Hip circumference -0.707*** -0.713***
Thigh circumference -0.531*** -0.575***
Mid-upper arm circumference -0.586*** -0.790***
Waist to hip ratio -0.841*** -0.536***
Waist to thigh ratio -0.714*** -0.570***
Hip to thigh ratio -0.015 -0.328*
Lower leg length -0.009 -0.011
Armspan 0.323* -0.065
MAR -0.768** -0.747***
MLR -0.745** -0.727***
Biceps skinfold -0.730*** -0.695***
Triceps skinfold -0.612*** -0.768***
Subscapular skinfold -0.678*** -0.661***
Suprailiac skinfold -0.763*** -0.694***
Z^skinfold -0.772*** -0.763***
LogioZ^skinfbld -0.809*** -0.781***
MAR = ratio o f  body mass to armspan; MLR = ratio o f  body mass to lower leg length; Z^skinfold = sum 
o f  biceps, triceps, subscapular and supra-iliac skinfolds. <0.001; <0.05.
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Table 3.1.3. Explained variance (r ) and SEE for predictions of body density and 
percent BF by regression equations from Tables 3.1.4 and 3.1.5 and by selected 
published equations.
Men {n = 63) Women {n = 84)
Equation r SEE SEE SEE SEE
% kg/1 % body % kg/1 % body
weight weight
1. Waist circumference 77.8 0.0092 4.1 70.4 0.0100 4.7
2. Triceps 76.9 0.0094 4.3 75.1 0.0092 4.3
3. BMI 67.0 0.0113 5.0 74.5 0.0093 4.4
4. Waist + Triceps 86.6 0.0072 3.2 79.0 0.0085 4.0
5. BMI + Triceps 84.5 0.0077 3.4 80.2 0.0082 3.9
6. LogioZ^skinfbld 80.1 0.0088 4.0 76.4 0.0090 4.2
7. MAR 69.1 0.0109 4.9 73.0 0.0096 4.5
8. MLR 61.1 0.0111 5.0 72.2 0.0097 4.6
9. MUAC 57.3 0.0128 5.8 73.3 0.0095 4.5
10. MAR + Triceps 84.4 0.0077 3.4 79.7 0.0083 3.9
11. MLR + Triceps 83.5 0.0078 3.4 79.3 0.0084 4.0
12. MUAC + Triceps 80.7 0.0084 3.8 77.0 0.0088 4.2
LogioZ^SF (D&W)* 81.0t 0.0084 3.8 81.0t 0.0102 4.6
LogioSySF+WC+FC (J&P)* 84.1 0.0073 3.2
LogioSySF+GC (J etal)^ 75.2 0.0079 3.6
S4SF = sum o f  biceps, triceps, subscapular and supra-iliac skinfolds; MAR = ratio o f body mass to 
armspan; MLR = ratio o f  body mass to lower leg length; MUAC = mid-upper arm circumference; WC, 
FC and GC = waist, forearm and gluteal circumferences, respectively. * figures obtained from other 
published equations are shown for comparison. References: D&W = Durnin and Womersley (1974); J&P 
= Jackson and Pollock (1978); i  et al -  Jackson et a l (1980). fhighest value quoted. P <0.001 for all 
equations.
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Table 3.1.4a. Regression equations predicting (a) body density (BD) and (b) the 
equivalent body fat (BF %) in 63 men.
Equation 1. Waist circumference
a) BD = 1.1674 - (0.00125 x Waist) - (0.000231 x Age)
b) BF % = (0.567 X Waist) + (0.101 x Age) - 31.8
Equation 2. Triceps skinfold thickness
a) BD = 1.1181 - (0.00289 x Triceps) - (0.000953 x Age)
b) BF % = (1.31 X Triceps) + (0.430 x Age) - 9.16
Equation 3. Body mass index (BMI)
a) BD = 1.1419 - (0.00290 x BMI) - (0.000527 x Age)
b) BF % = (1.33 X BMI) + (0.236 x Age) - 20.2
Equation 4. Waist circumference and triceps skinfold thickness
a) BD = 1.1554 - (0.000761 x Waist) - (0.00170 x Triceps) - (0.000532 x Age)
b) BF % = (0.353 X Waist) + (0.756 x Triceps) + (0.235 x Age) - 26.4
Equation 5. Body mass index and triceps skinfold thickness
a) BD = 1.1414 - (0.00160 x BMI) - (0.00213 x Triceps) - (0.000747 x Age)
b) BF % = (0.742 X BMI) + (0.950 x Triceps) 4- (0.335 x Age) - 20.0
Equation 6. Logig sum of four skinfold thicknesses
a) BD = 1.1862 - (0.0684 x Log]o%4 skinfold) - (0.000601 x Age)
b) BF % = (30.9 X LogioS4 skinfold) + (0.271 x Age) - 39.9
Units o f measurements: waist circumference (cm); skinfolds (mm); BMI (kg/in'^); age (years). /  and SEE 
values are given in Table 3.1.3.
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Table 3.1.4b. Regression equations predicting (a) body density (BD) and (b) the 
equivalent body fat (BF %) in 63 men.
Equation 7. Ratio of body mass to arm-span (MAR)
a) BD = 1.1425 - (0.167 x MAR) - (0.000529 x Age)
b) BF % = (76.7 X MAR) + (0.237 x Age) - 20.4
Equation 8. Ratio of body mass to lower leg length (MLR)
a) BD = 1.1471 - (0.0530 x MLR) - (0.000571 x Age)
b) BF % = (24.2 X MLR) + (0.256 x Age) - 22.6
Equation 9. Mid-upper aim circumference (MUAC)
a) BD = 1.1828 - (0.00333 x MUAC) - (0.000745 x Age)
b) BF % = (1.52 X MUAC) + (0.336 x Age) - 38.7
Equation 10. MAR and triceps skinfold thickness
a) BD = 1.1407 - (0.092 x MAR) - (0.00205 x Triceps) - (0.000746 x Age)
b) BF % = (42.6 X MAR) + (0.917 x Triceps) + (0.334 x Age) - 19.6
Equation 11. MLR and triceps skinfold thickness
a) BD = 1.1423 - (0.0280 x MLR) - (0.00209 x Triceps) - (0.000777 x Age)
b) BF % = (13.0 X MLR) + (0.933 x Triceps) + (0.348 x Age) - 20.4
Equation 12. MUAC and triceps skinfold thiclmess
a) BD = 1.1613 - (0.00165 x MUAC) - (0.00238 x Triceps) - (0.000882 x Age)
b) BF % = (0.757 X MUAC) + (1.07 x Triceps) + (0.398 x Age) - 29.0
Units o f  measurements: MUAC (cm); MAR and MLR (kg/cm); age (years). /  and SEE values are given 
in Table 3.1.3.
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Table 3.1.5a. Regression equations predicting (a) body density (BD) and (b) the 
equivalent body fat (BF %) in 84 women.
Equation 1. Waist circumference
a) BD = 1.1145 - (0.000924 x Waist) - (0.000465 x Age)
b) BF % = (0.439 X Waist) + (0.221 x Age) - 9.4
Equation 2. Triceps skinfold thickness
a) BD = 1.0851 - (0.00200 x Triceps) - (0.000586 x Age)
b) BF % = (0,944 X Triceps) + (0.279 x Age) + 4.6
Equation 3. Body mass index (BMI)
a) BD = 1.1088 - (0.00254 x BMI) - (0.000551 x Age)
b) BF % = (1.21 X BMI) + (0.262 x Age) - 6.7
Equation 4. Waist circumference and triceps skinfold thickness
a) BD = 1.1062 - (0.000482 x Waist) - (0.00140 x Triceps) - (0.000453 x Age)
b) BF % = (0.232 X Waist) + (0.657 x Triceps) + (0.215 x Age) - 5.5
Equation 5. Body mass index and triceps skinfold thickness
a) BD = 1.1039 - (0.00148 x BMI) - (0.00122 x Triceps) - (0.000505 x Age)
b) BF % = (0.730 X BMI) + (0.548 x Triceps) + (0.270 x Age) - 5.9
Equation 6. Logjo sum of four skinfold thicknesses
a) BD = 1.1622 - (0.0654 x LogioZ^skinfold) - (0.000574 x Age)
b) BF % = (30.8 X Logio2 4 skinfold) + (0.274 x Age) - 31.7
Uiiiitf o f  measurements: waist circumference (cm); skinfolds (mm); BMI (kg/m^); age (years), and SEE 
values are given in Table 3.1.3.
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Table 3.1.5b. Regression equations predicting (a) body density (BD) and (b) the 
equivalent body fat (BF %) in 84 women.
Equation 7. Ratio of body mass to arm-span (MAR)
a) BD = 1.1108 - (0.155 X MAR) - (0.000603 x Age)
b) BF % = (73.6 X MAR) + (0.287 x Age) - 7.6
Equation 7. Ratio of body mass to lower leg length (MLR)
a) BD = 1.1101 - (0.0466 x MLR) - (0.000630 x Age)
b) BF % = (22.0 X MLR) + (0.300 x Age) - 7.2
Equation 9. Mid-upper arm circumference (MUAC)
a) BD = 1.1299 - (0.00291 x MUAC) - (0.000512 x Age)
b) BF % = (1.38 X MUAC) + (0.243 x Age) - 16.7
Equation 10. MAR and triceps skinfold thickness
a) BD = 1.1047 - (0.0867 x MAR) - (0.00129 x Triceps) - (0.000582 x Age)
b) BF % = (41.3 X MAR) + (0.607 x Triceps) + 0.253 x Age) - 4.7
Equation 11. MLR and triceps skinfold thickness
a) BD = 1.1040 - (0.0252 x MLR) - (0.00133 x Triceps) - (0.000546 x Age)
b) BF % = (12.0 X MLR) + 0.626 x (Triceps + 0.260 x Age) - 4.3
Equation 12. MUAC and triceps skinfold thickness
a) BD = 1.1091 - (0.00139 x MUAC) - (0.00126 x Triceps) - (0.000518 x Age)
b) BF % = (0.676 X MUAC) + (0.582 x Triceps) + (0.246 x Age) - 7.1
Units o f measurements: MUAC (cm); MAR and MLR (kg/cm); age (years), r and SEE values are given 
in Table 3.1.3.
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Table 3.1.6. Characteristics of 146 men and 238 women from the independent 
validation (Wageningen) sample.
Men {n = 146) Women {n = 238)
Mean SD Range Mean SD Range
Age (years) 45.9 17.4 18.0-82.0 36.9 17.5 20.0-83.0
Height (cm) 179.9 7.7 151.3-202.0 167.7 7.0 150.7-185.9
Weight (kg) 81.1 11.7 54.4-120.8 67.75 12.9 43.7-109.6
Body mass index (kg/m^) 25.1 3.4 19.2-34.8 24.15 4.71 17.4-40.9
Waist circumference (cm) 93.3 10.8 70.5-115.0 82.6 11.96 62.0-113.0
Hip circumference (cm) 100.3 6.1 87.5-123.0 101.3 9.01 85.0-138.0
Waist to hip ratio 0.93 0.07 0.73-1.13 0.81 0.07 0.68-1.04
Triceps skinfold (mm) 13.6 6.0 4.0-35.5 20.0 7.7 7.0-44.0
Z^skinfbld (mm) 57.8 25.5 18.8-152.7 69.2 30.5 22.8-155.6
Body density (kg/1) 1.034 0.02 1.008-1.079 1.023 0.02 0.984-1.062
Body fat (% body weight) 26.7 7.7 8.9-41.0 34.1 8.8 16.3-53.1
MUAC = mid-upper arm circumference; Z^skinfold 
skinfolds.
sum of biceps, triceps, subscapular and supra-iliac
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Table 3.1.7. Mean body fat predicted by equations derived from determination study 
and by underwater weighing and their correlations, mean difference and standard errors 
(SE) and standard deviation of the difference in 146 men and 238 women from 
validation study.
Percentage body fat Difference (Pre-UWW)
Pre UWW r Mean SE SD
Men {n ~ 146)
Waist 25.71 26.65 0.839 -0.95 0.35 4.20
Triceps 28.33 26.65 0.823 1.67 0.55 6.64
BMI 24.01 26.65 0.843 -2.65 0.34 4.13
BMI + Triceps 26.87 26.65 0.850 0.22 0.46 5.55
Waist + Triceps 27.55 26.65 0.861 0.89 0.41 4.93
LogioZ^skinfold 25.88 26.65 0.867 -0.61 0.33 3.98
LogigZ^skinfbld (D&W) 24.47 26.65 0.843 -2.01 0.35 4.14
Women {n = 238)
Waist 35.03 34.06 0.868 0.97 0.28 4.38
Triceps 33.80 34.06 0.862 -0.26 0.33 5.12
BMI 32.19 34.06 0.879 -1.87 0.28 4.28
BMI + Triceps 32.67 34.06 0.883 -1.39 0.31 4.77
Waist + Triceps 34.76 34.06 0.883 0.70 0.29 4.54
LogioZ^skinfoId 33.88 34.06 0.882 -0.07 0.27 4.20
LogigZ^skinfbld (D&W) 32.32 34.06 0.860 -1.63 0.29 4.51
Pre = predicted body fat by anthropometric equations derived from the determination study; UWW = 
underwater weighing. D&W = Durnin and Womersley equations (1974).
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Table 3.1.8. Slopes of the difference of body fat prediction by derived equations 
(adjusted for age) and body fat measured by underwater weighing plotted against body 
fat measured by underwater weighing in 146 men and 238 women.
Men {n = 146) Women {n = 238)
Slope r P Slope r P
Waist -0.787 -0.432 <0.001 -0.933 -0.464 <0.001
Triceps 0.288 0.249 0.002 -0.042 -0.024 0.710
BMI -0.957 -0.515 <0.001 -0.651 -0.316 <0.001
BMI + Triceps 0.277 0.200 0.015 0.056 0.030 0.642
Waist + Triceps 0.191 0.123 0.134 -0.133 -0.069 0.292
LogioZ^skinfold -0.446 -0.232 0.005 -0.616 -0.296 <0.001
Log 1 0^ 4 skinfold (D&W) -0.859 -0.464 <0.001 -1.212 -0.624 <0.001
D&W = Durnin and Womersley equations (1974).
Table 3.1.9. Slopes of the difference of body fat prediction by derived equations 
(adjusted for age) and body fat measured by underwater weighing plotted against age in 
146 men and 238 women.
Men {n = 146) Women {n = 238)
Slope r P Slope r P
Waist -0.226 -0.055 0.512 0.303 0.076 0.242
Triceps 1.515 0.579 <0.001 1.034 0.303 <0.001
BMI 0.439 0.104 0.210 0.653 0.160 0.013
BMI + Triceps 1.344 0.430 <0.001 1.180 0.322 <0.001
Waist + Triceps 1.163 0.330 <0.001 0.779 0.202 0.002
LogioS4skinfold 1.214 0.276 <0.001 0.726 0.174 0.007
Logio24skinfold (D&W) -1.003 -0.237 0.004 -1.355 -0.349 <0.001
D&W  = Durnin and Womersley equations (1974).
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Table 3.1.10. Mean and 95% confidence limits of errors of body fat prediction by 
equations based on waist circumference, and skinfolds (Durnin and Womersley, 1974) 
from body fat measured by densitometry in different age groups of 146 men and 238 
women aged 18 to 83 years.
Equation type and age groups
Men {n = 146) Women {n = 238)
Mean 95% Cl n Mean 95% Cl n
Waist circumference
18-39 -0.5 -9.2, 8.2 48 0.6 -7.7, 8.9 138
40-59 -1.4 -9.0, 6.1 58 0.9 -8.7, 10.5 60
60-83 -0.7 -9.6, 8.2 40 0.9 -7.4, 9.3 40
Skinfold thicknesses (D&W)
18-39 -1.6 -8.7, 5.5 47 -0.9 -8.6, 6.7 138
40-59 -1.4 -9.8, 7.0 56 -0.5 -9.5, 8.5 58
60-83 -3.4 -12.0,5.2 40 -5 J -14.8,3.4 40
D&W = Durnin and Womersley equations (1974).
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Figure 3.1.1. Relations between body density by underwater weighing and age (a), waist 
circumference (b), and triceps skinfold thickness (c) in 63 males (M) and 84 females (F) 
in the determination study.
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Figure 3.1.2. Relation between observed body density by underwater weighing and 
predicted body density by waist circumference (a), body mass index (b), log sum of four 
skinfold thicknesses (c), and waist + triceps skinfold thickness (d), adjusted for age, in 
63 males (M) and 84 females (F) in the determination study.
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Figure 3.1.3. Plots of prediction errors of body fat (predicted minus reference 
densitometric method) by waist circumference in 146 men (a) and 238 women (d), and 
by the Durnin and Womersley (D&W) skinfold equations in men (b) and in women (e) 
against body fat measured by densitometry in the Wageningen validation sample. The 
errors of the two predictive methods are plotted against body fat by densitometry for 
comparison in men (c) and women (f).
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Figure 3.1.4. Plots of prediction errors of body fat (predicted minus reference 
densitometric method) by waist circumference and by the Durnin and Womersley 
(D&W) skinfold equations in 146 men (a) and in 238 women (b) against age in the 
Wageningen validation sample.
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3.2
LIMB LENGTHS AS INDICES OF STATURE IN ADULTS, AND 
ALTERNATIVES TO BODY MASS INDEX FOR CHAIR- OR BED
BOUND SUBJECTS
This section has been peer reviewed and has been published as
Han TS. Lean MEJ. Lower leg length as an index of stature in adults. 
International Journal of Obesity 1996; 20:21 -27.
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ABSTRACT
Objective'. To derive regression equations using lower leg length (knee height) or arm 
span to predict height, and equations using ratios of weight/lower leg length or 
weight/arm span to predict body mass index and % body fat.
Subjects'. Determination sample of 78 men and 82 women aged 17-70 years, and 
validation sample of 53 men and 121 women aged 18-82 years.
Measurements: Height, weight, lower leg length measured from the top of the patella 
with knee flexed at 90°, arm span, % body fat by densitometry, and age.
Results: Lower leg length gave good prediction of height (men: = 79%, SEE = 3.2 cm;
women: = 73%, SEE = 3.4 cm). Weight/lower leg length ratio was highly predictive
of body mass index (men: r^ =95%, SEE =1.1  kg/m^, women: = 94%, SEE =1.1
kg/m^), and gave an estimation comparable to that of body mass index for predicting % 
body fat (men: r^= 68%, SEE = 5.0% of body weight; women: r^= 72%, SEE = 4.6% of 
body weight). Applying these equations hased on lower leg length and weight/lower leg 
length ratio to a separate sample of men and women showed 95% of the errors of height 
estimate were within 6.5 cm, and of body mass index estimate were within 2 kg/m^. The 
same analysis for arm span showed the errors of body composition prediction were 
imacceptably high.
Conclusion: Lower leg length is useful for estimating hody composition when height 
measurement is not available.
Keywords: Anthropometry, height, knee height, ageing, stature, hody mass index, body 
composition, body fat.
74
INTRODUCTION
Body mass index (BMI) and other indices which include height are used as measures of 
body size and composition. Measuring height is often difficult in the critically ill, the 
elderly, the chair/bed bound and people with musculo-skeletal injury. Standing height 
differs significantly fi'om body length measured in supine subjects (Watt et al, 1994). 
Height has been predicted from demi-arm span in healthy men and women (Bassey, 
1986), but Chumlea et al (1985) found knee height to give better prediction in the 
elderly.
The recent paper by Roubenoff and Wilson (1993) recommended that knee height may 
have an advantage over height as an index of stature in expression of body composition. 
The present study aimed to evaluate limb lengths as possible substitutes for height in 
body composition indices when height measurement is unavailable or not reliable.
METHODS 
Subjects
Healthy subjects were recruited from the Glasgow area by invitations in the local press. 
Measurements of body stature and body composition were made in the determination 
sample of 78 men and 82 women aged 17-70 years, and validation sample of 53 men 
and 121 women aged 18-82 years available from the separate Glasgow MONICA study. 
This study was approved hy the Glasgow Royal Infirmary's Ethical Committee.
Body composition measurements
Body weight was measured by calibrated scales (Seca, Germany) to the nearest 100 g, 
and height was measured to the nearest millimetre with the subjects standing, back to the 
stadiometer (Castlemead, Herts, UK) in bare feet. The head was adjusted so that the 
Frankfort plane was horizontal. Feet kept parallel with heels together. The subject was 
encouraged to stretch upwards by applying gentle pressiue at the mastoid process. 
Lower leg length (LLL) was measured (Figure 3.2.1) with subjects sitting in a chair 
adjusted to about their knee height, and the lower legs and bare feet flexed at 90°. The
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lower legs, 25-30 cm apart, were adjusted to vertical position both side (Figure 3.2.1a) 
and front views (Figure 3.2.1b). A ruler standing on its edge was placed on top of the 
patellae. Lower leg length was taken to the nearest mm from the midpoint of the ruler to 
the floor by wooden metre rule, which was calibrated against a steel tape (Holtain, 
Crymych, UK) before use. This teclmique based on bony points aimed to reduce 
possible errors such as fi'om varying mass of the quadriceps (Chumlea et al, 1985). Arm 
span (AS) was measured between finger tips with subjects standing against the wall, 
both arms fully stretched horizontally. Diurnal variations in morning and afternoon 
height and weight of 15 men and 25 women aged 20-46 years, and intra- and inter­
observer differences in LLL and AS of 65 men and 69 women aged 17-71 years were 
studied.
Body density of subjects was estimated by underwater weighing, the detailed technique 
being described in the previous C hapter 3.1 (Lean et al, 1996). Percent body fat was 
calculated from body density (Siri, 1961).
Statistical analyses
Determination study: Linear regression analysis was used to derive equations based on 
LLL or AS (independent variables) to predict morning height (dependent variable), and 
equations based on the ratios of weight/LLL or weight/AS to predict BMI or body fat, 
with the aid of MINITAB statistical programme {Clecom, Birmingham, UK). The 
standard error (.y) of repeated measurements on the same subject was calculated as:
5  =  .^ 1  /  2l% X ^  (X ; -  y i )
where x,- and y,- are pairs of measurements for z = 1 to n, and the CV was calculated as 
5/overall mean (Bland, 1987).
Validation study: Errors of height and BMI predictions from equations based on LLL 
and AS, applied to the validation sample, were calculated as the difference of the 
measured values from the predicted values (Gregory et al, 1990).
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RESULTS
The mean values of anthropometric measurements of the determination sample was 
similai' to those of the population derived MONICA validation sample for the respective 
sexes, except women were slightly older in the validation sample (Table 3.2.1), on this 
basis body density and percent body fat are expected to represent larger general 
population. The distribution of height and BMI is similar to that of the general 
population (Gregory et al, 1990). The sample was not selected to be representative of the 
population so height loss with ageing well known from longitudinal studies could still 
exist (Shephard, 1991).
Reproducihility between trained observers for LLL and AS, as CV were 0.55% and 
0.72%, and within observer were 0.23% and 0.27% respectively. Study of diurnal 
variations (paired Mest) showed on average, weight increased by +0.26 (95% Cl: 0.16, 
0.35; P  <0.05) and height decreased by -0.08 cm (-1.0, -0.6; P  <0.001) in the afternoon 
compared to morning. These effects are compounded in estimates of BMI, so on 
average, BMI (weight/height^) would increase by +0.3 k%!m (1.2%) during the day.
Determination study
Equations based on LLL and AS were derived to predict height in 78 men and 82 
women (Table 3.2.2). With the addition of age, both equations using LLL for men and 
women improved significantly {P <0.05). However, AS were less highly predictive of 
height than LLL and an age factor did not improve the prediction significantly.
Limb lengths were used instead of height, with body weight to develop indices to predict 
BMI (Table 3.2.3) and with age to predict percentage body fat (BF%) measured by 
densitometry (Table 3.2.4) in 63 men and 75 women with wide ranges of BF% and age. 
The ratios of weight/limb length using various index powers ranging from 0.1 to 2 for 
the denominator showed weight/LLL and weight/AS^ related most strongly to BMI in 
both sexes. This is due to a mathematical phenomenon previously explained by
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Roubenof and Wilson (1993). These ratios explained more than 91% of variance of 
BMI, and with age adjustment, explained >68% and 72% of variance of BF% in men 
and women respectively.
Validation study
The derived equations (Tables 3.2.2 and 3.2.3) from the present study were used to 
estimate height in a separately studied sample of 53 men and 121 women (65 women did 
not have arm span measurement). Mean errors and 95% confidence interval limits of 
estimated height from measured height of each corresponding equation are presented in 
Table 3.2.5, showing LLL predicted height to within 6.5 cm (Equations la  & lb) 
There was little improvement in height prediction when equations based on LLL were 
adjusted for age (Equations 2a & b). Weight/LLL predicted BMI to within 2 kg/nf 
(Equations 4a & b). Plots of individual errors showed a systematic bias towards 
overestimating height in shorter subjects and underestimating height in taller subjects 
(Figures 3.2.2a & b). There was no systematic bias of height prediction in men of 
different ages (Figure 3.2.3a), but increasing overestimation of height in older women 
(Figure 3.2.3b). BMI prediction from LLL (Equations 4a & 4b) showed no systematic 
bias from degree of overweight (Figures 3.2.4a & b). There were large errors (Table
3.2.5) in predicting height (Equations 3a & 3b) and BMI (Equations 5a & 5b) from 
AS.
DISCUSSION
Lower leg length from the present study showed good prediction of height and BMI, 
while prediction from AS introduced unacceptable eiTors. This is not surprising perhaps, 
since LLL is part (about 30%) of height. Height prediction from LLL in men was not 
affected by age (Figure 3.2.1a), but tended to be overestimated in older women (Figure 
3.2.3b), which may be due to their decreasing in height as the result of ageing 
(Shephard, 1991), while LLL may be less affected. Therefore the estimated height could 
well be closer to their “true” height when the older women were at younger age. In the 
present study, there were no significant correlations between height and age in men from
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the determination sample (r = -0.183; P = 0.109) and validation sample (r = -0.182; P = 
0.191) or women (r = -0.117; P  = 0.294) in the determination sample, but there was a 
significant negative correlation between height and age in women from the validation 
study (r = -0.417; P  <0.001), which included women who were older than the rest.
The equations in the present study were derived and validated in a Caucasian population 
only. Subjects were free from diseases that may have greatly affected their standing 
height or LLL, but some did have difficulty in holding their arm horizontal for the AS 
measurement. When applying LLL to estimate height, increased errors may occur in 
those who have deformed lower legs, or subjects of other races, whose limb/height 
proportion may be very different.
The derived equations based on LLL alone (Equations la  & lb) may be more practical 
for height estimation, since they showed comparable prediction errors to equations based 
on LLL with age adjustment (Equations 2a & 2b) when applied to the validation 
sample (Table 3.2.5).
There are various clinical situations where it is not possible to measure height or 
compute BMI directly. Various limb lengths have been used to predict height (Table
3.2.6). Bassey (1986) found a conelation coefficient of 0.75 (r^= 56%) between height 
and demi-arm span in adult men and women. Higher prediction of height by knee height 
was observed by Chumlea et al (1985) in elderly men (r^ = 67%) and women (r^ = 56%), 
and increased when age was added to the equation (r^ =65% ) in women, but not men. 
The age coiTection probably compensates for vertebral degeneration particularly in older 
women. In oui* determination study, entering age into the equations that were based on 
LLL significantly increased height prediction by 2% in men (r = -2.7; P  < 0.01) and 4% 
in women (/^  = -3.5; P  <0.001).
Lower leg length and AS were highly reproducible in our study with CV less than 1%. 
Chumlea et al (1985) found knee height measurement in the elderly was more
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reproducible between obseiwers when lying recumhent (CV 0.52%) than sitting (CV 
1.26%). With increasing age in women knee height was shorter by 0.06 cm per year in 
their study, probably because their measurement included a small, variable, amount of 
quadriceps muscle. Some of the prediction errors in the present study may have come 
from the diurnal variations of height and weight.
In a cross-sectional study, Dequeker et al (1969) used AS to detect differences in supine 
hody length of women aged between 30 and 94 years, observed that AS was relatively 
constant tlnoughout all age groups, but their lying body length and length/AS ratio were 
lower in older women. Rouhenoff and Wilson (1993) showed knee height to he a better 
index than height for detecting changes in lean body mass with age. However they 
observed height was significantly lower in both older men and older women than 
younger subjects. Genant et al (1982) observed a lower vertebral bone density in those 
above the fifth decade or older. Since these studies were cross sectional, the effects of 
age or secular trend on height and limb length could not he deduced. However, some of 
the variance, particularly women may relate to spinal shortening with age in the present 
study. It is interesting that, within the women we studied, the ratio of measured 
height/LLL coiTelated negatively {r = -0.30; P <0.05) with age. If an arbitrary cut-off 
above age 45 years is taken in women, then there is a stronger negative correlation {r = - 
0.45, P <0.01) between height/LLL ratio and age. A more detailed longitudinal study of 
height/LLL in pre- and post-menopausal women would be of interest.
CONCLUSIONS
Lower leg length measured to the patella is a valuable index for estimating body 
composition when height measurement is not available, and it gives better estimates than 
arm span.
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Table 3.2.1. Personal data of 78 men and 82 women in the determination study, and 53 
men and 121 women in the validation study.
Mean (SD)
Determination sample Validation sample
Men 
{n = 78)
Women 
{n = 82)
Men 
(M = 53)
Women 
{n = 121)
Age (year's) 43.9 (14.4) 43.1 (13.3) 44.1 (13.2) 46.5 (14.6)
Range 16.8-66.6 22.3-70.7 17.9-66.6 17.6-81.8
Height (cm) 175.7 (5.8) 161.8(6.2) 175.7 (7.4) 159.8(6.6)
Range 156.0-188.9 141.0-178.0 155.2-190.0 142.5-180.0
Weight (kg) 79.4(15.7) 67.0(12.1) 77.3 (11.2) 61.0 (9.7)
Range 58.8-136.5 46.1-97.3 55.8-101.1 41.0-90.0
Body mass index (kg/m^) 25.9 (4.6) 25.8 (4.9) 25.1 (3.5) 24.0 (4.0)
Range 18.9-41.2 16.6-44.0 19.4-36.7 15.5-39.2
Lower leg length (cm) 53.6 (2.6) 49.4 (3.1) 54.2 (2.7) 48.2 (2.7)
Range 45.8-59.6 40.4-57.6 46.8-58.8 41.2-57.8
Arm span (cm) 176.5 (7.0) 160.2 (7.9) 171.4(10.6) 157.8 (9.4)*
Range 160.0-192.5 139.8-178.0 151.8-196.2 133.5-179.1
Body fat % (% of weight) 22.3 (8.9) 33.8(8.7)
Range 5.2-43.7 16.5-51.7
{n -  63) (% = 75)
*65 women in the validation study did not have arm span measured.
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Table 3.2.2. Equations to predict height derived from 78 men and 82 women in the 
determination study.
From lower leg length (LLL) in cm:
Equation la  Men: Height = (2.31 x LLL) + 51.1
Equation lb  Women: Height = (1.84 x LLL) + 70.2
From lower leg length (LLL) in cm and age in years:
Equation 2a Men: Height = (2.30 x LLL) - (0.063 x Age) + 54.9
Equation 2b Women: Height = (1.91 x LLL) - (0.098 x Age) + 71.3
From aim span between finger tips in cm:
Equation 3a Men: Height = (0.762 x Arm span) + 40.7
Equation 3b Women: Height = (0.693 x Arm span) + 50.3
95% confidence intervals of regression coefficients of independent variables and 
constants, and explained variance (r^) and standard error of the estimate to predict % 
body fat in equations 1, 2 and 3 to predict height.
Sex 95% Cl of coefficient and constant
Independent variable Constant r^ (SEE)
LLL
M Equation la 2.04, 2.58 36.6, 65.7 79 (3.2)
F Equation lb 1.59,2.09
LLL Age
73 (3.4)
M Equation 2a 2.03, 2.56 -0.110, -0.017 40.7, 69.1 81 (2.9)
F Equation 2b 1.67, 2.14 
AS
-0.154, -0.043 59.7, 83.0 76 (3.2)
M Equation 3a 0.632, 0.891 17.8, 63.5 64 (4.0)
F Equation 3b 0.587, 0.798 33.4, 67.2 68 (3.7)
All coefficients and constant are significant, P  <0.05; LLL = lower leg length; AS = armspan; M = male; 
F = female.
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Table 3.2.3. Equations to predict BMI derived from 78 men and 82 women in the 
determination study.
From weight/lower leg length (Wt/LLL) in kg/cm:
Equation 4a Men: BMI = (17.3 x Wt/LLL) + 0.24
Equation 4b Women: BMI = (20.0 x Wt/LLL) - 1.35
From weight/arm span between finger tips (Wt/AS^) in kg/m^:
Equation 5a Men: BMI = (0.936 x Wt/AS^) + 1.99
Equation 5b Women: BMI = (0.989 x Wt/AS^) + 0.04
95% confidence intervals of regression coefficients of independent variables and 
constants, and explained variance (r^) and standard error of the estimate to predict % 
body fat in equations in equations 4 and 5 to predict body mass index.
Sex 95% Cl of coefficient and constant r (SEE)
Independent variable Constant
Wt/LLL
M Equation 4a 16.4, 18.3 -1.16,1.64"' 95 (1.1)
F Equation 4b 19.2,21.3 -2.81,0.11"' 94(1.1)
W t/A^
M Equation 5a 0.878, 0.994 0.49, 3.49 93(1.2)
F Equation 5b 0.923, 1.055 -1.72, 1.78"' 91 (1.5)
All coefficients and constant are significant, P  <0.05 except ns = not significant; LLL = lower leg length; 
AS = armspan; M = male; F = female.
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Table 3.2.4. Equations to predict % body fat derived from 63 men and 75 women in the 
determination study.
From weight/lower leg length (Wt/LLL) in kg/cm and age in years:
Equation 6a Men: % Body fat = (24.2 x Wt/LLL) + (0.256 x Age) -22.6
Equation 6b Women: % Body fat =  (21.9 x  Wt/LLL) + (0.321 x  Age) -  8.1
From weight/arm span between finger tips (Wt/AS^) in kg/nE and age in years:
Equation 7a Men: % Body fat = (1.27 x Wt/AS^) + (0.215 x Age) - 17.8
Equation 7b Women: % Body fat = (1.13 x Wt/AS^) + (0.312 x Age) - 7.4
From body mass index (weight/height^) in kg/m^ and age in years:
Equation 8a Men: % Body fat = (1.33 x BMI) + (0.236 x Age) - 20.2
Equation 8b Women: % Body fat = (1.20 x BMI) + (0.287 x Age) - 7.8
95% confidence intervals of regression coefficients of independent variables and 
constants, and explained variance (r^) and standard error of the estimate to predict % 
body fat in equations 6, 7 and 8.
Sex 95% Cl of coefficient and constant (SEE)
Independent variable Constant
Wt/LLL
M Equation 6a 18.4,30.0 0.160, 0.352 -30.5, -14.7 68 (5.0)
F Equation 6b 17.2, 26.6 
Wt/AS^
0.207, 0.371 -15.7, -3.8 72 (4.6)
M Equation 7a 0.97, 1.57 0.118, 0.312 -24.6,-11.0 69 (4.9)
F Equation 7b 0.88, 1.38
BMI
0.227, 0.397 -13.4, -1.4 72 (4.6)
M Equation 8a 1.01, 1.65 0.137,0.335 -27.6, -12.8 67 (5.0)
F Equation 8b 0.97, 1.43 0.156, 0.316 -13.2, -2.4 75 (4.4)
All coefficients and constant are significant, P  <0.05; Wt = body weight; LLL = lower leg length; AS = 
armspan; BMI = body mass index; M = male; F = female.
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Table 3.2.5. Mean errors and 95% confidence interval of height and BMI predictions 
from equations (Tables 3.2.2 & 3.2.3) based on lower leg length and arm span, adjusted 
for age where appropriate, applied to the validation sample of 53 men and 121 women.
Dependent vaiiable
Height (cm) Mean error 95% Cl BMI (kg/m ) Mean error 95% Cl
Men Equation la 0.7 -5.0, 6.4 Equation 4a -0.2 -2.2, 1.9
Women Equation lb -1.0 -6.6, 4.7 Equation 4b 0.1 -1.8, 1.9
Men Equation 2a 1.1 -4.5, 6.8 Equation 5a 1.7 -2.2, 5.5
Women Equation 2b -1.1 -6.3, 4.2 Equation 5b 1.1 -3.2, 5.4
Men Equation 3a -4.4 -15.2, 6.5
Women Equation 3b -1.8 -10.8, 7.1
BMI = body mass index.
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Table 3.2.6. Selected studies reporting accuracy and errors of height prediction ftom 
regression equations based on limb lengths in Caucasian men and women.
Reference Sex n Age
(years)
Predictor Height (dependent 
variable) 
r  ^ SEE 
(%) (cm)
Han and Lean M 78 17-67 LLL 79 3.2
Han and Lean F 82 22-71 LLL 72 3.4
Chumlea a/ (1985) M 106 60-90 Knee Fit 67 3.8
Chumlea et al (1985) F 130 60-90 Knee Ht 67 3.8
Han and Lean 
Han and Lean
Chumlea a/ (1985) 
Chumlea et al (1985)
M 78 17-67 LLL+Age 81 2.9
F 82 22-71 LLL+Age 76 3.2
M 106 60-90 Knee Ht+Age 56 4.0
F 130 60-90 Knee Ht+Age 65 3.5
Han and Lean 
Han and Lean
Bassey (1986) 
Bassey (1986)
M 78 17-67 Arm span 64
F 82 22-71 Arm span 68
M 63 35 (SD 9.7) Demi-arm span 56
F 62 34(SD 9.1) Demi-arm span 55
4.0
3.7
4.2
3.3
M = male; F = female; LLL = lower leg length; Ht = height.
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Figure 3.2.1. Methods o f measuring lower leg length (see text for details).
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Figure 3.2.2. Plot of errors (predicted height - measured height) of height prediction by
regression equations (Equation la and lb) based on lower leg length against mean of
predicted height and measured height in 53 men (a) and 121 women (b).
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Figure 3.2.3. Plot of errors (predicted height - measured height) of height prediction by
regression equations (Equation la  and lb) based on lower leg length against age in 53
men (a) and 121 women (b).
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Figure 3.2.4. Plot of errors (predicted BMI - measured BMI) of BMI prediction by
regression equations (Equation 4a and 4b) based on lower leg length against mean of
predicted height and measured height in 53 men (a) and 121 women (b).
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—  3.3  —
THE INFLUENCE OF BODY COMPARTMENTS ON 
BIOELECTRICAL IMPEDANCE ANALYSIS AND DENSITOMETRY
This section has been peer reviewed and has been published as
Han TS Carter R, Gurrall JEP, Lean MEJ, The influence of fat free mass on 
prediction of body composition by bioelectrical impedance analysis and by 
densitometry. European Journal of Clinical Nutrition 1996; 50:542-48.
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ABSTRACT
Objective: To examine the effect of varying size of fat free mass (FFM) on the precision 
and bias of body composition prediction by bioelectrical impedance analysis (BIA) from 
four equations of Segal et al (BIA-Segal), Gray et al (BIA-Gray), Lukaski et al (BIA- 
Lukaski) and those from a manufacturer (BIA-EZC), by body mass index (BMI), and by 
skinfold methods with reference to estimation by densitometry.
Subjects: 73 men and 77 women aged 17-71 years, were measured for height, weight, 
FFM, bio electrical impedance, and age.
Results: BIA-Segal gave the highest precision (men: = 83%, women: = 75%) and
the least bias (men: slope = 0.88; women: slope = 0.81) of all BIA methods. There were 
poorer precision (r^ <50%) and more bias (slope <0.70) by BIA-Lukaski and BIA-EZC 
in both sexes, which were comparable to the simpler BMI method. The skinfold method 
gave -  83% and slope = 0.84 in men, and r" = 61% and slope = 0.86 in women. Bland 
and Altman analysis showed BIA-Segal gave prediction of FFM within ±6 kg of 95% 
confidence interval limit of agreement of that estimated by UWW in most subjects. 
Other BIA methods presented unacceptably large underestimates of up to 15-17 kg in 
FFM.
Conclusions: The BIA-Segal provide the best predictions of the methods tested, but 
using BMI- or waist-specific equations may be more practical than the original BIA- 
Segal method, which requires the subjects’ % body fat to be laiown in order to apply the 
correct equation. Other BIA methods are affected by large FFM, and not better than 
anthropometric methods in predicting FFM.
Keywords: fat free mass size, bioelectrical impedance, anthropometry, densitometry.
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INTRODUCTION
Body composition can be indirectly estimated by a variety of methods which take 
advantage of different physical, physiological and biochemical characteristics of body 
tissues. Multi-compartment models are being developed in attempts to reduce errors 
resulting from assumptions inherent in conventional two compartment models of body 
composition prediction, but estimation of each new compartment introduces new 
sources of error, and traditional two-compartment models such as underwater weighing 
(UWW) and total body potassium counting are still widely used as reference standards. 
Most simple anthropometric methods are derived from UWW data, such as equations 
from body mass index (weight/height^) (Deurenberg et al, 1991), waist circumference 
(C hapter 3.1; Lean et al, 1996) skinfold thicknesses (Diunin and Womersley, 1974), 
and from bioelectrical impedance analysis (BIA) (Segal et al, 1988; Gray et al, 1989, 
Lukaski et al, 1986).
It not clear how well these methods predict body composition in subjects of different 
size of fat free mass (FFM). The present study, was part of larger body composition 
studies which have generated and validated new equations to predict body composition 
from anthi'opometric measurements (C hapter 3.1; Lean et al, 1996). Here we have 
tested the influence of FFM on the precision and bias of FFM prediction and limits of 
agreement by BIA, calculated from thi'ee published somces, Segal et al (1988), Gray et 
al (1989), Lukaski et al (1986), and from a manufacturer (EZ Comp 1500), and the two 
antliropometric methods using BMI (Deurenberg et al, 1991) and skinfolds thicknesses 
(Durnin and Womersley, 1974) in 150 adult men and women aged 17 to 71 years, who 
had a wide range of body weight.
METHODS 
Subjects
After obtaining ethical approval (Glasgow Royal Infirmary's Ethical Committee), 73 
healthy Caucasian men and 77 women aged between 17-71 years were recruited by local 
advertisement. Body composition was assessed in the morning after an overnight fast.
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All 150 subjects had UWW, BIA and antlu'opometric measurements made for 
comparison in the UWW study.
Anthropometry
Body weight in light clothes was measured to the nearest 100 g, by electronic scales 
(SECA, Germany), calibrated with 8x10 kg standard weights before use. Height was 
measured by fixed stadiometer (Castlemead, Herts, UK) to the nearest mm with the 
Frankfliit plane horizontal. Skinfold thicknesses were measured at biceps, triceps, 
sub scapular and supra-iliac by calipers (Holtain, Crymych, UK) to the nearest 0.2 mm 
(Chapter 3.1; Lean et al, 1996; WHO, 1989). Percent body fat and thus FFM, was 
estimated from equations based on BMI (Deurenberg et al, 1991) and skinfold 
thicknesses (Durnin and Womersley, 1974) both of which corrected for age and sex.
Underwater weighing
Body density was taken as the mean of 4 measurements in each subject by UWW, with 
simultaneous 3-breath nitrogen dilution technique to correct for residual lung volume. 
The mean body fat was calculated from body density (Siri, 1961). Details for measuring 
body density are described elsewhere (Chapter 3.1; Lean et al, 1996).
Bioelectrical impedance analysis
Measurements were made with a tetrapolar BIA machine (EZ Comp 1500, Birmingham, 
UK) following the manufacturer's instructions. Subjects rested supine on a couch for 15- 
20 minutes in an enclosed thermoneutral (24-26 °C) room, without touching any 
metallic object. All jewellery was removed. The skin at the sensor pad sites was 
cleansed with alcohol to remove dead skin and oil, and dried by clean cloth. Two sensor 
pads were placed on the back of the right hand (on adjacent to the third metacarpal head, 
and the other on the arm just behind the wrist), and two on the right foot (one between 
the first and second metatarsals, and the other at the level of the malleoli). Arms were 
positioned at the sides without touching the trunk with the palm flat and prone. Legs 
were kept straight and apart. Subjects’ weight, height, age and sex were entered into the
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BIA machine for analysis with the measured bioelectrical impedance to calculate body 
composition from the manufacturer’s equations (BIA-EZC). Measurements were 
repeated tluee times replacing the sensor pads on each occasion. The impedance (Ohms) 
from the BIA machine was recorded for FFM and body fat determination using the 
published equations of Segal et al (1988) (BIA-Segal). They provide specific equations 
for men above and below 20 % body fat and for women above and below 30 % body fat. 
The data were also used in the equations of Gray et al (1989) (BIA-Gray) who give one 
general equation for men and two fatness-specific equations for women (above and 
below 48 % body fat). Finally, the equations of Lukaski et al (1986) (BIA-Lukaski) 
which aie only sex-specific, were applied.
Analysis
FFM estimations by BIA methods from four different somces (BIA-Segal, BIA-Gray, 
BIA-Lukaski, and BIA-EZC), by BMI, and by skinfold methods were compared with 
FFM measured by UWW method as reference standard. There were two issues in the 
comparison (Dunn, 1989). The first was estimation precision, or how well a 
measurement on the reference method predicted a value on the test method, estimated by 
the statistic which measured the percentage of the variation in the test method 
explained by the variation in the reference method. The limits of this statistics were 
100% if the precision was perfect and 0% if there was no relationship between test and 
reference. The second was the bias of the test method relative to the reference method, 
or the degree to which there was not a one to one correspondence between the reference 
and the test scales. In this work we estimated the bias by the slope of a straight line 
regression of the test method on the reference method. If there was no bias or the bias 
was constant, the line would have a slope of 1. None of the methods under test showed 
constant bias and the non-constant bias was therefore proportional to the increase or 
decrease in the slope from 1.
The Bland and Altman analysis (1986) was performed to determine the magnitude of the 
mean error of FFM prediction of the test methods, calculated as the FFM predicted by
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each test method minus the mean FFM estimated by each test method and the reference 
UWW method. The 95% confidence intervals for the limit of bias and limit of 
agreement of the mean error of FFM prediction were calculated as ±2 SE and ±2 SD of 
the mean error, respectively.
RESULTS
Men and women had similar means and ranges of age and BMI, but on average women 
had a larger proportion of fat than men (Table 3.3.1), Table 3.3.2 summarises the 
precision and bias estimates of FFM for each of the test methods relative to underwater 
weighing and illustrates the relative effect of the bias at high and low values of FFM. 
The fatness-specific equations of BIA-Segal gave the highest precision both in men (r^ = 
83%) and in women (r^ = 75%), and the least bias (men: slope = 0.88; women: slope = 
0.81) of all BIA methods. BIA-Lukaski and BIA-EZC both gave poor precision (r^ 
<50%) and high bias (slope <0.70) for both sexes, and were thus no better than the 
simpler BMI method. BIA-Gray gave intermediate precision (men: = 62%; women:
= 66%) and bias (men: slope = 0.78; women: slope = 0.74).
The skinfold method gave precision -  83%) and bias (slope = 0.84) of FFM 
prediction similar to the BIA-Segal in men, and poorer precision {r' = 61%), but slightly 
less bias (slope = 0.86) than BIA-Segal in women (Table 3.3.2).
The effect of bias of FFM prediction at either large FFM (men: 80 kg, women: 55 kg) or 
small FFM (men: 45 kg, women: 30 kg), was assessed from regression equations using 
the reference UWW method to predict a value from each of the test methods. All 
methods overestimated FFM of small subjects and underestimated that of large subjects. 
The consequence of this is that the test methods compressed the range of FFM values 
relative to the reference (UWW). The degree of bias from size of FFM was smallest by 
BIA-Segal both in small subjects (men: +1.3; women: +3.1 kg FFM), and in large 
subjects (men: -3.0, women: -1.7 kg FFM) of all BIA methods. The effect of bias of
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FFM prediction by skinfold method was similai*, overestimating by +2.5 kg in small 
men and +3.3 kg in small women, and miderestimating by -3.1 kg in large men and -0.3 
kg in large women. The degree of bias from size of FFM in other methods, particularly 
BIA-Lukaski and BIA-EZC were relatively large, overestimating up to 5 kg in small and 
underestimating 10 kg of FFM in large subjects (Table 3.3.2).
Figures 3.3.1a-f show FFM predicted by selected test methods plotted against FFM 
measured by UWW to demonstrate the precision and bias of selected test methods. If 
there was no bias, the regression line would be identical to the line of equality. The 
closer the dots to the line of equality, the higher the precision of FFM prediction by test 
methods.
The Bland and Altman analysis (1986) was used to determine the mean prediction errors 
and their 95% confidence intei*vals of the limit of bias (+2 SE of the mean error) and 
limit of agreement (±2 SD of the mean error) in subgroups of subjects divided into 
tertiles of FFM. All methods except for the BIA-Segal and skinfold methods had 
significant bias in underestimating FFM of largest subjects (third tertile of FFM in men) 
(Table 3.3.3; Figure 3.3.2), and all but BIA-Gray method, had significant bias in 
overestimating FFM of smallest subjects (first tertile of FFM in women) (Table 3.3.4; 
Figure 3.3.2). The limits of agreement between each predicted method and reference 
method of UWW showed BIA-Segal equation gave prediction mostly within (95% 
confidence interval) 6 kg of FFM, except a slightly higher underestimation of FFM in 
largest men (-8.5 kg). BMI and skinfold methods gave similai' limits of agreement in 
women. The worst prediction of FFM by other BIA equations appeared to be affected by 
large FFM. BIA- Gray miderestimated by 15 kg FFM, and BIA-Lukaski and BIA-EZC 
by more than 17 kg of FFM in largest men.
The major disadvantage of the equations of Segal et al (1988), which was recognised by 
the authors, is that body fat of test subjects above or below 20% (men), 30% (women)
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must be known before hand so that the appropriate equations can be applied. Since % 
body fat estimated by UWW is highly (P <0.0001) correlated with waist circumference 
(men: r  = 0.83; women: r = 0.78) or BMI (men: r = 0.75; women: r ~ 0.81), it is 
possible to apply their equations on the basis of waist or BMI. Regression analysis 
showed waist circumference cut-offs at 87 cm for men and 75 cm for women or BMI 23 
kg/m^ for men and 22 kg/m^ for women were equivalent to body fat 20% in men and 
30% in women (Han and Lean, unpublished observations).
DISCUSSION
This study tested the influence of vaiying size of FFM on the precision and bias of fat 
free mass prediction, using underwater weighing as the reference method, by four 
different equations of BIA and two anthi’opometric methods in healthy subjects. These 
methods are in general use for estimating body composition based on to the two 
compartment approach.
Although BIA methods investigated in this study used the same physical measurements, 
BIA-Segal and BIA-Gray equations included height and bioelectrical impedance as 
separ ate variables, whereas BIA-Lukaski uses the ratio of height/bioelectrical impedance 
(Z) as a single variable. The BIA-Segal equations were derived from a large pooled 
sample of four different laboratories containing 1069 men and 498 women, with fatness- 
specific equations to reduce systematic errors. The BIA-Gray equations, based on Segal 
et a /’s (1988) fatness-specific equations for very obese women (>48% of body weight as 
fat), did not improve prediction or bias on the BIA-Segal method.
BIA methods use equations containing data identical to the BMI method {i.e. weight, 
height, age and sex) but with the extra impedance measurement, which requires a 
standardised protocol and the availability of the BIA machine. In terms of precision, 
bias, and limits of agreements of FFM prediction with reference to UWW, the simple 
BMI method was as good as the two methods of BIA-Lukaski and BIA-EZC.
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It is well known that body composition prediction is influenced by ageing (Demenberg 
et al, 1989; Reilly et al, 1994) and by body fatness (Chapter 3.1; Lean et al, 1996) and 
fat distribution (Han and Lean, 1994). Hydration will affect body density by UWW and 
BIA methods. Increasing fatness is accompanied by increased intra-abdominal fat mass 
(Han et al, 1995a), and the errors of body composition prediction from subcutaneous 
skinfolds will be exaggerated in those with increased intra-abdominal fat mass. The 
major confounding influence on the BMI method is muscularity. Variation in 
muscularity is most marked in men, so this may explain the particularly poor precision 
of FFM prediction in men by this method.
CONCLUSIONS
Of the four BIA formulae compared, body composition prediction by bioelectrical 
impedance analysis using different equations according to the fat content, developed by 
Segal et al (1988), had the best precision and least bias, and closest agreement of FFM 
prediction with reference to the UWW method. The other methods were affected by 
varying size of FFM and no better than the simple BMI method (Deurenberg et al,
1991). Although the fatness-specific BIA-Segal equation (Segal et al, 1988) was 
comparable to the skinfold method (Durnin and Womersley, 1974), it is not practical as 
subjects’ percentage body fat must be known before hand for applying appropriate 
equations. Using waist- or BMI-specifrc equations may be more practical.
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Table 3.3.1. Characteristics of subjects.
Men {n = 73) Women {n = 77)
Mean SD Range Mean SD Range
Age (years) 43.7 14.3 16.8-66.6 42.9 13.4 22.3-70.7
Weight (kg) 79.0 14.5 58.8-122.1 66.7 12.4 46.1-97.3
Height (m) 1.75 0.06 1.61-1.88 1.62 0.06 143-1.78
Body mass index (kg/m^) 25.7 4.4 18.9-41.2 25.6 4.8 18.3-37.5
Fat free mass (kg)* 59.6 7.6 46.3-82.8 42.6 4.9 31.6-55.7
Body fat (% of body weight)* 23.6 8.5 5.2-43.7 34.8 8.9 16.5-51.7
* Estimated by underwater weighing (% body weight).
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Table 3.3.2. The precision of estimation (as measur ed by R )^ and bias (as measured by 
regression slope) of fat free mass estimated by different test methods: bioelectrical 
impedance, body mass index and skinfold, calibrated against fat free mass estimated by 
underwater weighing as a reference method. Estimates of fat free mass on the test 
methods for fat free mass by underwater weighing of 45 and 80 kg for men and 30 and 
55 kg for women are given to illustrate the effect of bias at both ends of the range of 
subjects in the study.
Method
Men (n = 73) Women {n = 77)
R^
(%)
Slope
(SE)
45 kg 
(SE)
80 kg 
(SE)
R^
(%)
Slope
(SE)
30 kg 
(SE)
55 kg 
(SE)
BIA-Segal 83 0.88 46.3 77.0 75 0.81 33.1 53.3
(0.046) (0.75) (1.00) (0.053) (0.72) (0.71)
BIA-Gray 62 0.78 45.8 72.9 66 0.74 33.2 51.8
(0.071) (1.18) (1.57) (0.062) (0.83) (0.82)
BIA-Lukaski 48 0.68 46.7 70.5 50 0.69 34.7 52.0
(0.084) (1.38) (1.84) (0.079) (1.07) (1.05)
BIA-EZC 46 0.69 46.2 70.4 47 0.68 35.0 51.9
(0.087) (1.43) (1.90) (0.082) (1.10) (1.08)
BMI 70 0.65 49.2 71.9 58 0.68 33.9 50.8
(0.050) (0.82) (1.09) (0.066) (0.89) (0.87)
Skinfold 83 0.84 47.5 76.9 61 0.86 33.3 54.7
(0.045) (0.74) (0.99) (0.079) (1.07) (1.05)
BIA = bioelectrical analysis; BMI = body mass index.
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Table 3.2.3. Mean errors of FFM prediction and limits of bias and limits of agreement
by different methods for subjects in each tertile of mean FFM in men.
95% confidence interval limits
Mean errorf Bias;]: Agreement §
First tertile o f  FFM {n = 24)%
BIA-Segal -0.3 -1.4, 0.7 -5.5, 4.8
BIA-Gray -2.0 -4.0, 0.0 -11.8,7.9
BIA-Lukaski -3.0* -4.8, -1.2 -11.8,5.8
BIA-EZC -3.8* -5.3, -2.3 -11.3,3.7
BMI -0.3 -1.7, 1.1 -7.2, 6.6
Skinfold 0.8 -0.2, 1.8 -4.1, 5.7
Second tertile o f  FFM (n = 25)%
BIA-Segal -0.3 -1.4, 0.9 -5.9, 5.4
BIA-Gray -2.4* -4.0, -0.8 -10.3,5.6
BIA-Lukaski -2.4* -4.9, -0.0 -14.7, 9.8
BIA-EZC -2.8* -5.6, -0.0 -16.9, 11.2
BMI 0.6 -1.0, 2.1 -6.9, 8.0
Skinfold 0.0 -1.3, 1.4 -6.7, 6.8
Third tertile o f  FFM {n = 24)%
BIA-Segal -0.9 -2.5, 0.7 -8.5, 6.7
BIA-Gray -3.1* -5.5, -0.7 -14.7, 8.5
BIA-Lukaski -3.5* -6.4, -0.6 -17.7, 10.8
BIA-EZC -3.3* -6.2, -0.5 -17.2, 10.6
BMI -3.1* -5.0, -1.3 -12.0, 5.8
Skinfold -0.3 -1.8, 1.1 -7.3, 6.6
FFM = fat free mass; BMI ^ body mass index; BIA == bioelectrical impedance analysis. Significance 
level: <0.05; fmean error = FFM by each test method minus FFM by UWW; $ limit o f  bias = ±2 SE o f
the mean errors; § limit o f  agreement = ±2 SD o f  the mean errors; ^mean FFM = (FFM by each test 
method + FFM by UWW)/2.
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Table 3.2.4. Mean errors of FFM prediction and limits of bias and limits of agreement
by different methods for subjects in each tertile of mean FFM in women.
95% confidence interval limits
Mean errorf Biasf Agreement§
First tertile o f  FFM {n = 26)%
BIA-Segal 1.1* 0.4, 1.8 -2.4, 4.6
BIA-Gray 0.7 -0.2, 1.5 -3.7, 5.0
BIA-Lukaski 1.0* 0.1, 2.0 -3.7, 5.7
BIA-EZC 1.0* 0.0, 2.3 -4.0, 6.0
BMI 0.8* 0.0, 1.6 -3.3, 4.9
Skinfold 1.4* 0.3, 2.5 -4.2, 7.0
Second tertile o f  FFM (n — 25)%
BIA-Segal 0.9 -0.2, 2.0 -4.6, 6.4
BIA-Gray 0.1 -1.2, 1.4 “6.3, 6.6
BIA-Lukaski 1.1 -0.4, 2.1 -6.5, 8.6
BIA-EZC 1.3 -0.3, 2.9 -6.8, 9.4
BMI -0.4 -1.9, 1.1 -7.9, 7.2
Skinfold 1.1 -0.2, 2.5 -5.7, 7.9
Third tertile o f  FFM (n = 26)%
BIA-Segal 0.1 1.0, 1.1 -5.2, 5.3
BIA-Gray -0.8 -2.0, 0.4 -6.9, 5.3
BIA-Lukaski 0.4 -1.5, 2.2 -8.8, 9.5
BIA-EZC 0.4 -1.4, 2.2 -8.7, 9.5
BMI -1.0 -2.3, 0.3 -6.7, 5.7
Skinfold 1.9* 0.3, 3.5 -6.1, 9.9
FFM = fat free mass; BMI = body mass index; BIA = bio electrical impedance analysis. Significance 
level: *P  <0.05; fmean error = FFM by each test method minus FFM by UWW; f  limit o f  bias = ±2 SE o f  
the mean errors; §limit o f agreement = ±2 SD of the mean errors; %mean FFM = (FFM by each test 
method + FFM by UWW)/2.
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Figure 3.3.1. Plots of fat free mass (FFM) predieted by bioelectrical impedance analysis 
(BIA) using equations from Segal et al (a and b), Lukaski et al (c and ), skinfold method 
(e and f) against FFM estimated by densitometry, showing the precision (R^) and bias 
(slope) of FFM prediction in 73 men and 77 women. Solid line indicates line of 
regression, and dashed line indicates line of equality.
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Figure 3.3.2. Plots of errors of FFM prediction (FFM predicted by test method minus 
FFM estimated by reference UWW method) against mean FFM (test method and the 
reference UWW method), for the test methods using equations from; a and b (Segal et 
al, 1988); c and d (Gray et al, 1989); e and f  (Lukaski et al, 1986). Vertical dashed lines 
separ ate tertiles of mean FFM.
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Figure 3.3.2. - continued. Plots of errors of FFM prediction (FFM predicted by test 
method minus FFM estimated by reference UWW method) against mean FFM (test 
method and the reference UWW method), for the test methods using equations from; g 
and h (from a manufacturer); i and j, from BMl (Deurenberg et al, 1991); k and 1, from 
skinfolds (Durnin and Womersley, 1974). Vertical dashed lines separate tertiles of mean 
FFM.
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4.1
WAIST CIRCUMFERENCE AS A MEASURE FOR INDICATING 
NEED FOR WEIGHT MANAGEMENT: DEVELOPMENT OF CUT­
OFFS FOR HEALTH PROMOTION
This section has been peer reviewed and has been published as
Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for 
indicating need for weight management. British Medical Journal 1996; 311:158- 
61.
Collaboration with WHO MONICA project.
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ABSTRACT
Objective: To test the hypothesis that a single measurement, waist circumference, might 
be used to identify people at health risk both from being overweight and from having a 
central fat distribution.
Design: A  community derived random sample of men and women and a second, 
validation sample.
Setting'. North Glasgow.
Subjects'. 904 men and 1014 women (first sample); 86 men and 202 women validation 
sample.
Main outcome measures: Waist circumference, body mass index, waist:hip ratio.
Results: Waist circumference >94 cm (37”) for men or >80 cm (31.5”) for women 
identified individuals with high body mass index >25 kg/m^ and those with lower body 
mass index but high waistihip ratio (>0.95 for men, >0.80 women) with a sensitivity of 
>96%, and specificity >97,5%. Waist circumference >102 cm (40”) for men or >88 cm 
(34.5”) for women identified subjects with body mass index >30 kg/m^ and those with 
lower body mass index but high waistihip ratio with a sensitivity of >96% and 
specificity >98%, with only about 2% of the sample being misclassified.
Conclusions: Waist circumference could be used in health promotion programmes to 
identify individuals who should seek and be offered weight management. Men with 
waist circumference >94 cm for men and women with waist circumference >80 cm 
should gain no further weight; men with waist circumference >102 cm and women with 
waist circumference >88 cm should reduce their weight.
Keywords: body mass index, waist circumference, waistihip ratio, weight loss, obesity, 
risk factors.
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INTRODUCTION
About half of all British adults have a body mass index (weight (kg)/height (m^)) of >25 
kg/m^, almost 15% >30 kg/m^ and these proportions are rising (Gregory et al, 1990; 
Bermett et al, 1995). Given the lack of success of the management of obesity and 
increasing associated health costs (Secretary of State for Health, 1991; Scottish Office, 
1992), greater emphasis on prevention is needed, particularly in young people, who 
often have little contact with health services. Wliile many health professionals are now 
familiar with the acceptable range for body mass index (20-25 kg/m^) (Beimett et al, 
1995; Cardiovascular Review Group Committee on Medical Aspects of Food, 1994) 
most members of the public cannot readily calculate their index to establish their own 
risk or need for weight management. Charts developed by the Health Education 
Authority (1991) are helpful, but are still not understood by many. Height must be 
measured accurately as small errors in the denominator are exaggerated by squaring.
The major metabolic cardiovascular risk factors (high blood pressure, plasma lipids, 
insulin resistance) all aggregate independently with both body mass index and waistihip 
ratio (Bjorntorp, 1987; Seidell et al, 1989b) and improve with weight loss (Casimirri et 
al, 1989; den Besten et al, 1988; Dennis et al, 1993; Kanaley et al, 1993; van Gaal, 
1990). The circumference of the waist relates closely to body mass index and is also the 
dominant measui'ement in the waistihip ratio, which reflects the proportion of body fat 
located intra-abdominally, as opposed to subcutaneously (Bjorntorp, 1987), and waist 
circumference is the best indicator of changes in intra-abdominal fat during weight loss 
(van der Kooy et al, 1993).
We evaluated waist circumference as a simple predictor of health risk from being 
overweight and through the central distribution of fat to indicate levels at which 
individuals should take action.
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METHODS 
Subjects
Determination study
We randomly recruited of 904 men and 1014 women, aged 25 to 74 years, fi'om the 
general population of north Glasgow between January and August 1992, excluding only 
those who were chair bound.
Validation study
We recruited separately 86 men and 202 women by advertising locally to test the 
proposed Action Level (levels at which individuals may at risk from being overweight) 
derived in the determination study.
Anthropometry
All measurements were made by trained observers with standard techniques (World 
Health Organisation, 1989): weight by digital scales (Seca, Germany) to within lOOg, 
without heavy clothing; height barefoot by portable stadiometer (Holtain, Crymych, 
United Kingdom) to 0.5 cm; circumferences to within 1 rmn with plastic tapes calibrated 
weekly, with waist mid-way between the lowest rib and iliac crest with the subject 
standing at the end of gentle expiration, and hips at the greater trochanters. We used the 
same methods determine and validate studies by different researchers.
Methods of analysis
Combination with indices in the range height^'* to height^ did not improve the 
correlations of waist circumference alone with body mass index ( r= 0.89; P <0.001 for 
both sexes). According to the criteria of Kliosla and Lowe (1967), height was therefore 
not used with waist circumference for further analyses.
We determined by cross tabulation between variables (Noruàis, 1993) two Action Level 
for waist circumference for weight management to identify most subjects with body 
mass index >25 kg/in^ (Action Level 1) and >30 kg/m^ (Action Level 2), while
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including a minimum of subjects who had lower body mass index and low waistihip 
ratio to maximise sensitivity and specificity (Hanson, 1988). High body mass index was 
defined at two levels as >25 or >30 k%!m for both men and women (Health Education 
Authority, 1991). On the basis of consensus from previous studies (Casimirri et al, 
1989; Den Besten et al, 1988; Dennis et al, 1993; Kanaley et al, 1993; van Gaal, 1990), 
high waistihip ratio was defined as >0.95 for men and >0.80 for women and low 
waistihip ratio as below these cut-offs.
RESULTS
Determination Study
The mean age (range 25 to 74 years), body mass index, and hip circumference were 
similar for men and for women (Table 4.1.1). However, men were heavier and taller and 
had a larger waist circumference and waistihip ratio than women. In both sexes, 
waistihip ratio correlated positively with body mass index (men, r  = 0.63; womeni r = 
0.39; both P <0.001) (Table 4.1.2). Waist circumference correlated weakly with height 
in men (r = 0.19; P  <0.05), but not women (r = 0.06, P  = 0.06). On average, men with 
waist circumference above ‘Action Level V were 2 cm taller than those below, 
accounting for 0.7 cm difference in waist circumference, but Action Level for waist 
circumference determined for four different height categories (not shown) did not differ.
Figure 4.1.1 shows distributions of the waist circumference related to body mass index 
divided by the proposed Action Level. Table 4.1.3 show the numbers in different 
categories of waist circumference, body mass index, waistihip ratio. ‘True positive’ 
subjects were those with high body mass index and those with lower body mass index 
but high waistihip ratio; ‘true negative’ subjects were those with low body mass index 
and those with high body mass index but low waistihip ratio. ‘False positive’ subjects 
were those with waist circumference above the Action Level but with low body mass 
index and waistihip ratio; false negative’ subjects were those with waist circumference 
below the Action Level but with high body mss index and waistihip ratio. These
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numbers were used to determine the sensitivity and specificity for waist circumference 
as an indicator of need for weight management (Table 4,1.4).
False negative subjects, who would be missed by health education, targeted using waist 
circumference, would represent under 1.5% of the population. 'False positive' 
individuals (1.7% of the total population) would he included inappropriately by health 
promotion directed at those with high waist circumference. Amongst false positives at 
Action Level, men had body mass indices 23.2-24.8 kgim  and waistihip ratios 0.91- 
0.95, and women had body mass indices 23.0-24.9 kg/m^ and waistihip ratios 0.77-0.80. 
Amongst false positives at Action Level 2, men had body mass indices 26.9-29.7 kg/m^ 
and waistihip ratios 0.88-0.94, and women had body mass indices 28.7-29.6 kglm  and 
waistihip ratios 0.79-0,80. Misclassified individuals were thus close to the levels at 
which weight loss would be recommended, and hazards of health promotion hased on 
waist circumference Action Levels would be minimal.
Validation study
The validation sample was younger than the determination sample, but had similar 
ranges of antliropometric measurements(Table 4.1.1). The Action Levels of waist 
circumference showed similarly high sensitivity (>94%) and specificity (>97%) for 
identifying high risk individuals in need of weight management (Tables 4.1.3 & 4.1.4). 
There was no significant relationship between waist circumference and height in either 
men {r = 0.07; P  = 0.54) or women {r = -0.13; P ~ 0.07).
DISCUSSION
The influences of body mass index and waistihip ratio on metabolic and cardiovascular 
disease are multiplicative (Lapidus et al, 1984; Larsson et al, 1984; Ohlson et al, 1985), 
so weight loss should be urged for all those with high body mass index, and can also be 
justified for those with lower body mass index but high waistihip ratio. Consensus 
emerging from prospective studies suggests cut-offs of waistihip ratio 0.95 in men and 
0.80 in women as figures above which health risk increases importantly. Metabolic risk
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factors, particularly serum triglycerides and high density lipoprotein cholesterol improve 
most from weight loss in men (Sonnichsen et al, 1992; Houmard et al, 1994; Wing et al,
1992) with waistihip ratio >0.95 and women (den Besten et al, 1988; Dermis et al, 1993; 
Kanaley et al, 1993) with waistihip ratio >0.80 (Table 4.1.5). In the present study, 48% 
of the women and a 33% of the men had waistihip ratios above these figures (Table 
4.1.2); well over half had body mass indices above 25 kg lm . The interaction between 
body mass index and waistihip ratio offers through waist circumference an opportunity 
to target individuals at highest risk in order to maximise the benefits of interventions 
(Davey Smith era/, 1993; Yudkin, 1993).
Many analyses have found strong positive correlations between waist circumference and 
body mass index. This relationship alone allows only limited prediction of body mass 
indexi in the present study, waist circmnference would misclassify about 4% men and 
7% women in attempting to identify those with body mass index >25 kg/m^, or 10% 
men and 11% women at body mass index >30 kg/m^. Health promotion targeted by 
waist circumference at those with body mass index >25 kg/m^ would miss about 21% of 
the total at risk population (>25 kg/m^), and about 10% of those identified would be 
targeted inappropriately. However, most of those with high waist circumference but 
body mass index below these conventional cut-offs have high waistihip ratio, which still 
justifies weight management. Most of those with higher hody mass index but waist 
circumference below the Action Level have low waistihip ratio, which would indicate a 
lower health risk, and less benefit from slimming. The Action Level for waist 
circumference derived here, based on both body mass index and waistihip ratio, are 
robust in that they misclassified only 1.5% of the overweight men and women.
The simplicity of measurement and its relation to hoth body weight and fat distribution 
are major advantages for waist circumference over body mass index and waistihip ratio. 
Self measurement and reporting of waist circumference has been reported to be 
acceptable in recent epidemiological studies (Rimm et al, 1990; Chan et al, 1994) but
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better information will be needed about possible self-reporting bias, and ability to 
monitor changes with weight management. Proof of the value of waist circumference 
measurements in predicting health risks will require longitudinal follow-up of morbidity 
and mortality, however waist circumference is more highly associated with metabolic 
function than waistihip ratio in adults (Houmard et al, 1994) and in children (Flodmark 
et al, 1994) and predicts myocai’dial infai’ction (Lapidus et al, 1984). The proposed 
Action Levels match the results of Chan et al (1994), who found progressively 
increasing relative risk of developing type 2 diabetes in men as waist circmnference rose 
fi'om 73.7-87.6 cm to 91.7-96.5 cm (relative risk = 2.2) and to those above 102.0 cm 
(relative risk = 12). Pouliot et al (1994) observed exponential increases in cardiovascular 
risk factors with waist circmnference above 87 cm in men and 78 cm in women, which 
correspond to waist circumference of Action Level 1, and further risk factor increases 
with waist circmnferences above Action Level 2. Proof of the value of waist 
circmnference will require longitudinal follow up of morbidity and moiJality. 
Longitudinal data from the Framingham study suggest that waist predicts mortality 
better than other antliropometric measures (Higgins et al, 1988).
CONCLUSIONS
Action Levels of waist circmnference (measmed using bony landmarks, midway 
between the iliac crests and the lowest rihs) identified in the present study could form 
the basis for health promotion to raise awareness, or to urge action in terms of weight 
reduction. The lower Action Level 1 of waist circumference 94 cm (men) and 80 
(women) represents a tlneshold above which health risks are increase - particularly for 
young men (Chan et al, 1994; Must et al, 1992). Fmther weight gain and rise in waist 
circmnference from Action Level 1 towards Action Level 2, should be prevented. The 
upper Action Levels 102 cm for men and 88 cm for women eorrespond with the point 
when symptoms of breathlessness and arthiitis begin to develop from overweight, and 
health risks are such that medical consultation and active weight loss should be urged.
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Table 4.1.1. Characteristics of subjects in determination sample and independent 
validation sample.
Determination sample Validation sample
Men 
{n = 904)
Women 
{n = 1014)
Men 
in = 86)
Women 
(n = 202)
Mean SD Mean SD Mean SD Mean SD
Age (years) 51.0 14.1 50.8 14.0 44.9 14.1 37.5 12.6
Weight (kg) 75.9 13.7 65.9 14.5 80.3 16.1 66.6 13.5
Height (cm) 170.7 7.0 158.2 6.5 174.9 6.6 162.2 6.7
BMl (kg/m2) 26.0 4.1 26.3 5.5 26.2 4.7 25.4 5.3
Waist (cm) 93.3 11.9 82.0 12.3 93.1 14.8 80.1 14.2
Hips (cm) 100.5 7.7 101.7 11.1 99.8 8.1 101.7 9.8
Waistihip ratio 0.93 0.07 0.80 0.07 0.93 0.09 0.79 0.10
BM l = body mass index
Table 4.1.2. Number of subjects in determination sample in different categories of body 
mass index and waistihip ratio.
Body mass index (kg/m^)
<20 20- 25- >30 Total
Men
0.72-<0.95 99 241 201 23 564
0.95-1.13 0 52 183 105 340
Total 99 293 384 128 904
Women
0.65-<0.80 61 267 143 54 525
0.80-1.20 13 139 186 151 489
Total 74 406 329 205 1014
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Table 4.1.3. Number of men and women in different categories of body mass index and 
waistihip ratio in groups classified by waist circumference Action Level in 
determination sample and validation sample.
Determination
sample
Validation
sample
Men
«=904
Women
«=1014
Men
«=86
Women
«=202
Action Level 1 
Waist >94 cm for men and 80 >cm for women 422 512 24 88
With body mass indexi
>25 389 437 16 81
<25 33 75 9 7
<25 but high waistihip ratio 25 68 2 4
<25 and low waistihip ratio* 8 7 0 3
Waist <94 em for men and 80 <cm for women 482 502 61 114
With body mass indexi
<25 359 405 61 107
>25 13 97 0 7
>25 but high waistihip ratio 113 83 9 7
>25 and low waistihip ratiot 10 14 2 0
Action Level 2 
Waist >102 cm for men and 88 >cm for women 210 292 35 50
With body mass indexi
>30 116 184 33 30
<30 94 108 2 20
<30 but high waistihip ratio 82 106 9 19
<30 and low waistihip ratio* 12 2 0 1
Waist <102 cm for men and 88 <cm for women 694 722 55 156
With body mass indexi
<30 682 701 40 151
>30 12 21 11 5
>30 but high waistihip ratio 8 19 0 1
>30 and low waistihip ratio | 4 2 0 0
High waistihip ratio >0.95 for men and >0.80 for women; low waistihip ratio <0.95 for men and <0.80 for 
women; * false positive subjects; Jfalse negative subjects.
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Table 4.1.4. False positive and false negative subjects and sensitivity and specificity for 
men and women in determination sample and in validation sample by waist 
circumference to identify those with body mass index and >25 or >30 and those with 
lower body mass index but waistihip ratio >0.95 (men) or >0.80 (women).
Body mass index 
(kg/m^)
Waist
(cm)
False
positive
False
negative
Sensitivity
(%)
Specificity
(%)
Determination samplei 
Men (n = 904)
25- >94 8/340 10/280 96.8 98.2
>30 >102 12/541 4/105 97.9 97.8
Women (« = 1014) 
25- >80 7/328 14/337 96.5 98.3
>30 >88 2/471 2/151 99.2 99.6
Validation samplei 
Men (« = 86) 
25- >94 0/38 2/32 94.1 100
>30 >102 0/49 0/15 100 100
Women {n = 202) 
25- >80 3/98 0/63 100 97.1
>30 >88 1/120 0/28 100 99.2
negatives/(true negatives + false positives).
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Figure 4.1.1. Relation between waist circumference and body mass index in men and in 
women from determination sample and the two Action Levels of waist circumference 
that identify subjects with body mass index >25 or >30 kglva and with waistihip ratio 
>0.95 for men and >0.80 for women. Dotted line shows Action Level 1, solid line 
Action Level 2. O Waistihip ratio >0.95 men, >0.80 womeni false negative in upper left 
quadrant; #  waistihip ratio <0.95 men, <0.80 womeni false positives in lower right 
quadrant. Linear regressioni body mass index = (0.307 x waist circumference) - 2.6 
(men); body mass index = (0.394 x waist circumference) - 6.0 (women).
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4.2
WAIST CIRCUMFERENCE AS A SCREENING TOOL FOR 
CARDIOVASCULAR RISK FACTORS: EVALUATION OF 
RECEIVER OPERATING CHARACTERISTICS (ROC)
This section has been peer reviewed and has been published as
Han TS. van Leer ME, Seidell JC, Lean MEJ. Waist circumference as a 
screening tool for cardiovascular risk factors: evaluation of receiver operating 
characteristics (ROC). Obesity Research 1996; 4:533-47.
Collaboration with MORGEN project
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ABSTRACT
Objective'. To evaluate the receiver operating characteristics (ROC) to determine the cut­
offs of waist circumference as a potential population directed screening tool for 
hypercholesterolaemia (>6.5 mmol/1), low high density lipoprotein cholesterol (<0.9 
mmol/1), and hypertension (treated and/or systolic >160 and/or diastolic blood pressure 
>95 mmHg), in 2183 men and 2698 women aged 20-59 years selected at random from 
Dutch civil registries.
Main outcome measures'. Height, weight, body mass index (BMl) waist circumference, 
total plasma cholesterol and high density lipoprotein cholesterol concentrations, and 
blood pressure.
Results'. ROC curves showed that sensitivity equalled specificity at waist circumferences 
between 93-95 cm in men and 81-84 cm in women for identifying individual risk 
factors, and 92 cm in men and 81 cm in women for identifying those with at least one 
risk factor. Sensitivity and specificity were equal at levels between 61% to 69% for 
identifying individual risk factors, with positive predictions (56.8% in men and 37.8% in 
women) within 2% of those using previously defined ‘Action Level 1’ of waist 
circumference 94 cm in men and 80 cm in women (58.8% in men and 37.4% in women). 
Risk prediction by antlnopometric methods is relatively low: ROC areas for identifying 
each risk factor hy waist varied from 55 to 60%, and reached about 65% for identifying 
at least one risk factor. Height accoimted for less than 0.3% of variance in waist 
circumference. Using BMl at 25 kg/m^ gave similar prediction to waist, hut its 
combination with waist did not improve predictive values.
Conclusions: Measurement of waist circumference ‘Action Level 1’ at 94 cm (37 
inches) in men and 80 cm (32 inches) in women could be adopted as a simpler valid 
alternative to BMl for health promotion, to alert those at risk of cai'diovascular disease, 
and as a guide to risk avoidance by self-weight management.
Key words: epidemiology, fat distribution, health, obesity, weight management
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INTRODUCTION
Large waist circumference reflects both high hody fatness (body mass index) and central 
fat distribution (waist to hip ratio) (Chapter 4.1; Lean et al, 1995). Waist circumference 
has also heen shown to relate closely to the metabolically active intra-abdominal fat 
(Pouliot et al, 1994; Seidell et al, 1988), Després and his colleagues (1990) have 
suggested that waist circumference may be the most important anthiupometric index of 
fat distribution as a predictor of cardiovascular risk, in preference to waist to hip ratio. 
We have proposed two ‘Action Levels’ of waist circumference for health promotion 
purposes, to identify subjects with increasing (‘Action Level 1’: men 94 cm, women 80 
cm) or high (‘Action Level 2’: men 102 cm, women 88 cm) health risk (Chapter 4.1; 
Lean et al, 1995). These ‘Action Levels’ of waist circumference have been replicated in 
different populations and shown to classify individuals at increased cardiovascular risk 
both in men and women (Chapter 5.2; Han et al, 1995c).
The present study was designed to examine whether different criteria or ‘cut-offs’ of 
waist circumference are necessary to identify individuals who are at increased risks of 
different risk factors, i.e. hypercholesterolaemia (European Atherosclerosis Society, 
1987; WHO MONICA Project, 1988), low plasma high density lipoprotein cholesterol 
(European Atherosclerosis Society, 1987), hypertension (WHO MONICA Project, 
1988), and at least one of these risk factors. We are aware that total cholesterol/high 
density lipoprotein cholesterol ratio may give a better index of cai'diovascular risk than 
single measures. This will be addressed in future study, but the present paper is limited 
to single measures and the category of any one risk factor includes both total cholesterol 
and high density lipoprotein cholesterol. The ‘Action Levels’ of waist circumference 
proposed on the basis of body mass index and waist to hip ratio by Lean et al (1995) 
were related to the cut-offs of waist circumference that identified the highest nmnbers of 
subjects with and without the risk factors, i.e. where sensitivity and specificity of 
prediction were equal for different risk factors (Sturmans, 1984).
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METHODS 
Subjects
A random sample of 2183 men and 2698 women aged 20-59 years was selected fi’om the 
civil registries in Amsterdam, Maastricht and Doetinchem, as part of the MORGEN 
(monitoring risk factors and health in The Netherlands) project to determine the prevalence 
of risk factors for chi’onic diseases, and also other specific clnonic conditions in a sample 
of the general population living in various par ts of the Netherlands. The measurements 
were made in basic health service centres in Amsterdam (the capital city in the West), 
Doetinchem (a small town in the East) and Maastricht (a town in the South). To obtain 
equal numbers in each age group, the sample was stratified according to gender and five 
year age groups. The response rate was approximately 50% in Amsterdam and Maastricht, 
and 80% in Doetinchem.
Anthropometry
All measurements were made by trained investigators. Body weight in light clothes was 
measured to the nearest 0.1 kg, and height to the nearest 0.5 cm. Body mass index was 
calculated as weight/height^ (kg/m^). Waist circumference midway between lower rib 
and iliac crest, and hip circumference at the level of the great trochanters were measured 
in duplicate using flexible tape to the nearest mm (WHO Expert Committee, 1995).
Cardiovascular risk factors
Sitting blood pressure was measured using random zero sphygmomanometer, by 
technicians who had been trained by a physician. Small ( 9x18  cm), medium (size 12 x 23 
cm) or large (15 x 33 cm) cuff was used to fit upper arms of different sizes. Systolic (frrst- 
phase Korotkoff) and diastolic (fifth-phase Korotkoff) hlood pressure were measured twice 
on the left upper arm, and the average was used for analysis.
Total and high density lipoprotein-cholesterol were determined enzymatically using 
Boehringer test kit (Katterman et al, 1984). High density lipoproteins were isolated by 
precipitating apo-B containing lipoproteins with magnesium phosphotungstate described
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by Lopes-Virella et al (1977). This method used a mixture a 2 ml of plasma, 200 pi of 
sodium phosphotungstate solution, and 50 pi of MgCl2 . All cholesterol analyses were 
performed at the Clinical Chemistry Laboratory, University Hospital of Dijkzigt in 
Rotterdam, which is part of the standar dization program (WHO Regional Lipid Center for 
Em'ope in Prague, Czechoslovakia, and the Centers for Disease Control in Atlanta, USA).
Analysis
The criteria for cut-offs of cardiovascular risk factors were selected before analysis, based 
on consensus figur*es from the European Atherosclerosis Society (1987) and the World 
Health Organization (1988). Hypercholesterolaemia was defined as plasma cholesterol 
>6.5 mmol/1 (European Atherosclerosis Society, 1987; WHO MONICA Project, 1988), 
low high density lipoprotein-cholesterol as <0.9 mmol/1 (European Atherosclerosis 
Society, 1987), and hypertension as systolic blood pressure >160 mrnHg and/or diastolic 
blood pressure >95 mmHg and/or the use of antihyperfensive agents (WHO MONICA 
Project, 1988).
Statistical methods
The numhers of subjects at different levels of waist circumference with or without 
cardiovascular risk factors were determined by cross tabulation, and these numbers were 
used to determine the receiver operating characteristics of waist circumference in the 
identification of risk factors. Sensitivity was defined as the percentage of the total 
number of subjects with risk factor who were identified correctly by high (above the cut­
off level) waist circumference, and specificity as the percentage of the total number of 
subjects without risk factor who were correctly identified hy low (below cut-off level) 
waist circumference. Positive prediction was calculated as the percentage of subjects 
with waist circumference above the cut-off level who had the risk factor, and negative 
prediction as the percentage of those with waist circumference below cut-off level who 
did not have the risk factor (Sturmans, 1984),
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Sensitivity and specificity for predicting risk factor prevalence by various waist 
circumferences were plotted against waist circumference. The cut-offs where waist 
circumference identified the highest numbers of subjects with and those without the risk 
factors were obtained by interpolation from the intersect at which the lines of sensitivity 
and specificity crossed each other (i.e. where sensitivity equalled specificity) (Stimnans, 
1984). The areas of the receiver operating characteristic (ROC) curves for waist 
circumference in identifying risk factors were examined using the modified equations of 
Hanley and McNeill (1982).
Adjustments for body mass index and waist to hip ratio were not made because of 
multicollinearity with waist circumference (Belsley et al, 1980). Height accounted for 
less than 0.3% of variance in waist circumference (Figures 4.2.1a & b), and was not 
subsequently used in analysis of waist circumference. Statistical analyses performed 
SAS computer prograimne (SAS Institute, Gary, USA).
RESULTS
Mean age, body mass index, hip circumference and total cholesterol were similar- in men 
and women. Men had higher waist circumference, waist to hip ratio and blood pressure, 
and lower high density lipoprotein cholesterol than women (Table 4.2.1). Waist 
circumference coixelated significantly {P <0.001) with body mass index (men: r = 0.860, 
women: r = 0.850) and waist to hip ratio (men; r ~ 0.84, women: r = 0.81). Body mass 
index also correlated significantly {P <0.001) with waist to hip ratio both in men {r = 
0.64) and women (r = 0.51). The relationships between waist circumference and height 
(Figures 4.2.1a & b) were extremely weak, and therefore waist circumference was not 
adjusted for height.
The numbers (%) of subjects who had cholesterol >6.5 mmol/1 were 323 (14.9%) in men 
and 401 (15.0%) in women, 564 (26.0%) men and 159 (6.0%) women had high density 
lipoprotein <0.9 mmol/1, 191 men (9.7%) men and 198 (7.3%) women were considered
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to be hypertensive, and there were 887 (40.6%) men and 657 (24.4%) women who had 
at least one of these risk factors.
The levels of waist circumference that coixectly identified the maximum numbers of 
subjects with and without the risk factors, i.e. the highest value of (sensitivity + 
specificity)/2, were around 95 cm in men (Figure 4.2.2a) and 80 cm in women (Figure 
4.2.2b). The exact cut-offs that identified the maximum numbers of subjects with and 
without the risk factors were obtained by inteipolation from the point at which sensitivity 
crossed specificity. These cut-offs were very close to waist circumference at the 
proposed ‘Action Level 1’ (94 cm in men, 80 cm in women) in both men and women 
(Tables 4.2.2a & b; Figures 4.2.3 & 4.2.4): the cut-offs for identifying each risk factor 
tended to be a little higher than ‘Action Level V in women, and below ‘Action Level 1 ’ 
in men, but the differences were mostly less than 2 cm. The cut-offs for identifying 
those with at least one risk factor in men (92 cm) were 2 cm below ‘Action Level 1’ (94 
cm), but almost identical to ‘Action Level V  (80 cm) in women (80.6 cm).
The differences in sensitivity and in specificity between the cut-offs and ‘Action Level 
r  were within 10 % (within 5 % in most cases) of each other. The differences in 
positive and in negative predictions of risk factors were very small between these levels. 
Positive prediction of those with at least one or more risk factors was higher than that of 
each individual risk factor, both in men (56.8 %) and women (37.8 %), but negative 
predictions were slightly lowered (Tables 4.2.2a & b).
Table 4.2.3 shows that waist circumference ‘Action Level V performed similarly to 
body mass index 25 kgtm  for identifying those with risk factors (positive prediction) 
and those without risk factors (negative prediction) both in men and women. Including 
subjects with waist circumference below ‘Action Level 1’ but whose body mass index 
was above 25 kg/m^ did not further improve the prediction of cardiovascular risk factors. 
The cut-off of waist circumference for identifying at least one risk factor (92 cm) was 
used as the general cut-off for each individual risk, showed slightly better negative
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prediction but was less good in positive prediction than ‘Action Level 1’ (Table 4.2.4). 
The equivalent cut-offs of waist in women (80.6 cm) was not analysed further, since it 
was so close to ‘Action Level 1’ (80 cm).
The estimated areas of the receiver operating characteristic curves for waist 
circumference in identifying each risk factor varied between 55-60%, and about 65% for 
identifying at least one risk factor.
DISCUSSION
Waist circumference correlated highly (r >0.8; P <0.001 hoth in men and women) with 
body mass index and waist to hip ratio in the present study, and can identify those with a 
combination of high or low body mass index and high waist to hip ratio (Chapter 4.1; 
Lean et al, 1995). The ‘Action Levels’ of waist circumference for men and women were 
derived to indicate the need for weight management (Chapter 4.1; Lean et al, 1995), 
based on the conventional cut-off of body mass index 25 kgiva or 30 kgim  and waist to 
hip ratio in men 0.95 and 0.80 in women. These ‘Action Levels’ have been proposed for 
use in health promotion as likely to indicate increasing risks from obesity related 
complications, avoiding the need to calculate body mass index, or errors from inaccurate 
height measuiement (Chapter 3.1; Lean et al, 1996). The present study provides 
justification for ‘Action Level 1’ (94 cm in men, 80 cm in women) on the ground that it 
is remarkably close to the cut-offs of waist associated with increased risk (92 cm in men, 
80.6 cm in women) of any one or more major cardiovascular risk factors. On this basis, 
use of a cut-off of waist circumference allows prediction as good as body mass index for 
all the major cardiovascular risk factors, and for the total number of people at risk.
The cut-offs in the present study for men and women are different, since the derivation 
were based on relative risk within each sex. Our previous study of the same subject 
sample showed men and women have the same absolute prevalence of cardiovascular 
risk factors for a given waist circumference (Chapter 5.2; Han et al, 1995c). Pouliot et 
al have suggested a cut-off of waist circumference in predicting health risks o f 100 cm
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both for men and for women (Pouliot et al, 1994). However, although a cut-off of 100 
cm will give a valid cut-off for absolute level of risk, irrespective of gender, a larger 
number of women with risk of preventable disease would not be identified.
The areas of the receiver operating characteristic curves for waist circumference in 
identifying individual risk factors of 55-60% and at least one risk factor of 65% were 
thus relatively low, but similar to the level expected from other anthropometric 
measurements in identifying health risks (WHO Expert Committee, 1995). Using waist 
circumference as a tool to screen for risk factors would inevitably misclassify at least 35 
% of subjects by falsely including subjects who have waist circumference above the cut­
off but without risk factors, and excluding those whose waist circumference below the 
cut-off but with risk factors. The figures used as cut-offs for total cholesterol >6.5 
mmol/1 (European Atherosclerosis Society, 1987; WHO MONICA Project, 1988), for 
high density lipoprotein cholesterol <0.9 mrnol/1 (European Atherosclerosis Society, 
1987) and for systolic >160 and diastolic blood pressure >95 mmHg (WHO MONICA 
Project, 1988) are widely used to indicate elevated cardiovascular risk, but fairly 
conservative. The yield of individuals who would fulfil risk factor criteria at a lower- 
level of risk, e.g. high density lipoprotein <1.0 rnmol/1, total cholesterol >5.2 mmol/1, 
would be greater than those identified by the risk factor levels employed in the present 
paper, and would lower the intersect where sensitivity equals specificity by waist 
circumference of about 3 cm (data not shown). We have examined the relationships 
between waist circumference and risk factors, including plasma triglyceride, elsewhere 
(Chapter 7; Han et al, 1997a). Unfortunately, plasma triglyceride, which relates closely 
to waist circumference, and metabolic risk, was not available for the present analysis.
It is theoretically possible that age might modify the amount of intra-abdominal fat at 
any given waist circumference. Examination of waist circumference for two separate age 
groups of 20-39 and 40-59 years showed that compai-ed to the cut-off for the whole 
population (Figures 4.2.3 4.2.4), the intersect where sensitivity equalled specificity in
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predicting risk factors was about 3 cm lower in younger subjects, and 3 cm higher in 
older subjects in both sexes (data not shown). This observation agrees with other 
suggestions that higher body mass index is not strongly associated with coronary heart 
disease in older subjects. If the criteria used to define levels of risk were slightly lowered 
for younger subjects, and raised for older subjects (on the basis that for any given level 
of metabolic risk factor, younger subjects are more likely to develop premature 
cardiovascular disease), then the age specific cut-offs of the two age groups would he 
even huther apart. On this hasis, adopting lower waist circumference ‘Action Level 1’ 
for younger people - say 90 cm (35 inches) in men and 76 cm (30 inches) in women, 
could be justified.
Sensitivity and specificity are inversely related. The decision for choosing a cut-off 
depends on the purpose and potential use (WHO, 1995). Lowering the cut-off of waist 
circumference would increase sensitivity for risk identification, but include more 
subjects who do not have the risk factors (false positives). Selecting a higher cut-off 
would increase specificity, but more subjects who have the risk factors (false negatives) 
would be missed from screening for potential health risks. The figures for waist 
circumference ‘Action Levels’ (Chapter 4.1; Lean et al, 1995) were proposed to alert 
people to increasing health risks. Subjects with waist circumference helow ‘Action 
Level 1 ’ do not need to lose weight but should be aware of potential health risks when 
their waist approaches this level, used as the first line of warning. In the range between 
‘Action Level 1’ and ‘Action Level 2’, termed the ‘Alert Zone’ (94-102 cm in men, BO­
SS cm in women), subjects should not further gain weight, with lifestyle modification 
such as increasing physical activity level, and some self-managed weight loss if 
possible. Patients in this waist range of ‘Alert Zone’ with problems like non-insulin- 
dependent diabetes mellitus, hypertension, or angina would benefit from more active 
weight loss. Above this range, termed the ‘Action Zone’(>102 cm in men, and >88 cm 
in women), every body should be urged to take action to seek professional help to 
achieve sustained weight loss and for risk factor screening.
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Although justified by several lines of evidence, cut-offs ai'e always slightly arbitrary. 
Increased risks of breast cancer in women (den Tonkelaar et al, 1995), type 2 diabetes in 
men (Chan et al, 1994), and other risk factors of diabetes and of heart disease (Pouliot et 
al, 1994) have been shown to associate with waist circumference levels that are 
remarkably close to the ‘Action Level V both in men and in women, suggesting that 
waist circumference may have a wider value, but the present paper has concentrated on 
cardiovascular risk factors. Financial constraints could favour the choice of higher cut­
offs to reduce screening costs for lai’ge numbers of subjects. Using lower cut-offs may 
have greater health benefits, particularly if young people can be alerted to a developing 
weight problem or adverse fat distribution, and thereby encouraged to prevent weight 
gain at an early age. It is now increasingly recognised that overweight is a disease per se 
(Stunkard, 1996), and preventing weight gain for those with waist circumference 
approaches the ‘Action Level V  (94 cm in men, 80 cm in women) may be more 
effective than attempting weight loss for those with waist circumference has reached the 
‘Action Zone’ (>102 cm in men, and >88 cm in women).
Because of the high correlations between waist circumference, waist to hip ratio and 
body mass index with one another, pairing these variables together in statistical analysis 
for adjustments would not be appropriate due to the effect of multicollinearity (Belsley 
et al, 1980). This was confirmed when body mass index and waist circimiference were 
combined, with little more improvement in predictive values for identifying risk factors 
(Table 4.2.3). Most subjects with adverse risk factors have both waist circumference 
above ‘Action Level 1’ and body mass index above 25 kg/m^. Conversely most subjects 
without risk factors have both waist circumference below ‘Action Level 1’ and body 
mass index below 25 kg/m^. Combining body mass index and waist to hip ratio also 
gave no improvement of risk factor prediction over waist circumference alone (results 
not shown).
Earlier studies ofhody composition and body fat distribution to identify subjects at risk 
of cardiovascular disease and type 2 diabetes have mainly focused on body mass index
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and waist to hip ratio (Lapidus et al, 1984; Larsson et al, 1984). Recently, waist 
circumference has been recognised as a good measure of abdominal fat and particularly 
the more metabolically active intra-abdominal fat (Pouliot et al, 1994; Ross et al, 1992 
& 1993; Seidell et al, 1988; Seidell et al, 1992). Large waist includes most overweight 
subjects either with or without central fat distribution (Chapter 4.1; Lean et al, 1995). 
Young and Gelskey (1995) have suggested that overweight subjects with low waist to 
hip ratio have similar risk factors as those who are overweight with high waist to hip 
ratio. However, the absolute size of intra-abdominal fat mass may be the critical factor 
(already increased by high body mass index), and this was not considered by these 
authors. It is possible that certain risk factors relate more to body mass index than to 
waist to hip ratio, but using the waist circumference for health promotion simplifies this 
problem. The term ‘central obesity’ is confusing, since distribution may be central of 
peripheral, independent of body mass index, whilst those with high body mass index all 
tend to a more central fat distribution. In relation to metabolic risk factors, waist 
circumference is consistently more indicative of complications than any other 
anthropometric methods (Chan et al, 1994; den Tonkelaar et al, 1995; Edwards et al, 
1994; Giovannucci et al, 1995; Pouliot et al, 1994; Seidell et al, 1992), but the positive 
predictions of cardiovascular risk for waist circumference of about 15-40% individual 
risks are not particularly high. The classification of subjects’ level of risk is improved 
when any one or more risk factor is included (and 60% in men and 40% in women). 
Risk not accounted for by anthropometric measures might be identified for health 
promotion from a family history of premature heart disease, non-insulin dependent 
diabetes mellitus or hypertension.
CONCLUSIONS
The waist circumference ‘Action Level 1’ proposed by Lean et al (1995) to indicate the 
need for weight management, reflecting both high body mass index and high waist to 
hip ratio, corresponded closely to the levels of waist circumference associated with 
increased risk of each individual cardiovascular risk factor and the combination of any 
one or more of these risk factors. ‘Action Level 1’ at 94 cm (37 inches) in men and 80
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cm (32 inches) in women may be useful thi'ough health promotion with a message to 
avoid weight gain (and thus to avoid hypeiiipidaemia or hypertension) as pait o f the 
measures designed to prevent cardiovascular disease. Application of the data in this 
study should be restricted to white populations only. Further validation for other etlinic 
groups such as blacks or Asians is required, since body density, fat distribution and 
statui'e may be different.
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Table 4.2.1. Physical and metabolic characteristics of 2183 men and 2698 women.
Men Women
Mean SD Mean SD
Age (years) 42.7 10.5 42.5 10.7
Weight (kg) 81.4 11.9 68.3 11.3
Height (cm) 177.9 7.4 165.1 6.8
Body mass index (kg/m^) 25.7 3.4 25.1 4.2
Waist circumference (cm) 91.6 10.4 80.3 10.9
Hip circumference (cm) 101.7 6.4 102.1 8.3
Waistihip ratio 0.90 0.07 0.79 0.07
Total cholesterol (mmol/1) 5.4 1.1 5.4 1.1
HDL cholesterol (mmol/1) 1.1 0.3 1.4 0.4
Systolic blood pressure (inmHg) 122.8 15.6 115.5 15.4
Diastolic blood pressure (mmHg) 77.8 10.4 74.1 9.9
HDL = high density lipoprotein.
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Figure 4.2.1. The relationship between waist circumference and height in 2183 men (a) 
and 2698 women (b), showing regression line (solid) and the line of zero correlation 
(dashed).
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Figure 4.2.2. The average values of the sum of sensitivity plus specificity for waist 
circumference to identify subjects above or below 6.5 mmol/1 of plasma cholesterol (T ), 
0.9 mmol/1 of high density lipoprotein cholesterol (A), 160 mmHg of systolic blood 
pressure or 95 mmHg of diastolic blood pressure (■), and with or without any one or 
more cardiovascular risk factor ( • )  plotted against waist circumference in 2183 men (a) 
and 2698 women (b).
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Figure 4.2.3. Percentile plot of sensitivity and speeificity values for waist circumferenee 
to identify subjects above or below 6.5 mmol/1 of plasma cholesterol (a), 0.9 rmnol/1 of 
high density lipoprotein cholesterol (b), 160 mmHg of systolie blood pressure or 95 
mmHg of diastolic blood pressure(c) and with or without any one or more 
cardiovascular risk factors in 2183 men (d).
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Figure 4.2.3. Percentile plot of sensitivity and specificity values for waist cireumference 
to identify subjects above or below 6.5 mmol/1 of plasma cholesterol (a), 0.9 mmol/1 of 
high density lipoprotein cholesterol (b), 160 mmHg of systolic blood pressure or 95 
mmHg of diastolic blood pressure(c) and with or without any one or more 
cardiovascular risk factors in 2698 women (d).
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4.3
THE INFLUENCES OF HEIGHT AND AGE ON WAIST 
CIRCUMFERENCE AS AN INDEX OF ADIPOSITY
This section has been peer reviewed and has been published as
Han TS. Seidell JC, Currall JEP, Morrison CE, Deurenberg P, Lean MEJ. The 
influences of height and age on waist circumference as an index of adiposity in 
adults. International Journal of Obesity 1997; 21:83-89.
Han TS. Seidell JC, Lean MEJ. Waist circumference remains useful predictor of 
coronary heart disease. British Medical Journal 1996; 312:1227-28. [Letter]
Collaboration with MORGEN project
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ABSTRACT
Objective'. To assess the influences of height and age on the differences in waist 
circumference between individuals of different stature.
Subjects'. 3319 males and 4358 females from four studies in the UK and the Netherlands. 
Measurements'. Waist circumference, body weight, height, and age.
Results'. Lineal' regression analysis of logio height as the independent variable on log^o 
waist as the dependent variable was used to determine the optimal index power (OIP) (*’) 
to minimise the influence of height in the relationships of waist/height^. Six out of eight 
samples of men and women had OIP of height not significantly different from zero, with 
the remaining two groups had OIP between 0.15-0.58, indicating that height had very 
limited influence on the differences in waist circumference measurement between 
individuals. Age adjustment increased the relationship between waist and height, with 
OIP of 0.19-0.89 in men and 0.02-0.58 in women. Without age adjustment, height 
explained 0.3-3.5% and 0.1-2.5% variance in waist in men and in women respectively, 
and the corresponding variances were 0.4-7.5% in men and 0.0-2.6% in women with age 
adjustment. A similar analysis of weight and height showed the OIP of height in 
weight/height^ ratio ranged from 1.32-2.25 in men, and 0.87-1.74 in women without age 
adjustment, and from 1.47-2.24 in men and 1.25-1.96 in women with age adjustment. 
Conclusion'. Height and age had limited influences on the differences in waist between 
Caucasian subjects of different statme. Waist alone may be used to indicate adiposity or 
to reflect metabolic risk factors. In contrast, the influence of height on body weight is 
important.
Keywords', body mass index, cardiovascular disease, epidemiology, fat distribution, 
obesity, stature
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INTRODUCTION
Body mass index (BMI) relates highly to total body fatness by densitometry (Chapter 
3.1; Lean et al, 1996; Deurenberg et al, 1991), and has been widely used to indicate 
risks of overweight related morbidity and mortality (Royal College of Physicians, 1983). 
More recent understanding of the importance of the more metabolically active 
abdominal fat mass, particularly intia-abdominal fat mass, resulted in many ratios being 
proposed as anthropometric indicators, which include waist measurement as the 
dominant var iable, since waist circumference or diameter is highly related to abdominal 
fat mass (Han et al, 1995b; Seidell et al, 1989a; Pouliot et al, 1994; Ross et al, 1992; 
Ross et al, 1993, van der Kooy et al, 1993). Height has been used as the denominator of 
abdominal fat mass indicators in efforts to eliminate a presumed relationship between 
waist circumference and stature Kamiel et al, 1991; Valdez et al, 1991; Richelson et al, 
1995; Higgins et al, 1988). Another proposed index involving height is the abdominal 
sagittal diameter/height ratio, to indicate subjects with increased metabolic risk factors 
(Richelson et al, 1995). The initial rationale for deriving ratios with waist measurement 
as the numerator was that metabolic risk factors are related more highly to central fat 
distribution than to total body fat, which is mainly located in areas other than the 
abdomen. The ratio waist to hip was thus developed, using the hip cireumference to 
control for subcutaneous body fatness or body size and to accentuate the relationship 
with fat distribution. The ratio of waist to thigh was derived, since the size of the thigh 
reflects muscularity. More recently, it has been suggested that it is the absolute amount 
of intra-abdominal fat which influences health risk, not the distribution pattern (Kahn, 
1993).
The present study aimed to determine the influences of height and age on the differences 
in waist circumference between individuals of different stature from four separately 
recruited Caucasian samples from Scotland and The Netherlands, based on the principles 
for determining adiposity (Khosia and Lowe, 1967).
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METHODS 
The principles for developing anthropometric ratios to indicate adiposity
Anthi'opometric ratios such as weight for height ai*e derived so that differences in the 
variable of interest between individuals can be compaied, while the influences of other 
structural variables are eliminated (Khosia and Lowe, 1967; Berm, 1971). Since body 
weight correlates significantly with height, taller individuals are generally heavier than 
shorter ones. Thus in order to compare the differences in adiposity (the vaiiable of 
interest) between individuals it is the relative weight that matters, so differences in 
height must be eliminated. A simple method described by Khosia and Lowe to 
determine the optimal index power of height (•’) in the relationship weight/height*’ for a 
set of individuals is to regress logjo height (independent variable) on logio weight 
(dependent variable). The regression coefficient ((3) of logio height obtained in the 
equation is the optimal index power (*’) of height in the weight/height*’ ratio, at which the 
differences of the derived ratio between subjects are dependent on body weight and 
uncorrelated with height (Khosia and Lowe, 1967).
An example from one of the male groups (MORGEN) in the present study shows that 
weight correlates positively (r = 0.441; P  <0.001) with height. After logarithmic 
transformation, logio height is used as independent variable and logio weight as the 
dependent variable in linear regression analysis, to obtain the equation: logio weight = 
1.57 X logio height " 1-62. The regression coefficient 1.57 is the optimal index power of 
w eight/height^ratio: w eight/height^has a zero correlation with height in this sample 
(Table 4.3.3). The conventional BMI (weight/height^) had a low correlation with height 
(r -  -0.140) in this sample.
Subjects and measurements
Four separate samples of 4881 Dutch men and women from the MORGEN study and 
384 from Wageningen body composition studies, and 1918 Scots fiom the Glasgow 
MONICA study and 494 from the Glasgow body composition studies, had 
antliropometry measured following essentially identical standard protocols (WHO,
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1989). Waist circumference was measured with flexible tape to the nearest mm, midway 
between the lateral iliac crest and lowest rib, at the end of gentle expiration. Weight in 
light clothes was measured to the nearest 100 g, and height barefoot and head in the 
horizontal Frankfort plane using a stadiometer to the nearest 0.5 cm. All measuring 
instruments were calibrated with standards before use. The men and women from the 
MORGEN and MONICA studies were randomly recruited from the general population, 
so they are expected to be representative of entire population of the Netherlands and 
Glasgow respectively. The other two groups were healthy subjects recruited for a variety 
of physiological measurements, and exhibit wide ranges of anthropometric variables 
(Chapter 3.1; Lean et al, 1996; Deurenberg et al, 1991).
Analysis
The relationships between height and waist circumference and body weight were 
assessed by linear regression analysis. Optimal index powers ( )^ in the ratios 
waist/height^ or weight/height^ for men and for women in the four separate studies were 
obtained from the linear regression coefficient between logio height (independent 
variable) and logio waist or logio weight (dependent variable).
RESULTS
Subjects had wide ranges of age and antlu'opometry (Table 4.3.1). Dutch men and 
women were taller than the Scots. Mean waist circumference and body mass index were 
similar between the groups of men and between the groups of women, except that 
Glasgow women had higher values than the other female groups.
Plots from the MORGEN study show a significant {P <0.001) positive correlation 
between weight and height (Figures 4.3.1a & b), and this correlation decreased towards 
zero (Figures 4.3.2a & b) when height^ was incorporated as its denominator (BMI). On 
the other hand, waist circumference alone had an almost zero correlation with height in 
both sexes (Figures 4.3.3a & b). Similar trends were observed in the other thi'ee studies 
(Table 4.3.2).
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Height coiTelated significantly (P <0.001) with body weight in men {r range 0.375 to 
0.505) and in women (r range 0.165 to 0.320) (Table 4.3.2). As expected, the 
correlation of height with BMI (weight/height^) was much less, and tended to be 
negative both in men (r range -0.213 to 0.064), and in women (r range -0.248 to -0.054). 
In the same subjects from all four studies, height explained no more than 1.6% of 
vai'iance of waist circumference in seven out of eight groups, except the male group 
from the Glasgow MONICA study which was slightly higher {r^ = 3.3%). The 
relationship between height and weight or waist became more positive when adjusted for 
age (Table 4.3.2), while age adjustment appealed not to alter the relationship between 
height and BMI.
Without age adjustment, regression analysis to derive the optimal index power in the 
waist/height*’ ratio (Table 4.3.3) showed this value was close to zero in all the samples 
studied, indicating that there was no significant lineai* relationship between height and 
waist measurement. Only the MONICA men and MORGEN men did the 95% 
confidence interval excluded zero. The MORGEN sample was large enough to analyse 
by decades of age, and this resulted in optimal power between 0.36 to 0.58 in men and 
0.06 to 0.26 in women.
Weight/height ratio included for comparison showed one group with optimal index 
power of height reasonably close to the index power 2 of body mass index in men. The 
remaining tliree groups had optimal index power of height close to 1.5. Three out of four 
female groups had optimal index power of height close to 1, and the remaining group 
value was close to 1.5. The index power 2 (namely BMI) was included within the 95% 
confidence intervals for thr ee of the eight ten year age bands in the MORGEN sample.
In the samples studied, age correlated positively (P <0.001) with waist circumference (r 
range from 0.214 to 0.612 in men, and 0.197 to 0.464 in women), and age correlated 
negatively (P <0.001) with height (r range -0.200 to -0.508 in men, and -0.216 to -0.269
148
in women), which in cross sectional studies could reflect either height loss through 
ageing or alternatively a secular trend towards a taller population (van Leer et al, 1992. 
The possible influence of age on the relationship between waist circumference or weight 
and height was examined by stratifying subjects into four groups, 20-29, 30-39, 40-49, 
and 50-59 years in the MORGEN sample (Table 4.3.3), or by regression analysis of 
logio height on logio waist or on logio weight adjusting for age in each sample (Table 
4.3.4), showed the optimal index powers increased to between 0.19-0.89 in men and 
between 0.02-0.58 in women for waist/height*’, and between 1.47-2.38 in men and 
between 1.25-1.96 in women for weight/height^.
Correlations between height and waist/height^ ratios with various index powers of height 
ranging from 0 to 1 in the MORGEN study group showed the weakest correlation 
coefficients occuiTed when the index powers (‘’) of waist/heighf’ were between 0.25-0.50 
in men and 0-0.25 in women. Age adjustment for the MORGEN sample of all ages 
showed the weakest correlation between waist/height*’ and height were 0.50 in men and 
0.25 in women (Table 4.3.5).
Without age adjustment, height explained 0.3-3.5% and 0.1-0.8% of variance of waist 
circumference in men and in women respectively, and the corresponding values with age 
adjustment were 0.4-7.5% in men and 0.0-2.6% in women.
The relationship between waist circumference and height was fiirther analysed in the 
MORGEN sample. Subjects were stratified into two groups according to the waist 
circumference ‘Action Level V (94 cm in men, 80 cm in women) (Chapter 4.1; Lean et 
al, 1995). Table 4.3.6 shows that there were weak but significant associations between 
height and waist circumference in men and women with waist circumferences below the 
‘Action Level ’. The proportion of variance in the waist circumference explained by 
height in those with a waist circumference above the ‘Action Level ’ was 0.64% in men 
and 0.03% in women.
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DISCUSSION
Without age adjustment, the optimal index power of height in the waist/heighf’ ratio was 
consistently close to zero in both sexes of all eight samples studied. Men generally have 
higher optimal index powers than women in the weight/height^ relationship, indicating a 
greater influence of height on weight in men. Adjustment of age by regression analysis 
or by dividing the population into ten yeai' age bands accentuated the relationship 
between height and waist or weight. By stratifying subjects fi'om the MORGEN sample 
according to ‘Action Level 1’ (94 cm in men and 80 cm in women) (C hapter 4.1; Lean 
et al, 1995), we have shown that height correlated slightly higher with waist in those 
with a waist circumference below ‘Action Level V, but in those with a waist ahove 
‘Action Level 1% the proportion of age adjusted vaiiance in waist circumference 
explained by height was only 0.64% {P <0.05) in men and 0.03% (P = not significant) in 
women (Table 4.3.6). Thus in those who need weight management, height does not 
importantly influence variations in waist circumference. In their studies of coronary 
heart disease in relation to the physique of London busmen, Eleady et al { \96 \)  came to 
the same conclusion that height adjustment for waist circumference was not necessary, 
since little difference was made to the results.
In mathematical terms, the indices reflecting adiposity such as BMI and waist 
circumference respectively should have a zero correlation with height to eliminate the 
influence of stature. Deurenberg et al (1991) have demonstrated that weigh/height*’ 
index as a measure of body fatness does not necessarily have to be completely 
independent of height, due to significant correlation between body fatness and height. 
The relationship between intra-abdominal fat mass and height in 20 women, aged 20-51 
years, has been examined in a study using magnetic resonance imaging (C hapter 4.4; 
Han et al, 1997b). Intra-abdominal fat mass did not correlate significantly with height 
{r' = 1.3%, P = 0.40), but coiTelated more highly with waist circumference (r^ = 77.8%, 
P <0.001), abdominal sagittal diameter (r^ == 77.4%, P <0.001) transverse diameter (r^ = 
77.4%, P <0.001) and body mass index (r^ = 72.3%, P  <0.001) than with waist hip ratio 
(r^ = 32.5%, P  <0.05). Ratios of waist/height’’ of different index powers did not increase
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upon the variance in intra-abdominal fat mass explained by waist circumference alone. 
Neither intra-abdominal fat mass (P = 0.40) nor waist circumference (P = 0.31) related 
significantly to height in these women.
It is perhaps surprising to find that physical stature as indicating by height has such 
limited influence on waist circumference. However waist circumference is a body 
dimension which contains relatively little bone (only the spine). The relationship in men 
is very weak and limited to certain age bands. In women, spinal shortening from 
osteoporosis could tend to increase waist circumference, and this may be more 
pronounced so reducing any relationship in older and shorter women, thus accounting 
for the inverse relationships (Figure 4.3.3b).
Practicality must be taken into account when deriving antliropometric indices (WHO, 
1995), to establish the advantage of ratios or other complex expressions over the single 
variable alone, ease of computation of the ratio (Berm, 1971), the availability of the 
variables for measurement, and reliability of measurement in the field. If the 
measurements for a ratio are easy to obtain and it gives much better prediction than the 
single variable, then using the ratio is justified. For example, many attempts (Khosia and 
Lowe, 1967; Beim, 1971) have been made to derive new indices of adiposity fiom 
weight and height in order to better the body mass index (weight/height^), but most of 
these ratios are sex or population specific, as confirmed in the present study. By 
consensus, weight/height^ is still the ratio of choice. Although the BMI does not have a 
perfect zero correlation with height, it is a reasonable approximation for many purposes, 
the index power 2 is rather conveniently remembered, and easy to calculate. Although 
weight/height^ ratio was originally derived from Caucasian populations it is commonly 
used to assess body weight in other ethnic groups. Examination of its validity may still 
be required in these groups.
The slight differences in optimal index powers between the four study populations 
(Table 4.3.3) could be explained by systematic differences in anthropometric
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measurements between centres, although no such differences in teclinique have been 
identified, and the same measurement protocols were used (WHO, 1989). Alternatively 
there may be minor morphological differences between the populations related to factors 
such as physical activity, diet, and use of hormone replacement therapy. There were 
differences in age ranges, the Wageningen sample contained subjects up to 83 years, 
whereas other samples were mostly less than 70 years (MONICA and Glasgow) or less 
than 60 years (MORGEN). All subjects studied were older than 18 years. With age 
adjustment, optimal index powers between samples became more similar to each other. 
The influence of age on the association between waist circumference and height in the 
large MORGEN sample was relatively small and probably not o f practical importance 
for most purposes.
Studies of magnetic resonance imaging (Chapter 4.4; Han et al, 1997b; Ross et al, 
1992; Ross et al, 1993) and computed tomography (Pouliot et al, 1994) showed waist 
explained 80- 90% of variance in total body fat. We have shown that large waist 
circumference alone identifies most subjects with high BMI or high waist to hip ratio 
(Chapter 4.1; Lean et al, 1995), and can be used to predict total body fat as measured 
by densitometry, at least as well as by the conventional skinfold method and without 
bias when fat distribution is altered (Chapter 3.1; Lean et al, 1996). Waist 
circumference also relates strikingly to cardiovascular risk factors (Pouliot et al, 1994; 
Chapter 5.2; Han et al, 1995c). Waist/height ratio correlates tightly with BMI (r >0.9). 
Seidell et al (1992) have previously shown waist/height ratio was no better than 
waist/thigh ratio or waist circumference alone in predicting cardiovascular risk factors.
CONCLUSIONS
Height and age have limited influence on the differences in waist circumference between 
individuals of different statme. Waist alone may be a useful indicator of adiposity in 
either men or women in Caucasian populations without the need to adjust for height. 
This is in contrast to measures of weight, where a positive correlation with statme 
necessitates adjustment for height, as the conventional weight/height^ ratio for BMI.
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Table 4.3.1. Characteristics of subjects from the Netherlands and Scotland.
Study 
n (M/F)
Dutch Scots
All studies 
3319/4358
MORGEN
2183/2698
Wageningen
146/238
MONICA
904/1014
Glasgow
86/408
Mean SD Mean SD Mean SD Mean SD Mean SD
Men
Age (years) 42.7 10.5 45.9 17.4 51.0 14.1 44.9 14.1 45.2 12.6
Waist (cm) 91.6 10.4 93.3 10.8 93.3 11.9 93.1 14.8 92.2 11.0
Weight (kg) 81.4 11.9 81.1 11.7 75.9 13.7 80.3 16.1 79.8 12.8
Height (m) 1.78 0.07 1.80 0.08 1.71 0.07 1.75 0.07 1.76 0.08
BMI (kg/m^) 25.7 3.4 25.1 3.4 26.0 4.1 26.2 4.7 25.8 3.6
Women
Age (years) 42.6 10.7 36.9 17.5 50.8 14.0 43.5 14.3 44.3 12.9
Waist (cm) 80.3 10.9 82.6 12.0 82.0 12.3 86.3 14.3 81.4 11.8
Weight (kg) 68.3 11.3 67.8 12.9 65.9 14.5 75.9 16.9 68.4 13.0
Height (m) 1.65 0.07 1.68 0.07 1.58 0.07 1.61 0.06 1.6.3 0.07
BMI (kg/m^) 25.1 4.2 24.2 4.7 26.3 5.5 29.2 6.5 25.7 4.9
BMI = body mass index
153
Table 4.3.2. Correlation coefficients, unadjusted and age adjusted, between height 
(independent variable) and body weight, body mass index, and waist circumference in 
Dutch and Scottish men and women.
Study n
Weight BMI Waist
Crude Age
adjusted
Crude Age
adjusted
Crude Age
adjusted
Men
MORGEN 2183 0.441*** 0.490*** -0.140*** -0.063** 0.051* 0.193***
Wageningen 146 0.375*** 0.361*** -0.213** -0.159": -0.150": 0.061":
MONICA 904 0.505*** 0.506*** 0.064": 0.090** 0.186*** 0.275***
Glasgow 86 0.385*** 0.497*** -0.018": 0.085": 0.068": 0.245*
Women
MORGEN 2698 0.252*** 0.304*** -0.248*** -0.198*** -0.036": 0.054**
Wageningen 238 0.173** 0.283*** -0.248*** -0.119": -0.057": 0.162*
MONICA 1014 0.320*** 0.338*** -0.054": -0.011": 0.059": 0.137***
Glasgow 408 0.165*** 0.238*** -0.188*** -0.113* -0.088": -0.001":
<0.05; <0.01; <0.001; ns = not significant
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Table 4.3.3. Optimal index powers (when height has zero correlation with the derived 
ratios) of the denominator height in the ratios of waist/height and weight/height derived 
from regression analysis of logigheight on log^gwaist, and on lo g w eig h t respectively, 
with foui' age bands in the MORGEN study.
Waist/height^ Weight/height^
Study n OIP SE 95% Cl OIP SE 95% Cl
Men
MORGEN
20-29 333 0.36 0.13 0.10, 0.62 1.72 0.15 1.42, 2.02
30-39 544 0.56 0.11 0.33, 0.78 1.85 0.14 1.57, 2.13
40-49 672 0.38 0.10 0.18, 0.58 1.68 0.13 1.48, 1.93
50-59 634 0.58 0.10 0.39, 0.77 1.86 0.12 1.63,2.10
All ages 2183 0.15 0.06 0.03, 0.26 1.57 0.07 1.44, 1.70
Wageningen 146 -0.42 0.22 -0.86, 0.02 1.32 0.25 0.82, 1.82
MONICA 904 0.58 0.10 0.39, 0.78 2.25 0.12 2.01,2.50
Glasgow 86 0.17 0.44 -0.71, 1.05 1.78 0.49 0.82, 2.75
Women
MORGEN
20-29 448 0.10 0.14 -0.17,0.37 1.14 0.18 0.79, 1.49
30-39 644 0.23 0.11 0.02, 0.44 1.45 0.13 1.19, 1.71
40-49 817 0.26 0.11 0.04, 0.48 1.23 0.13 0.97, 1.48
50-59 789 0.06 0.11 -0.15, 0.28 1.15 0.13 0.89, 1.41
All ages 2698 -0.11 0.06 -0.23, 0.01 1.04 0.07 0.90, 1.18
Wageningen 238 -0.18 0.22 -0.61, 0.26 0.87 0.28 0.32, 1.42
MONICA 1014 0.22 0.11 0.00, 0.43 1.74 0.15 1.45,2.03
Glasgow 408 -0.38 0.21 -0.79, 0.02 0.89 0.27 0.35, 1.42
OIP = optimal index power
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Table 4.3.4. Optimal index powers (when height has zero correlation with the derived 
ratios) of the denominator height in the ratios of waist/height and weight/height derived 
from regression analysis of log^gheight on log^Qwaist, and on logioweight respectively, 
with age adjustment.
Study
Waist/height^ Weight/height*^
n OIP SE 95% Cl OIP SE 95% Cl
Men
MORGEN 2183 0.51 0.05 0.41,0.62 1.82 0.07 1.68, 1.95
Wageningen 146 0.19 0.24 -0.28, 0.67 1.47 0.29 0.89, 2.05
MONICA 904 0.89 0.10 0.69, 1.09 2.38 0.13 2.12,2.63
Glasgow 86 0.73 0.34 0.05, 1.41 2.24 0.44 1.38,3.11
Women
MORGEN 2698 0.17 0.06 0.06, 0.29 1.25 0.07 1.11, 1.39
Wageningen 238 0.58 0.21 0.16, 0.99 1.49 0.29 0.92, 2.06
MONICA 1014 0.54 0.11 0.31,0.76 1.96 0.16 1.65, 2.27
Glasgow 408 0.02 0.20 -0.38,0.41 1.39 0.27 0.87, 1.92
OIP = optimal index power
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Table 4.3.5. Correlations between height and waist/height*^ ratios of various index 
powers in the MORGEN study in all subjects with and without age adjustment, and in 
four different age bands.
Age group Correlation coefficients
(years) n Waist Waist/Ht"-^' Waist/Ht"'"" Waist/Ht"'" Waist/Ht
Men
20-29 333 0.140* 0.038"' -0.064"' -0.164** -0.259***
30-39 544 0.192*** 0.104* 0.013"' -0.077"' -0.166***
40-49 672 0.138*** 0.046"' -0.047"' -0.139*** -0.228***
50-59 634 0.228*** 0.130** 0.029"' -0.074"' -0.174***
All ages 2183 0.051* -0.042"' -0.132*** -0.220*** -0.303***
fAll ages 2183 0.193*** 0.098*** 0.001"' -0.096*** -0.191***
Women
20-29 448 0.024"' -0.058"' -0.139** -0.216*** -0.289***
30-39 644 0.080* -0.009"' -0.097* -0.184*** -0.266***
40-49 817 0.077* -0.001"' -0.076* -0.151*** -0.224***
50-59 789 -0.018"' -0.063"' -0.143*** -0.220*** -0.293***
All ages 2698 -0.036"' -0.112*** -0.186*** -0.258*** -0.325***
t  All ages 2698 0.054** -0.028"' -0.109*** -0.188*** -0.263***
*P <0.05; <0.01; ***P <0.001; ns = not significant; ns = not significant; Ht, height; fage adjusted.
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Table 4.3.6. Correlation coefficients between height and waist circumference in subjects 
identified by waist circumference ‘Action Level 1% in the MORGEN study (94 cm in 
men, 80 cm in women).
Men Women
Age (y) Waist <94 cm Waist >94 cm Waist <80 cm
*P <0.05; **P <0.01; <0.001; fage adjusted.
Waist >80 cm
n r n r n r n r
1 20-29 285 0.198** 48 -0.001 363 0.123* 85 -0.125
30-39 386 0.202*** 158 -0.043 442 0.153** 202 -0.038
40-49 374 0.138** 298 0.092 417 0.120* 400 0.032
50-59 267 0.157* 367 0.120* 259 0.102 529 -0.022
All ages 1312 0.053 871 0.049 1481 0.056* 1217 -0.040
fAll ages 1312 0.192*** 871 0.080* 1481 0.131*** 1217 -0.018
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Figure 4.3.1. The relationship between body weight and height in men 2183 (a) and 
2896 women (b), showing the regression line (solid) and line of zero correlation 
(dashed).
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4.4
PREDICTING INTRA-ABDOMINAL FATNESS BY MAGNETIC 
RESONANCE IMAGING AND COMPUTERISED TOMOGRAPHY 
FROM ANTHROPOMETRIC MEASURES FOR HEALTH 
PROMOTION: THE INFLUENCE OF STATURE
This section has been peer reviewed and will be published as
Han TS. McNeill G, Seidell JC, Lean MEJ. Predicting intra-abdominal fatness 
from anthropometric measures: the influence of stature. International Journal of 
Obesity ^9Q7', (in press).
Collaboration with Professor JC Seidell
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ABSTRACT
Objective: To investigate the influence of height on the relationships between the intra­
abdominal fat and anthi'opometric measui'cs.
Subjects: Twenty healthy female volunteers aged 20 to 51 years from Aberdeen, and 71 
men and 34 women aged 19 to 85 years from Nijmegen, The Netherlands.
Outcome measures: Intra-abdominal fat volumes by magnetic resonance imaging (MRI) 
in Aberdeen and cross-sectional areas at L4-L5 level by computerised tomography (CT) 
in Nijmegen, height, body mass index (BMI), waist circumference, waist sagittal and 
transverse diameters, waist to hip ratio, and skinfolds.
Results: In the MRI study the women with BMI 20-33 kg/m^, waist circumference 62-97 
cm, height 148-172 cm, and intra-abdominal fat volume 0.07-2.66 kg, waist 
circumference gave the highest correlation of simple indices with intra-abdominal fat 
volume, explaining 77.8% of variance. Single cross-sectional MRI cuts predicted 
volume with r = 0.94-0.99. Height in various levels of index power was not related to 
waist circumference, waist diameters, BMI, or skinfolds and did not improve prediction 
o f intra-abdominal fat volume or of cross-sectional intra-abdominal fat ai'ea at any level. 
The CT study of men and women with BMI 18-32 kg/m^ and 19-38 kg/m^, waist 
circumference 71-112 cm and 74-125 cm, height 158-197 cm and 151-182 cm, and 
intra-abdominal fat area 13-274 cm^ and 19-221 cm^ respectively, height also had little 
influence on the relationships of intra-abdominal fat area with waist circumference or 
with any other indices of adiposity in linear' or quadratic model. Compared to younger 
subjects, intra-abdominal fat area was higher in older subjects for a given waist. 
Conclusion: Height does not importantly influence the differences in measui'es of 
adiposity or intra-abdominal fat volume in women, or intra-abdominal fat area in both 
sexes. Age does influence the prediction of intra-abdominal fat from waist 
circumference, but waist circumference alone has a predictable simple relationship with 
intra-abdominal fat volume or ai’ea, which is likely to relate to the prediction of health 
risk for health promotion.
Key words: body fat distribution, cai'diovascular disease, computerised tomography, 
health promotion, height, magnetic resonance imaging, obesity.
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INTRODUCTION
Increasing international concern about obesity, and its rising prevalence (Gregory et a/, 
1990; Bennett et al, 1995) and the recognition of the independent importance of body fat 
distribution has stimulated interest in identifying or predicting those at greatest health 
risk. For the purpose of health promotion directed at the general public, a single 
measurement of waist girth has been proposed as an indicator for alerting people to 
increased health risks associated with both total fatness and intra-abdominal fat 
accumulation (C hapter 4.1; Pouliot et al, 1994; Lean et al, 1995). We have shown that 
differences in waist circumferences between subjects are virtually unaffected by 
differences in heights, particulaily amongst those who need weight management, namely 
waist above 94 cm in men, 80 cm in women (C hapter 4.3; Han et al, 1996b). These 
conclusions are not entirely new. In their studies of body shape and related health risk of 
London busmen, Morris and colleagues initially adjusted the size of trouser waist (proxy 
for waist circumference) for height (Morris et al, 1956), but in subsequent studies which 
also included the measurement of waist circumference, these authors realised that height 
adjustment made little difference in the comparisons of waist circumference between 
subjects of different stature (Heady et al, 1961). Sanders (1959) came to the same 
conclusion that height should be ignored when comparing differences in skinfold 
thicknesses, since there was no relationship between the two variables.
A recent study of a mixed group of 16 men and 31 women suggested that the cross- 
sectional area of intra-abdominal fat (in a single computerised tomography cut at the L4- 
L5 level) related slightly more highly with waist to height ratio (r = 0.83) than waist 
circumference alone (r = 0.75). A separate study of 97 men and 60 women found that 
intra-abdominal fat area was related linearly to waist in women but quadratically in men, 
and that the total variance was lower in men than in women (Sclireiner et al, 1996).
The present study examined the influence of stature on the relationships between 
measures of adiposity and intra-abdominal fat volume estimated from the tliree
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dimensional volume measuied by magnetic resonance imaging in women, and intra­
abdominal fat ai'ea measured by computerised tomography in both sexes.
METHODS 
Subjects
From larger studies of the influence of intra-uterine growth on fat distribution in 110 
women in Aberdeen (Han, 1994), twenty healthy premenopausal women agreed to take 
part in detailed body composition assessment using magnetic resonance imaging. Data 
from a previous study in The Netherlands of body composition using computerised 
tomography scans in 71 men and 34 women in whom structural abnormalities had been 
excluded, referred to the Radiodiagnostic Institute of the University hospital in 
Nijmegen (Seidell et al, 1987), were analysed.
Intra-abdominal fat volume using magnetic resonance imaging
Intra-abdominal fat volume was measured by magnetic resonance imaging (Aberdeen 
Mark II, 0.08 Tesla). The pulse sequence teclinique using inversion/saturation recovery, 
with gain factor of four, repetition time of 1000 ms, and slice thickness of 20 mm, was 
used to synthesise the images in order to distinguish fat from other tissues. Intra­
abdominal fat ai’eas were determined from four cross-sectional images of equal distance 
between xiphisternum and anterior iliac crest, traced by hand using the computer 
‘mouse’. The number of pixels were converted to Système Internationale units from 
calculated values of % (3.15 mm) and y  (3.95 mm) axes of the computer screen. Fat 
volume was calculated using a truncated cone model (Kvist et al, 1988) and then 
converted to fat mass assuming adipose tissue contains 80% of fat, 2% protein, 18% of 
water with negligible minerals (Garrow, 1974), with corresponding densities of 0.900, 
1.34 and 0.993 kg/1 (Siri, 1961), giving an average adipose tissue density of 0.9255 kg/1. 
Thus fat mass was converted from adipose tissue by a factor of 0.9255 x 80%.
165
Intra-abdominal fat area using computerised tomography
Methodology has been described in detail by Seidell et al (1987). In brief, a single scan 
was made at the level of foui-th-fifth lumbar vertebrae using computerised tomography 
scanner (Siemens UB Med, Germany). Data from the scans were analysed using 
histogram-based volumetric analysis technique to determine fat area set at the range of 
-150 to -50 Hoimsfield units. The area of intra-abdominal fat was obtained using a light 
pen cursor tlii'ough the muscles separating the subcutaneous and intra-abdominal fat.
Anthropometry
In the magnetic resonance imaging study, weight in light clothes was measured to the 
nearest 100 g, and height was measured barefoot with head in the horizontal Frankfort 
plane, using a stadiometer to the nearest 0.1 cm. Waist circumference midway between 
the lateral lower ribs and the iliac crest, and hip circumference at the widest part over the 
greater trochanters were measured according to standard protocols (World Health 
Organisation, 1989). Waist sagittal and transverse diameters were measured by 
pelvimeter (CMS Weighing Ltd, London) at the same level as for waist circumference, 
in standing position to the nearest mm. Skinfold thicknesses were measured at biceps, 
triceps, subscapular, and supra-iliac using skinfold calipers (Holtain, Crymych, UK). All 
measuring instruments were calibrated with standards before use. In the computerised 
tomography study, measurements of weight and height were obtained using similar 
methods. Waist circumference was measured at the umbilical level, and hip 
circumference was taken from the widest level. Two skinfold thicknesses at the sites of 
abdomen and supra-iliac crest were measured (Seidell et al, 1987).
Statistical analysis
Multiple lineal' regression analysis was performed to determine the relationships 
between measui'es of adiposity and intra-abdominal fat measures. Analyses used the 
SPSS statistical package (SPSS Inc., version 6.1.1, Chicago, Illinois).
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RESULTS 
Magnetic resonance imaging study
Subjects’ characteristics are shown in Table 4.4.1. The body mass index distribution 
was similar to that of the British population (Gregory et al, 1990; Bennett et al, 1995). 
All four cross-sectional intra-abdominal fat areas correlated highly with the intra­
abdominal fat volume. The area at L4, just above the iliac crest gave the lowest 
prediction (r = 0.94) and that at the 2/3 distance from xiphisternum to anterior iliac crest 
gave the highest (r = 0.99). Table 4.4.2 shows that intra-abdominal fat areas between 
xiphisternum and iliac crests and intra-abdominal fat volume correlated highly and 
similarly with all measurements including waist circumference, and with body mass 
index but less well with waist to hip ratio or other antliropometric ratios. In this single 
sex study, dividing waist by height did not improve prediction of cross-sectional fat area 
compared to waist circumference alone, at every level between the xiphisternum and 
iliac crest. Waist circumference measured at the umbilical level was used instead of that 
measured between lowest rib margin and iliac crest in the analysis with intra-abdominal 
fat and the influence of height gave almost identical results (data not presented). In a 
larger study of 110 women which included the magnetic resonance imaging study (Han, 
1994), waist circumference measuied at the umbilical level (mean = 87.3, SD 15.5 cm) 
was 10% (mean difference = 8.0, SD 4.3 cm) bigger than that at the standardised level 
(World Health Organisation, 1989) midway between lowest rib margin and the iliac crest 
(mean = 79.3, SD 13.4 cm). Multiple linear regression analysis showed that the addition 
of age (/ value for age = -0.308, P  = 0.762) did not change the relationships between 
waist circumference and intra-abdominal fat volume. Table 4.4.3 shows that height did 
not significantly correlate with intra-abdominal fat volume or any other indices of 
adiposity. Waistdieight*’ ratios of different levels of index power (p) for height were 
calculated. Waist circumference alone (waistiheight^) (Figure 4.4.1a) was related more 
closely to intra-abdominal fat volume than waist to height ratio (waist:height^) (Figure 
4.4.1b). Logaritlrmic or quadratic transformation showed waist to height ratio produced 
no further improvement in predicting intra-abdominal fat volume over waist alone (data 
not shown). Table 4.4.4 shows that waist to height ratios of different levels of index
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power did not improve correlations with intra-abdominal fat volume over waist 
circumference alone.
Computerised tomography study
Subject characteristics are shown on Table 4.4.5. Compared to women in the magnetic 
resonance imaging study (Table 4.4.1), women in the computerised tomography study 
were older, and had similar body mass index (26.0 kg/m^ versus 25.2 kg/m^) but larger 
waist circumference (94.6 cm versus 78.6 cm). The difference in waist circumference 
between the women in the two studies is likely to result from different landmarks being 
used (umbilical for computerised tomography study, midway between lowest rib margin 
and iliac crest in magnetic resonance imaging study), and the difference would be much 
less if  the same level were used (see result section of the magnetic resonance imaging 
study). Multiple linear regression analysis in Table 4.4.6 shows that age was 
significantly related to intra-abdominal fat area in both sexes and to indices of adiposity 
in women only. The addition of height to the model did not significantly improve 
prediction in either sex. Low correlation between body mass index and age in men was 
partly explained by their non-linear relationship, weight increased up to 55 years and 
then decreased (figure not presented).
Table 4.4.7 shows that waist to height ratio was similar to waist circumference alone in 
predicting intra-abdominal fat area in men and women. Adjusting for age using partial 
correlation analysis increased all significant correlations between intra-abdominal fat 
area and all antluopometric indices except waist to height ratio (decreased) in men. Thus 
waist to height ratio and waist circumference were similar in prediction of intra­
abdominal fat area after age adjustment. In women, all significant correlations decreased 
when adjustment was made for age. Subjects were stratified into two age groups at 50 
years (Table 4.4.8). Variances were determined using curve estimation to see if there 
were curvilinear relationships between intra-abdominal fat area and waist circumference 
or waist to height ratio. There were slight differences in variances between the linear and 
quadratic relationships, and only men aged >50 years showed any evidence for
168
difference between waist and waist to height ratio. The data set is too small to be 
confident that this is a real result.
Figures 4.4.2a & b show, for men and women sepai'ately, that dividing the subjects into 
two groups above and below 50 years, intra-abdominal fat area was linearly related to 
waist circumference. For a given waist circumference, younger men had significantly 
lower intra-abdominal fat area than older men. The gradients between the two age 
groups in women were not significantly (P >0.05) different from each other.
DISCUSSION
The magnetic resonance imaging study in healthy female volunteers confirms the robust 
prediction of intra-abdominal fat volume from a simple waist circumference. The results 
on tln'ee-dimensional fat volume strengthens the data obtained from oui* study of single 
cut computerised tomography in men and in women sepai'ately. Neither waist 
circumference nor any other indices of adiposity nor intra-abdominal fat volume 
correlated with height. Therefore dividing indices by height to create ratios would 
violate the principle for deriving indices of adiposity (Benn, 1971). There may be 
sepai'ate influence of height on health risks, independent of body fat, but height does not 
contribute in measurement of intra-abdominal fat or fatness.
For use in health promotion, waist alone is already becoming established as a better 
predictor of risk factors related to body fat than more complicated ratios, such as waist 
to hip ratio or waist to height ratio, firstly because of ease of communication, and 
secondly because it is at least as powerful in predicting risk (Chapter 5.2; Han et al, 
1995c) and mortality (Higgins et al, 1988) as the ratios. We have previously 
demonstrated a lack of association between height and waist circumference (Chapter 
4.3; Han et al, 1996b; Han et al, 1997c). Changes in waist circumference have been 
shown to correlate (P <0.05) with changes in intra-abdominal fat (r = 0.81) (Lemieux et 
al, 1996a), and changes in a variety of cardiovascular risk factors including total 
cholesterol {r = 0.31), low density lipoprotein cholesterol {r = 0.35) and blood pressure
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(r = 0.26) ill women (C hapter 7; Han et al, 1997a). Changes in waist to hip ratio were 
not related to changes in either intra-abdominal fat (Lemieux et al, 1996a) or changes in 
cardiovascular risk factors (C hapter 7; Han et al, 1997a; Lemieux et al, 1996a).
Suggestions that a ‘waist to height ratio’ should be used in health promotion have been 
made, based on a study of single computerised tomography image just above the iliac 
crest (L4-L5) in a mixed group of 16 men and 31 women (Ashwell et al, 1996). 
However, it may not be appropriate to analyse men and women together, since the 
intercepts for the two sexes were significantly different (Ashwell et al, 1996). Our 
present computerised tomography analysis, combining 71 men and 34 women produced 
a small difference in the opposite direction: intra-abdominal fat area at L4-L5 correlated 
higher with waist circumference alone (r = 0.79, r = 0.77 after age adjustment) than with 
waist to height ratio (r = 0.77, r = 0.72 after age adjustment). Pouliot et al (1994) 
analysed 81 men and 70 women separately, and found waist circmnference correlated 
with intra-abdominal fat area measured by computerised tomography at L4-L5 similarly 
to our single magnetic resonance images (r = 0.87) in women, and a correlation of 0.77 
in men. Treuth et al (1995) observed a correlation of 0.84 between intra-abdominal fat 
area and waist circumference in women. These authors came to the same conclusion as 
ours, recommending the use of waist circumference as an index for intra-abdominal fat 
accumulation and associated morbidity. Waist sagittal diameter gave similar results to 
waist circumference in the present magnetic resonance imaging study.
In the present study, the close correlations between the volume and single cuts of intra­
abdominal fat justify the use of a single scan in lai'ger studies in terms of time and costs. 
Table 4.4.2 shows that the best single scan was at the level of 2/3 the distance between 
xiphisternum and anterior iliac crest, approximately at the L2-L3 level in most subjects 
with /  = 0.98. The present study of magnetic resonance imaging had a relatively small 
sample of 20 women but the small sample size was compensated for by multiple scans, 
thus the results would be expected to be more robust than single scans. A recent study of
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magnetic resonance imaging (Abate et al, 1997) in 49 men showed similar results with 
best prediction of volume from a single cut at L2-L3 ~ 0.85).
Intra-abdominal fat area was linearly related to waist circumference (Table 8) in both 
sexes, therefore the present study did not support the findings of Sclireiner et al (1996), 
who observed a quadratic relationship in men. Age had important effects on fat 
distribution. When the subjects were divided into two age groups separated at 50 years 
in either sex, the gradients of the relationships between intra-abdominal fat area and 
waist circumference were significantly different in men (Figure 4.4.2a), but not in 
women (Figure 4.4.2b), namely for a given waist circumference, men above 50 years 
had significantly more intra-abdominal fat than those below 50 years. Significant 
differences in women of different age group might emerge if more extreme age groups 
could be compared, for example those above 60 versus those below 40 years. Similarly, 
it was observed that for a given body mass index, older subjects tended (not significant) 
to have more intra-abdominal fat than younger ones (data not presented). Lemieux et al 
(1996b) found similar results and have proposed higher cut-offs of waist circumference 
for younger people (below 40 years) to identify those with an intra-abdominal fat area 
above 130 cm^. However, separate cut-offs in different age groups could only be 
justified if evidence is produced to indicate different associations of health risk with the 
same amount of intra-abdominal fat at different ages. Furthermore, other factors could 
influence intra-abdominal fat deposition, including illnesses such as non-insulin 
dependent diabetes mellitus, smoking and alcohol drinking. Separate cut-offs for these 
people might give greater predictive accuracy, but would complicate the whole issue in 
terms of health promotion directed at the general public.
CONCLUSIONS
Waist circumference alone explained 78% of the variance in intra-abdominal fat volume 
by magnetic resonance imaging in women, and there was no further improvement using 
waist:height^ ratios of different levels of index power. In both men and women, height 
did not greatly influence the relationship between intra-abdominal fat area by
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computerised tomography. In men, the slope of the relationship between intra-abdominal 
fat area and waist circumference was greater in those over 50 yeai's than those under 50 
years, so a given waist circumference is associated with more intra-abdominal fat area in 
older people than younger people. A similar trend was observed in women, but the 
difference in slopes was not significant. However, before this finding is used to derive 
different cut-off values for health screening, we would argue that the relationships 
between waist circumference and risk factors at different ages need to be further 
examined.
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Table 4.4.1. Chai'acteristics of 20 women in the magnetic resonance imaging study.
Mean SD Range
Age (years) 34.4 10.0 20.0-51.1
Weight (kg) 66.8 14.0 46.0-96.1
Height (cm) 162.3 6.5 148.4-171.9
Body mass index (kgW ) 25.2 4.5 19.6-33.0
Waist circumference (cm) 78.6 10.7 61.6-97.3
Waist sagittal diameter (cm) 20.5 3.6 15.5-27.0
Waist transverse diameter (cm) 27.7 3.0 23.1-33.0
Waist to hip ratio 0.78 0.07 0.67-0.89
Subcutaneous skinfolds (mm)'*^ 67.4 27.2 30.3-122.5
Intra-abdominal fat volume (kg) 0.96 0.77 0.07-2.66
*Sum o f  skinfolds measured at biceps, triceps, subscapular and supra-iliac sites.
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Table 4.4.3. Proportions of the variance of intra-abdominal fat volume (measured by 
magnetic resonance imaging) and indices of adiposity explained by height in 20 women, 
using linear regression analysis.
Adjusted / P
Intra-abdominal fat volume 0.013 0.394
Waist circumference 0.004 0.312
Waist sagittal diameter 0.005 0.354
Waist transverse diameter 0.006 0.201
Waist to hip ratio 0.002 0.339
Body mass index 0.020 0.334
Subcutaneous skinfolds* 0.010 0.522
*Sum o f skinfolds measured at biceps, ti'iceps, subscapular and supra-iliac sites.
Table 4.4.4. Variances of intra-abdominal fat volume (measured by magnetic resonance 
imaging) explained by waist to height ratios of different levels of index power for height 
in 20 women, using linear regression analysis.
Waist to height*’ ratios of different levels of index power 
^050 ^025 O.OOt Ô25 Ô5Ô 0/75 l.OOJ
Adjusted /  (%) 77.0*** 77.8*** 77.8*** 77.1*** 75.4*** 72.9*** 69.6***
***P <0 .0 0 1 ; fw aist to height" -  waist circumference alone; Jwaist to height' =  waist to height ratio.
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Table 4.4.5. Characteristics of 71 men and 34 women in the computerised tomography 
study.
Men (n = 71) Women (« = 34)
Mean SD Range Mean SD Range
Age (years) 52.0 17.2 19.4-84.7 52.6 13.3 19.4-72.1
Weight (kg) 73.5 11.3 54.0-102.0 69.6 12.3 50.0-103.0
Height (cm) 177.6 8.5 158.4-197.0 164.2 6.3 151.3-182.0
Body mass index (kg/m^) 23.4 3.1 17.8-31.6 26.0 5.0 19.4-38.3
Waist circumference (cm) 90.9 9.5 71.4-111.5 94.6 14.7 74.0-125.4
Waist to hip ratio 0.96 0.05 0.08-1.10 0.94 0.08 0.79-1.09
Subcutaneous skinfolds (mm)* 32.4 15.6 9.5-80.0 50.2 22.0 13.2-87.5
Intra-abdominal fat area (cm^) 89.9 53.0 12.7-274.0 91.8 52.7 18.8-221.0
*Sum o f skinfolds measured at abdomen and supra-iliac sites.
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Table 4.4.6. Proportions of variance and t values of intra-abdominal fat area measured 
by computerised tomography and anthr opometric indices explained by age and height in 
71 men and 34 women, using multiple linear regression analysis.
Men {n = 71) Women (n = 34)
Predictor: Age
ÜA fA Pa UA (a Pa
Intra-abdominal fat area 0.141 3.540 <0.001 0.272 3.748 <0.001
Waist circumference -0.001 0.978 0.332 0.262 3.663 <0.001
Waist to hip ratio -0.007 0.721 0.473 0.093 2.089 0.045
Body mass index -0.013 0.235 0.235 0.121 2.411 0.021
Subcutaneous skinfolds* 0.043 -2.042 0.045 0.091 2.100 0.044
Predictors: Age + Height
6-1 pR Ufi+A 6-1 Pr
Intra-abdominal fat area 0.147 -1.029 0.231 0.289 -1.354 0.185
Height 0.361 -6.409 <0.001 0.038 -1.543 0.132
Waist circumference -0.009 0.663 0.510 0.275 -1.272 0.212
Waist to hip ratio -0.013 -0.761 0.450 0.148 -1.762 0.088
Waist to thigh ratio 0.497 0.401 0.690 0.372 -1.552 0.131
Body mass index 0.008 -1.576 0.120 0.216 -1.721 0.095
Subcutaneous skinfolds* 0.032 0.463 0.645 0.107 -1.257 0.218
u = variance proportion (adjusted); t ^ t  value; A age; H = height; u^+a == total o f  variance proportions 
from height and age combined; *sum o f  skinfolds measured at abdomen and supra-iliac sites.
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Table 4.4.7. Correlation coefficients between intra-abdominal fat ai*ea measured by 
computerised tomography and anthropometric indices in 71 men and 34 women, with 
and without age adjustment.
Men (n = 71) Women (« = 34)
Unadjusted Age adjusted:}: Unadjusted Age adjusted:}:
Waist circumference 0.820*** 0.847*** 0.800*** 0.719***
Waist to height ratio 0.890*** 0.873*** 0.795*** 0.713***
Waist to hip ratio 0.748*** 0.778*** 0.503*** 0.401***
Body mass index 0.752*** 0.805*** 0.806*** 0.770***
Subcutaneous skinfoldsf 0.550*** 0.720*** 0.702*** 0.653***
Height -0.008"' 0.080"' -0.313"' -0.216"'
***p  <0.001, ns = not significant; fsum  o f skinfolds measui'cd at abdomen and supra-iliac sites; Jpartial 
correlation analysis.
Table 4.4.8. Variances of intra-abdominal fat area (measured by computerised 
tomography) explained by waist circumference or waist to height ratio in 71 men and 34 
women, using linear or quadratic regression analysis.
Men (n = 71) Women ( n - 34)
<50 years 
/ ( % )
>50 years 
/ ( % )
<50 years 
/ ( % )
>50 years 
/ ( % )
Waist circumference Linear 75.7 71.8 49.1 58.9
Quadratic 76.8 71.8 52.0 59.5
Waist to height ratio Linear 76.4 77.9 53.4 58.6
Quadratic 76.4 79.0 55.4 59.0
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Figure 4.4.1. Plots between intra-abdominal fat volume measured by magnetic 
resonance imaging and waist circumference (intra-abdominal fat volume = 0.0641 x 
waist circumference - 4.072) (a), and waist to height ratio (intra-abdominal fat volume = 
10.126 X waist to height ratio - 3.943) (b) in 20 women.
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Figure 4.4.2a. Plots between intra-abdominal fat area measured by computerised 
tomography and waist circumference for separate age groups above and below 50 years 
in 71 men [<50 year age group: intra-abdominal fat area = 3.96 (95% Cl: 3.11 to 4.81) x 
waist circumference - 288.9 (95% Cl: -366.1 to -211.7); >50 year age group: intra- 
abdominal fat ai'ca = 5.04 (95% Cl: 3.98 to 6.09) x waist circumference - 356.3 (95% 
Cl: -453.1 to -259.6)]. Differences between gradients are significant {P <0.05).
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Figure 4.4.2b. Plots between intra-abdominal fat ai'ea measured by computerised 
tomography and waist circumference for sepai’ate age groups above and below 50 years 
in 34 women [<50 year age group: intra-abdominal fat area = 1.98 (95% Cl: 0.82 to 
3.13) X waist circumference - 114.3 (95% Cl: -216.0 to -12,5); >50 year age group: 
intra-abdominal fat area = 2.85 (95% Cl: 1.67 to 4.03) x waist circumference - 170.5 
(95% Cl: -290.0 to -51.0)]. Differences between gradients are not significant (P >0.05).
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RELATIONSHIP BETWEEN VOLUMES AND AREAS FROM 
SINGLE TRANSVERSE SCANS OF INTRA-ABDOMINAL FAT 
MEASURED BY MAGNETIC RESONANCE IMAGING
This section has been prepared for publication as
Han TS, Kelly IE, Walsh K, Greene R, Lean MEJ. Relationship between 
volumes and areas from single transverse scans of intra-abdominal fat 
measured by magnetic resonance imaging, (in preparation).
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ABSTRACT
Objective: To determine the level of a single transverse scan of intra-abdominal fat 
between LI to L5 that best predicts intra-abdominal fat volumes.
Subjects: Sixteen male and seven female patients with non-insulin-dependent diabetes 
mellitus, aged 44-74 years.
Outcome measures: Volumes and areas fi'om single scans of intra-abdominal fat 
measured by magnetic resonance imaging with a 1.5 Tesla magnetic field.
Results: Intra-abdominal fat volumes calculated from fat areas between 8 to 9 cross- 
sectional transverse single scans of 20 mm thickness. Men and women, respectively, had 
mean body mass index of 27.9 (SD 3.0) and 31.6 (SD 4.7) kg/m^, and intra-abdominal 
fat volumes 2.3 (SD 0.5) and 2.5 (SD 0.6) kg. Intra-abdominal fat area of the fourth scan 
(in the direction of LI to L5) gave the highest prediction of total intra-abdominal fat 
volumes both in men (r = 0.959, P  <0.001) and in women (r = 0.973, P  <0.001). The 
intra-abdominal fat area of the third scan gave an almost as good prediction. These third 
and fourth levels of scans corresponded to L2 and L3 vertebrae in most subjects. The 
intra-abdominal fat areas scamied from the sixth and seventh level, corresponded to the 
frequently used L4-L5, had lower correlations with intra-abdominal fat volumes. There 
were no sex differences in the prediction o f volumes from areas of intra-abdominal fat. 
Intra-abdominal fat ai'eas from the fourth scan explained 93% of variance (SEE = 0.14 
kg) of total intra-abdominal fat volumes.
Conclusions: In large studies of intra-abdominal fat using magnetic resonance imaging, 
a single intra-abdominal fat area at the levels between L2 and L3 vertebrae, i.e. close to 
the level for measuring waist circumference as defined by the World Health 
Organisation (1995), offers a cheaper and faster method, with high prediction of total 
intra-abdominal fat volumes.
Keywords: fat distribution, health promotion, methodology, obesity, visceral fat.
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INTRODUCTION
Increased accumulation of the metabolically active intra-abdominal fat (Kissebah et al, 
1982) is thought to be responsible for a variety of metabolic disorders (Bjorntorp, 1990). 
This topic has been reviewed in detail in Chapter 1. Measuring total abdominal fat 
using magnetic resonance imaging (MRI) requires a series of consecutive images in 
order to calculate the volume. Measuring total volume in studies of large numbers of 
subjects is not practical due to time consuming and high costs. Oui' previous MRI study 
of twenty women has shown that a single cut at 2/3 the distance between xlphisternum 
and anterior iliac crest, approximately at the L2-L3 level in most subjects gave the 
highest correlation with intra-abdominal fat volume (Chapter 4.4, Table 4.4.2). This 
section, describes the methods for measuring extra- and intra-abdominal fat volumes 
using multiple MRI scans, and determines the level of a single transverse scan of intra­
abdominal fat between LI to L5 that best predicts intra-abdominal fat volumes.
METHODS 
Subjects
Sixteen men and seven women with non-insulin-dependent diabetes mellitus took part in 
a randomised, double blind twelve week follow up study of the effects of troglitazone (a 
thiazolidinedione compound which enhances the effects of insulin in peripheral tissues 
and the liver) on intra-abdominal fat mass. Subjects underwent comprehensive 
physiological assessments as well as body composition measurements using a variety of 
standard techniques including underwater weighing, anthropometry and MRI (Kelly et 
al, 1997). This section presents only the analysis of baseline MRI data.
Magnetic resonance imaging
The tissues of the abdomen were scanned using MRI machine (Siemens, Germany) (see 
Figure 1.2.5, page 15 of Chapter 1) with a magnetic field strength of 1.5 Tesla. 
Ordinary spin echo sequences was used with repetition time (TR) of 350 ms and echo 
time (TE) of 12 ms for the abdomen measurement.
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Abdominal fat measurement
Calibrations o f  lipid and water
A  lump of lard (lipid) was placed next to a container of water in the MRI scanner to 
simulate lipid in adipose tissue (AT) and lean tissue in vivo. The scan was analysed to 
obtain the threshold value where only the fat in the lard could be imaged (whilst the 
imaging of water just disappears). Pilot tests determined the tlireshold value to be at 300 
(arbitrary units) for every subject for subsequent calculations.
Abdominal fa t imaging
Four sagittal images of the trunk were scamied to find the vertebral column. To obtain 
reproducible imaging volumes, the volume of the abdomen was taken to extend from the 
bottom of the inferior plate of the LI vertebra to the bottom of inferior plate of the L5 
(Figure 4.5.1a). Data were collected from as many 20 mm thick sections (Figure 
4.5.1b) as could completely fit within that interval. This imaging volume approximately 
corresponds to the levels from xlphisternum to anterior iliac crest in our previous MRI 
studies (Han et al, 1997b, see Chapter 4.4), but was more reproducible.
Calculations o f  intra-abdominal and extra-abdominal adipose tissue and fa t volumes 
After setting an appropriate threshold value (300 window level) that separates fat (lipid) 
from lean tissues (water), the volume of intra-abdominal and extra-abdominal AT were 
calculated. The number of pixels for total abdominal AT was obtained from the region 
of interest by encircling the whole abdomen contents with an ovoid line (Figure 4.5.1c). 
To obtain the number of pixels for intra-abdominal AT, the ovoid line was then reduced 
to encircle the intra-abdominal contents at the position of the fascial plane to separate 
intra-abdominal from extra-abdominal AT (Figure 4.5.1d). Total volume of abdominal 
AT (mm^) was obtained by summing the AT areas in eight (or nine in eight men) 
transverse scans obtained in each subject, and multiplied by 20 mm (slice thickness). A 
factor of 10'^ was used to convert mm^ to litre of AT volume, and then to volume of fat 
(kg) assuming AT contains 80% of fat, 2% protein, 18% of water with negligible 
minerals (Garrow, 1974), with corresponding densities of 0.900, 1.34 and 0.993 kg/1
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(Siri, 1961), giving an average AT density of 0.9255 kg/1. Thus fat was converted from 
AT by a factor of 0.9255 x 80%. The difference between the total volumes of abdominal 
fat and intra-abdominal fat provides the total volume of extra-abdominal fat.
Statistical analysis
Relationships between volumes and single areas of intra-abdominal fat were determined 
using linear regression analysis in each sex separately, and partial coirelation in both 
sexes together, to control for sex.
RESULTS
Table 4.5.1 shows the chaiacteristics of sixteen men and seven women. Most subjects 
were overweight with large intra-abdominal fat deposition, as expected in patients with 
non-insulin-dependent diabetes mellitus.
Table 4.5.2 shows the coirelations between single intra-abdominal fat areas scanned at 
20 imn intervals between the LI and L5 vertebrae. Eight cross-sectional images of intra­
abdominal fat areas between LI and L5 were obtained in most subjects, and nine images 
in eight men with longer trunk. All single areas correlated highly with total volumes of 
intra-abdominal fat. Intra-abdominal fat areas in the fouifri (in the direction of LI to L5) 
gave the best correlation with the volumes both in men (r = 0.959, P <0.001) and in 
women (r = 0.973, P <0.001). Correlations between these two variables remained 
highest when men and women were analysed together, with or without adjustment for 
sex. Figure 4.5.2 shows the close relationship between total intra-abdominal fat 
volumes and intra-abdominal fat areas taken at the fourth scan. Table 4.5.3 shows the 
regression equations to predict volumes from areas of intra-abdominal fat sepai'ately for 
men and women and for both sexes combined. The areas from the fourth scan explained 
93% of variance (SEE = 1 . 4  kg) of the volumes of intra-abdominal fat in men and 
women together. Adjusting for sex in multiple linear regression analysis did not improve 
the prediction and sex was not a significant factor (data not presented). The gradients 
and intercepts of the regression lines were not significantly different between the two
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sexes. Intra-abdominal fat areas from the third scan also correlated well with the total 
volumes. The third and foui’th scanning levels in the present study corresponded 
approximately to the L2 and L3 vertebrae in most subjects. Intra-abdominal fat areas 
from the sixth and seventh levels corresponded to that from the frequently used L4-L5 
level for a single image, had lower con'elations with intra-abdominal fat volumes.
DISCUSSION
In the present study, after a pilot study, a single tlireshold (300) was set for all subjects 
to distinguish fat tissue from other tissues. Because intra-abdominal fat locates within an 
almost circular perimeter of fascial plane (Figure 4.5.1c-d), an ovoid was used to 
encircle this region of interest for calculations. The coefficient of variation using this 
method for repeated calculations (Bland, 1987) was less than one percent, which 
improved on the previous ‘hand drawn’ method in the earlier MRI study (Chapter 4.4).
Measuring total intra-abdominal fat volume is time consuming, requiring many scans, 
which adds on to the high costs. The present study has shown that both in men and in 
women, the intra-abdominal fat areas in the third and fourth scans (in the direction of LI 
to L5), which approximately correspond to the levels of L2 and L3 vertebrae, gave the 
highest prediction of intra-abdominal fat volumes. Single intra-abdominal fat areas from 
levels 6 and 7, which correspond to the frequently used L4-L5 level in scanning 
teclmique (Lemieux et al, 1996b), had lower correlations with the volumes. These 
findings are supported by our previous MRI study of women and the very recent 
publication of Abate et al (1997), suggesting that a single scan at L2-L3 is valid for 
estimating total intra-abdominal fat volumes.
CONCLUSIONS
The present study employed a novel method for intra-abdominal fat calculations. Intra­
abdominal fat area from a single transverse cross-sectional scan at approximately L2-L3, 
is a valid estimate of total intra-abdominal fat volume, which could be used in studies of 
large number of subjects to save time and costs.
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Table 4.5.1. Characteristics of 16 men and 7 women.
Men (n = 16) Women (n = 7)
Mean SD Range Mean SD Range
Age (years) 56.2 6.3 44.1-65.7 62.3 9.1 49.1-74.1
Weight (kg) 81.1 11.7 61.7-107.2 77.6 11.5 61.8-94.0
Height (cm) 171.0 6.8 159.0-183.0 156.9 4.2 149.0-162.0
Body mass index (kg/m^) 27.9 3.0 22.9-34.1 31.6 4.7 24.6-37.1
Waist circumference (cm) 100.3 9.9 82.1-122.5 107.1 9.0 96.2-120.6
Intra-abdominal fat area from 
LI to L5 vertebra (cm^)
Level 1 232.2 47.5 145.3-308.2 205.2 59.5 110.9-275.8
Level 2 199.7 51.5 108.9-287.2 178.5 66.6 77.0-261.7
Level 3t 210.2 53.3 124.0-291.7 209.9 62.2 100.6-278.7
Level 41- 194.3 41.3 135.3-245.0 208.9 57.9 136.1-298.3
Level 5 200.4 51.7 135.1-299.4 232.4 63.6 155.1-322.2
Level 6X 175.5 43.2 116.1-245.9 218.2 57.5 137.6-300.7
Level 7:|: 158.2 35.2 106.4-203.9 219.2 52.4 156.7-287.4
Level 8 139.1 29.8 83.8-187.3 226.4 47.8 155.2-295.2
Level 9§ 140.8 28.8 95.9-179.1
Total fat volume from 
LI to L5 vertebra (kg)T|
Abdominal fat 3.90 0.52 3.14-4.85 6.04 1.15 4.42-7.53
Intra-abdominal fat 2.34 0.47 1.71-2.99 2.52 0.63 1.64-4.64
Extra-abdominal fat 1.56 0.09 1.00-2.06 3.53 0.67 2.70-4.36
tCorrespond to the levels o f L2 and L3 vertebrae, i.e. close to the level for measuring waist 
circumference as defined by the World Health Organisation (1995); ^correspond to the levels o f L4 and 
L5 vertebrae; §nine transverse scans were fitted in between LI and L5 in eight men; j^see methods section 
for calculations o f  total abdominal fat volumes from cross sectional transverse abdominal fat areas.
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Table 4.5.2. Correlation coefficients between total intra-abdominal fat volumes and 
intra-abdominai fat areas from single transverse scans of at different levels between LI 
to L5 vertebrae, measured by magnetic resonance imaging in 16 men and 7 women.
Both sexes together
Men Women Unadjusted Sex adjustedj'
Scan level
Level 1 0.864*** 0.802*** 0.763*** 0.839***
Level 2 0.840*** 0.846*** 0.789*** 0.842***
Level 3 J 0.921*** 0.958*** 0.921*** 0.933***
Level 4:j: 0.959*** 0.973*** 0.966*** 0.965***
Level 5 0.883*** 0.957*** 0.910*** 0.912***
Level 6§ 0.909*** 0.949*** 0.902*** 0.925***
Level 7§ 0.913*** 0.881*** 0.813*** 0.897***
Level 8 0.864*** 0.872*** 0.675*** 0.864***
Level 9^ 0.912*** — 0.912*** —
fPartial correlations; fcorrespond to the levels o f  L2 and L3 vertebrae; §correspond to the levels o f  L4 
and L5 vertebrae; Ifnine transverse scans were fitted in between LI and L5 in eight men.
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Table 4.5.3. Regression equations to predict intra-abdominal fat volume from intra­
abdominal fat area separately and together for men and women.
Dependent variable: Independent variable: Intra-abdominal fat area
Intra-abdominal (cm^)
fat volume (kg)
Gradient (xlO) Intercept r SEE
P 95% Cl P 95% Cl (%) (kg)
M ent 0.110*** 0.091,0.129 0.204"' -0.165,0.572 91.4 0.139
Womenf 0.105*** 0.077,0.134 0.316"' -0.303, 0.934 93.6 0.158
Both sexes 0.108*** 0.095,0.121 0.244"' -0.026, 0.513 92.9 0.138
tN o  differences in gradients or intercepts between men and women, P >0.05; ***? <0.001, ns = not 
significant.
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Figure 4.5.1. Abdominal fat images from magnetic resonance imaging (MRI).
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■s Men: r = 0.959, f  <0.001 
• "  " Women: r = 0.973, P  <0.001
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Figure 4.5.2. Relationship between total volumes and single transverse cross-sectional 
ai’eas of intra-abdominal fat scanned at the fom-th level of the distance from LI to L5 
vertebra, measured by magnetic resonance imaging, in 16 men and 7 women. 
Regression equation for both sexes (adjusted variance = 92.9%, SEE = 0.138 kg): Intra- 
abdominal fat volume (kg) = 0.1082 (95% Cl: 0.0949 to 0.1214, P <0.001) x 10 x 
Intra-abdominal fat area (cm^) + 0.2436 (95% Cl: -0.0262 to 0.5134, P  = 0.074),
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5.1
ASSOCIATIONS BETWEEN BODY FAT DISTRIBUTION AND 
LIFESTYLE FACTORS
This section has been submitted for publication as
Han TS. Bijnen FCH, Lean MEJ, Seidell JC. Separate associations of waist and 
hip circumference with lifestyle factors, (submitted).
Collaboration with MORGEN project
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ABSTRACT
Objective-. To study the associations of lifestyle factors with waist circumference, hip 
circumference, and body mass index.
Design-. Cross-sectional study in a random sample of 5887 men and 7018 women aged 
20-59 years, selected from the civil registries of Amsterdam, Maastricht and 
Doetinchem, in the Netherlands.
Results-. Results were compared to those in reference groups: non-smokers, occasional 
drinkers, highest educated, physically active, employed subjects, women who had no 
live births, or 20-29 year-olds. In multivariate logistic regression analysis, odds ratios 
(95% confidence interval) for those with a waist above the previously defined Action 
Level 2 (>94 cm in men, >88 cm in women) were significantly lower in smokers, and 
higher in heavy drinkers, inactive subjects, unemployed persons, those educated below 
secondary level, women who had >3 live births, and older age. Mean waist to hip ratio 
adjusted for body mass index and age were higher in these subjects. Residual analysis 
showed that the risk of having larger waist than expected from their body mass index 
were 1.2 times (1,1 to 1.4) in male smokers, 1.4 times (1.2 to 1.7) in male and 1.7 times 
(1.3 to 2.2) in female heavy drinkers, 1.6 times (1.5 to 1.8) in inactive men, and 1.3 
times (1.1 to 1.5) in unemployed women. The risk of having smaller hips than expected 
from body mass index were 1.2 times (1.1 to 1.4) in male and 1.2 times (1.0 to 1.3) in 
female smokers, 1.2 times (1.1 to 1.3) in men and 1.1 times (1.0 to 1.2) in women who 
were inactive.
Conclusions-. Each lifestyle factor may influence the size of waist and the hips 
differently, and understanding these influences is important for health promotion 
directed at general public.
Keywords-. Body shape, drinking, health promotion, physical activity, smoking.
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INTRODUCTION
When waist circumference approaches Action Level 1 (94 cm in men, 80 cm in women), 
subjects should be aware of the increased health risks. In the ‘Alert Zone’ between 
Action Level 1 and Action Level 2 (94-102 cm in men, 80-88 cm in women), people 
should not further gain weight, most should modify lifestyle such as increasing physical 
activity level, and some would benefit from self managed weight loss. Above this range, 
in the ‘Action Zone’ (>102 cm in men, >88 cm in women), every body should be urged 
to take action to seek professional help to achieve sustained weight loss and for risk 
factor screening (Chapter 4.2; Han et al, 1996c).
Associated with overweight, indicated by high body mass index, and adverse body fat 
distribution, indicated by high waist to hip ratio or large waist circumference, are 
clusters of symptoms and associated secondary chronic diseases, which are confounded 
by smoking (Shimokata et al, 1989; Lissner et al, 1992; Troisi et al, 1991), physical 
inactivity (Troisi et al, 1991), parity (den Tonkelaar et al, 1990), and low educational 
level (Seidell et al, 1986a). The relationship between alcohol consumption and body 
fatness is still unclear (Prentice, 1995). Published relationships between lifestyle factors 
and body fat distribution are difficult to interpret because they involve the waist to hip 
ratio, which could be related to either or both the waist and hip circumferences. Waist to 
hip ratio is related to both increased visceral fat and reduced leg muscle areas in men 
(Seidell et al, 1989a). Higher frequency of impaired glucose tolerance in Indian 
compared to Swedish men has been shown to relate to the ratio of lower leg muscle to 
total body muscle, not to excess visceral fat (Chowdhury et al, 1996). Patients with 
Cushing’s syndrome have both increased visceral fat and peripheral muscle wastage 
(Rebuffé-Scrive et al, 1988). High waist to hip ratio in alcoholic men is related to 
reduced gluteal muscle (Kvist et al, 1993). Dissociating the relative contributions of the 
two measui'es in waist to hip ratio in the associations with lifestyle factors may have 
important implications in terms of the interpretations of the associations between 
metabolic complications and the distribution of body ‘fat’ or ‘muscle’.
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The present study addressed two main issues: firstly, to highlight the associations of 
measures of overweight and abdominal fat distribution, with the main focus on the waist 
circumference Action Levels, with age and lifestyle factors, and secondly, to elucidate 
the associations of the lifestyle factors with waist and hip circumferences.
METHODS 
Subjects
Men {n ~ 5887) and women {n = 7018) aged 20-59, recruited into the ongoing 
MORGEN (Monitoring of Risk Factors and Health in The Netherlands) study in the 
1993 to 1995 cohorts.
Anthropometry and lifestyle factors
All anthropometric measurements were made according to the World Health 
Organisation (1989) recommendations by paramédical personnel. Subjects wore light 
clothes dui'ing measurements of body weight to the nearest lOOg using calibrated scales, 
height in bare feet to the nearest mm, waist circumference in duplicate at the level 
between the lowest rib margin and iliac crest, and hip circumference at the widest 
trochanters to the neai'est mm, the mean values of circumferences were used in analysis. 
Waist to hip circumferential ratio was computed, and body mass index was calculated as 
weight (kg) divided by height squared (m^). Lifestyle factors were obtained from a 
questionnaire.
Statistical analysis
1. Associations between lifestyle factors with adiposity
The prevalence of overweight and adverse fat distribution in each lifestyle group were 
determined by cross tabulation. Independent dummy variables were created for age and 
lifestyle factors (Appendix 5.1,1).
Logistic regression analysis used fat distribution and overweight, dichotomised at pre­
selected cut-off based on published criteria, as dependent variables. Waist circumference
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was dichotomised at Action Level 2 (102 cm in men and 88 cm in women) (Chapter 
4.1; Lean et al, 1995), body mass index at 30 kg/m^ (WHO, 1989), and waist to hip ratio 
at 0.95 in men and 0.80 in women (US Department of Agriculture and US Department 
of Health and Human Services, 1990). Linear regression analysis using least squares 
means to adjust body mass index and age for obtaining the mean values o f waist to hip 
ratio, in different lifestyle groups.
2. Residuals analysis to determine the relative contributions o f  waist and hip 
circumferences in their associations with lifestyle factors 
Linear regression analysis using body mass index as independent predictor of waist or 
hip circmnference was used to determine their respective residuals with and without age 
adjustment. Figure 5.1.1 illustrates the relationship between waist circumference and 
body mass index. The residuals obtained (measured circumference minus circumference 
predicted from their body mass index) were dichotomised to create dependent variables, 
the lower (negative residuals) waist than expected group and the higher (positive 
residuals) hips than expected group were used as reference groups (value of 0) for higher 
waist than expected and lower hips than expected (value of 1) respectively.
RESULTS
1. Associations o f  waist circumference Action Level 2, body mass index and M>aist to 
hip ratio with age and lifestyle factors 
Subject characteristics are shown in Table 5.1.1. Compared to the reference groups: 20- 
29 years, non-smokers, occasional alcohol drinkers, physically active subjects, most 
educated subjects, those currently employed, and women who never had a live birth 
(Appendix 5.1.1), Tables 5.1.2a & b show that heavy drinkers and non-drinkers 
(women only), inactive subjects, those with lower education (below educational level 2), 
unemployed subjects, housewives, and women who had given to 3 or more live births, 
were more likely to associate with waist circumference above Action Level 2. Smokers 
were associated with small waist circumference.
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Lifestyle factors related to body mass index similai'ly to waist circumference (for clarity, 
results not presented), but there were some differences in there relationships with waist 
to hip ratio. The odds ratios for those with waist to hip ratio >0.95 in men and >0.80 in 
women were not significantly different between smokers and non-smokers. Compared to 
their respective reference groups (Appendix 5.1.1), odds ratios for high waist to hip 
ratio (>0.95 in men, >0.80 in women) (US Department of Agriculture and US 
depailment of Health and Human Services, 1990) were significantly higher in older 
subjects, heavy drinkers, inactive subjects, the least educated, unemployed subjects 
(women only) and housewives, and women who had given to live births (data not 
presented). Figures 5.1.2a & b show the mean values of waist to hip ratio for selected 
lifestyle factors, with adjustments for body mass index and age. Compared to the 
reference groups (Appendix 5.1.1), mean values of waist to hip ratio were higher in 
smokers, physically inactive subjects, heavy drinkers and unemployed women. Older 
age, lower educated subjects, women who had given to live birth, and housewives were 
also significantly associated with high waist to hip ratio (results not shown).
2. Residuals analysis to determine the influences o f lifestyle factors on expected waist 
and expected hips fo r  a given body mass index 
Compared to their reference groups (Appendix 5.1.1), Tables 5.1.3a & b show that 
those with waist circumference larger than expected for their body mass index were 
significantly associated with increasing age, smoking in the past and present (men only), 
heavy alcohol consumption, inactivity (men only), lower education, unemployment and 
high parity (women only). Hip circumference smaller than expected was significantly 
associated with increasing age, smoking in the past (men only) and in the present, 
inactivity, lower education, and high parity in women. Early retired subjects were less 
likely to have waist lai'ger (men only) or hips smaller than expected.
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DISCUSSION
Some of the associations described in the present paper have been found for individual 
lifestyle factors in other studies (Seidell, 1991). We have, however, been able to conduct 
a systematic epidemiological analysis for lifestyle effects on waist circumference, 
referring to the previously defined Action Level 2 (Chapter 4.1; Lean et al, 1995), body 
mass index at 30 kg/m^ (WHO, 1989), and waist to hip ratio (0.95 in men, 0.80 in 
women) (US Department of Agriculture and US department of Health and Human 
Services, 1990), and explored the appropriate adjustments for confounders. The results 
also provide valuable information for health promotion aiming to prevent adiposity and 
its consequences. We have also examined the associations between lifestyle factors and 
waist circumference defined at Action Level 1 (94 cm in men, 88 cm in women) or body 
mass index at 25, and found similar trends to the associations with higher cut-offs, but 
with lower odds ratios (data not presented).
Aging, which is not modifiable, was the most important determinant for large waist 
circumference. Lifestyle factor relations to waist circumference were very similar to 
those for body mass index. This is because the two measures correlate very strongly (r 
>0.85). Waist to hip ratio showed more disparities from these two indices in the 
associations with lifestyle factors. Relationships with a ratio are difficult to interpret. 
The present study used residual analysis to describe the relative associations of waist 
and hip circumferences with lifestyle factors, and to identify possible effects of certain 
lifestyle factors on specific part of the body.
Although waist and hip circumferences correlated highly with body mass index (r >0.8), 
there are mean residuals of ±4 cm in waist and ±3 cm in hips (Tables 5.1.3a & b). A 
measured waist circumference larger than expected may indicate excess abdominal 
subcutaneous fat or visceral fat accumulation, whereas a hip circumference less than 
expected may reflect reduced femoral fat, small pelvic bone structure or gluteo-femoral 
muscle atrophy. Previous studies largely referred the waist to hip ratio as an indicator of 
fat distribution. In cross-sectional studies, residuals analysis provides a relatively simple
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method to dissociate individual associations of waist and hips circumferences. For 
example, both heavy drinkers (Figures 5.1.2a & b) and those in the lowest educational 
level (data not shown) had a high waist to hip ratio, but residuals analysis revealed that 
heavy drinkers had waist larger than expected, whereas those in the lowest educational 
level had hips lower than expected for a given body mass index (Tables 5.1.3a & b). 
Wliereas male smokers appeared to have normal waist to hip ratio, they were shown to 
have larger waist and smaller hips than expected.
In both sexes, smokers had lower body mass indices than non smokers, agreeing with 
previous findings (Shimokata et al, 1989; Lissner et al, 1992), and also smaller waist 
circumferences, but their waist was larger (not significant in women) and hips were 
smaller than expected for their body mass index. A tliree year longitudinal study has 
shown that smokers gained waist more and hips less than predicted from gain in body 
mass, thus a gain in waist to hip ratio was observed findings (Shimokata et al, 1989). 
Lissner et al (1992) found women who continued to smoke gained significantly more 
waist to hip ratio than those who stopped smoking. In the present study, male ex­
smokers had waist larger and hip circumference smaller than expected from their body 
mass index, but less so than smokers. Female ex-smokers had measured waist and hips 
as expected from their body mass index. Thus smoking cessation reduces the likelihood 
of excessive abdomen and recessive hips.
Heavy drinkers, especially men, had large waist circumferences, supporting the 
commonly observed ‘beer belly’ phenomenon. There was some evidence (not 
significant) for smaller hips than expected, perhaps in keeping with Kvist et al (1993) 
who found alcoholic men have reduced femoral muscle mass compared to non-drinkers. 
In the present study, only male heavy drinlcers were associated with body mass index 
>25 kg/m^, whereas female heavy drinkers had a similar body mass index to those who 
drank occasionally (results not shown). Previous studies even found an inverse 
relationship in women (Colditz et al, 1991). This paradoxical relationship in women has
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been discussed by Prentice (1995), who suggested that other lifestyle factors such as 
increased level of physical activity may offset the additional energy from alcohol.
Least educated men and women were twice and fours times, respectively, more likely to 
have a waist circumference exceeding Action Level 2 (>102 cm in men, >88 cm in 
women) and high waist to hip ratio, than the highest educated group, but they also had 
high body mass indices. For both sexes waist was as predicted from body mass index, 
but hips were smaller than expected. Less educated subjects within and between 
countries are generally more overweight, and have more adverse fat distribution (Seidell 
et al, 1986a; Seidell, 1995a). Lack of knowledge or interest in healthy lifestyle, and poor 
eating habits associated with lower educational level may explain this phenomenon.
Subjects who were least physically active were more likely to have waist above Action 
Level 2, and waist larger (not significant in women) and hips smaller than expected from 
their body mass index. It is likely that the association between physical inactivity and 
high waist to hip ratio (Figures 5,1.2a & b) indicates both increased abdominal fat 
deposition and skeletal muscle atrophy. Wlien other leisure physical activities were 
incorporated to sport participation to create physically active group who did both sport 
and other leisure activities and inactive group who did neither, it was found that inactive 
women were 1.5 times more likely to have waist larger than expected fr*om their body 
mass index (data not shown). This analysis was not presented because the question for 
other leisuie activities was not available in 1993 cohort. Our findings support recent 
health promotion message, encouraging a more physically active lifestyle (Pate et al, 
1995; Blair et al, 1996a), which may prevent weight gain or lead to more favourable 
tissue distribution (Houmard et al, 1994; Kanaley et al, 1993) and a variety of other 
health benefits (Blair et al, 1996b; Bouchard et al, 1994).
Compared to those who had a job, unemployed persons had increased risk of lai’ge waist 
circumference. It has been shown that unemployed people more frequently seek medical 
consultations than those who have a job (Carr-Hill et al, 1996). Weight gain has been
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observed in those who lost their job (Eley et al, 1997; Morris et al, 1992). Housewives 
had higher body mass index, waist to hip ratio and waist circumference. Exposure to 
food may explain these associations. Women who had more children also had higher 
waist and waist to hip ratio, and their waist was larger and hips were smaller than 
expected. Women with high waist to hip ratio are less likely to conceive compared to 
those who had lower waist to hip ratio (Zaadstra et al, 1993), but den Tonkelaar et al 
(1990) have shown women with high parity were associated with increased waist to hip 
ratio.
CONCLUSIONS
Overweight and adverse fat distribution are associated with increasing age, 
unemployment, parity in women, low education, and by poor lifestyle factors, including 
physical inactivity, heavy alcohol consumption, and smoking. Each lifestyle factor 
influences the size of waist and the hips differently and imderstanding these influences is 
important for health promotion. Thus modifiable lifestyle factors such as smoking 
cessation, drinking less heavily, and a more physically active lifestyle should all be 
encouraged, leading to an overall healthier body shape.
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Table 5.1.1. Characteristics of 5881 men and 7018 women.
Men Women
Mean SD Mean SD
Age (yeai’s) 42.9 10.7 42.2 11.0
Weight (kg) 82.0 12.0 68.5 11.5
Height (cm) 178.4 7.3 165.7 6.7
Body mass index (kg/m^) 25.8 3.5 25.0 4.2
Waist circumference (cm) 92.3 10.8 81.0 11.1
Hip circumference (cm) 101.8 6.6 102.2 8.4
Waist to hip ratio 0.905 0.072 0.791 0.070
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Table 5.1.2a. Odds ratios waist circmnference above Action Level 2 (>102 cm) in
different groups of lifestyle factors in men.
Independent variables f n Proportion:]: Odds ratio 95% confidence interval
20-29 years 909 4.4 1.00
30-39 years 1389 11.3 2.63**» 1.83,3.80
40-49 years M i l 19.3 q qy*** 3.15,6.35
50-59 years 1812 28.6 6.42*** 4.54, 9.07
297
Non smokers 1788 14.7 1.00
Ex-smokers 1946 22.4 1.04 0.87, 1.24
Smokers 2129 16.7 0.77* 0.64, 0.93
41
Occasional drinkers 1393 18.2 1.00
Non-drinkers 1021 15.5 0.99 0.79, 1.24
Moderate drinkers 2215 16.4 1.05 0.85, 1.30
Heavy drinkers 1258 22.6 1.45** 1.15, 1.81
X^ 26
Physically active 2858 12.1 1.00
Physically inactive 3026 23,6 1.72*** 1.48,2.00
X^ 132
Educational level 3 1523 11.4 1.00
Educational level 2 1733 14.1 1.48*** 1.19, 1.83
Educational level 1 2631 24.4 2.08*** 1.71,2.51
X^ 135
Employed 4508 16.6 1.00
Early retirement 432 14.6 0.99 0.73, 1.35
Unemployed 721 28.2 1.32** 1.09, 1.61
X^ 62
***P  <0.001, **P <0.01, <0.05; fall independent variables were entered simultaneously in
multivariate analysis; $ percentage o f  subjects with waist circumference above Action Level 2.
205
Table 5.1.2b. Odds ratios waist circumference above Action Level 2 (>88 cm) in
different groups of lifestyle factors in women.
Independent variables^ n Proportion^ Odds ratio 95% confidence interval
20-29 years 1263 7.6 1.00
30-39 years 1585 13.8 1.53** 1.16, 2.02
40-49 years 2150 25.1 2.90*** 2.22, 3.78
50-59 years 2020 40.7 4.83*** 3.70, 6.31
% 589
Non smokers 2526 24.2 1.00
Ex-smokers 1860 26.7 1.11 0.95, 1.29
Smokers 2620 21.6 0.84* 0.73, 0.97
IL 16
Occasional drinkers 3503 21 .\ 1.00
Non-drinkers 1651 19.5 1.30*** 1.12, 1.52
Moderate drinkers 1560 21.2 1.06 0.88, 1.28
Heavy drinkers 304 24.3 1.20 0.88, 1.64
'I 43
Physically active 3274 17.5 1.00
Physically inactive 3743 29.4 1.30, 1.66
' i 136
Educational level 3 1378 10.7 1.00
Educational level 2 1765 14.8 1.66*** 1.32,2.08
Educational level 1 3875 2.7 2.61*** 2.14,3.19
% 379
Employed 3471 17.6 1.00
Early retirement 450 14.7 1.08 0.80, 1.46
Unemployed 676 32.5 1.42*** 1.16, 1.72
Housewives 2151 33.0 1.14* 0.99, 1.30
% 222
No live birth 2137 12.8 1.00
1-2 live births 3172 26.1 1.16 0.97, 1.39
3 or more live births 1709 33.5 1.42*** 1.17, 1.73
% 240
<0.001, <0.01, *P <0.05; fa ll independent variables were entered simultaneously in
multivariate analysis; ^percentage o f  subjects with waist circumference above Action Level 2.
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Table 5.1.3a. Odds ratios for waist circumference larger or hip circrmiference smaller
than expected for a given body mass index in subjects in different groups of lifestyle
factors in men.
Independent 
variables §
Waist larger than expected j" 
(Mean 4.28, SE 0.06 cm)
Hip smaller than expected;j; 
(Mean 3.28, SE 0.05 cm)
Odds ratio 95% confidence 
interval
Odds ratio 95% confidence 
interval
20-29 years 1.00 1.00
30-39 years 2.10*** 1.72, 2.56 1.48*** 1.24, 1.78
40-49 years 3.50*** 2.88, 4.26 1.92*** 1.60,2.31
50-59 years 5.72*** 4.68, 6.98 2.63*** 2.18,3.18
Non smokers 1.00 1.00
Ex-smokers 1.23* 1.03, 1.37 1.17* 1.02, 1.35
Smokers 1.23** 1.07, 1.42 1.21** 1.05, 1.39
Occasional drinkers 1.00 1.00
Non-drinkers 0.90 0.76, 1.08 1.04 0.88, 1.24
Moderate drinkers 1.04 0.88, 1.22 1.05 0.90, 1.22
Eleavy drinkers 1.40*** 1.18, 1.70 1.10 0.92, 1.31
Physically active 1.00 1.00
Physically inactive 1.64*** 1.46, 1.84 1.18* 1.05, 1.32
Educational level 3 1.00 1.00
Educational level 2 1.00 0.86, 1.16 j 44*** 1.24, 1.67
Educational level 1 1.06 0.92, 1.22 1.87*** 1.63,2.15
Employed 1.00 1.00
Early retirement 0.74** 0.59, 0.94 0.73** 0.59, 0.91
Unemployed 0.94 0.79, 1.11 1.05 0.89, 1.25
<0.001, <0.01, <0.05; fmeasured waist greater than predicted waist using BMI (predicted
waist ^ 2.639 x BMI + 24.283; ^ 74.7%, P  <0.001); $ measured hip greater than predicted hip using
BMI (predicted hip = 1.414 x BMI + 65.369; =  56.9, P  <0.001); §all independent variables were
entered simultaneously in multivariate analysis with adjustment for waist residual in hip analysis, and hip 
residual in waist analysis.
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Table 5.1.3b. Odds ratios for waist circumference larger or hip circumference smaller
than expected for a given body mass index in subjects in different groups of lifestyle
factors in women.
Independent 
variables §
Waist larger than expectedf 
(Mean 4.85, SE 0.07 cm)
Hip smaller than expected^ 
(Mean 3.45, SE 0.04 cm)
Odds ratio 95% confidence 
interval
Odds ratio 95% confidence 
interval
20-29 years 1.00 1.00
30-39 years 1 80*** 1.50,2.15 1.36*** 1.14, 1.62
40-49 years 2.32*** 1.93,2.80 1.53*** 1.28, 1.83
50-59 years 3.50*** 2.89, 4.25 1.80*** 1.49,2.17
Non smokers 1.00 1.00
Ex-smokers 0.99 0.87, 1.13 0.92 0.81, 1.04
Smokers 1.10 0.98, 1.24 1.15* 1.03, 1.30
Occasional drinkers 1.00 1.00
Non-drinkers 0.99 0.87, 1.12 1.24*** 1.09, 1.40
Moderate drinkers 1.14 0.98, 1.31 1.10 0.95, 1.27
Heavy drinkers 1.68*** 1.29,2.18 1.19 0.92, 1.54
Physically active 1.00 1.00
Physically inactive 1.09 0.98, 1.21 1.10* 1.00, 1.22
Educational level 3 1.00 1.00
Educational level 2 1.12 0.96, 1.30 1.24*** 1.06, 1.44
Educational level 1 1.05 0.91, 1.22 1.56*** 1.36, 1.80
Employed 1.00 1.00
Early retirement 0.90 0.73, 1.12 0.77* 0.62, 0.95
Unemployed 1.27** 1.06, 1.51 1.17 0.98, 1.39
Housewives 1.10 0.97, 1.25 1.14 1.01, 1.29
No live birth 1.00 1.00
1-2 live births 1.03 0.90, 1.19 1.10 0.96, 1.26
>3 more live births 1.29** 1.10, 1.51 1.25** 1.07, 1.47
***p  <0.001, **P <0.01, *P <0.05; treasured  waist greater than predicted waist using BMI (predicted 
waist = 2.232 x BMI + 25.224; /  =  71.3%, P  <0.001); ^measured hip greater than predicted hip using 
BMI (predicted hip = 1.697 x BMI + 59.809; /  = 72.2%, P  <0.001); §all independent variables were 
entered simultaneously in multivariate analysis with adjustment for waist residual in hip analysis, and hip 
residual in waist analysis.
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Figure 5.1.1. Illustration of residuals obtained from regression between waist 
circumference and body mass index in men.
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Figure 5.1.2. Mean values o f waist to hip ratio with adjustments for body mass index 
and age in different categories of selected lifestyle factors in men (a) and in women (b).
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Appendix 5.1.1. Categories of lifestyle factors as independent variables to predict waist 
circumference, body mass index, and waist to hip ratio.
Reference group Dummy variables
1 2 3
Age (years) 20-29 30-39 40-49 5& j9
Smoking Non-smokers Ex-smokers Current smokers
Alcohol
consumption
(glasses/day)
Occasional
(<1)
Non-drinkers
(0)
Moderate 
(1 to <3)
Heavy
Physical activity Physically active 
(sport participation)
Physically inactive 
(do not do sport)
Educational level Level 3
(higher vocational 
or university)
Level 2 
(vocational or 
higher secondary)
Level 1 
(lower than 
secondary) '
Employment Cuirently
employed
Unemployed Housewives Early
retirement
Parity (live births) None 1-2 >3
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—  5.2  —
WAIST CIRCUMFERENCE ACTION LEVELS IN THE 
IDENTIFICATION OF CARDIOVASCULAR RISK FACTORS
This section has been peer reviewed and has been published as
Han TS. van Leer EM, Seidell JC, Lean MEJ. Waist circumference Action 
Levels in the identification of cardiovascular risk factors: prevalence study in a 
random sample. British MedicalJournal 1996; 311:1041-45.
Collaboration with MORGEN project
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ABSTRACT
Objective: To determine the frequency of cardiovascular risk factors of individuals 
categorised by previously defined Action Levels of waist circumference.
Design: Prevalence study in a random sample.
Setting: The Netherlands.
Subjects: 2183 men and 2698 women aged 29-59 years selected at random fi’om the civil 
registry of Amsterdam, Maastricht, and Doetinchem.
Main outcome measures: Waist circumferences, waist to hip ratio, body mass index 
(weight (kg)Zheight (m^)), total plasma eholesterol concentration, high density 
lipoprotein cholesterol concentration, blood pressure, age and lifestyle.
Results: A  waist circumference exceeding 94 cm in men or 80 cm in women correctly 
classified subjects with body mass index >25 kgim  and waist to hip ratio >0.95 in men 
and >0.80 in women with a sensitivity and specificity >96%. Men and women with at 
least one cardiovascular risk factor (total cholesterol >6.5 mmol/1, high density 
lipoprotein cholesterol <0.9 mmol/1, >160 mmHg systolic, >95 mmHg diastolic blood 
pressuie) were identified with sensitivities of 57% and 67% and specificities of 72% and 
62% respectively. Compared with those with waist measmements below Action Levels, 
age and lifestyle adjusted odds ratios for having at least one risk factor were 2.2 (95% 
confidence interval: 1.8, 2.8) in men with a waist measui'ement of 94-102 cm and 1.6 
(1.3, 2.1) in women with a waist measurement of 80-88 cm. In men and women with 
larger waist measurements these age and lifestyle adjusted odds ratios were 4.6 (3.5,6.0) 
and 2.6 (2.0,3.2) respectively.
Conclusions: Waist circumference identifies people at with increased cardiovasculai' 
risks.
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INTRODUCTION
Lean et al (1995; see Chapter 4.1) recently proposed waist circumference as a simple 
measurement to indicate the need for weight management. Waist circumference related 
both to body mass index and waist to hip ratio. Two Action Levels of waist 
circumference were determined to identify people whose health risks were increasing 
(Action Level 1: men 94 cm, women 80 cm) or high (Action Level 2: men 102 cm, 
women 88 cm).
The ongoing Dutch Monitoring Project on Risk Factors for Clironic Diseases 
(MORGEN project) which started in 1993, offered the opportunity in a large sample of 
men women to validate the Action Levels in a large sample of men and women and to 
assess the prevalence of cardiovascular risk factors and relative risks of subjects 
according to their waist circumference.
METHODS 
Subjects
A random sample of 2183 men and 2698 women aged 20-59 years was selected from the 
civil registry in Amsterdam, Maastricht and Doetinchem. Sampling was part of the 
MORGEN-proj ect to determine the prevalence of risk factors for clironic diseases, and 
also other specific clironic conditions in the general population living in various parts of 
The Netherlands. Measurements were made in basic health services in Amsterdam (in 
the West), Doetinchem (a small town in the East) and Maastricht (in the South). To 
obtain similar numbers of subjects at each age we stratified the sample by sex and five 
year age group. The response rate to invitations was roughly 50% in Amsterdam and 
Maastricht, and 80% in Doetinchem. All measurements were by trained investigators.
Anthropometry
Body weight in light clothes was measured to the neaiest 0.1 kg, and height to the 
nearest 0.5 cm. Body mass index was calculated as weight (kg) divided by height (m^). 
Waist circumference midway between lower rib and iliac crest and hip circumference at
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the level of the great trochanters were measured in duplicate to the nearest mm using 
flexible tape (WHO, 1989).
Cardiovascular risk factors
Sitting blood pressure was measured using a random zero sphygmomanometer, small (9 
X 18 cm), medium (12 x 23 cm) and large (15 x 33 cm) cuffs being used as appropriate. 
Systolic (Korotkoff phase I) and diastolic (Korotkoff phase V) blood pressure was 
measured twice on the left upper arm and the average used for analysis. Total and high 
density lipoprotein cholesterol concentrations were determined enzymatically with a 
Boehringer kit (Katterman et al, 1984). High density lipoprotein was isolated by 
precipitating apolipoprotein B containing lipoproteins with magnesium 
phosphotungstate (Lopes-Virella et al, 1977). All cholesterol analyses were performed at 
the clinical chemistry laboratory, University Hospital of Dijkzigt, Rotterdam, under 
standardisation programmes (World Health Organisation Regional Lipid Centre for 
Europe in Prague, Czechoslovakia, and the Centres for Disease Control, Atlanta).
Analysis
Hypercholesterolaemia was defined as plasma cholesterol >6.5 mmol/1 (European 
Atherosclerosis Society, 1987; WHO, 1988), low high density lipoprotein-cholesterol as 
<0.9 mmol/1 (European Atherosclerosis Society, 1987), and hypertension as systolic 
blood pressure >160 mmHg, or diastolic blood pressure >95 mmHg, or use of 
antihypertensive agents (WHO, 1988). Subjects were placed in either of two categories 
for each of tlnee lifestyle factors: smoking (current cigarette smokers or non-smokers), 
drinking (alcohol drinkers or non-drinkers), and physical activity (affirmative or 
negative answers to the question “Are you performing sports, including jogging and 
fitness training?”).
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Statistical methods
Sensitivity was defined as the percentage of all subjects with a risk factor who were 
identified correctly by high (above Action Level) waist circumference, and specificity as 
the percentage of all subjects without a risk factor who were identified correctly by low 
(below Action Level) waist circumference. Positive prediction was calculated as the 
percentage of subjects with a waist circmnference above Action Level who had the risk 
factor, and negative prediction as the percentage of subjects with a waist circumference 
below Action Level who did not have a risk factor (Sturmans, 1984; Swinscow, 1983).
Linear regression analysis and partial correlations were used to determine the 
relationships between variables. Logistic regression analysis was employed to determine 
the relative risk o f prevalence of cai'diovascular risk factors for subjects categorised by 
the two waist circumference Action Levels, with adjustments for age, alcohol 
consumption, cigarette smoking, physical activity, and education level. We did not 
adjust for body mass index and waist to hip ratio because of multicollineaiity with waist 
circumference (Belsley et al, 1980). Height accounted for less than 0.3% of variance in 
waist circumference and was excluded from the analysis. Statistical analyses used the 
SAS/STAT computer programme (SAS Institute, Philadelphia).
Cross tabulation was used to determine the sensitivity and specificity (Sturmans, 1984) 
of waist circumference Action Levels defined by Lean et al (1995; Chapter 4.1), Action 
Level 1 : men 94 cm, women 80 cm; Action Level 2: men 102 cm and women 88 cm - to 
identify subjects with body mass index values above 25 or above 30 kg/m^ for men and 
for women (the conventional cut-off points) and waist to hip ratio above 0.95 for men 
and 0.80 for women. Cross tabulation with waist measurement cut-offs defined by Lean 
et al (1995; Chapter 4.1) at Action Levels 1 and 2 were used to determine the 
sensitivity, specificity, and positive and negative predictions (Sturmans, 1984) of 
cardiovascular risk factors (high cholesterol concentration, low high density lipoprotein 
concentration, hypertension) at levels defined by the World Health Organisation (1989) 
and the European Atherosclerosis Society (1987).
216
RESULTS
Mean age, body mass index, hip circumference and total plasma cholesterol were similar 
in men and women. Men had a higher waist circumference, waist to hip ratio and blood 
pressure and lower high density lipoprotein cholesterol concentration (Table 5.2.1).
1. Replication of Action Levels to identify subjects with high body mass 
index and high waist to hip ratio
The Action Levels defined by Lean et al (1995; Chapter 4.1), using waist 
circumference (Action Level 1: men 94 cm, women 80 cm; Action Level 2: men 102 
cm, women 88 cm), were applied to this sample to identify subjects with a high body 
mass index (>25 or >30 kglm  in men and in women) and high waist to hip ratio (>0.95 
in men, >0.80 in women). Sensitivity was over 97.5% and specificity over 96.0% with 
only 2% false positive results and 0.8% false negative results with Action Level 1 and 
1.4% false positive results and 0.3% false negative results in Action Level 2 for the 
entire sample (Table 5.2.2).
2. Implications of Action Levels on cardiovascular risk factors
The prevalence (Figure 5.2.1) and mean (Table 5.2.3) values of adverse cardiovascular 
risk factors (except decreases in high density lipoprotein cholesterol concentration) 
increased with waist circumference in men and women. Correlations of waist 
circumference, body mass index and waist to hip ratio with risk factors (total cholesterol 
concentration, high density lipoprotein cholesterol concentration, systolic and diastolic 
blood pressure) were similar and remained significant in partial correlations controlling 
for age, alcohol consumption, cigarette smoking, physical activity and education (Table
5.2.4).
Sensitivity and specificity for identifying risk factors from waist circumference (Table
5.2.5) at Action Level 1 were between 57-72% both in men and women, with positive 
prediction varying between 16-38% in men and 10-22% in women for individual risk
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factors. Positive prediction increased to 59% in men and 37% in women who had one or 
more risk factors. Negative prediction was much higher, varying between 81 and 96% 
for individual risk factors and 71% in men and 85% in women who did not have any risk 
factors. Both positive and negative predictions by Action Level 1 were higher than the 
prevalence of subjects with (positive) and without (negative) risk factors in the whole 
population. Positive predictions of cai’diovascular risk factors increased further in 
subjects identified by Action Level 2, with a reduction in negative prediction (Table
5.2.5).
The relative risk of adverse cardiovascular risk factors identified by using odds ratios 
(adjusted for age, alcohol consumption, cigarette smoking, physical activity and 
education levels by logistic regression) with reference to subjects with waist 
circumference below Action Level 1, increased significantly as waist circumferences 
rose above Action Levels 1 and 2 (Table 5.2.6; data adjusted for age, and lifestyle). For 
health promotion simple waist circumference cut-off points would be used. Differenees 
in prediction with or without adjustments were similar, with the same patterns of relative 
risks (data not shown).
DISCUSSION
The present study supports our eailier finding that waist Action Levels identify those 
with high body mass and central fat distribution with high sensitivity and specificity 
(Chapter 4.1; Lean et al, 1995). In addition, the study shows a close relation between 
waist circumference and cardiovaseular risk factors. Waist circumference cut-off 
measurement identified (positive prediction) cardiovascular risk factors at one and a half 
times to twice the prevalence in the whole population at Action Level 1 and two and a 
half to three times at Action Level 2 (Table 5.2.6). Negative prediction by the Action 
Levels remained higher than the prevalence in the entire population. These results 
suggest that Aetion Levels using waist circumference may provide a valuable, simple 
method for alerting people at increased risk of cardiovascular disease who might benefit 
from weight management. The risk factor criteria used (cholesterol concentration >6.5
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mmol/1, high density lipoprotein concentration <0.9 mmol/1, blood pressure >160/95 
mmHg) are conservative. Figures for risk prevalence would be higher if lesser levels of 
risk were assessed.
Waist circumference has previously been related to cardiovascular risk factors (Higgins 
et al, 1988; Kannel et al, 1991; Seidell et al, 1992), In this study waist circumference 
correlated similaiiy to body mass index and waist to hip ratio with most of the 
cardiovascular risk factors. Adjusting for influences such as age, education and lifestyle 
had little effect. Higgins et al (1988) reached similar conclusions in the Framingham 
study, showing that waist circumference was associated with 24 year age adjusted 
mortality and also that waist circumference gave better risk prediction amongst smokers. 
In this study after adjustment for age and other lifestyle factors, smokers of both sexes 
had consistently more cardiovascular risk factors than non-smokers in any category of 
waist circumference (results not shown). With increasing age the serum cholesterol 
concentration increases substantially in women. Covariance between age and waist 
measurement prevents further increase in predictive power of waist circumference for 
high cholesterol concentration above Action Level 2.
Seidell (1995c) reviewed anthiopometric methods to assess abdominal fat, concluding 
that waist circumference alone was probably the most practical measurement for use in 
health promotion. For that purpose, practical cut-off measurements of waist 
circumference are required. Waist circumference relates closely to intra-abdominal fat 
mass (Seidell et al, 1988; Ross et al, 1992; Ross et al, 1993; Fouliot et al, 1994), and 
changes in waist circumference reflect changes in cardiovascular risk factors 
(Sonnichsen et al, 1992; Wing et al, 1992; Wing et al, 1995; Hellenius et al, 1993). 
Positive prediction of individual risk factors was fairly low but increased considerably 
when one or more of the risk factors were being identified (Table 5.2.5). Recent studies 
find large waist circumference strongly associated with risk factors of insulin resistance 
syndrome in women (Edwards et al, 1994) and non-insulin-dependent diabetes mellitus 
in men (Chan et al, 1994), and risks of breast cancer in women (den Tonkelaar et al.
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1995) and colonic cancer in men (Giovamiucci et al, 1995), suggesting that waist 
circumference may have a wider value as a measure for total health risks.
CONCLUSIONS
Action Levels of waist circumference proposed previously could be employed to 
identify sections of the population at high risk of chr onic disease from high total plasma 
cholesterol concentration, low high density lipoprotein cholesterol concentration, and 
hypertension who might benefit from weight management.
2 2 0
Table 5.21. Physical and metabolic characteristics of2183 men and 2698 women.
Men Women
Mean SD Mean SD
Age (years) 42.7 10.5 42.5 10.7
Weight (kg) 81.4 11.9 68.3 11.3
Height (cm) 177.9 7.4 165.1 6.8
Body mass index (kg/m^) 25.7 3.4 25.1 4.2
Waist circumference (cm) 91.6 10.4 80.3 10.9
Hip circumference (cm) 101.7 6.4 102.1 8.3
Waist to hip ratio 0.90 0.07 0.79 0.07
Total cholesterol (mmol/1) 5.4 1.1 5.4 1.1
HDL cholesterol (mmol/1) 1.1 0.3 1.4 0.4
Systolic blood pressure (mmHg) 122.8 15.6 115.5 15.4
Diastolic blood pressure (mmHg) 77.8 10.4 74.1 9.9
HDL = high density lipoprotein.
2 2 1
Table 5.2.2. False positive and false negative findings, sensitivity and specificity in 
categorising men and v/oinen by waist circumference to identify those with body mass 
index >25 at Action Level 1 or >30 kg/m^ at Action Level 2 and those with lower body 
mass index but waist to hip ratio >0.95 (men) or >0.80 (women).
Action Level of 
waist circumference
False False 
cm positive negative
Sensitivity
(%)
Specificity
(%)
Men (n = 2183)
Action Level 1 >94 cm 40/1035 22/475 97.42 97.03
Action Level 2 >102 cm 45/1603 7/151 97.80 97.61
Women (n = 2698)
Action Level 1 >80 cm 59/1219 16/710 98.64 96.17
Action Level 2 >88 cm 22/1778 6/303 98.99 98.96
True positive describes people with high body mass index and those with lower body mass index but high 
waist to hip ratio, correctly identified by waist circumference above Action Level. True negative 
describes people with low body mass index and those with higher body mass index but low waist to hip 
ratio. False positive describes people with waist circumference above Action Level but low body mass 
index and low waist to hip ratio. False negative describes people with waist circumference below Action 
Level but with high body mass index and high waist to hip ratio. These numbers were used to detennine 
the sensitivity and specificity (Sturmans, 1984).
2 2 2
Table 5.2.3. Mean serum lipid concentrations and blood pressuie of men and women in 
different categories of waist circumference.
Waist Total HDL Systolic Diastolic
circumference cholesterol cholesterol blood pressure blood pressure
(cm) (mmol/1) (mmol/1) (mmHg) (mmHg)
n Mean (SE) Mean (SE) Mean (SE) Mean (SE)
Men (n = 2183)
<94 1312 5.17(0.03) 1.15(0.01) 119.4 (0.4) 75.3 (0.3)
94-<102 515 5.71 (0.05) 1.04 (0.01) 126.8 (0.6) 80.4 (0.4)
>102 356 5.88 (0.06) 0.98 (0.02) 129.6 (0.7) 83.4 (0.4)
Women (n = 2698)
<80 1481 5.14(0.03) 1.47 (0.01) 111.2 (0.4) 71.3 (0.2)
80-<88 608 5.59 (0.04) 1.37(0.01) 117.5 (0.6) 75.4 (0.4)
>88 609 5.78 (0.04) 1.26 (0.01) 123.9 (0.6) 79.6 (0.4)
All categories significantly different (analysis o f  variance), P  <0.001; HDL = high density lipoprotein.
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Table 5.2.4. Correlation coefficients between waist circumference, body mass index and 
waist to hip ratio and risk factors unadjusted and adjusted for alcohol consumption, 
cigarette smoking, physical activity, education levels and age.
Waist circumference Body mass index Waist to hip ratio
Un­
adjusted
Adjusted Un­
adjusted
Adjusted Un­
adjusted
Adjusted
Men (n = 2183)
Total cholesterol 0.344 0.232 0.319 0.247 0.335 0.189
HDL cholesterol -0.269 -0.305 -0.287 -0.311 -0.249 -0.292
Systolic blood pressure 0.336 0.249 0.306 0.239 0.348 0.244
Diastolic blood pressure 0.371 0.283 0.354 0.287 0.384 0.288
Women (n = 2698)
Total cholesterol 0.265 0.106 0.217 0.099 0.290 0.114
HDL cholesterol -0.261 -0.280 -0.254 -0.245 -0.242 -0.269
Systolic blood pressure 0.372 0.237 0.335 0.226 0.301 0.188
Diastolic blood pressure 0.374 0.261 0.345 0.250 0.330 0.203
HDL = high density lipoprotein.
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Figure 5.2.1. Prevalence rates of men and women with low high density lipoprotein 
cholesterol concentration (<9 mmol/1), hypercholesterolaemia (>6.5 mmol/1), 
hypertension (treatment with hypertensive agents, or systolic pressure >160 mmHg, or 
diastolic pressure >95 mmHg), and any one or more risk factors.
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5.3
THE PREVALENCE OF LOW BACK PAIN AND ASSOCIATIONS 
WITH BODY FATNESS, FAT DISTRIBUTION AND HEIGHT
This section has been peer reviewed and will be published as
Han TS, Schouten JSAG, Lean MEJ, Seidell JC. The prevalence of low back 
pain and associations with body fatness and fat distribution and height. 
InternationalJournal of Obesity ^Q97 (in press).
Collaboration with MORGEN project
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ABSTRACT
Objective: To examine the associations of low back pain symptoms with waist 
circumference, height, waist to hip ratio and body mass index, and to test the 
interactions between (1) waist circumference and height, and (2) waist to hip ratio and 
body mass index.
Setting: Cross-sectional study set in The Netherlands of random sample of 5887 men 
and 7018 women aged 20-60 years.
Results: The prevalences of low back pain in men and women in the past 12 months 
were 46% and 52%, of whom 17% and 21% had low back pain for a total of 12 or more 
weeks, and 13% and 18% had symptoms suggestive of intervertébral disc herniation. 
After adjustments for age, smoking and education, more women in the highest tertile of 
waist circumference reported low back pain in the past 12 months (odds ratio = 1.2, 95% 
confidence interval: 1.1 to 1.4), low back pain for a total of 12 or more weeks (odds ratio 
= 1.5, 95% confidence interval: 1.3 to 1.8), and intervertébral disc herniation symptoms 
(odds ratio = 1.3, 95% confidence interval: 1.1 to 1.6) than women in the lowest waist 
tertile. Corresponding values of low back pain symptoms for women with high body 
mass index or high waist to hip ratio were similai' to those with high waist. There were 
no significant differences between men in different tertiles of waist, waist to hip ratio or 
body mass index reporting low back pain symptoms. Tallest subjects did not report low 
back pain symptoms more often than shortest subjects. There were no significant 
interactions between waist and height or between waist to hip ratio and body mass index 
on low back pain symptoms.
Conclusion: Women who are overweight or with a laige waist have a significantly 
increased likelihood of low hack pain. There are no significant interactions between 
waist and height, or waist to hip ratio and body mass index on low back pain symptoms.
Key words: body mass index, fat distribution, low back pain, obesity, stature, weight.
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INTRODUCTION
Low back pain is one of the commonest symptoms in Western societies, responsible for 
an enormous burden of cluonic disease, and is associated with high medical health cai’e 
and social costs (Wells, 1985). Overweight, indicated by high body mass index is 
associated with poor subjective ill health and poor musculoskeletal functioning (Seidell 
et al, 1986a). Overweight persons more frequently seek medical care for 
back/joint/muscle complaints (Seidell et al, 1986b).
It is generally assmned that overweight and low back pain are related (Popkess-Vawter 
and Patzel, 1992). However, scientific evidence to support this relationship is scanty 
(Garzillo and Garzillo, 1994) and some is conflicting (Brennan et al, 1987; Croft and 
Rigby, 1994; Wright et al, 1995). Associations between body fat distribution and low 
back pain aie not well documented, although it may be postulated that subjects who 
carry excessive abdominal fat mass over a long period may be at risk of low back pain, 
as a result of altered postui'e to counterbalance the protruding fat mass. Prolapsed 
intervertébral disc is commonly believed to be more frequent in taller people 
(Heliovaara, 1987). Height may relate independently to low back pain from large 
abdominal fat mass, and may aggravate back pain associated with stooping especially in 
those with large waist or large abdominal fat mass. These persons may require more 
reactive forces to counteract the gravitational pull on this fat mass to achieve balance, 
especially when bending forward for lifting or when walking down stairs, as a result, 
more strain may be exerted on their lower back. The same hypothesis could be proposed 
for those with central fat distribution, indicated by high waist to hip ratio, who may be at 
increased risk of low back pain independently from total fatness, measured by body 
mass index.
The present study examined the associations of low back pain symptoms with waist 
circumference, height, waist to hip ratio and body mass index, and to test the 
interactions between (1) waist circumference and height, and (2) waist circumference to 
hip ratio and body mass index on low back pain symptoms.
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METHODS 
Subjects
In the present study, the 1993 to 1995 cohorts were available from the ongoing 
MORGEN (Monitoring of Risk Factors and Health in The Netherlands) project, which is 
undertaken as a public health surveillance to monitor cluonic diseases, risk factors and 
their consequences. Subjects were randomly recruited from tlnee towns, Amsterdam, 
Maastricht and Doetinchem. To obtain similar numbers of subjects at each age, the 
sample was stratified by sex and five year age group. The numbers of 5887 men and 
7018 women aged 20-60 years in the present study represent those who attended the 
health centres for measurements including antliropometry. Those who did not attend the 
health centres or were of non-Dutch nationality were excluded bom  analyses.
Measurements
Symptoms of low back pain were obtained from questionnaire. Those who responded 
affirmatively to having low back pain in the past 12 months, were then asked whether 
they had radiating pain to the knees or feet, to indicate symptoms of intervertébral disc 
herniation. This symptom was only accepted in the presence of low back pain, to avoid 
including those with other causes of radiated pain. The subjects were asked about the 
total duration of low back pain in the past 12 months. Those who had low back pain for 
a total of twelve weeks or more were classified as having chronic low back pain. The 
reference groups for the tlnee classes o f low back pain were composed of those who did 
not fulfil the criteria for the symptom under analysis, thus the reference group when 
analysing one symptom included some subjects with other symptom(s) of low back pain.
All anthi’opometric measurements were made according to the World Health 
Organisation (1995) recommendations by trained field scientists. Subjects wore light 
clothes during measurements of body weight to the nearest lOOg using calibrated scales, 
height in bare feet to the nearest mm, waist circumference in duplicate at the level 
between the lowest rib margin and iliac crest, and hip circumference at the widest
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trochanters to the nearest mm. Waist to hip circumferential ratio was computed, and 
body mass index was calculated as weight (kg) divided by height squaied (m^).
Males and females were analysed separately. Confounding factors were divided into 
classes for analysis. Age: 10 year groups (20-29 year group as reference), smoking: non- 
smokers, ex-smokers and current smokers (non-smokers as reference), educational 
levels: secondary education or lower, vocational or higher secondary education, and 
higher vocational or university education (higher vocational or university education as 
reference).
Statistical analysis
The prevalence of low back pain symptoms, using cross tabulation, were computed in 
quintiles of waist circumference, height, body mass index, and waist to hip ratio, and 
plotted to examine the type of curve for the relationships between low back pain 
symptoms and adiposity indices.
Statistical analyses were performed using SAS version 6.1 (Cary, USA). All cut-off 
points were decided before analysis. Tertiles of antlnopometric variables in the present 
sample were identified at 86.9, 95.9 cm in men and 75.0, 84.0 cm in women for waist 
circumference; and 175.0, 181.5 cm in men and 162.5, 168.5 cm in women for height; 
0.872, 0.936 in men and 0.756, 0.815 in women for waist to hip ratio; 24.1, 26.9 kg/m^ 
in men and 22.8, 25.9 kg/m^ in women for body mass index.
Logistic regression analysis was also performed to estimate the relative risks (odds ratios 
and 95% confidence intervals) of low back pain symptoms in different categories of 
anthi'opometry. Crude, age adjusted, and age, smoking status and educational level 
adjusted odds ratios were calculated.
The adjusted prevalence of low back pain symptoms in combination of tertiles of waist 
and height, and combination of tertiles of waist to hip ratio and body mass index were
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calculated using analysis of vaiiance, adding age, smoking and education as covariates. 
Logistic regression analysis was used to estimate the maximum likelihood of the models 
to examine the interaction between waist circumference and height, and waist to hip 
ratio and body mass index. Calculations were made for the difference of log likelihood 
(X )^ obtained in the model predicted by dummy variables of waist tertiles (two variables) 
and height tertiles (two variables) subtracted bom  % obtained in the same model with an 
addition of four dummy variables from combinations of waist tertile 2 and height tertile 
2, waist tertile 2 and height tertile 3, waist tertile 3 and height tertile 2, and waist tertile 3 
and height tertile 3, with reference to the group of lowest waist tertile combined with 
lowest height tertile. This analysis was repeated for waist to hip ratio and body mass 
index in the relationship with low back pain symptoms. Interaction between variables 
was considered if the resultant % value exceeded the 5% significance level (4 degrees of 
beedom).
RESULTS
Subject characteristics are shown in Table 5.3.1. Tables 5.3.2a & b and Figures 5.3.1a 
& b (only chronic low back pain was selected for illustration) show the prevalence of 
clu'onic low back pain and intervertébral disc herniation increased with increasing waist, 
waist to hip ratio, and body mass index in both men and women, with women having 
more complaints of low back pain symptoms than men. About half of the population 
studied had low back pain in the past 12 months, 20% reporting symptoms which lasted 
a total of twelve weeks or more, and 15% had symptoms of intervertébral disc 
herniation. The pattern between low back pain and height was weak in women but more 
consistent in men, with shortest men (tertile 1) showing the greatest frequency of low 
back pain symptoms. Examination of plots did not reveal any tendency to low back pain 
in the very tall.
The relative risks (odds ratios) of low back pain symptoms in those with antliropometric 
measurements in the upper two tertiles were compared to those in the lowest tertile
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(Table 5.3.3a & b). Without adjustments, more subjects with large waist circumference, 
high waist to hip ratio and high body mass index reported symptoms of low back pain, 
with the exception of low back pain in the past 12 months in men. The relationships 
were weaker after adjustments for age, smoking and education, but more women with 
large waist circumference continued to report symptoms of low back pain than those 
with smallest waist circumference. Relative risks from being overweight, assessed by 
body mass index, were slightly lower than bom  those having large waist circumference 
for each symptom of low back pain. In women, high waist to hip ratio significantly 
associated only with clironic low back pain. There was no evidence of taller subjects 
being more at risk of low back pain than shorter subjects.
The age, smoking and education adjusted prevalence of low back pain symptoms (only 
clii'onic low back pain was selected for illustration) in different combinations of tertiles 
o f waist and height (Figures 5.3.2a & b), and body mass index and waist to hip ratio 
(Figures 5.3.3a & b) were plotted. Analysis of maximum likelihood (adjusted for age, 
smoking and education) showed that waist circumference and height did not interact on 
any symptom of low back pain (x^ range 1.6-4.6, P >0.5) either in men or in women, the 
interaction between high waist to hip ratio and high body mass index on symptom of 
intervertébral disc herniation did not reach the 5% signibcance level in either men (x^ -  
6.8, P <0.2) or women (x^ = 8.5, P <0.1). In men, little evidence for an interaction 
between waist to hip ratio and body mass index on chionic low back pain was obseiwed 
(Figure 5.3.3a), but there was some suggestion for this effect in women {% = 8.0, P 
<0.1) (Figure 5.3.3b). There was no evidence for an interaction between waist and 
height or waist to hip ratio and body mass index on low back pain in the past 12 months 
in either sex. Thus, the present study did not bnd that stratification by height or body 
mass index was necessaiy when assessing the associations between low back pain and 
waist circumference, and waist to hip ratio respectively.
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DISCUSSION
As well as investigating the associations between low back and pain and body mass, the 
present study examined its relationships with body fat distribution. Clironic low back 
pain (lasting a total of twelve weeks or more in the past 12 months), and symptoms of 
intervertébral disc herniation (low back pain during the past 12 months with radiating 
pain to the knees or feet) were more prevalent in those with increased abdominal fatness, 
indicated by large waist circumference, and in overweight subjects (high body mass 
index). After adjusting for confounding factors (aging, smoking and low educational 
level), no significant relationship remained between low back pain and any of the 
indices of adiposity in men. The relationships were stronger in women, and remained 
significant for waist circumference and body mass index. There was little evidence for 
any interactions between waist circumference and height, or body mass index and waist 
to hip ratio on symptoms of low back pain.
Using body mass index to indicate overweight may misclassify people with excessive 
muscularity rather than excessive fatness (Wellens et al, 1996), and does not take 
account of fat distribution. We have found that chronic low back pain (Figures 5.3.3a & 
b) or symptoms of intervertébral disc herniation (Figures not presented) were most 
common in those with high waist to hip ratio when they are overweight. A prolonged 
burden of excess weight may cause low back pain tlirough increased load compression 
on the intervertébral discs (Eklund and Corlett, 1984), or increased stress on the spine 
when bending to lift objects or stepping down stairs. Excess central fat might have 
specific mechanical effects including altered gait, which may affect the efficiency of 
shock absorbance by the bearing joints, leading to increased stress and strain on the 
spine. Biomechanical studies in subjects with large abdominal fat mass, indicated by 
large waist circumference, may help clarify the aetiology of low back pain.
Crude odds ratios for chionic low back pain and symptoms of intervertébral disc 
herniation in different categories of indices of adiposity were all significant. The present 
study defined the symptom of chronic low back pain as a total of twelve or more weeks
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of back pain in the past 12 months. This cut-off point was arbitrary. Alternative analyses 
using Tow back pain lasting a total of seven weeks or more in the last 12 months’, or 
employing reference group as those who did not have any low back pain in the past 
twelve months were also performed. The results obtained showed no substantial 
differences to the results presented herein. After adjustments for age, smoking and 
education, only women with high body mass index and large waist remained 
significantly at risk of low back pain. Age had the most powerful confounding effect 
(data not shown).
The analysis between indices of adiposity and low back pain is complicated by smoking, 
since smokers tend to have higher waist and smaller hips than expected compared to 
non-smokers (Shimokata et al, 1989). In the present study, smokers were at significantly 
increased risk of low back pain symptoms, independently from all the other factors 
considered (results not shown), confirming previous findings (Wright et al, 1995; Deyo 
and Bass, 1989). Data in the present study were not adjusted for occupation or physical 
activity because of their unknown causal relationships with low back pain. Education is 
probably a more valid adjustment than occupation in relation to low back pain, because 
occupations change.
Comparing the relative risks of low back pain in subjects of highest quintiles and lowest 
quintiles of anthropometry would increase the contrast (Figure 5.3.1), thus give higher 
odds ratios, but with wider 95% confidence intervals due to smaller numbers in each 
category. The odds ratios for symptoms of low back pain only changed by less than 0.1 
unit (results not shown) when subjects in extreme quintiles of antliropometric 
measurements were compared instead of tertiles. To test interactions between 
measurements, employing tertiles was more appropriate, since very few subjects had a 
combination of body mass index in the highest quintile and waist to hip ratio in the 
lowest quintile.
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Using unadjusted prevalence, there were more shorter subjects with low back pain. 
However older subjects are generally shorter than younger subjects (C hapter 3.2; Han 
and Lean, 1996; van Leer et al, 1992), due to both losses in height associated with aging 
and secular trends towards taller populations (van Leer et al, 1992). After age and 
lifestyle adjustments, there was no association between height and low back pain. Other 
evidence on symptoms of low back pain and height is conflicting. Heliovaara (1987) 
foimd men above 180 cm and women above 179 cm had 2 and 4 times the risk of 
herniated lumbar intervertébral disc compared to the those who were 10 cm shorter. 
Other studies have found no association between height and low back pain (Kelsey, 
1975; Kelsey et al, 1984). A study of men and women with low back pain has shown 
spinal mobility decreases with increasing body weight, whilst height had negligible 
effects (Mellin, 1987).
CONCLUSIONS
There are no significant interactions between waist circumference and height or waist to 
hip ratio and body mass index in the relationships with symptoms of low back pain. 
Women who are overweight, or those with a predominant abdominal fat mass, indicated 
by large waist circumference, are at greatly increased risk of low back pain. Associations 
between anthropometric measui'es and low back pain are much weaker or non­
significant in men. Although the relative risks of low back pain symptoms related to 
overweight or large waist circumference were comparatively low in women, the high 
prevalence of these symptoms indicates a huge burden on the health care resouices 
attributable to overweight, and the absolute impact of overweight on low back pain 
imposes an enormous claim on medical care facilities (Wells, 1985).
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Table 5.3.1. Characteristics of 5887 men and 7018 women.
Men Women
Mean SD Range Mean SD Range
Age (years) 42.9 10.7 20.3-60.0 42.2 11.0 20.2-59.9
Weight (kg) 82.0 12.0 44.4-157.0 68.5 11.5 36.6-153.0
Height (cm) 178.4 7.3 152.0-210.0 165.7 6.7 134.5-190.0
Body mass index (kg/m^) 25.8 3.5 15.7-50.1 25.0 4.2 14.9-58.3
Waist circumference (cm) 92.3 10.8 64.0-155.0 81.0 11.1 56.5-150.0 .
Hip circumference (cm) 101.8 6.6 69.0-150.0 102.2 8.4 76.4-165.0
Waist to hip ratio 0.905 0.072 0.621-1.369 0.791 0.070 0.567-1.302
Non-smokers (%) 30.5 36.1 .
Ex-smokers (%) 33.2 26.6
Current smokers (%) 36.3 37.4
Secondaiy education or lower 
Vocational or higher
44.7 — — 55.2 — —
secondary education 
Higher vocational or
29.5 — — 25.2 — —
university education 25.8 — --- 19.6 — —
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Table 5.3.2a. Prevalence of symptoms of low back pain in tertiles of anthropometric
measurements in 5887 men.
Low back pain in 
the past 12 months
(%)
Cluonic low 
back painf
(%)
Symptoms of 
intervertébral 
disc herniation^ 
(%)
Total prevalence 45.6 16.6 13.4
Waist circumference tertile 1 45.2 13.3 10.2
Waist circumference tertile 2 44.1 15.5 12.9
Waist circumference tertile 3 47.5 20.7 16.7
5.0 40.9*** 36.6***
Height tertile 1 47.7 19.6 15.4
Height tertile 2 44.0 16.0 12.3
Height tertile 3 45.6 14.6 12.6
5.5 17.9** 9.4**
Waist to hip ratio tertile 1 44.4 13.2 8.9
Waist to hip ratio tertile 2 46.1 16.4 14.3
Waist to hip ratio tertile 3 46.4 20.1 16.8
1.8 34.1*** 55.2***
Body mass index tertile 1 43.3 13.6 9.9
Body mass index tertile 2 45.5 17.0 14.1
Body mass index tertile 3 48.1 20.3 16.1
x'§ 9.3** 32.2*** 33.3***
"I'Low back pain for a total o f  12 weeks or more in the past 12 months; :];low back pain with radiating pain 
to the knees or feet; §differences in prevalence between tertiles o f anthropometry: <0 .0 0 1 , **P
<0 .0 1 .
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Table 5.3,2b. Prevalence of symptoms of low back pain in tertiles of anthropometric
measurements in 7018 women.
Low back pain in 
the past 12 months
(%)
Chronic low 
back painf
(%)
Symptoms of 
intervertébral 
disc herniationf 
(%)
Total prevalence 52.3 20.5 17.6
Waist circumference tertile 1 48.2 14.8 13.5
Waist circumference tertile 2 52.7 20.5 16.6
Waist circumference tertile 3 55.9 25.9 22.4
28.1*** 89.2*** 66.5***
Height tertile 1 52.7 23.1 19.3
Height tertile 2 52.0 19.2 17.5
Height tertile 3 52.3 19.5 16.2
0.2 13.1** 7.6*
Waist to hip ratio tertile 1 49.2 15.0 14.3
Waist to hip ratio tertile 2 51.4 21.1 16.3
Waist to hip ratio tertile 3 56.1 25.0 21.9
23.5*** 72.4*** 50.3***
Body mass index tertile 1 48.3 16.8 14.1
Body mass index tertile 2 53.1 20.0 16.1
Body mass index tertile 3 55.7 24.9 22.8
26.1*** 48.6*** 66.4***
-{ Low back pain for a total o f  12 weeks or more in the past 12 months; JIow back pain with radiating pain 
to the knees or feet; §differences in prevalence between tertiles o f  anthi'opometry: < 0 .0 0 1 ,
<0.01, <0.05.
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Table 5.3.3a. Logistic regression analysis to predict low back pain by body mass index, 
waist to hip ratio, waist circumference and by height, entered the model individually, 
unadjusted and adjusted for age, smoking and education, in 5887 men.
Independent 
variables §
Low back pain in the 
past 12 months
Chroxric low back 
paixif
Symptoms of 
intervertébral disc 
herniationf
OR 95% Cl OR 95% Cl OR 95% Cl
Unadjusted
Waist tertile 1 1.00 1.00 1.00
Waist tertile 2 0.96 0.84, 1.09 1.19 1.00, 1.43 1.30* 1.06, 1.58
Waist textile 3 1.10 0.97, 1.25 1.70*** 1.43,2.01 1.76*** 1.46, 2.13
Height tertile 1 1.00 1.00 1.00
Height tertile 2 0.86* 0.76, 0.98 0.78** 0.66, 0.92 0.77** 0.64, 0.93
Height tertile 3 0.92 0.81, 1.05 0.70*** 0.59, 0.83 0.79* 0.66, 0.95
WHR tertile 1 1.00 1.00 1.00
WHR tertile 2 1.07 0.94, 1.22 1.29** 1.08, 1.54 1.71*** 1.40,2.09
WHR tertile 3 1.08 0.96, 1.23 1 66*** 1.40, 1.96 2.07*** 1.70,2.52
BMI tertile 1 LOO 1.00 1.00
BMI tertile 2 1.09 0.96, 1.24 1.20* 1.01, 1.44 \ 49**^ 1.23, 1.82
BMI textile 3 1.22* 1.07, 1.38 1.61*** 1.36, 1.91 1.74*** 1.44, 2.11
Adjusted fo r age, smoking and education
Waist textile 1 1.00 1.00 1.00
Waist textile 2 0.89 0.78, 1.02 0.94 0.78, 1.14 0.99 0.80, 1.21
Waist tertile 3 0.97 0.85, 1.12 1.13 0.94, 1.37 1.13 0.92, 1.39
Height textile 1 1.00 1.00 1.00
Height tertile 2 0.91 0.80, 1.03 0.93 0.79, 1.10 0.93 0.77, 1.12
Height tertile 3 1.00 0.88, 1.15 0.97 0.81, 1.17 1.15 0.94, 1.40
WHR textile 1 1.00 1.00 1.00
WHR textile 2 0.97 0.85, 1.11 0.93 0.77, 1.13 1.24 1.00, 1.53
WHR textile 3 1.00 0.79, 1.06 0.98 0.80, 1.19 1.23 0.99, 1.53
BMI textile 1 1.00 1.00 1.00
BMI textile 2 1.05 0.93, 1.20 1.01 0.84, 1.21 1.23* 1.01, 1.51
BMI textile 3 1.11 0.97, 1.28 1.15 0.96, 1.38 1.21 0.99, 1.49
0 R =  odds ratio; Cl = confidence interval; WHR = waist to hip ratio; fL ow  back pain for a total o f  12 
weeks or more in the past 12 months; :|;low back pain with radiating pain to the knees or feet; §reference 
to tertile 1 (odds ratio = 1.00) o f  each anthropometric variable; <0.001, <0.01, <0.05.
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Table 5.3.3b. Logistic regression analysis to predict low back pain by body mass index, 
waist to hip ratio, waist circumference and by height, entered the model individually, 
unadjusted and adjusted for age, smoking and education, in 7018 women.
Independent
Low back pain in the 
past 12 months
Chx'onic low back 
painf
Syxnptoms of 
intervertébral disc 
herxiiationf
vai'iables§ OR 95% Cl OR 95% Cl OR 95% Cl
Waist tertile 1 
Waist tertile 2 
Waist tertile 3
1.00
1.20**
1.36***
1.07, 1.34 
1.22, 1.53
Unadjusted
1.00
1.48*** 1.27,1.73 
2.01*** 1.74,2.33
LOO
1.28**
1.85***
1.08, 1.50 
1.59,2.16
Height tertile 1 
Height textile 2 
Height tertile 3
1.00
0.97
0.98
0.87, 1.09 
0.88, 1.10
1.00
0.79**
0.81**
0.69, 0.91 
0.70, 0.93
1.00
0.89
0.81**
0.76, 1.03 
0.70, 0.94
WHR textile 1 
WHR tertile 2 
WHR textile 3
1.00
1.09
1.32***
0.98, 1.23 
1.18, 1.48
1.00
1.51***
1.89***
1.30, 1.76 
1.63,2.19
LOO
1.16
1.68***
0.99, 1.37 
1.44, 1.95
BMI textile 1 
BMI tertile 2 
BMI tertile 3
1.00
1.21**
1.34***
1.08, 1.36 
1.20, 1.51
1.00
1.24**
1.65***
1.07, 1.44 
1.43, 1.91
1.00
1.17
1.80***
LOO, 1.38 
1.55,2.09
Waist tertile 1 
Waist tertile 2 
Waist textile 3
1.00 
1.12 
1 21**
Adjusted fo r  age, smoking and education 
1.00 1.00 
1.00,1.27 1.26** 1.08,1.48 1.06 
1.06,1.37 1.49*** 1.27,1.75 1.32***
0.90, 1.25 
1.12, 1.57
Height textile 1 
Height tertile 2 
Height tertile 3
1.00
1.03
1.12
0.91, 1.16 
0.99, 1.26
1.00
0.89
1.06
0.77, 1.03 
0.91, 1.22
1.00
1.00
1.06
0.86, 1.17 
0.91, 1.25
WHR tertile 1 
WHR textile 2 
WHR textile 3
1.00
1.02
1.14*
0.91, 1.15 
1.01, 1.30
1.00
1.27**
1.35***
1.09, 1.50 
1.15, 1.58
1.00
0.95
1.14
0.80, 1.12 
0.96, 1.35
BMI textile 1 
BMI tertile 2 
BMI textile 3
1.00
1.15*
1.21**
1.02, 1.29 
1.06, 1.37
1.00
1.07
1.23**
0.92, 1.24 
1.05, 1.44
LOO
1.00
1.35***
0.85, 1.18 
1,15, 1.60
OR= odds ratio; Cl == confidence interval; WHR = waist to hip ratio; fL ow  back pain for a total o f  12 
weeks or more in the past 12 months; :{:low back pain with radiating pain to the knees or feet; §reference 
to tertile 1 (odds ratio ^ 1.00) o f  each anthropometric variable; ***p  <0.001, **P <0.01, *P <0.05.
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Figure 1. Plots of the prevalence of chronic low back pain against quintiles of 
antln’opometry: •  waist circumference, A height, O  waist to hip ratio, and ■ body mass 
index in 5887 men (a) and in 7018 women (b).
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Figure 2. Prevalence (adjusted for age, smoking and education) of chronic low back 
pain in tertiles of waist circumference and tertiles of height in 5887 men (a) and in 7018 
women (b).
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Figure 3. Prevalence (adjusted for age, smoking and education) of chronic low back 
pain in tertiles of waist to hip ratio and tertiles of body mass index in 5887 men (a) and 
in 7018 women (b).
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5.4
SYMPTOMS OF RESPIRATORY INSUFFICIENCY IN RELATION 
TO BODY FAT AND FAT DISTRIBUTION
This section has been submitted for publication as
Han TS. Smit HA, Lean MEJ, Seidell JC. Symptoms of respiratory insufficiency 
in relation to fat and fat distribution, (submitted).
Collaboration with MORGEN project
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ABSTRACT
Objective: To relate respiratory symptoms to measures of abdominal fat distribution and 
overweight, in people with and without evidence of underlying lung disease.
Design: Random sample of 5887 men and 7018 women aged 20-59 years, in a cross- 
sectional study set in The Netherlands.
Measures: Shortness of breath, wheezing, coughing, and bringing up phlegm.
Results: Compared to the lowest tertile with adjustments for age and lifestyle factors, 
those with waist circumference in the highest tertile were 2.4 times (95% confidence 
intervals 2.0 to 3.0) in men and 2.6 times (2.2 to 3.0) in women more likely to have 
shortness of breath when walking uphill or upstairs, 1.8 times (1.4 to 2.4) in women to 
be woken up by shortness of breath. Women with large waist were about 1.5 times more 
likely to wheeze when not having a cold, to cough or to bring up phlegm for more than 3 
months a year. Respiratory symptoms related to body mass index or to waist to hip ratio 
were similar to waist circumference. The relationships with shortness of breath were 
present as aggravating factors in smokers and people with indicators of underlying lung 
disease (wheeze, cluonlc productive cough), and remained as symptoms of abdominal 
fat distribution or overweight in non-smokers and those without evidence of any 
underlying lung disease.
Conclusions: Increased waist circumference, body mass index and waist to hip ratio all 
associate with a variety of respiratory symptoms. These important symptoms of 
abdominal fat distribution and overweight represent an important burden of ill health at 
a population level.
Keywords: Health promotion, lung disease, obesity, quality of life, smoking.
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INTRODUCTION
The prevalence of overweight, body mass index (weight/height^) greater than 30 kg/m^, 
in Western countries is more than 10% (Bennett et al, 1995; Kuczmarski et al, 1994; 
Seidell, 1995a). These persons aie at increased risk of many chronic diseases such as 
diabetes, cardiovascular diseases and premature death (Manson et al, 1995; Simopoulos 
and van Itallie, 1984). Extreme overweight is associated with poor lung function (Luce, 
1980; Zerah et al, 1993). Compared to non-overweight subjects, the total work of 
breathing while at rest in overweight subjects is about twice as high (Sharp et al, 1964). 
Decreased respiratory compliance is thought to play an important role. Luce (1980) has 
suggested that decreased chest wall compliance associated with overweight (Sharp et al, 
1964a; Naimark and Cherniak, 1960) may be explained by the accumulation of fat in 
and ai'ound the ribs, diaphragm and abdomen. Respiratory compliance in these subjects 
has been observed to markedly reduce when lying recumbent, it was calculated that the 
mass loading of excessive fat mass was similar to having weight loaded on a person 
(Shaip et al, 1964b). Large abdominal fat mass may compress the lungs, which may 
cause hypoventilation, leading to mismatch in ventilation/perfusion, hence hypoxia 
(Luce, 1980; Bedell et al, 1958; Farebrother et al, 1974; Holley et al, 1967). Sleep apnea 
is common in overweight subjects and has been related to large waist circumference 
(Grunstein et al, 1993; Wilcox et al, 1994), and weight loss improves this symptom 
(Surratt et al, 1992).
Although most overweight people are aware of breathlessness on exertion (Dempsey et 
al, 1966), the nature of the relationships between overweight, particularly with increased 
waist to hip ratio or increased waist circumference, and symptoms of respiratory 
insufficiency are not well established. The present study aimed to examine the 
associations between respiratory symptoms and high body mass index, high waist to hip 
ratio, or large waist circumference.
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METHODS 
Subjects
Men (n = 5887) and women (n = 7018), aged 20-59 years were randomly recruited from 
three towns, Amsterdam, Maastricht and Doetinchem in the Netherlands from 1993 to 
1995, in the ongoing MORGEN (Monitoring of Risk Factors and Health in The 
Netherlands) study undertaken as a public health surveillance to monitor chronic 
diseases, risk factors and their consequences. To obtain similar numbers of subjects at 
each age, the sample was stratified by sex and five year age group. The response rate to 
invitations was about 50%. The numbers of subjects in the present study represent those 
who attended the health centres for measurements including anthropometry. Those who 
did not attend the health centres or were of non-Dutch nationality were excluded from 
analyses.
Respiratory symptoms were obtained from a selection of questions that were used in the 
European Respiratory Health survey (Burney et al, 1994). Eight symptoms were 
selected for analysis including wheezing in the past twelve months when not having a 
cold, coughing daily (day or night) for a total of 3 or more months per year, bringing up 
phlegm daily (day or night) for a total of 3 or more months per year, chronic productive 
cough (periods of cough with phlegm in the past 3 years for at least 3 weeks per year, 
being woken up by shortness of breath during past 12 months, shortness of breath when 
walking uphill/stairs, and shortness of breath when walking at normal pace with people 
of the same age.
Anthropometric measurements were made according to the World Health Organisation 
(1995) recommendations by paramedical personnel. Subjects wore light clothes during 
measui'ements of body weight to the nearest lOOg using calibrated scales, height in bare 
feet to the nearest mm, waist circumference in duplicate at the level between the lowest 
rib mai'gin and iliac crest, and hip circumference at the widest trochanters to the nearest 
mm. Waist to hip circumferential ratio was computed, and body mass index was 
calculated as weight (kg) divided by height squared (m^).
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Statistical methods
All statistical analyses were performed using SAS version 6.1 (Cary, USA). Respiratory 
symptoms were dichotomous. Tertiles for anthropometric variables were created to 
define the levels of overweight (body mass index), central fat distribution (waist to hip 
ratio), and waist circumference was examined since waist reflects both overweight and 
fat distribution (C hapter 4.1; Lean et al, 1995). The age adjusted prevalence of 
respiratory symptoms was calculated for subjects in tertiles of anthropometry, using 
analysis of variance, adding age as a covaiiate. Logistic regression analysis, unadjusted, 
adjusted for age, and adjusted for age and lifestyle factors, was performed to estimate 
the relative risk (odds ratios and 95% confidence intervals) o f respiratory symptoms in 
different tertiles of antliropometry. Separate analysis in different groups of smoking 
status was performed, since smoking is a strong determinant of respiratory symptoms, 
thus eliminating possible residual confounding effects of smoking. For convenience of 
presentation, only odds ratios with adjustments for age and lifestyle factors were 
tabulated.
Males and females were analysed separately, potential confounding factors considered 
dummy variables of age: divided into 10 year groups (20-29 year group as reference), 
smoking: non-smokers, ex-smokers, and current smokers (non-smokers as reference), 
educational level: secondaiy education or lower (educational level 1), vocational or 
higher secondary education (educational level 2), and higher vocational education or 
imiversity education (educational level 3) (educational level 1 as reference), leisure 
activity: non participants, and participants in leisure sport (non-participant as reference).
Thiee types of subjects with chronic productive cough, wheeze, and smokers were 
considered in a separate group to assess the possible aggravation of shortness of breath 
from obesity. Those who never smoked and who did not have chi'onic productive cough 
or wheeze were considered separately to assess the impact of overweight or abdominal 
fat on shortness of breath in people with normal lungs.
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RESULTS
Subject characteristics are shown in Table 5.4.1. In general, the age adjusted prevalence 
of subjects with respiratory symptoms significantly increased with increasing 
anthropometric measurements, and more strongly in women (Tables 5.4.2a & b). In 
men (Table 5.4.2a), non-linear relationships between anthr opometric measurements and 
wheezing when not having a cold and chi'onic productive cough, and an inverse 
relationship between body mass index and bringing up phlegm were observed.
Age and lifestyle factors adjusted odds ratios to estimate relative risks of having 
respiratory symptoms (Table 5.4.3) showed that those who had large waist 
circumference (tertile 3) were associated with 2 to 2.5 times the risk of having shortness 
of breath when walking uphill/stairs, about 2 times in men and 2.5 to 3.5 in women the 
risk of having shortness of breath when walking at normal pace with others of their age. 
In women only, the risks of wheezing without a cold, of being woken up by shortness of 
breath and chionic productive cough, were all increased by about 1.5 times in tertile 3 
compared to those with low (tertile 1). Compared to men with waist circumference in 
tertile 1, odds ratio for chi'onic productive cough in men with waist in tertile 2 were 
significantly less than 1, i.e. chronic productive cough was associated with low waist 
circumference. Compared to the lowest tertile, the odds ratios for these respiratory 
symptoms in subjects with high body mass index or with high waist to hip ratio (results 
not shown) were similar (mostly to within 0.1 unit of odds ratios) to the odds ratios 
presented in Table 5.4.3 for waist circumference.
Figures 5.4.1a & b show that within separate groups of non-smokers and smokers, the 
prevalence of those with shortness of breath when walking uphill or upstairs increased 
with increasing waist circumference, and significantly (P <0.001) higher in smokers for 
each level of waist circumference. After excluding subjects with underlying lung disease 
(wheezing and chronic productive cough) in non-smokers (Tables 5.4.4a & b), the risk 
for shortness of breath continued to persist in those with large waist circumference, high 
body mass index, or high waist to hip ratio.
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DISCUSSION
The present study shows that the age adjusted prevalence of respiratory symptoms 
increased with increasing waist circumference, body mass index and waist to hip ratio. 
Compared to the lowest tertile those with waist circumference, body mass index, or 
waist to hip ratio in tertile 3 were at 2-3 times more likely to have shortness of breath 
when walking uphill or walking with their peers (same age) at normal pace. Women 
with high measures of adiposity also had significant risks of other respiratory symptoms 
such as wheezing, coughing, and being woken up by attack o f shortness of breath, the 
latter could indicate sleep apneas or coronary disease.
Shortness of breath is usually taken to indicate respiratory disease, but can in fact be a 
symptom of overweight per se, i. e. excessive body mass and central fat distribution, as 
demonstrated in subjects who did not have chronic productive cough or wheeze and 
those who have never smoked (Tables 5.4.4a & b). One of the most distinctive features 
of overweight is poor physical fitness. These persons are less able to perform physical 
work effectively. The excessive body mass requires increased effort by overweight 
subjects for movement (Dempsey et al, 1966). Subject to exercise testing, overweight 
subjects demonstrate increased O2  consumption and CO2  production, leading to 
increased ventilation (Dempsey et al, 1966). Thus, these subjects ai'e more likely to be 
out of breath more easily than leaner subjects for a given work load.
Data from the present study show subjects with chionic productive cough were most 
prevalent both in the highest and in the lowest tertile of body mass index and waist 
circumference. Smoking was more prevalent in those with productive cough (about 50% 
in both sexes) than other subjects (<35%) making the analysis more complicated. It is 
known that smoking is related to relatively low body mass index and low waist 
circumference (accompanying paper), but the risk of having shortness of breath in 
smokers with a waist in lower tertiles was similar to that in non-smokers with the largest 
waist circumference (Figures 5.4.1a & b). Within the group of smokers and those with 
symptoms of lung disease, shortness of breath continued to increase in those with higher
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body mass, high waist to hip ratio or larger waist circumference (Tables 5.4.4a & b). 
There was no evidence for residual confounding effects of smoking when separate 
analysis were made for subjects in different smoking status (data not shown). Subjects in 
the advanced stage of chronic productive cough (clii'onic bronchitis) may be prone to 
weight loss (Mitchell and Filley, 1964; Vandenbergh et al, 1967). Different types of 
patients of different anthropometric characteristics, e.g. the overweight, hypoxic ‘blue 
bloaters’ and the underweight, emphysematous ‘pink puffers’, exist in those with 
chronic broncliitis (Filley et al, 1968) may explain these differences. In patients with 
established respiratory disease, a vicious cycle with limited physical activity contributes 
to weight gain, and increased frequency of acute infective exacerbation. Cachexia is also 
common in patients with severe lung disease (Mitchell et al, 1964; Wilson et al, 1989), 
and malnutrition or negative energy balance in this group aggravates respiratory distress 
through wasting of respiratory muscles (Vandenbergh et al, 1967; Donahoe et al, 1989; 
Openbrier ef a/, 1983; Thurlbeck, 1978).
The relationship between body weight and subjects with clironic productive cough, a 
diagnosis for clironic bronchitis, is less clear than that with emphysema, which 
associates with severe weight loss (Filley et al, 1968; Donahoe et al, 1989; Green and 
Muers, 1992). Openbrier et al (1983) found all four bronchitic patients in their study had 
body weight above standard weight, whereas Steele and Heard observed the mean 
weight of 12 patients was lower than the control group (Steele and Heard, 1973).
CONCLUSIONS
Overweight men and women, and those with central fat distribution or increased waist 
circumference are all at increased risk of respiratory symptoms, particularly shortness of 
breath when performing basic activities such as climbing stairs or walking at normal 
pace with people of their age. These symptoms are aggravated by smoking and by 
underlying lung disease. Preventing weight gain and healthy lifestyle should be 
recommended to decrease the risk of these symptoms associated with adiposity.
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Table 5.4.1. Characteristics of 5881 men and 7018 women.
Men Women
Mean SD Range Mean SD Range
Age (years) 42.9 10.7 20.3-60.0 42.2 11.0 20.2-59.9
Weight (kg) 82.0 12.0 44.4-157.0 68.5 11.5 36.6-153.0
Height (cm) 178.4 7.3 152.0-210.0 165.7 6.7 134.5-190.0
Body mass index (kgW ) 25.8 3,5 15.7-50.1 25.0 4.2 14.9-58.3
Waist circumference (cm) 92.3 10.8 64.0-155.0 81.0 11.1 56.5-150.0
Hip circumference (cm) 101.8 6.6 69.0-150.0 102.2 8.4 76.4-165.0
Waist to hip ratio 0.905 0.072 0.621-1.369 0.791 0.070 0.567-1.302
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Table 5.4.3. Odds ratios of respiratory symptoms in different tertiles of waist 
circumference, adjusted for age, smoking, physical activity, and education.
Waist circumference
Tertile 1 Tertile 2 Tertile 3
Odds Odds 95% Cl Odds 95% Cl
ratio ratio ratio
MEN {n -  5887)
Wlieezing when not having a coidf 1.00 0.90 0.71, 1.15 1.21 0.96, 1.54
Coughing for >3 months/year^ 1.00 1.13 0.87, 1.47 1.19 0.91, 1.55
Bring up phlegm >3 months/year]: 1.00 0.96 0.73, 1.26 1.04 0.79, 1.37
Chronic productive cough§ 1.00 0.83* 0.70, 0.99 0.96 0.80, 1.15
Woken by shortness of breath 1.00 0.87 0.63, 1.20 1.18 0.86, 1.62
Shortness of breath - uphill/stairs § 1.00 1.11 0.89, 1.37 2.41*** 1.97, 2.96
Shortness of breath - normal pace^ 1.00 0.81 0.55, 1.20 1.80*** 1.27, 2.54
WOMEN {n = 7018)
Wheezing when not having a coldf 1.00 1.06 0.84, 1.34 1.64*** 1.31,2.07
Coughing for >3 months/year J 1.00 1.10 0.86, 1.41 1.55*** 1.21, 1.98
Bring up phlegm >3 months/yearj 1.00 1.08 0.81, 1.45 1.39* 1.04, 1.86
Chronic productive cough§ 1.00 1.01 0.86, 1.17 1.13 0.96, 1.33
Woken by shortness of breath 1.00 1.13 0.86, 1.49 1.82*** 1.40,2.38
Shortness of breath - uphill/stairs§ 1.00 1.45*** 1.24,1.69 2.55*** 2.19, 2.98
Shortness of breath - normal pace^j 1.00 1.64*** 1.24,2.17 2.25,3.84
***P <0.001, * *P <0.01, <0.05; Cl =  confidence interval; "| in the past 12 montlis; :|:in the past 3 years;
§coughing with phlegm >3 weeks/year in the past 3 years; §when walking uphill/stairs ^when walking at 
normal pace with others o f  the same age.
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Figure 5.4.1 . Age adjusted prevalence (SE) of shortness of breath when walking 
uphill/stairs in different tertiles of waist in men (a) and women (b) who never smoked 
(dashed line) and those who were cmrent smokers (solid line).
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5.5
ASSOCIATIONS OF STATURE, BODY MASS AND FAT 
DISTRIBUTION WITH NON-INSULIN-DEPENDENT DIABETES 
MELLITUS
This section has been submitted for publication as
Han TS, Feskens EJM, Lean MEJ, Seidell JC. Associations of stature, body 
mass and fat distribution with Type 2 (non-insulin-dependent) diabetes mellitus. 
(submitted)
Collaboration with MORGEN project
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ABSTRACT
Objective'. To establish the associations of statui’e, body mass index, waist to hip ratio 
and waist circumference with Type 2 (non-insulin dependent) diabetes mellitus.
Setting'. Random sample of 5887 men and 7018 women aged 20-59 years, in a cross- 
sectional study set in The Netherlands.
Results'. The crude prevalence of Type 2 diabetes (overall 1.58% in men, 0.94% in 
women) was significantly (P <0.01) higher in shorter subjects and those with high body 
mass index, high waist to hip ratio and larger waist circumference. Compared to the 
tallest tertile, age adjusted odds ratios (95% confidence intervals) for Type 2 diabetes 
were 5.1 (2.0 to 13.3) in men and 2.1 (1.1 to 4.0) in women whose height was in the 
shortest tertile. Compared to the lowest tertile, the age adjusted odds ratios for Type 2 
diabetes were 19.7 (4.7 to 83.5) in men and 6.3 (2.4 to 16.4) in women with waist to hip 
ratio in the highest textile, 4.4 (2.2 to 9.0) in men and 2.5 (1.2 to 4.9) in women with 
body mass index in the highest tertile, and 5.2 (2.2 to 12.3) in men and 3.2 (1.4 to 7.0) in 
women with waist circumference in the highest tertile. Additional adjustments for 
cigai’ette smoking, alcohol consumption, physical activity and educational level slightly 
redueed the strength of these associations, and odds ratio for shoidest women became 
non-significant.
Conclusions'. Although in longitudinal studies waist is a powerful predictor o f diabetes 
incidence, Type 2 diabetes in a cross-sectional survey is associated with shoitness in 
stature, as well as large waist circumference and high body mass index, and particularly 
strongly with high waist to hip ratio, suggesting that the development of Type 2 diabetes 
may modify hip circumference independently of body fat.
Keywords'. Body constituent, early growth, health promotion, height, skeletal muscle
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INTRODUCTION
Type 2 (non-insulin-dependent) diabetes mellitus is a disease o f nutrient storage and 
metabolism which associates with several other metabolic aberrations such as 
hyperlipidaemia and hypertension. Increased visceral fat mass is a major characterising 
featui'e, possibly aetiologically important through increased fatty acid release into the 
portal system (Bjorntorp, 1991; Bjorntorp, 1996) but these mechanisms have not been 
elucidated. It is well established that the measure of waist to hip ratio strongly relates 
with the development o f Type 2 diabetes (Hartz et al, 1983; Ohlson et al, 1985; Chan et 
al, 1994). This association has usually been interpreted as the result of central fat 
distribution, central obesity, upper body obesity, or truncal fatness. However, waist 
circumference is more highly predietive of intra-abdominal fat than waist to hip ratio 
(Seidell et al, 1988; Pouliot et al, 1994).
Type 2 diabetes has also been suggested as a consequenee of developmental failure of 
vital organs, such as the pancreas and the liver, particularly in those who were exposed 
to poor nutritional conditions at a critical stage of fetal development (Barker, 1994). It is 
well established that short stature can reflect underdevelopment during the critical 
growth periods (Floud et al, 1990).
The present study aimed to assess the prevalence and relative risks of Type 2 diabetes in 
relation to body statuie and to body fatness and fat distribution.
METHODS 
Subjects
Dutch men (n = 5887) and women {n = 7018) aged 20-59, recruited into the ongoing 
MORGEN (Monitoring of Risk Factors and Health in The Netherlands) study in the 
1993 to 1995 cohorts from Amsterdam, Maastricht, and Doetinchem. To obtain similar 
numbers of subjects at each age, the sample was stratified by sex and five year age 
group.
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Anthropometry
Anthropometric measurements were made according to the World Health Organisation 
recommendations (WHO, 1989) by trained field scientists. Subjects were wearing light 
elothes during measurements of body weight to the nearest lOOg using calibrated scales, 
height without shoes to the nearest mm, waist circumference in duplicate at the level 
between the lowest rib margin and iliac crest, and hip circumference at the widest 
trochanters to the nearest mm. Waist to hip circumferential ratio was computed, and 
body mass index was calculated as weight (kg) divided by height squared (m^).
Definition o f  non-insulin dependent diabetes mellitus (Type 2 diabetes)
Subjects with known diagnosed Type 2 diabetes or with newly diagnosed Type 2 
diabetes from random blood glucose concentration of >11.1 mmol/1 (WHO, 1985) in the 
present survey, were selected as having the disease. Five men and nine women treated 
with insulin were excluded. Blood glucose was measuied by World Health Organisation 
standardised laboratory at the Academic Dijkzig Hospital of the Erasmus University in 
Rotterdam.
Statistical methods
Statistieal analyses were performed using SAS version 6.1 (Cary, USA). Tertiles were 
created for height, body mass index, waist to hip ratio and waist circumference. The 
prevalence of Type 2 diabetes were determined for subjects in each tertile of 
antliropometry, using cross tabulation with Chi square statistic. Logistic regression 
analysis for unadjusted and adjusted for age and lifestyle factors was performed to 
estimate the relative risks (odds ratios and 95% confidence intervals) of Type 2 diabetes 
in tertiles of height, body mass index, waist to hip ratio and waist circumference. We 
have already demonstrated the lack of significant correlation between waist and height 
in these subjects for the 1993-1994 cohorts (Chapter 4.3; Han et al, 1996b; Han et al, 
1997c). Thus waist to height ratio was not created. Height was entered in multivariate 
logistic regression analysis as independent variable in the assoeiations of Type 2 
diabetes with waist or with waist to hip ratio.
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Confounding factors
Males and females were analysed separately. Dummy variables were created for the 
following confounding factors; age: stratified by 10 year age categories, smoking: non- 
smokers, ex-smokers, and cmrent smokers, alcohol: non-drinkers, occasional drinkers 
(<1 glass per day), moderate drinkers (1 to 2 glasses per day), and heavy drinkers (>3 
glasses per day), educational level: secondary education or lower (educational level 1), 
vocational or higher secondary education (educational level 2), and higher vocational 
education or university education (educational level 3), physical activity: non 
participants, and participants in leisure sport.
RESULTS
Table 5.5.1 shows subjects with known Type 2 diabetes and those with newly diagnosed 
Type 2 diabetes were similar in age. It is clear that both of these groups of subjects with 
metabolic complications were older, shorter, heavier, and they had higher body mass 
index, higher waist to hip ratio and larger waist circumference than subjects without 
Type 2 diabetes. Mean (SD) duration of known Type 2 diabetes was 5.5 (6,7) years in 
men and 7.6 (9.1) in women, and age of diagnosis was 45.6 (9.7) in men and 43.3 (9.1) 
in women.
Tables 5.5.2a & b show that the unadjusted prevalence of Type 2 diabetes was 
relatively high in categories of short stature, higher body mass index, higher waist to hip 
ratio and larger waist circumference. In both sexes, compared to lowest tertile (highest 
tertile in the case of height) the age adjusted odds ratios for Type 2 diabetes were 
significantly higher in the shortest tertile of height, third tertile of waist to hip ratio, 
body mass index and waist circumference (Figure 5.5.1). Table 5.5.3 shows that after 
additional adjustment for cigarette smoking, alcohol consumption, educational level and 
physical activity, the strength of the associations was slightly reduced, and the 
relationship between Type 2 diabetes and height in women became non-significant.
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Adjustments for height and waist to hip ratio, or height and waist circumference had no 
substantial changes to odds ratios (within 0.1 unit) of either height, waist to hip ratio or 
waist cireumference. Excluding the 30 men and 15 women who were newly diagnosed 
with Type 2 diabetes (random blood glucose >11.1 mmol/1), did not change the results 
considerably (within 0.1 unit of odds ratios: results not presented).
DISCUSSION
The present study confirmed previous findings for the associations between high waist 
to hip ratio, high body mass index, and large waist eircumference with Type 2 diabetes, 
hyperglycaemia and insulin resistance (Bjorntorp, 1991; Bjorntorp, 1996; Jolmson et al, 
1992; Kohit et al, 1993; Weidner et al, 1995). After age adjustment, shorter men were 5 
times and shorter women were 2 times more likely to have Type 2 diabetes compared to 
taller subjects. Shorter men remained to associate significantly with Type 2 diabetes 
even additional after adjustments for educational level, smoking and physical activity 
level, suggesting that this association was independent of social class and lifestyle 
habits. Our findings support previous studies of Brown et al{\99V) who have observed a 
negative correlations between glucose tolerance and height, and that of Mooy et al 
(1995) who have shown that shortness of statui’e was a significant determinant of 
glucose intolerance. Since both short stature (Floud et al, 1990) and Type 2 diabetes 
(Barker, 1994) reflect reduced development during the critical periods of growth, these 
factors may be linked in the aetiology of Type 2 diabetes. Early growth 
underdevelopment, refleeted by low birth weight, has been shown to associate with high 
waist to hip ratio in men (Alvarsson et al, 1994) and inereased waist circumference in 
women (Jarrett and Fitzgerald, 1992). All these adverse antlii’oponietric measures are 
characteristics of poor health. Barker et al (1990) have shown that shorter populations 
have higher risks of mortality from cai'diovascular disease, chronic bronchitis, and 
cancers in men and women. A study of diabetes in rural Tanzania has shown that the 
prevalence of impaired glucose tolerance, but not diabetes, tended to be higher in shorter 
men and shorter women (McKeigue, 1991). According to the thrifty phenotype 
hypothesis (Hales and Baiker, 1992), the risk of diabetes for shorter subjects in the study
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of Swai et al (1992) would not be great, since rural Tanzanians were not be exposed to 
overnutrition.
Our observations indieate greater risk of Type 2 diabetes in shorter people, particularly 
men, even after adjusting for age, lifestyle factors and body fat distribution, and this 
would be in broad agreement with the findings of Barker’s group (Law et al, 1992). A 
possible mechanism would be the alterations in mass of metabolically important tissues 
- pai'ticularly skeletal muscle. Indeed, high waist to hip ratio was most strongly related 
to Type 2 diabetes in the present study. If intra-abdominal fat were the only influence on 
development o f Type 2 diabetes, then waist cireumference alone should be at least as 
strongly assoeiated with Type 2 diabetes as waist to hip ratio, sinee the waist reflects 
intra-abdominal fat (Seidell et al, 1988, Pouliot et al, 1994) (itself determined by total 
fatness and by fat distribution), whilst the hip circumference includes contributions from 
the bone structure of the pelvis, and the truncal muscles which make up one of the main 
organs for glucose metabolism and insulin action (DeFronzo, 1988). Our study (Seidell 
et al, 1997) of the same subjects, using residual analysis to dissociate the contributions 
of the waist and hip circumference to Type 2 diabetes, showed clearly that as well as 
large waist, a smaller hip circumference than expected from a given body mass index 
was importantly associated with Type 2 diabetes, these assoeiations were independent of 
height. Hartz et al (1984) used discrimination analysis to adjust for relative weight, age 
and hips or waist found that waist cireumference was positively and hip circumference 
was negatively associated with diabetes in women. It is possible that increased intra­
abdominal fat precedes the development o f Type 2 diabetes, and muscle atrophy follows 
afterwards, since insulin action and glucose clearance are related similarly (Carey et al, 
1996) or more highly with waist circumference than with waist to hip ratio in non­
diabetic subjects (Pouliot et al 1994; Weidner et al, 191995). This could explain the 
consistently different associations with Type 2 diabetes in longitudinal and cross- 
sectional studies. Ohlson et al (1985) have shown that waist circumference was at least 
as strong (P = 0.0012) as waist to hip ratio (P = 0.0037) in predicting the development 
o f Type 2 diabetes over thirteen and a half year s in men, even after body mass index was
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accounted for. A five year follow up study in men (Chan et al, 1994) confirmed these 
findings showing that with reference to those in the lowest quintile, prediction of Type 2 
diabetes development in men with waist eircumference in the fifth quintile (age adjusted 
relative risk 12) was more strongly than those with waist to hip ratio in the fifth quintile 
(age adjusted relative risk 4). Lemieux et al (1996a) have found that seven year changes 
in indices of glucose-insulin homeostasis were related to changes in visceral fat and 
waist circumference, but not to waist to hip ratio in non-diabetic women. If muscle loss 
leads to lower hips when Type 2 diabetes develops, then only waist would prediet the 
development of Type 2 diabetes, whilst waist to hip ratio would be a better marker of 
existing Type 2 diabetes. This would require prospective study.
Prentice and Jebb (1995) have suggested that physical inactivity may be an important 
factor contributing factor to the rising prevalence of overweight (Greogory et al, 1990; 
Bemiett et al, 1995) since average energy intake in Britain has apparently declined. The 
prevalences of overweight (Knowler et al ,1981) and associated Type 2 diabetes in Pima 
Indians are amongst the highest in the world (Knowler et al, 1978), and Fontvieille et al 
(1993) have shown that Pima Indian children are less physically active than Caucasian 
children. In a study of 24 healthy men, Seidell et al (1989a) have shown that those with 
increased waist to hip ratio were associated with relatively less thigh muscle, raised 
insulin and decreased musele endurance. These findings point towards an important role 
of peripheral muscle in the association between altered body morphology and related 
diseases such as Type 2 diabetes. The link of diabetes with redueed oxidative muscle 
fibres is established (Lillioja et al, 1987). Exercise can prevent muscle atrophy or 
increase muscle mass, and alter muscle morphology towards higher oxidative capacity 
by increased vaseularisation (Âstrand and Rodahl, 1986), increased oxidative enzymes 
and mitochondrial density, upregulation of insulin receptors and increased insulin 
sensitivity (Devlin et al, 1992). It has been suggested that regular exercise may prevent 
the development of Type 2 diabetes (Helmrich et al, 1991). We have found that those 
who are physically inactive have a smaller hip circumference than expected for their 
given body mass index (C hapter 5.1).
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CONCLUSIONS
Although in longitudinal studies waist is as least as powerful as waist to hip ratio in 
predicting diabetes incidence, Type 2 diabetes in a cross-sectional survey is associated 
with shortness in statuie, large waist circumference and high body mass index, and 
particularly strong with high waist to hip ratio, suggesting that the development of Type 
2 diabetes may modify hip eircumference independently of body fat.
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Table 5.5.1. Characteristics of subjects with known Type 2 diabetes, newly diagnosed 
Type 2 diabetes (random blood glucose concentration of >11.1 mmol/1), and other 
subjects.
Known Type 2 
diabetes
Newly diagnosed 
Type 2 diabetes
Other subjects
Mean SE Mean SE Mean SE
MEN (n = 63) (n == 30) (n =
Age (years) 51.1 0.91 53.1 1 . 0 2 42.7 0.14
Weight (kg) 85.6 1.99 97.2 3.37 81.9 0,16
Height (cm) 173.1 0.83 176.4 1.36 178.5 0 . 1 0
Body mass index (kg/m^) 28.5 0.56 31.2 0.95 25.7 0.05
Waist circumference (cm) 1 0 0 . 0 1.58 1 1 1 . 2 2.56 92.1 0.14
Hip circumference (cm) 1 0 2 . 1 1.09 109.4 2.31 101.7 0.09
Waist to hip ratio 0.977 0.007 1.017 0 . 0 1 2 0.904 0 . 0 0 1
Age (years) 50.8 1.03 51.8 2.13 42.1 0.13
Weight (kg) 79.3 2.28 71.9 4.29 68.4 0.14
WOMEN (n =■51) (n =-1 5 ) (n =
Height (cm) 162.9 0.83 159.7 1.53 165.7 0.08
Body mass index (kg/m^) 29.9 0 . 8 8 28.2 1 . 6 6 24.9 0.05
Waist circumference (cm) 96.7 2.13 92.3 3.68 80.9 0.13
Hip circumference (cm) 108.5 1.82 103.5 3.41 1 0 2 . 2 0 . 1 0
Waist to hip ratio 0.891 0.013 0.891 0.018 0.790 0 . 0 0 1
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Table 5.4.2a. Crude prevalence and age adjusted odds ratios for Type 2 diabetes in
different tertiles of anthropometry, in 5887 men.
Prevalence Odds
ratio
95% confidence 
interval
n = 93t
Body mass index tertile 1 (<24.1 kg/m^) 0.46 1 . 0 0
Body mass index tertile 2 (24.1-26.9 kg/m^) 0.87 1.30 0.57, 2.94
Body mass index tertile 3 (>26.9 kg/m^) 3.41 4.40*** 2.16, 8.95
x^ :i: 65***
Waist to hip ratio tertile 1 (<0.872) 0 . 1 0 1 . 0 0
Waist to hip ratio tertile 2 (0.872-0.936) 0 . 6 6 4.07 0.90, 18.52
Waist to hip ratio tertile 3 (>0.936) 3.98 19.70*** 4.65, 83.51
X^î 1 1 1 ***
Waist circumference tertile 1 (<86.9 em) 0.32 1 . 0 0
Waist circumference tertile 2 (87.0-95.9 cm) 0.98 1.89 0.75,4.81
Waist circumference tertile 3 (>96.0 cm) 3.33 5.22*** 2.21, 12.34
x"î
Height tertile 3 (>181.5 cm) 0.60 1 . 0 0
Height tertile 2 (175.0-181.3 em) 1.64 1.20, 8.49
Height tertile 1 (<174.8 cm) 2.61 5.13*** 1.98, 13.26
x'$ 24***
<0.001, <0.01, *P <0.05; fnumber o f  subjects with Type 2 diabetes; ^difference in prevalences
between tertiles.
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Table 5.5.2b. Crude prevalence and age adjusted odds ratios for Type 2 diabetes in
different tertiles of anthropometry, in 7018 women.
Prevalenee Odds
ratio
95% confidence 
interval
n = 661
Body mass index tertile 1 (<22.8 kg/m^) 0.51 1 . 0 0
Body mass index tertile 2 (22.8-25.9 kg/m^) 0.34 0.52 0.21, 1.32
Body mass index tertile 3 (>25.9 kg/m^) 2 . 0 1 2.47* 1.24, 4.90
x ' t
Waist to hip ratio tertile 1 (<0.756) 0 . 2 1 1 . 0 0
Waist to hip ratio tertile 2 (0.756-0.815) 0.30 1.05 0.33,3.38
Waist to hip ratio tertile 3 (>0.815) 2.31 6.27*** 2.40, 16.41
y jsHîHHî
Waist circumference tertile 1 (<75.0 cm) 0.35 1 . 0 0
Waist circumference tertile 2 (75.0-84.0 cm) 0.39 0.78 0.28, 2.04
Waist circumference tertile 3 (>84.0 cm) 2.03 3.16** 1.44, 6.96
x h
Height tertile 3 (>168.5 cm) 0.49 1 . 0 0
Height tertile 2 (1630-168.0 cm) 0.80 1.31 0.63, 2.74
Height tertile 1 (<162.5 cm) 1.55 2.07* 1.06,4.04
X^î 15**
<0.001, <0.01, *P <0.05; fnnmber o f subjects with Type 2 diabetes; $ difference in prevalences
between tertiles.
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Table 5.5.3. Odds ratios for Type 2 diabetes in different tertiles of anthi’opometry, 
adjusted for age, smoking, alcohol consumption, physical activity, and education, in 
5887 men and 7018 women.
Men {n = 93 f) Women (n ~ 6 6 f)
Odds
ratio
95% confidence 
interval
Odds
ratio
95% confidence 
interval
Body mass index fertile 1 1 . 0 0 1 . 0 0
Body mass index tertile 2 1.34 0.59, 3.06 0.52 0.21, 1.30
Body mass index tertile 3 4.07*** 1.98,8.35 2.07* 1.03,4.19
Waist to hip ratio tertile 1 1 . 0 0 1 . 0 0
Waist to hip ratio tertile 2 4.16 0.91, 19.00 0.98 0.31,3.14
Waist to hip ratio tertile 3 18.36*** 4.29, 78.49 5.31*** 2.02, 13.96
Waist tertile 1 1 . 0 0 1 . 0 0
Waist tertile 2 1.93 0.76, 4.94 0.75 0.28, 1.98
Waist tertile 3 2.07, 11.70 2.67* 1.20,5.91
Height tertile 3 1 . 0 0 1 . 0 0
Height tertile 2 3.07* 1.70,8.16 1.25 0.60, 2.62
Height tertile 1 4.42** 1.26, 11.51 1.62 0.82,3.18
***p  <0.001, **P <0.01, *P <0.05; fnumber o f  subjects with Type 2 diabetes.
274
c/3
<D
'S si S<D
l i
o  1(UII.a
1
i
3.5
3.0
2.5
2.0
1.5 
1.0 
0.5
0
□ MEN 
■ WOMEN
1 2 3
W aist circum ference tertiles
Figure 5.5.1. Prevalence of Type 2 diabetes mellitus in different tertiles of waist 
circumference (in men: fertile 1 <87.0 cm, tertile 2 = 87.0-96.0 cm, tertile 3 >96 cm; in 
women: tertile 1 <75.0 cm, tertile 2 = 75.0-84.0 cm, tertile 3 >84 cm).
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5.6
QUALITY OF LIFE IN RELATION TO OVERWEIGHT AND FAT 
DISTRIBUTION
This section has been submitted for publication as
Han TS. Tijhuis MAR, Lean MEJ, Seidell JC. Quality of life in relation to 
overweight and body fat distribution, (submitted).
Collaboration with MORGEN project
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ABSTRACT
Objective: To examine the quality of life in overweight subjects and those with high 
body mass index and adverse fat distribution.
Design: Cross-sectional study.
Setting: Monitoring Risk Factors and Health in The Netherlands (MORGEN) project. 
Subjects: 1885 men and 2156 women aged 20-59 years, randomly sampled from the 
civil registries of Amsterdam, Maastrieht and Doetinchem in 1995.
Main outcome measures: Measures of quality of life using SF-36 questiomiaire.
Results: Compared to those in the lowest tertile, subjects with largest waist 
circumference were 1.8 times (95% confidence interval 1.3 to 2.4) in men and 2.2 times 
(1.7 to 2.9) in women more likely to have difficulties bending, kneeling or stooping, 2.2 
times (1.4 to 3.7) in men and 1.7 (1.2 to 2.6) in women to have difficulties in walking 
several blocks, and 1.3 times (1.0 to 1.9) in men and 1.5 times (1.1 to 1.9) in women to 
have difficulties in lifting or canying groceries. Anthropometric measines were less 
strongly associated with items from other health concepts concerning social fmictioning, 
role limitations due to physical problems or due to emotional problems, mental health, 
vitality, pain, or health change in one year. Quality of life measmes related to body mass 
index and waist to hip ratio similarly to waist cireumference.
Conclusions: People who have large waist circumference, high body mass index or high 
waist to hip ratio are more likely to have impaired quality of life, with poor self rated 
health, and limitations in the basic activities of daily living.
Keywords: epidemiology, health promotion, obesity, subjective health.
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INTRODUCTION
In Western countries, 10-20% of men and women have a body mass index (BMI) above 
30 k g W  and figures have been increasing (Bennett et al, 1990; Kuczmarski et al, 1994; 
Seidell, 1995a). Although overweight and central fat distribution are associated with 
increased risks of clironic diseases such as diabetes (Ohlson et al, 1985), cardiovascular 
diseases (Lapidus et al, 1984; Lars son et al, 1984), caneers (den Tonkelaar et al, 1995; 
Giovaimucei et al, 1995), and premature death (Manson et al, 1995; Simopoulos and 
van Itallie, 1984), it is surprising that the quality of life in overweight subjects is less 
well documented.
Early studies have indicated that overweight subjects aie more likely to have poorer 
physical functioning status, a measure of quality of life (Stewart et al, 1983). With 
advancing age, overweight persons aie more likely to develop serious limitations in 
performing basic daily activities (Launer et al, 1994). These persons impose an 
enormous burden on health care resouices (Seidell, 1995b; Colditz, 1992). Poor physical 
function and quality of life attributable to overweight is important in terms of public 
health, and should be addressed by preventive measures, and promotion of healthy 
living. The quality of life in subjects with adverse fat distribution, i.e. large waist 
circumference and high waist to hip ratio (WHR), to our laiowledge, has not been 
reported in the literatuie. The present study examined the quality of life in overweight 
subjects, and those with central fat distribution and large waist circumference.
METHODS 
Subjects
1885 men and 2156 women aged 20-59 were recruited randomly from eivil registries for 
the ongoing MORGEN (Monitoring Risk Factors and Health in The Netherlands) 
project 1995 cohort, from Amsterdam, Maastricht, and Doetinchem. To obtain similar 
numbers of subjects at each age, the sample was stratified by sex and five year age group 
(Smit et al, 1994). The response rate to invitations was about 50%.
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Anthropometry
All anthropometric measurements were made according to the World Health 
Organisation recommendations (1989) by trained paramedic personnel. Subjects wore 
light clothes during measurements of body weight to the nearest lOOg using calibrated 
scales, height in bare feet to the nearest mm, waist circumference in duplicate at the 
level between the lowest rib margin and iliae crest, and hip cireumference at the widest 
trochanters to the nearest mm. Waist to hip circumferential ratio was computed, and 
BMI was calculated as weight (kg) divided by height squared (m^).
Quality of life
Nine ‘health concepts’ were calculated from thirty-six items rated by subjects using the 
standardised RAND-36 questionnaire, Dutch version (van der Zee and Sanderman, 
1995), which was adapted from the standardised SF-36 Health Sui'vey (Medical 
Outcomes Trust, 1994). These health concepts comprised measures of functioning - the 
ability to perform daily tasks and activities, and measures o f well being - subjective 
internal states including how people feel physieally and emotionally and how they think 
and feel about their health (Stewart et al, 1994). The nine health concepts were physieal 
functioning, role functioning limitations due to poor physical health, bodily pain, 
general health, vitality, social functioning, role functioning limitations due to poor 
emotional health, mental health, and health transition in one year.
Lifestyle and demographic factors as confounding factors
Dummy variables (Appendix 5.6.1) for possible confounding factors were created to 
adjust for the associations between adiposity and health concepts and individual items.
Statistical methods
Statistical analyses were performed using SAS version 6.1 (Cary, USA). All thirty-six 
items of the nine health eoneepts were examined in relation to anthi’opometrie 
measurements.
279
Standardising scores for the nine health concepts
Thirty-six items of reported health were appropriately converted and standardised into 
percentage scale based on the equation described by van der Zee and Sanderman (1995) 
and Medical Outcomes Trust (1994). These items were grouped accordingly to make up 
the nine health concepts (Table 5.6.1).
Definition o f  ‘good' and ‘poor'fo r  the nine health concepts
Distributions of standai'dised scores were examined from the plots (not shown) to 
determine arbitrary cut-offs for the health concepts. It was decided that subjects with 
less than 66.7% of the standardised score were elassified as having a ‘poor’ health 
concept, and those with 66.7% or above (i.e. upper tertile of the scores) were considered 
as having a ‘good’ health concept. For the health transition concept, which had only a 
two point scale, seores below 50% were considered as poor health, and 50% or above as 
good health. These cut-offs classified between 10 to 25% subjects as having ‘poor’ 
health for most concepts, except higher proportion subjects (40-50%) who had ‘poor’ 
vitality and ‘poor’ general health (Appendix 5.6.2).
Definition o f  ‘good' and ‘poor ' health fo r  the 36 individual items
Each item was arbitrarily dichotomised such that scores above average for items with an 
odd numbered scale (3 or 5 points) were considered as "good' health and average or 
lower as "poor' health. For items with even scale (2, 4 or 6  points), the scores for "good' 
health and "poor ' health were evenly divided.
Logistic regression analysis
Odds ratios and 95% confidence intervals (Cl) were determined to estimate the relative 
risks of ‘poor’ health in those with high BMI, WHR and large waist circumference, 
adjusted for age, lifestyle and demographic factors. Possible interactions between height 
and WHR, and height and waist circmnference were examined using maximum 
likelihood analysis for the differenee of chi square statistic when the interaction terms 
(combinations of tertiles) were added to the model, with referenee to tallest subjects who
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had lowest (tertile 1) WHR, or lowest waist circumference. Similar analysis for the 
interaction between BMI and WHR was performed to see if  fat distribution accentuated 
poor self-rated health in subjects of different fatness, with reference to those with lowest 
BMI and lowest WHR. Interactions between age and antlii'opometric measurements on 
health concepts were also examined, with reference to the youngest group (20-29 years) 
who had lowest BMI, lowest WHR, lowest waist circumference, or were tallest.
RESULTS
Subject characteristics are shown in Table 5.6.1. Tertiles of anthropometric variables in 
the present sample were identified at 87.3, 96.1 cm in men and 74.8, 84.0 cm in women 
for waist circumference; and 175.5, 181.5 cm in men and 163.0, 168.0 cm in women for 
height; 0.873, 0.938 in men and 0.756, 0.816 in women for WHR; 24.15, 26.84 kg/m^ in 
men and 22.67, 25.63 k%/m in women for BMI.
The present study examined a wide range of quality of life measures, found that they 
were related similarly to all indices of adiposity currently in use. For clarity of 
presentation, only results for items from the health concepts of physical functioning ( 1 0  
items) and general health (5 items) in relation to waist circumference are tabulated in the 
present study.
Risks o f  ‘poor ' health indicated by the nine health concepts
After adjustment for age, and lifestyle and demographic factors, compared to those in 
tertile 1, those with waist circumference (Figures 5.6.1a & b), in tertile 3 were two to 
thi’ee times more likely to associate with ‘poor’ physical functioning (score <66.7%) and 
less strongly with other health concepts (results not shown). Similar results (data not 
presented) were observed for BMI and WHR.
Risks o f  ‘p o o r’ health indicated by the 36 individual items o f  health concepts 
Results for items of physical functioning (10 items) and general health (5 items) are 
presented in Tables 5.6.2 and 5.6.3. Compared to those in the lowest tertile, the odds
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ratios, adjusted for age, lifestyle and demographic factors, for limitations in physical 
functioning were significantly higher in those with highest tertile of waist circumference 
(Tables 5.6.2a & b), and most marked in women in that they had more problems of 
lifting or carrying groceries, walking one flight of stairs or walking a distance of one 
block.
In men, those in the highest tertile of waist expected their health to get worse more often 
than those in the lowest tertile, and reported the answer for ‘excellent’ health as ‘don’t 
Icnow’ or as a ‘false’ statement. In women, those with largest waist circumference 
considered their health in general as ‘not good’.
O f the remaining 16 items from the health concepts concerning social functioning, role 
limitations due to physical problems or emotional problems, mental health, vitality, 
pain, and health change since last year, only a few were related to anthropometry. For 
clarity, only significant odds ratios for high or low tertiles are reported in this section. 
Compared to subjects with lowest tertile, men with largest waist were 1.80 times (95% 
confidence interval 1.18 to 2.28) more likely to feel worn out a good bit to all the time 
(vitality item), women with largest waist were 1.33 times (1.00 to 1.72) more likely to 
feel they accomplished less than they would like with work or other regular daily 
activities in the past four weeks as a result of physical health problems (physical role
functioning item), and 1.27 times (1.00 to 1.61) to not feel that they have a lot of energy
a good bit to all the time (vitality item) with waist in the third tertile.
Analysis fo r  interactions between anthropometric measures and age 
Examination of interactions between anthropometric variables on the nine health 
concepts showed there were weak interactions range 8  to 10 with 4 degrees of 
freedom, P <0.05) in men and in women for only a few relationships. Logistic 
regression analysis was performed to identify the subgroup most related to poor health 
concepts. Compared to subjects with a combination of lowest BMI and lowest WHR, the 
odds ratio for role limitations due to physical problems was 9.5 (1.2 to 74.8) in men, and
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‘poor’ general health was 1.98 (1.14 to 3.43) in women with highest BMI and highest 
WHR. Compared to those with both smallest waist and tallest height, the odds ratio for 
women who had ‘poor’ physical functioning was 2.01 (1.05 to 3.83) for those with 
largest waist and shortest height, and 2.95 (1.30 to 6.69) in women with both largest 
waist and tallest height. Adjusted odds ratio for women who had more bodily pain was 
2.07 (1.20 to 3.57) in tallest women with largest waist. There was only one interaction 
between anthiopometric measurements and age on health concepts, which was height in 
women {% = 22.8, 6  degrees of freedom, P <0.01). Compared to those 20-29 years and 
tallest, the odds ratio for ‘poor’ general health was 1.62 ( 1 . 0 1  to 2.61) in women aged 
50-59 with height in tertile 2. There was no evidence for subjects with low BMI and 
high WHR having different health concepts from those with low BMI and low WHR.
DISCUSSION
In the present study quality of life measures related similarly to waist circumference, 
BMI and WHR. Compared to the lowest tertile, subjects with high BMI, high WHR or 
large waist circumference were more likely to have ‘poor’ physical functions, limiting 
many common, basic activities of daily living, including difficulties in walking several 
blocks and bending, kneeling or stooping. Women with adverse anthropometry had 
more severe problems than men such as walking one block, or one flight of stairs, lifting 
or carrying groceries. These results suggest that subjects who are overweight, with 
adverse fat distribution may be less able to care for themselves, their quality of life and 
possibly that of their relatives would be affected.
Examination of items from the general health concept showed that subjects with large 
waist were more likely to expect their health to get worse (men) and to consider their 
health in general as not good (women). The subjects’ current indices of adiposity did not 
relate to reported change in health since one year previously, perhaps because some had 
changed weight and fat distribution as well as their health. Poor subjective health is a 
determinant of mortality independent o f physical health status (Mossey and Shapiro, 
1982; Kaplan and Camacho, 1983; Idler et al, 1990; Pijls et al, 1993). It has been shown
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that subjects who performed activities of daily living with difficulties were at 2 to 3 
times more at risk of death (Kaplan et al, 1988).
Unadjusted odds ratios were higher (results not shown), age had the most powerful 
confounding effects on the relationships between anthiopometric variables and quality 
of life. We found no important interactions between height and waist circumference or 
WHR, or interactions between age and BMI, WHR or waist circumference.
The present study defined ‘good’ health based on the 9 health concepts as equal or above 
66.7% and ‘poor’ health as below 66.7% (except for health transition health concept 
which used 50%) standardised scores respectively. There are no definitive cut-offs for 
these health concepts, but Stewart et al (1994) have shown that patients with chronic 
diseases who were more physically active had scores mostly above 66.7% and those 
who were less active had scores mostly below 66.7%. ‘Good’ health indicated by the 36 
individual items was defined as above average scores and poor health items as average 
or below scores. These cut-offs were arbitrary, if good self rated health was defined 
more broadly, i.e. average or above scores, then the prevalence of poor self rated health 
would be lower. Launer et al (1994) also categorised fair and poor scores together, based 
on their strong association with disability. Previous findings have shown that elderly 
subjects above 65 years who rated their health as fair had twice the risk of death within 
two years compared to those who rated their health as excellent (Mossey and Shapiro, 
1982), and Schoenfeld et al (1994) found the risk of death in those whose self rated 
health was fair was similar to subjects with poor rating. There may be an overrating of 
health amongst those who consider their health as fair (Maddox and Douglass, 1973; 
LaRue et al, 1979). Poorly rated health was associated with adverse adiposity, but 
questions were not designed to assess self rated health addressing the subjects own 
perception of this link.
Quality of life may include many dimensions, psychosocial health is probably one 
example, and its association with overweight and fat distribution has been extensively
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studied. Negative attitudes towards overweight (Staffieri, 1978), peer pressure, and 
social discrimination impose heavy pressme upon these persons (Allon, 1979; Sobal et 
al, 1995). Severely overweight men (BMI >34 kg/m^) and women (BMI >38 kg/m^) 
have been shown to rate their current health as poorer and mood states less positive than 
non-overweight subjects (Sullivan et al, 1993). Even at an early age (9 years), 
overweight children have been shown to have low self-esteem (Hill and Silver, 1995). 
The fear of being overweight may lead to behavioural changes such as slimming, 
particularly in women who are not even overweight (Seidell et al, 1986a). Despite their 
apparent associations with unfavourable perceptions by others, and with poor physical 
health, there was little evidence in the present study to suggest that overweight subjects, 
those with central fat distribution, or large waist were having more non-physical 
problems such as mental health, social fimctioning, or role limitations due to emotional 
problems.
CONCLUSION
This study provides convincing evidence that large waist circumference, high WHR and 
high BMI are important indicators of physical difficulties with simple daily activities. 
The data present a very wonying profile of ill health and disabilities, affecting a large 
and increasing proportion of adults.
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Table 5.6.1. Characteristics, and raw and standardised self rated health scores of 1885 
men and 2156 women. Low scores indicate poor health, and high scores indicate good 
health.
Characteristics
Men Women
Mean SD Range Mean SD Range
Age (years) 42.7 10.9 20.3-60.0 41.4 1 1 . 0 20.2-59.9
Weight (kg) 82.2 12.3 45.7-157.0 68.4 11.5 38.6-153.0
Height (m) 1.79 0.07 1.52-2.06 1 . 6 6 0.07 1.42-1.89
Body mass index (kg/m^) 25.7 3.6 15.7-50.1 24.8 4.1 16.5-58.3
Waist circumference (cm) 92.2 1 1 . 0 64.0-155.0 80.9 1 1 . 1 60.0-135.5
Hip circumference (cm) 1 0 1 . 6 6 . 8 69.0-150.0 1 0 1 . 8 8.3 74.4-160.0
Waist to hip ratio 0.907 0.073 0.621-1.369 0.793 0.072 0.603-1.302
Raw score
Physical fimctioning 28.1 3.2 10.0-30.0 27.5 3.4 10.0-30.0
Social functioning 9.0 1 . 6 2 .0 - 1 0 . 0 8.7 1 . 8 2 .0 - 1 0 . 0
Role limit-physical:{: 7.4 1 . 2 4.0-8.0 7.2 1.4 4.0-8.0
Role limit-emotional§ 5.5 0.9 3.0-6.0 5.4 1 . 0 3.0-6.0
Mental health 24.0 3.9 6.0-30.0 23.0 4.1 5.0-30.0
Vitality 17.6 3.5 4.0-24.0 16.7 3.6 4.0-24.0
Bodily pain 51.9 1 0 . 2 11.0-60.0 50.0 10.7 11.0-60.0
General health 19.2 3.5 5.0-25.0 19.1 3.5 5.0-25.0
Health transition 3.0 0 . 6 1.0-5.0 3.1 0.7 1.0-5.0
Standardised score'^
Physical functioning 90.3 15.8 0 .0 - 1 0 0 . 0 87.6 16.8 0 .0 - 1 0 0 . 0
Social functioning 86.9 20.4 0 .0 - 1 0 0 . 0 83.5 2 2 . 1 0 .0 - 1 0 0 . 0
Role limit-physicalj" 84.7 29.5 0 .0 - 1 0 0 . 0 79.7 34.0 0 .0 - 1 0 0 . 0
Role limit-emotionalj 85.0 30.3 0 .0 - 1 0 0 . 0 80.4 34.9 0 .0 - 1 0 0 . 0
Mental health 76.2 15.6 4.0-100.0 72.2 16.4 0 .0 - 1 0 0 . 0
Vitality 67.9 17.4 0 .0 - 1 0 0 . 0 63.5 17.9 0 .0 - 1 0 0 . 0
Bodily pain 83.5 20.9 0 .0 - 1 0 0 . 0 79.7 21.9 0 .0 - 1 0 0 . 0
General health 70.8 17.4 0 .0 - 1 0 0 . 0 70.4 17.7 0 .0 - 1 0 0 . 0
Health transition 49.6 15.5 0 .0 - 1 0 0 . 0 52.2 17.3 0 .0 - 1 0 0 . 0
* Calculated using equation from van der Zee and Sanderman (1995); frole limitations due to physical 
functioning problems; :j:role limitations due to emotional problems.
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Table 5.6.2. Age and lifestyle adjusted odds ratios of poor scores (<67.7% of 
standardised scores) for individual items describing physical functioning in second and 
third tertiles (first tertile as reference) of waist circumference.
Tertile 1 Tertile 2 Tertile 3
Items ofphysical functioning
Odds
ratio
Odds
ratio
95% Cl Odds
ratio
95% Cl
MEN (« =  1885) 
Vigorous activities 1 . 0 0 1 . 2 1 0.95, 1.55 1 .6 8 *** 1.29,2.17
Moderate activities 1 . 0 0 1.04 0.70, 1.54 1.58* 1.08,2.33
Lifting or carrying groceries 1 . 0 0 1.03 0.73, 1.45 1.34 0.95,1.90
Walking several flights of stairs LOO 0.99 0.67, 1.45 2.16*** 1.50,3.11 '
Walking one flight of stairs 1 . 0 0 0 . 6 6 0.37, 1.17 1.27 0.75,2.13
Bending or kneeling 1 . 0 0 1 . 1 1 0.82, 1.50 1.75*** 1.30, 2.36
Walking more than a mile 1 . 0 0 1.28 0.88, 1.87 2.31*** 1.60,3.34
Walking several blocks 1 . 0 0 1.04 0.61, 1.77 2.23** 1.36,3.65
Walking one block 1 . 0 0 0.95 0.52, 1.74 1.71 0.97,3.01
Bathing or dressing 1 . 0 0 1.25 0.62, 2.52 1.83 0.93,3.60
WOMEN {n = 2156) 
Vigorous activities 1 . 0 0 1 . 2 0 0.96, 1.49 1 .6 8 *** 1.32,2.13
Moderate activities 1 . 0 0 1.27 0.95, 1.69 1.78*** 1.34, 2.36 ^
Lifting or carrying groceries 1 . 0 0 1 . 1 1 0.86, 1.43 1.45** 1.12, 1.87
Walking several flights of stairs 1 . 0 0 1.19 0.89, 1.60 1.87*** 1.40,2.49
Walking one flight of stairs 1 . 0 0 1 . 1 1 0.70, 1.76 1 .8 8 ** 1.22,2.90 )
Bending or kneeling 1 . 0 0 1.24 0.95, 1.63 2 .2 0 *** 1.68, 2.87
Walking more than a mile 1 . 0 0 1.15 0.85, 1.57 1.75*** 1.29,2.38
Walking several blocks 1 . 0 0 1 . 0 0 0.65, 1.54 1.73** 1.15,2.58
Walking one block 1 . 0 0 1 . 0 1 0.62, 1 . 6 6 1 . 2 2 0.75,1.97
Bathing or dressing 1 . 0 0 1.04 0.55, 1.99 0.80 0.40, 1.59
***? <0.001, <0.01, *P <0.05; Cl = confidence interval.
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Table 5.6.3. Age and lifestyle adjusted odds ratios of poor scores (<67.7% of 
standardised scores) for individual items describing general health in second and third 
tertile (first tertile as reference) waist circumference.
Items o f  general health
Tertile 1 
Odds 
ratio
Tertile 2 Tertile 3
Odds
ratio
95% Cl Odds
ratio
95% Cl
MEN (%= 1885)
Poor health in general 1 . 0 0 1.04 0.71, 1.53 1.23 0.83, 1.81
Getting sick a little easier 1 . 0 0 1.17 0.84, 1.64 1.23 0.86, 1.75
Health not as good as anybody 1 . 0 0 1.14 0.89, 1.45 0.97 0.75, 1.27
Expecting worse health 1 . 0 0 1.28* 1 .0 1 , 1.62 1.39* 1.08, 180
No excellent health§ 1 . 0 0 1.30 0.98, 1.73 1.35* 1 .0 0 , 1.82
WOMEN {n = 2156)
Poor health in general 1 . 0 0 0.91 0.64, 1.27 1.52* 1.09,2.13
Getting sick a little easier 1 . 0 0 0.85 0.64, 1.12 1.18 0.89, 1.57
Health not as good as anybody 1 . 0 0 1 . 1 1 0.88, 1.40 0.97 0.76, 1.24
Expecting worse health 1 . 0 0 1.03 0.82, 1.28 0.96 0.75, 1.21
No excellent health§ 1 . 0 0 1.09 0.84, 1.41 1.28 0.99, 1.67
***?  <0.001, **P <0.01, *P <0.05; Cl = confidence interval; §responded as “don’t know” or “false” to 
the question “ do you rate your health as excellent? (dont’t know, true or false)”.
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Figure 1. Odds ratios (95% confidence intervals) for subjects with ‘poor’ (<66.7% of 
standardised scores) physical functioning health concept in different tertiles of waist 
circumference in men (a) and in women (b) (Odds ratios were adjusted for age, cigarette 
smoking, alcohol drinking, physical activity, educational level, marital status, 
employment, household composition, intimate contact, and parity (in women).
289
Appendix 5.6.1. Age, lifestyle and demographic factors as possible confounders 
considered in analysis of the associations of quality of life with body mass and fat 
distribution.
Reference group Dummy variables
1 2 3
Age (years) 20-29 30-39 40-49 50-59
Smoking Non-smokers Ex-smokers Current
smokers
Alcohol consumption 
(glasses/day)
Occasional
(<i)
None
(0 )
Moderate 
(1 to <3)
Heavy
( ^ )
Physical activity Active (do 
sport)
Inactive (do no 
sport)
Educational level Level 3 (higher 
vocational or 
university)
Level 2 
(vocational or 
higher secondary)
Level 1 
(lower than 
secondary)
Marital status Single Married or 
cohabiting
Divorced or 
widowed
Employment Currently
employed
Unemployed Housewives Retired*
Household composition Living with 
someone
Living with no 
one
Intimate contact')' No one 1 - 2 3-5 > 6
Parity (live births) None 1 - 2 >3
^Retired early; fDiscussing personal matters with other people.
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Appendix 5.6.2. Proportions of subjects with standardised scores below 66.67% for the 
nine health concepts in the RAND-36 questionnaire.
Men (%) Women (%)
Physical functioning 8.44 10.76
Social functioning 17.24 23.47
Role limit-physical:): 16.82 23.01
Role limit-emotional § 23.45 27.92
Mental health 21.49 30.10
Vitality 43.98 54.27
Bodily pain 15.44 2 1 . 1 0
General health 37.61 38.78
Health transition 13.32 12.52
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6.1
IMPAIRMENT OF HEALTH AND QUALITY OF LIFE IN THE 
OVERWEIGHT ACCORDING TO STANDARD CUT-OFFS OF 
BODY MASS INDEX
This section has been submitted for publication as
Lean MEJ, Han TS. Seidell JC. Impairment of health and quality of life in the 
overweight according to standard cut-offs of body mass index, (submitted).
Collaboration with MORGEN project
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ABSTRACT
Objective’. To estimate the prevalence and risks of chronic disease, secondary symptoms 
and poor quality of life associated with overweight, using standardised body mass index 
(BMI) cut-offs (25 and 30 kgW ).
Design: Cross-sectional study in a random sample set in the Netherlands.
Subjects: 5887 men and 7018 women aged 20-59 years selected from the civil registry of 
Amsterdam, Maastricht and Doetinchem.
Main outcome measures: Symptoms of respiratory insufficiency, low back pain, type 2 
diabetes, caidiovascular risk factors, and physical functioning.
Results: People with BMI below 25 kg/m^ were considered the reference group, with 
low prevalence of symptoms of obesity-related diseases and good subjective health. 
Between 25-30 kg/m^, the prevalences of these all increased, and above 30 kg/m^ were 
greatly increased. After adjustments for age and lifestyle factors, odds ratios (95% 
confidence intervals) in those with a BMI >30 kg/m^ were 3.5 (2.8 to 4.4) in men and 
3.3 (2.8 to 3.9) in women for shortness of breath when walking upstairs, 4.6 (2.4 to 8 .8 ) 
in men and 5.4 (2.8 to 10.5) in women for type 2 diabetes, 5.5 (4.5 to 6 .6 ) in men and 
2.9 (2.4 to 3.4) in women for at least one major cardiovascular risk factor. Both men and 
women with BMI >30 kg/m^ were twice as likely to have difficulties in performing a 
range of basic daily physical activities. Compared to women with BMI <25 kg/m^, those 
with BMI >30 kg/m^ were 1.5 times more likely to have symptoms of intervertébral disc 
herniation. Significantly more overweight women had problems associated with low 
back pain including hindrance to their daily business, absence from work and medical 
consultation. The calculated population attributable risks to estimate the excess risk of ill 
health attributable to overweight were between 10-40%.
Conclusions: Health risks for a range of problems aie presented using the standard BMI 
cut-offs. Overweight is associated with increased risks of clironic disease, secondary 
symptoms and impairment of quality of life, which could amoimt to huge health care 
expenditure.
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INTRODUCTION
Health service burdens are heavily imposed by clusters of symptoms, risk factors and 
secondary diseases associated with overweight and adverse fat distribution, leading to 
coronary heart disease, strokes, non-insulin dependent diabetes mellitus (NIDDM), and 
several cancers. Recent estimates costs per aimum for treating this ill health were 195 
million pounds in Britain (Office of Health Economics, 1994), and 70 billion dollars in 
the United States (Institute of Medicine, 1995). These figures present major concerns to 
the health service, since the prevalence of overweight is still rising in many countries 
(Kuczmarski, 1992; Seidell 1995a; Bemiett et al, 1995; Gregory et al, 1990).
Estimating total burdens of disease and financial costs associated with overweight has 
been hampered by a lack of consistent evidence using standard cut-offs for body mass 
index (BMI) and standardised referent populations. From the ongoing MORGEN project 
(monitoring cardiovascular health in The Netherlands), we have shown that waist 
circumference, BMI and waist to hip ratio all relate closely and similarly to a variety of 
symptoms and clironic diseases (C hapter 5). Hitherto, data have been analysed by 
tertiles of BMI, and division by median, tertiles, and quintiles have been performed for 
epidemiological research for statistical reasons.
The present study summarises the prevalence of major chronic diseases, symptoms and 
impairment of quality of life related to overweight, and calculated the odds ratios 
according to the BMI categories adopted by World Health Organisation (1995) - i.e. 
BMI >25 kg/m^, or BMI >30 kg/m^, with reference to BMI <25 kg/m^.
METHODS 
Subjects
Dutch men (n ~ 5887) and women (« = 7018) aged 20-59 were recruited randomly from 
civil registries for the ongoing MORGEN (Monitoring Risk Factors and Health in The 
Netherlands) project 1993 to 1995 cohorts, from Amsterdam, Maastricht, and 
Doetinchem. To obtain similar numbers of subjects at each age, the sample was
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stratified by sex and five year age group. The response rate to invitations was about 
50%. Information on quality of life was available in the 1995 cohort of 1885 men and 
2156 women. The numbers of subjects in the present study represent those who attended 
health centres for biochemical and physiological measurements.
Measurements
All anthropometric measurements were made according to the World Health 
Organisation (1995) recommendations by trained paramedical persomiel. Subjects wore 
light clothes during measurements of body weight to the nearest lOOg using calibrated 
scales, height in bare feet to the nearest mm. BMI was calculated as weight (kg) divided 
by height squared (m^). Lifestyle factors were obtained from a questionnaire.
Symptoms and diseases
Major symptoms and diseases associated with overweight were selected from our 
previous studies (C hapter 5). Symptoms of respiratory insufficiency included shortness 
of breath, wheezing, coughing and bringing up phlegm (C hapter 5.4). Risk factors for 
cardiovascular disease included hypercholesterolaemia (plasma total cholesterol >6.5 
mmol/1), low high density lipoprotein cholesterol (<0.9 mmol/1) and hypertension 
(systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or 
the use o f antihypertensive agents) (C hapter 5.2; Han ei al, 1995c). Known and newly 
diagnosed (random blood glucose >11.1 mmol/1) NIDDM were included, and Insulin 
treated patients were excluded as indistinguishable from insulin dependent diabetes 
mellitus (C hapter 5.5; Seidell et al, 1997). Symptoms of low back pain were obtained 
fi'om questionnaire. Those who responded affirmatively to having low back pain in the 
past 12 months, were then asked whether they had radiating pain to the knees or feet, to 
indicate symptoms o f  intervertébral disc herniation. This symptom was only accepted in 
the presence of low back pain, to avoid including those with other causes of radiated 
pain. The subjects were asked about the total duration of low back pain in the past 12 
months. Those who had low back pain for a total of twelve weeks or more were
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classified as having chronic low back pain. The reference groups for the tlnee classes of 
low back pain were composed of those who did not fulfil the criteria for the symptom 
under analysis, thus the reference group when analysing one symptom included some 
subjects with other symptom(s) of low back pain (Chapter 5.3; Han et al, 1997d). From 
ten items rated by subjects using the standardised Dutch RAND-36 questionnaire, which 
has been adapted from the standardised SF-36 Health Survey the concept of physical 
functioning, was calculated to represent quality of life. Distributions of standardised 
scores were examined from the plots (not shown) to determine arbitrary cut-offs for the 
health concepts. It was decided arbitrarily that subjects with less than 66.7% o f  the 
standardised score would be classified as having a 'poor ’ health concept, and those with 
66.7%) or above were considered as having a ‘good’ health concept. This cut-off 
classified 8.4% of all men and 10.8% of all women as having ‘poor’ physical 
functioning. Each of the ten items comprising the physical functioning health concept 
was arbitrarily dichotomised such that scores above average (with an odd numbered 
scale of 3 or 5 points) were considered as 'good’ health, and average or lower scores 
were classed as 'poor ’ health. For items with even scale (2, 4 or 6  points), the scores for 
'good’ health and 'poor’ health were evenly divided (C hapter 5.6).
Lifestyle and demographic factors as confounding factors
Dummy variables (Appendix 6.1.1) for possible confounding factors were created to 
adjust for the associations between adiposity and health concepts and individual items.
Statistical methods
Statistical analyses were performed using SAS version 6.1 (Cary, USA). Logistic 
regression analysis was used to estimate the odds ratios and 95% confidence intervals of 
symptoms of disease and ‘poor’ quality of life in those with BMI in the categories of 
between 25-30 kg/m^ and >30 k.g!m, compared to those with body mass index <25 
kg/m^, adjusted for age, lifestyle and demographic factors (Appendix 6.1.1).
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Population attributable risk
The population attributable risk, i.e. the proportionate excess risk of ill health associated 
with exposure to the risk of overweight based on BMI cut-off at 25 kg/m^ (PAR2 5 ) was 
calculated as (Kalni and Sempos, 1989; Kleinbaum et al, 1982):
“ 1*25^ (O R 25 " 1)4^25 ^ (G R 25 " 1 )] +  1 ) 
where P2 5  is the proportion of subjects exposed to the risk of overweight, i.e. all subjects 
with BMI >25 kg/m^, OR2 5  is the age and lifestyle adjusted odds ratio for a symptom or 
disease in subject group with BMI >25 kg/m^ compared to the reference group with BMI 
<25 kg/m^. Population attributable risk using BMI cut off at 30 kg/m^ (PAR30) was 
calculated the same way, with the proportion of subjects exposed to BMI >30 kg/m^, 
and the odds ratios for a disease in subjects with BMI >30 kg/m^ compared to the 
reference group with BMI <30 kg/m^. The difference between PAR2 5  and PAR3 0  gives 
PAR2 5 . 3 0  for BMI between 25-30 kg/m^. This equation is valid only when the odds ratio 
is equal or greater than 1 .
RESULTS
Characteristics of subjects are shown in Table 6.1.1. Overall prevalence of disease, 
symptoms and poor quality of life is shown in Table 6.1.2. There were 45% men and 
31% women whose BMI were between 25-30 kg/m^ and 11% men and 11% women 
above 30 kg/m^. The prevalence of these health risks increased with increasing BMI 
(Tables 6.1.3a & b), and highest in those with BMI above 30 kg/m^. Figures 6.1.1a & 
b show that within separate groups of non-smokers and smokers, the prevalence of those 
with shortness of breath when walking uphill or upstairs increased with increasing BMI, 
and significantly (R <0.001) higher in smokers for each level of BMI.
After adjustments for age and appropriate lifestyle factors, compared to those with BMI 
below 25 kg/m^, the risk for clironic disease, symptoms and quality of life increased 
significantly (Tables 6.1.4a & b), with the highest risk in those with BMI above 30 
kg/m^. Figure 6.1.2 shows the proportions of subjects whose daily life activities were
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affected by low back pain. About a third of men and women reported that, due to low 
back pain, their daily business was hindered, they had to be absent from work, and more 
than forty percent sought medical consultation as a result of low back pain. Table 6.1.5 
shows that after adjustments for age and lifestyle factors, the proportions of these 
consequences of low back pain were significantly higher in women with BMI above 30 
kg/m^ compared to women with BMI below 25 kg/m^. The proportion of daily business 
hindered due to low back pain was significantly higher in men with BMI 30 kg/m^ 
compared to men with BMI below 25 kg/m^. Figure 6.1.3 shows the odds ratios (95% 
confidence interval limits) for ‘poor’ physical function health concept were two and half 
times higher in subjects with BMI above 30 kg/m^ compared to those with BMI below 
25 kg/m^.
Tables 6.1.6 a & b show the proportions of subjects ‘exposed’ to overweight, with BMI 
above 25, or 30 kg/m^, and the odds ratios for ill health. These values were used to 
calculate the population attributable risks for symptoms of disease and ‘poor’ quality of 
life in those with BMI >25 or >30 kg/m^. Table 6.2.7 shows that the excess proportions 
of subjects with poor health attributable to overweight (BMI >25 kg/m^) were 
approximately 10 to 40 percent. The difference in population attributable risks from 
BMI categories of >25 and >30 kg/m^ is the population attributable risk for those with a 
BMI between 25 to 30 kg/m^. This difference of population attributable risk was as high 
as the values for category above 30 kg/m^.
DISCUSSION
Attempts to quantify the impact of obesity on health and health service costs have been 
confused by lack of standardisation. For example, the relative risks for NIDDM have 
been quoted as up to 40 for men with BMI above 30 kg/m^ or 93 for women with BMI 
above 35 kg/m^, depending on the reference population used (Chan et al, 1994; Colditz 
et al, 1995). Some use all those below the cut-off, others obtain very high relative risks 
by using the lowest risk group, e.g. BMI <22 kg/m^ as the reference population. Many
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epidemiological studies have compared risks in tertiles of populations often with BMI
tertile range (25-27 kg/m ). Surprisingly few studies have estimated health risks in 
groups which would be considered obese, i.e. BMI >30 kg/m^ (WHO, 1995). The 
present study has combined data from a number of analyses which have shown that 
overweight, indicated by BMI in the highest tertile is associated with increased risk of 
chronic disease, symptoms and risk factors of major diseases, and poor quality of life in 
terms of difficulties in performing basic activities of daily living (Chapter 5). The data 
are presented here in a standardised format, relating prevalences of a range of health 
problems in the overweight to those in a referent population with BMI <25 kg/m^. Using 
this approach it is now possible to derive population attributable risks (Table 6.1.6) in a 
consistent way for estimating the cost obesity in different countries. The BMI cut-offs 
employed (BMI 25-30, >30 kg/m^) are conventional for most of the world, and have 
been adopted by WHO (1995). Even in this relatively large, detailed study, numbers 
preclude divisions into smaller categories, e.g. by BMI 28 kg/m^, or BMI >35 kg lm .
The Dutch population studied has physical characteristics similar to those of most 
Western/Caucasian populations, so the data can probably be generalised with caution. 
The patterns of health problems associated with being overweight are similar to those 
identified by analysis of tertiles, so most are significantly affected by BMI class. For 
some symptoms the increased prevalence with BMI >30 kg/m^ is particularly striking, 
e.g. shortness of breath when walking upstairs or uphill is present in 46% of women and 
34% of men, chionic low back pain in 25% women, 20% men. It is also clear that the 
BMI range 25-30 kg/m^ is not benign, with respect to elevated cardiovascular risk 
factors in both sexes, and a wide range of important symptoms in women (Table 6.1.4). 
The increased prevalence of shortness of breath is again striking at almost 30% of 
women with BMI 25-30 kglvci and we have previously shown that overweight affects 
shortness of breath in both smokers and non-smokers (Chapter 5.4).
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In addition to these analyses, which should be of value to health economics and policy 
makers. Table 6.1.5 presents new data on some major social consequences of being 
overweight. Again it is clear that BMI 25-30 kg/m^ after appropriate adjustments for age, 
smoking and education, has a significant impact amongst women, although these 
problems only become apparent with >30 kg/m^ in men. Odds ratios are likely to be 
overestimated if the prevalence is high (Lee, 1994). Thus the results of some items of 
the physical fimctioning health concept (Tables 6.1.3a & b) in the present study should 
be interpreted with caution.
It is a potential limitation of the present analysis that the age range of subjects was 20-59 
years. Some of the conditions and symptoms under study (e.g. NIDDM, shortness of 
breath) are well known to be much more prevalent in the elderly - indeed the majority of 
NIDDM patients are aged over 60 years. On the other hand, the impact of overweight or 
obesity, measured as odds ratio may not be age related, and the present study did not 
find any such relationship. In the present study there were too few NIDDM subjects for 
subgroup analysis, but compared to the reference group (BMI <25 kg/m^), the odds 
ratios for respiratory symptoms and cardiovascular risk factors in the overweight (BMI 
25-30 kg/m^ or >30 kg/m^) remained similar’ in different age bands. In the absence of 
directly comparable data in elderly subjects it therefore seems reasonable to apply 
standard figures of odds ratios for men and women, of all ages. Table 6.1.7 shows the 
population attributable risks based on BMI 25 and 30 kg/m^, providing standard values 
for estimating excess costs of ill health due to overweight.
CONCLUSIONS
The results of this study provide justification for using BMI 25 and 30 k g W  as cut-offs 
to indicate medical concern for a range of complications. The data for the first time 
allow prediction of the burden of disease to be made in a consistent way using standard 
WHO (1995) cut-offs of BMI.
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Table 6.1.1. Characteristics of 5887 men and 7018 women.
Men Women
Mean SD Range Mean SD Range
Age (years) 42.9 10.7 20.3-60.0 42.2 1 1 . 0 20.2-59.9
Weight (kg) 82.0 1 2 . 0 44.4-157.0 68.5 11.5 36.6-153.0
Height (cm) 178.4 7.3 152.0-210.0 165.7 6.7 134.5-190.0
Body mass index (kg/m^) 25.8 3.5 15.7-50.1 25.0 4.2 14.9-58.3
Waist circumference (cm) 92.3 1 0 . 8 64.0-155.0 81.0 1 1 . 1 56.5-150.0
Hip circumference (cm) 1 0 1 . 8 6 . 6 69.0-150.0 1 0 2 . 2 8.4 76.4-165.0
Waist to hip ratio 0.905 0.072 0.621-1.369 0.791 0.070 0.567-1.302
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Table 6.1.2. Unadjusted prevalence in total population of 5887 men and 7018 women 
(1885 men and 2156 women had information on quality of life) with clironic disease, 
symptoms and poor quality of life.
Men
% 95% Cl
Women
% 95% Cl
Respiratory symptoms
Wheezing when not having a cold 9.2 8.5, 10.0 8.4 7.7, 9.2
Woken up by shortness o f breath 5.0 4.4, 5.6 6 . 1 5.5, 6.7
Coughing for more than 3 months 7.7 7.0, 8.4 7.5 6 .8 , 8 . 2
Bring up phlegm for more than 3 months 6 . 8 6.2, 7.5 5.0 4.3, 5.6
Shortness of breath when walking uphill/stairs 16.0 15.1, 17.0 24.7 23.7, 25.6
Shortness of breath when walking with others 4.6 4.0, 5.1 7.4 6.9, 7.9
Cardiovascular risk factors
High total cholesterol (>6.5 mmol/1) 14.6 13.7, 15.5 13.5 12.7, 14.3
Low HDL-cholesterol (<0.9 mmol/1) 21.3 20.3, 22.3 5.1 4.6, 5.6
Hypertension* 10.3 9.5, 11.1 8.3 7.7, 8.9
At least one risk factor 38.0 36.8,39.3 23.5 22.5, 24.5
Diabetes
Non-insulin dependent diabetes mellitus 1 . 6 1.3, 1.9 0.9 0.7, 1.2
Symptoms o f  low back pain
Clironic low back pain (total >12 weeks/year) 16.6 15.6, 17.6 20.5 19.6,21.4
Symptoms of intervertébral disc hermiation 13.4 12.5, 14.3 17.6 16.7, 18.4
‘Poor ' quality o f  life 
Difficulties in physical functioning
Vigorous activities! 50.1 47.8, 52.4 54.0 51.7,56.3
Moderate activities! 13.7 12.1, 15.3 24.1 22.5, 25.7
Lifting/carrying groceries! 17.5 15.8, 19.3 32.6 30.8, 34.3
Walking several flights of stairs! 15.8 14.1, 17.4 2 2 . 2 20.5, 23.9
Walking one flight of stairs! 6.4 5.2, 7.5 8.9 7.8, 10.0
Bending, kneeling! 25.4 23.4, 27.4 28.2 26.2, 30.2
Walking more than a mile! 15.2 13.5, 16.8 18.4 16.7, 20.0
Walking several blocks! 8 . 0 6 .8 , 9.3 9.4 8.2, 10.7
Walking one block! 5.5 4.4, 6.5 6.5 5.4, 7.5
Bathing or dressing! 4.0 3.1, 4.9 3.1 2 .2 , 4.0
‘Poor’ physical functioning concept! 8.4 7.2, 9.7 1 0 . 8 9.5, 12.0
* Systolic >160 or diastolic blood pressure >95 mmHg or medication for hypertension; fsingle items of
physical functioning concept; $<66.7% standardised scores.
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Table 6.1.3a. Unadjusted prevalence of subjects with chronic disease, symptoms and 
poor quality of life in different categories of body mass index, in men.
Men Body mass index (kg/mQ
<25 25-30 >30 X
Proportions of subjects (44.0) (10.8)
Respiratory symptoms
Wheezing when not having a cold 8.5 9.3 1 2 . 1 7.9*
Woken up by shortness of breath 4.6 5.1 6.5 4.0
Coughing for more than 3 months 7.9 7.6 7.4 0 . 2
Bring up phlegm for more than 3 months 6 . 6 6 . 8 7.7 0.9
Shortness of breath when walking uphill/stairs 1 1 . 2 16.4 34.3 203.3***
Shortness of breath when walking with others 3.1 4.3 113
Cardiovascular risk factors
High total cholesterol (>6.5 mmol/1) 9.4 17.2 24.6 1 2 2 .0 ***
Low HDL-cholesterol (<0.9 mmol/1) 13.5 24.5 39.7 239.0***
Hypertension! 3.7 13.1 25.7 308.4***
At least one risk factor 23.6 45.1 66.9 510.2***
Diabetes
Non-insulin dependent diabetes mellitus 0 . 6 1 . 8 4.7
Low back pain
Chronic low back pain (total >12 weeks/year) 14.5 17.9 2 0 . 0 17.1***
Symptom of intervertébral disc hermiation 10.9 15.0 16.4 24.6***
‘Poor ’ quality o f  life 
Difficulties in physical functioning
Vigorous activities! 43.9 52.1 66.4 36.0***
Moderate activities! 1 0 . 8 14.8 20.4 14.7***
Lift/carry groceries! 14.2 18.4 26.5 18.6***
Walking several flights of stairs! 1 0 . 8 16.9 30.8 52.0***
Walking one flight of stairs! 5.3 6 . 1 11.9 12.4***
Bending, kneeling! 20.9 24.7 45.5 53.8***
Walking more than a mile! 11.5 15.9 26.1 28.4***
Walking several blocks! 5.8 8.7 14.2 17.2***
Walking one block! 4.7 5.0 10.4 11.4***
Bathing or dressing! 2.9 4.1 8 . 1 11.4***
‘Poor’ physical functioning concept§ 5.3 9.1 18.0 36.2***
<0.001, **P  <0.01, <0.05; ! systolic >160 or diastolic blood pressure >95 mmHg or medication
for hypertension; Jsingle items of physical functioning concept; §<66.7% standardised scores.
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Table 6.1.3b. Unadjusted prevalence of subjects with symptoms of disease and poor 
quality of life in categories of body mass index, in women.
Women
Proportions of subjects
Body mass index (kg/m ) 
<25 25-30 >30 
(58.1) (30.6) (11.4)
X
Respiratory symptoms
Wheezing when not having a cold 7.1 9.2 13.3 35.8***
Woken up by shortness of breath 5.1 7.4 8 . 2 19.6***
Coughing for more than 3 months 6 . 2 8.9 10.7 27.6***
Bring up phlegm for more than 3 months 4.2 5.4 7.6 ly  y***
Shortness of breath when walking uphill/stairs 18.4 28.5 46.4 304.8***
Shortness of breath when walking with others 4.5 9.5 19.6 226.9***
Cardiovascular risk factors
High total cholesterol (>6.5 mmol/1) 9.4 19.1 19.8 143.4***
Low HDL-cholesterol (<0.9 mmol/1) 3.4 5.8 1 1 . 8 1 0 1 .8 ***
Hypertension! 3.9 1 0 . 6 24.6 395.8***
At least one risk factor 15.4 30.8 45.4 424.2***
Diabetes
Non-insulin dependent diabetes mellitus 0.4 1 . 0 3.8 82.4***
Low back pain
Clii'onic low back pain (total >12 weeks/year) 17.8 24.2 24.7 44 9*%^
Symptom of intervertébral disc hermiation 14.9 2 0 . 0 25.1 59 9* :^*
‘Poor ’ quality o f  life 
Difficulties in physical functioning
Vigorous activities! 47.9 60.3 72.4 60.6***
Moderate activities! 18.4 31.7 36.0 60.7***
Lift/carry groceries! 25.7 40.9 49.1 76.1***
Walking several flights of stairs! 16.2 28.4 39.5 80.6***
Walking one flight of stairs! 5.4 1 1 . 6 21.5 69.7***
Bending, kneeling! 20.7 36.7 48.3 103.3***
Walking more than a mile! 14.4 2 1 . 8 31.6 45.4***
Walking several blocks! 6.7 11.3 2 0 . 2 45.2***
Walking one block! 4.5 7.3 15.4 38.8***
Bathing or dressing! 2 . 8 2.9 5.7 5.7
‘Poor’ physical fimctioning concept§ 7.1 14.1 2 2 . 8 59.6***
***p  <0.001, **P <0.01, *P <0.05; fsystolic >160 or diastolic blood pressure >95 mmHg or medication
for hypertension; $single items of physical functioning concept; §<66.7% standardised scores.
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Table 6.1.4a. Odds ratios for clironic disease, symptoms and poor quality of life in 
categories of body mass index, adjusted for age and lifestyle factors (see Appendix 
6 .1 .1 ), in men.
Men Body mass index (kg/m^)
25-30 >30
ORt 95% Cl O Rt 95% Cl
Respiratory symptoms
Wheezing when not having a cold 1.14 0.94, 1.40 1.50** 1.13,2.01
Woken up by shortness of breath 1.04 0.80, 1.35 1 . 2 2 0.84, 1.79
Coughing for more than 3 months 0.98 0.79, 1.21 0 . 8 8 0.62, 1.25
Bring up phlegm for more than 3 months 1 . 0 0 0.79, 1.25 1.06 0.75, 1.50
Shortness of breath when walking uphill/stairs 1.43*** 1.20, 1.69 3.51*** 2.82, 4.38
Shortness of breath when walking with others 1.18 0.87, 1.59 2.85*** 2.01,4.04
Cardiovascular risk factors
High total cholesterol (>6.5 mmol/1) 1.58*** 1.33, 1.88 2 .2 2 *** 1.76, 2.81
Low HDL-cholesterol (<0.9 mmol/1) 2.26*** 1.94, 2.63 4.78*** 3,87, 5.90
Hypertension:); 2.89*** 2.27, 3.68 5.88*** 4.43, 7.79
At least one risk factor 2.37*** 2.09, 2.69 5.45*** 4.48, 6.63
Diabetes
Non-insulin dependent diabetes mellitus 1.98* 1.10,3.60 2.41,8.78
Low back pain
Clii'onic low back pain (total >12 weeks/year) 1 . 0 2 0 .8 8 , 1 . 2 0 1.05 0.83, 1.32
Symptom of intervertébral disc hermiation 1.31 0.95, 1.34 1 . 1 2 0.87, 1.44
‘Poor ' quality o f  life 
Difficulties in physical functioning
Vigorous activities § 1.13 0.92, 1.40 1.78*** 1.27, 2.51
Moderate activities § 1.15 0.83, 1.58 1.38 0.89, 2.14
Lift/carry groceries § 1.06 0.80, 1.42 1.42 0.96, 2.11
Walking several flights of stairs § 1.44* 1.05, 1.96 2 .6 8 *** 1.79,4.00
Walking one flight of stairs§ 0 . 8 6 0.55, 1.36 1.46 0.83,2.58
Bending, kneeling § 0.95 0.74, 1.22 2  \ 1.54,3.06
Walking more than a mile§ 1.33 0.98, 1.81 2.16*** 1.44,3.24
Walking several blocks § 1.26 0.84, 1.90 1.84* 1.08,3.12
Walking one block§ 0 . 8 6 0.53, 1.40 1 . 6 8 0.92, 3.04
Bathing or dressing§ 1.15 0.65, 2.02 1.97 0.99, 3.92
‘Poor’ physical functioning concept# 1.36 0.88, 2.09 2.55*** 1.51,4.30
<0.001, **P <0.01, *P <0.05; |'odds ratio with reference to body mass index <25; Jsystolic >160 or
diastolic blood pressure 2:95 mmHg or medication for hypertension; §single items of physical functioning
concept; #<66.7% standardised scores.
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Table 6.1.4b. Odds ratios for ciironic disease, symptoms and poor quality of life in 
categories of body mass index, adjusted for age and lifestyle factors (see Appendix
6.1.1), in women.
Women Body mass index (kg/m )
25-30 >30
ORt 95% Cl ORt 95% Cl
Respiratory symptoms
Wheezing when not having a cold 1.35** 1.11, 1.65 \ qq*** 1.55,2.57
Woken up by shortness of breath 1.41** 1.23, 1.77 1.47** 1.08, 1.99
Coughing for more than 3 months 1.46*** 1.89, 1.80 1.64*** 1.25,2.17
Bring up phlegm for more than 3 months 1.24 0.96, 1.60 1.69** 1.22, 2.34
Shortness of breath when walking uphill/stairs 1.61*** 1.41, 1.83 3.27*** 2.76,3.89
Shortness of breath when walking with others 1.91*** 1.54, 2.37 3.89*** 3.04, 4.97
Cardiovascular risk factors
High total cholesterol (>6.5 mmol/1) 1.52*** 1.29, 1.79 1.38** 1.10, 1.72
Low HDL-cholesterol (<0.9 mmol/1) 1.67*** 1.29,2.17 2.30*** 2.45, 4.44
Hypertension^ 1.95*** 1.57,2.43 4.75*** 3.72, 6.07
At least one risk factor 1.72*** 1.50, 1.97 2.87*** 2.40,3.43
Diabetes
Non-insulin dependent diabetes mellitus 1.67 0.84,3.31 5.38*** 2.77, 10.4Ê
Low back pain
Chronic low back pain (total >12 weeks/year) 1 .2 0 ** 1.05, 1.36 1.14 0.95, 1.37
Symptom of intervertébral disc hermiation 1.17* 1.01, 1.35 1.48*** 1.22, 1.79
Poor ’ quality o f  life 
Difficulties in physical functioning
Vigorous activities § 1.35** 1.10, 1.67 2.06*** 1.48, 2.87
Moderate activities § 1.52*** 1.19, 1.92 1.48* 1.06, 2.07
Lift/caiiy groceries§ 1.42** 1.14, 1.77 1.62** 1.19, 2.22
Walking several flights of stairs § 1.64*** 1.28, 2.09 2.26*** 1.63,3.13
Walking one flight of stairs § 1 .6 6 ** 1.16,2.39 2.81*** 1.83,4.13
Bending, kneeling§ 1 .6 8 *** 1.34, 2.10 2.28*** 1.67,3.12
Walking more than a mile§ 1.41** 1.08, 1.83 1.96*** 1.39, 2.76
Walking several blocks § 1.47* 1.03,2.09 2.38*** 1.58,3.63
Walking one block§ 1 . 2 2 0.80, 1.87 2.36*** 1.45,3.83
Bathing or dressing § 0.80 0.43, 1.48 1.60 0.77,3.30
‘Poor’ physical functioning concept# 1.61** 1.15,2.24 2.41*** 1.60,3.63
***P <0.001, **P <0.01, *P <0.05; fodds ratio with reference to body mass index <25; $ systolic >160 or
diastolic blood pressure >95 mmHg or medication for hypertension; §single items of physical functioning
concept; #<66.7% standardised scores.
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Table 6.1.5. Prevalence of subjects whose daily life were affected due to low back pain 
in the past twelve months {n = 2467 men, 3448 women) in different categories of body 
mass index, adjusted for age, smoking and education.
Men Women
Body mass index (kg/nV) Body mass index (kg/m^)
<25 25-30 >30 <25 25-30 >30
Proportions (% )t (42.1) (46.2) (11.7) (56.0) (31.9) ( 1 2 .2 )
Daily business hindered 28.2 27.4 34.9* 25.3 30.2** 32.3**
Absence from work 25.4 23.0 27.6 18.8 23.2* 28.4**
Medical consultation 39.3 40.9 40.5 39.6 44.7** 45.7**
Job redundancy 1 1 . 2 1 2 . 2 15.2 8 . 2 9.2 10.9
Job modification 8.7 8.3 8.7 7.0 7.7 3.2*
mass index category.
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Table 6.1.6a. Odds ratios of symptoms of chi’onic diseases and poor subjective health in 
different categories o f body mass index, adjusted for age and lifestyle factors (see 
Appendix 6.1.1), in men.
Men Body mass index
>25 >30
ORt 95% Cl ORtt 95% Cl
Respiratory symptoms P = 0.560:1: P - 0.108:):
Wheezing when not having a cold 1 .2 2 » 1.01, 1.48 1.39* 1.07, 1.82
Woken up by shortness of breath 1.07 0.84, 1.38 1 . 2 0 0.84, 1.69
Coughing for more than 3 months 0.97 0.78, 1.19 0.89 0.65, 1.24
Bring up phlegm for more than 3 months 1 . 0 1 0.81, 1.25 1.07 0.78, 1.47
Shortness of breath when walking uphill/stairs 1.76 1.50,2.07 2.83*** 2.34,3.44
Shortness of breath when walking with others 1.50 1.13, 1.98 2.57*** 1.9.1,3.45
Cardiovascular risk factors P = 0.560:1: P = 0.108:):
High total cholesterol 1.69»»» 1.43,2.00 1.67*** 1.36, 2.04
Low HDL-cholesterol 2.62*** 2.26, 3.03 2 .8 8 *** 2.40, 3.46
Hypertension 3.42»»» 2.71,4.31 2  yq*** 2.26,3.45
At least one risk factor 2.75*** 2.44,3.10 3.25*** 2.71,3.89
Diabetes P =: 0.560:): P = 0.108$
Non-insulin dependent diabetes mellitus 2.51*** 1.42, 4.44 2.82*** 1.78,4.46
Symptoms o f  low back pain P == 0.560 P == 0.108
Chronic low back pain (total >12 weeks/yeai’) 1.03 0.89, 1.19 1.03 0.83, 1.28
Symptom of intervertébral disc hermiation 1.13 0.96, 1.33 1.04 0.82, 1.30
‘Poor ’ quality o f  life 
Difficulties in physical functioning
P == 0.566* P == 0 . 1 1 2 :):
Vigorous activities § 1.23* 1.00, 1.50 1 .6 6 ** 1.21,2.28
Moderate activities § 1.19 0 .8 8 , 1.62 1.27 0.85, 1.88
Lifting carrying groceries§ 1.13 0.86, 1.49 1.37 0.96, 1.96
Walking several flights of stairs§ 1 .6 6 *** 1.24, 2.23 2.15*** 1.51,3.04
Walking one flight of stairs § 0,99 0.64, 1.52 1.60 0.97, 2.64
Bending, kneeling§ 1.14 0.90, 1.44 2.23*** 1.64,3.05
Walking more than a mile§ 1.49** 1.11, 1.98 1.82** 1.27, 2.60
Walking several blocks§ 1.38 0.93,2.04 1.59* 1.01,2.52
Walking one block§ 1.03 0.65, 1.61 1.83* 1.08,3.09
Bathing or dressing§ 1.32 0.78, 2.24 1.81* 1.01,3.25
‘Poor’ physical frinctioning concept^ 1.60* 1.06, 2.40 2 .1 0 ** 1.35,3.26
***p  <0.001, **P  <0.01, *P<0.05; odds ratio with reference to body mass index group fbelow  25 and 
tjb e lo w  30 kg/m^; ;|:P = proportion o f  subjects ‘exposed’ to the risk o f  overweight; §single items o f  
physical functioning concept; %<66.7% standardised scores.
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Table 6.1.6b. Odds ratios of symptoms of chronic diseases and poor subjective health in 
different categories of body mass index, adjusted for age and lifestyle factors (see 
Appendix 6.1.1), in women.
Women Body mass index
>25 >30
ORt 95% Cl ORtt 95% Cl
Respiratory symptoms P = 0.419} P = 0.114}
Wheezing when not having a cold 1.52*** 1.27, 1.82 1.75*** 1.38, 2 . 2 2
Woken up by shortness of breath 1.44*** 1.16, 1.77 1.25 0.94, 1.67
Coughing for more than 3 months 1.52*** 1.25, 1.84 1.39* 1.07, 1.80
Bring up phlegm for more than 3 months 1.34*** 1.08, 1.73 1.55** 1.15, 2.09
Shortness of breath when walking uphill/stairs 1.96*** 1.74, 2 . 2 1 2.62*** 2.23, 3.07
Shortness of breath when walking with others 2.40*** 1.97, 2.92 2.81*** 2.27, 3.48
Cardiovascular risk factors P = 0.419} P = 0.114}
High total cholesterol 1.48*** 1.27, 1.72 1 . 1 0 0.90, 1.35
Low HDL-cholesterol 2 .1 1 *** 1 .6 6 , 2.67 :L56*** 1.96, 3.33
Hypertension 2.59*** 2 . 1 2 , 3.17 3.31*** 2.70, 4.07
At least one risk factor 1,98*** 1.74, 2.24 2 .2 1 *** 1.87, 2.61
Diabetes P = 0.419} P = 0.114}
Non-insulin dependent diabetes mellitus 2.71*** 1.48, 4.96 4.04*** 2.41, 6.75
Symptoms o f  low back pain P = 0.419} P = 0.114}
Clironic low back pain (total >12 weeks/year) 1.19** 1.05, 1.35 1.05 0 .8 8 , 1.26
Symptom of intervertébral disc hermiation 1.25** 1.09, 1.42 1.38*** 1.15, 1.64
Poor ’ quality o f  life P = 0.395} P = 0.106}
Difficulties in physical functioning
Vigorous activities § 1.50*** 1.23, 1.81 1.84*** 1.33, 2.53
Moderate activities§ 1.51*** 1 .2 1 , 1 . 8 8 1.24 0.90, 1.70
Lifting carrying groceries § 1 .2 0 , 1.80 1.40* 1.04, 1.90
Walking several flights of stairs# pyq*** 1.43, 2.24 1.82*** 1.34, 2.48
Walking one flight of stairs# j qy*** 1.42, 2.74 2 .2 0 *** 1.50, 3.24
Bending, kneeling# 1.82*** 1.48, 2.24 1.83*** 1.36, 2.47
Walking more than a mile# 1.55*** 1 .2 2 , 1.96 1.69* 1 .2 2 , 233
Walking several blocks# 1.71*** 1.25, 2.35 2 .0 0 *** L36, 2.95
Walking one block# 1.53** 1.05, 2 . 2 2 2.16*** 1.39, 3.36
Bathing or dressing# 1 . 0 0 0.59, 1.70 1.75 0 .8 8 , 3.46
‘Poor’ physical functioning concept^ 1.82*** 1.34, 2.47 \ qq**$ 1.33, 2.82
***p  <0.001, **P <0.01, *jP<0.05; odds ratio with reference to body mass index group fbelow  25 and 
ttb e lo w  30 kg/m^; $P = proportion o f  subjects ‘exposed’ to the risk o f  overweight; §single items o f  
physical functioning concept; ^<66.7% standardised scores.
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Table 6.1.7. Population attributable risks of ill health due to overweight.
Population attributable risk (%) 
WomenMen
>25* >30 A A >25* >30 AA
Respiratory symptoms
Wheezing when not having a cold 1 1 . 0 4.0 17.9 7.8
Woken up by shortness of breath 3.8 2 . 1 15.6 2 . 8
Coughing for more than 3 months NA NA 17.9 4.3
Bring up phlegm for more than 3 months 0 . 6 0 . 8 12.5 5.9
Shortness of breath when walking uphill/stairs 29.9 16.5 28.7 15.6
Shortness of breath when walking with others 21.9 14.5 37.0 17.1
Cardiovascular risk factors
High total cholesterol 27.9 6 . 8 16.7 1 . 1
Low HDL-cholesterol 47.6 16.9 31.7 15.1
Hypertension 57.5 16.2 40.0 2 0 . 8
At least one risk factor 49.5 19.6 29.1 1 2 . 1
Diabetes
Non-insulin dependent diabetes mellitus 45.8 16.4 41.7 25,7
Symptoms o f  low back pain
Clironic low back pain (total >12 weeks/year) 1.7 0.3 7.4 0 . 6
Symptom of intervertébral disc hermiation 6 . 8 0.4 9.5 4.2
Poor ’ quality o f  life 
Difficulties in physical functioning\
Vigorous activities} 11.5 6.9 16.5 8 . 2
Moderate activities} 9.7 2.9 16.8 2.5
Lifting carrying groceries} 6.9 4.0 15.7 4.1
Walking several flights of stairs} 27.2 11.4 23.8 8 . 0
Walking one flight of stairs} NA 6.3 27.7 11.3
Bending, kneeling} 7.3 1 2 . 1 24.5 8 . 1
Walking more than a mile} 21.7 8.4 17.9 6 . 8
Walking several blocks} 17.7 6 . 2 21.9 9.6
Walking one block} 1.7 8.5 17.3 1 1 . 0
Bathing or dressing} 15.3 8.3 0 . 0 7.4
‘Poor’ physical functioning concept} 25.4 1 1 . 0 24.5 9.1
N A  = not applicable as OR <1; reference group with body mass index * below 25 and **below 30 kg/m ; 
fsingle items o f physical functioning concept; %<66.1% standardised scores.
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Figure 6.1.1. Age adjusted prevalence of shortness of breath when walking uphill or 
upstairs in smokers and non-smokers in different categories of body mass index based 
on the WHO (1995) standard cut-offs, in men (a) and in women (b).
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Figure 6.1.2. The proportions of subjects whose daily activities were affected by low 
back pain in the past twelve months.
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Figure 6.1.3. Odds ratios for poor physical functioning (standardised scores <66.7%) in 
men (a) and women (b) in different categories of body mass index based on the standard 
WHO (1995) cut-offs. Odds ratios adjusted for age, lifestyle and demographic factors.
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Appendix 6.1.1. Age, lifestyle and demographic factors as possible confounders 
considered in analysis of the associations of symptoms of clnonic disease and impaired 
quality of life with body mass index.
Reference group Dummy variables ' 1
1 2 3 1
Age (years)^’*’’^ ’^ ’^ 20-29 30-39 40-49 50-59
Smoking"^'"’*'’''’" Non-smokers Ex-smokers Current smokers
Alcohol consumption 
(glasses/day)^’'’’‘^’®
Occasional
(< 1 )
None
(0 )
Moderate 
(1 to <3)
Heavy
(>3)
Physical activity Active 
(do sport)
Inactive 
(do no sport)
Educational level Level 3
(higher vocational 
or university)
Level 2 Level 1 
(vocational or (lower than 
higher secondary) secondary)
Marital status^ Single Married or 
cohabiting
Divorced or 
widowed
Employment'^ Currently
employed
Unemployed Housewives Retired
early
Household
composition*^
Living with 
someone
Living with no 
one
Intimate contactf^ No one 1 - 2 3-5 > 6
Parity (live births)*^ None 1 - 2 >3
diabetes, ‘ low back pain, and Equality o f  life; fdiscussing personal matters with other people.
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6.2
IMPAIRMENT OF HEALTH AND QUALITY OF LIFE FROM 
ABDOMINAL FAT ACCUMULATION, USING WAIST 
CIRCUMFERENCE ‘ACTION LEVEL’
This section has been submitted for publication as
Han TS. Lean MEJ, Seidell JC. Impairment of health and quality of life from 
abdominal fat accumulation, using waist circumference Action Levels, 
(submitted).
Collaboration with MORGEN project
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ABSTRACT
Objective', To estimate the prevalence and risks of clii'onic disease, secondary symptoms 
and poor quality of life associated with waist circumference, using standardised cut-offs. 
Design'. Cross-sectional study in a random sample set in the Netherlands.
Subjects'. 5887 men and 7018 women aged 20-59 years selected from the civil registiy of 
Amsterdam, Maastricht and Doetinchem.
Main outcome measures'. Symptoms of respiratory insufficiency, low back pain, non­
insulin-dependent diabetes, cardiovascular risk factors, and physical functioning.
Results'. People with waist below Action Level 1 (<94 cm in men, <80 cm in women) 
were considered the reference population with low prevalence of symptoms of obesity 
related diseases and good subjective health. Between Action Level 1 and Action Level 
2: 94-102 cm in men, 80-88 cm in women), the prevalence of these all increase, and 
above Action Level 2 (>102 cm in men, > 8 8  cm in women) greatly increased. After 
adjustments for age and lifestyle factors, odds ratios (95% confidence intervals) in those 
with a waist above Action Level 2 were 3.1 (2.5 to 3.7) in men and 2.7 (2.3 to 3.1) in 
women for shortness of breath when walking upstairs, 4.5 (2.5 to 7.8) in men and 3.8 
(1.9 to 7.3) in women for non-insulin-dependent diabetes, 4.2 (3.6 to 5.0) in men and 2.8 
(2.4 to 3.2) in women for at least one major cardiovascular risk factor. Both men and 
women with waist above Action Level 2 were twice more likely to have difficulties in 
performing a range of basic activities of daily living. Women with waist above Action 
Level 2 were 1.5 times more likely to have low back pain for a total >12 weeks a year or 
symptoms of intervertébral disc herniation, and significantly more of them had problems 
associated with low back pain including hindrance to their daily business, absence from 
work, medical consultation, and job redundancy. The calculated population attributable 
risks to estimate the excess risk of ill health attributable to waist above the Action 
Levels were between 10-40%.
Conclusions'. Symptoms and secondary diseases related to lai’ge waist share a huge 
health cai’e expenditure, demanding major health promotion programme. The data justify 
the employment of Action Levels of waist circumference for health promotion.
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INTRODUCTION
National health burdens are aggravated by clusters of secondary symptoms associated 
with overweight and adverse fat distribution, including coronary heart disease, strokes, 
non-insulin dependent diabetes mellitus (NIDDM), and several cancers. Recent 
estimates costs per aimum for treating this ill health were 195 million pounds in Britain 
(Office of Health Economics, 1994), and 70 billion dollars in the United States (Institute 
of Medicine, 1995). These figures present major concerns to the health service, since the 
prevalence of overweight is still rising in many countries (Kuczmarski, 1992, Seidell 
1995a; Bennett et al, 1995; Gregory et al, 1990).
From the ongoing MORGEN project (monitoring cardiovascular health in The 
Netherlands), we have shown that waist circumference, body mass index and waist to 
hip ratio all relate closely and similarly to a variety of symptoms of cluonic diseases 
(Chapter 5). For the purpose of public health promotion. Action Levels of waist 
circumference, based on body mass index and waist to hip ratio have been derived as a 
simpler method of risk assessment than by attempting to combine these two rather 
complex indices (Chapter 3.1; Lean et al, 1995). Waist does not need to adjusted for 
height as an index of adiposity and fat distribution (Chapter 4.3; Han et al, 1997c), 
although height may have separate association with health.
The present study summarised the risks of symptoms from major clironic diseases and of 
poor subjective health in relation to waist circumference categories based on the 
previously derived Action Levels (Chapter 3.1; Lean et al, 1995).
METHODS 
Subjects
Dutch men (n = 5887) and women (% = 7018) aged 20-59 were recruited randomly from 
civil registries for the ongoing MORGEN (Monitoring Risk Factors and Health in The 
Netherlands) project 1993 to 1995 cohorts, from Amsterdam, Maastricht, and 
Doetinchem. To obtain similar numbers of subjects at each age, the sample was
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stratified by sex and five year age group. The response rate to invitations was about 
50%. Information on quality of life was available in the 1995 cohort of 1885 men and 
2156 women. The numbers of subjects in the present study represent those who attended 
the health centres for biochemical and physiological measui'cments.
Measurements
All measurements and questiomiaire assessment were performed by trained paramedical 
persomiel. Waist circumference was measured in duplicate at the level between the 
lowest rib margin and iliac crest (WHO, 1995).
Symptoms of disease
Major symptoms and diseases associated with overweight were selected from our 
previous studies (C hapter 5). Symptoms of respiratory insufficiency included shortness 
of breath, wheezing, coughing and bringing up phlegm (C hapter 5.4). Risk factors for 
cardiovascular disease included hypercholesterolaemia (plasma total cholesterol >6.5 
mmol/1), low high density lipoprotein cholesterol (<0.9 mmol/1) and hypertension 
(systolic blood pressure >160 mmHg and/or diastolic blood pressure >95 mmHg and/or 
the use of antihypertensive agent) (C hapter 5.2; Han et al, 1995c). Known and newly 
diagnosed (random blood glucose >11.1 mmol/1) NIDDM were included, and insulin 
treated patients were excluded as indistinguishable from insulin dependent diabetes 
mellitus (C hapter 5.5; Seidell et al, 1997). Symptoms of low back pain were obtained 
from questionnaire. Those who responded affirmatively to having low back pain in the 
past 12 months, were then asked whether they had radiating pain to the laiees or feet, to 
indicate symptoms o f  intervertébral disc herniation. This symptom was only accepted in 
the presence of low back pain, to avoid including those with other causes of radiated 
pain. The subjects were asked about the total duration of low back pain in the past 12 
months. Those who had low back pain for a total of twelve weeks or more were 
classified as having chronic low back pain. The reference groups for the three classes of 
low back pain were composed of those who did not fulfil the criteria for the symptom
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under analysis, thus the reference group when analysing one symptom included some 
subjects with other symptom(s) of low back pain (Chapter 5.3; Han et al, 1997d). From 
ten items rated by subjects using the standardised Dutch RAND-36 questionnaire, which 
has been adapted from the standardised SF-36 Health Survey the concept of physical 
functioning, was calculated to represent quality of life. Distributions of standardised 
scores were examined from the plots (not shown) to determine arbitrary cut-offs for the 
health concepts. It was decided arbitrarily that subjects with less than 66.7% o f  the 
standardised score would be classified as having a 'poor ’ health concept, and those with 
66.7% or above were considered as having a 'good’ health concept. This cut-off 
classified 8.4% of all men and 10.8% of all women as having ‘poor’ physical 
functioning. Each of the ten items comprising the physical functioning health concept 
was arbitrarily dichotomised such that scores above average (with an odd numbered 
scale of 3 or 5 points) were considered as 'good’ health, and average or lower scores 
were classed as 'poor ’ health. For items with even scale (2, 4 or 6  points), the scores for 
'good’ health and 'poor ’ health were evenly divided (C hapter 5.6).
Lifestyle and demographic factors as confounding factors
Dummy variables (Appendix 6.2.1) for possible confounding factors were created to 
adjust for the associations between adiposity and health concepts and individual items.
Statistical methods
Statistical analyses were performed using SAS version 6.1 (Cary, USA). Logistic 
regression analysis was used to estimate the odds ratios and 95% confidence intervals of 
symptoms of disease and ‘poor’ quality of life in those with waist circumference in the 
categories o f between ‘Action Level 1 and Action Level 2 (94-102 cm in men and 80-88 
cm in women) or above Action Level 2 (>102 cm in men and > 8 8  cm in women), 
compaied to those with waist below Action Level 1 (<94 cm in men and <80 cm in 
women), adjusted for age, lifestyle and demographic factors (Appendix 6.2.1).
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Population attributable risks
The population attributable risk, i.e. the proportionate excess risk o f ill health associated 
with exposure to the risk of large waist based the waist circumference Action Level 1 
cut-off (PAR^li) was calculated as (Kahn and Sempos, 1989; Kleinbaum et al, 1982):
P A P - a l i  P a l i  ^  ( O R a l i  " I V P a l i  ^  ( C I R a l i  " 1 ) ]  ^ L  
where P^li is the proportion of subjects exposed to the risk of large waist circumferenee, 
i.e. all subjects with waist above Action Level 1, OR^^i is the age and lifestyle adjusted 
odds ratio for a symptom or disease in subject group with waist above Aetion Level 1 
compared to the reference group with waist below Action Level 1. Population 
attributable risk using waist circumference cut-off at Action Level 2 (PARal2 ) was 
calculated the same way, with the proportion of subjects exposed to waist above Action 
Level 2, and the odds ratios for a disease in subjects with waist above Aetion Level 2 
compared to the reference group with waist below Action Level 2. The difference 
between PARali and PARal2  gives PARali-al2  for waist circumference between Action 
Levels 1 and 2. This equation is valid only when the odds ratio is equal or greater than 1.
RESULTS
Characteristics of all subjects studied from 1993 to 1995 are shown in Table 6.2.1. The 
characteristics were similar each year’s cohort and are described elsewhere (Chapter 5).
The number of subjects and the overall prevalence for each symptom studied are 
presented in Table 6.2.2. The prevalence of symptoms and ‘poor’ quality of life rose 
with increasing waist circumference (Table 6.2.3). After adjustments for age and 
appropriate lifestyle factors, compared to those with waist below Aetion Level 1, those 
with waist above Action Level 2 were several times more likely to be at risk of poor 
health (Tables 6.2.4a & b).
Figures 6.2.1a & b show that within separate groups of non-smokers and smokers, the 
prevalence of those with shortness of breath when walking uphill or upstairs increased 
with increasing BMI, and significantly {P <0.001) higher in smokers for each level of
321
waist circumference. Figure 6.2.2 shows the proportions of subjects whose daily life 
activities were affected by low back pain. About a third of men and women reported 
that, due to low back pain, their daily business was hindered, they had to be absent from 
work, and more than foidy percent sought medical consultation as a result of low baek 
pain. Table 6.2.5 shows that after adjustments for age and lifestyle factors, the 
proportions of these consequences of low back pain were significantly higher in women 
with waist circumference above Action Level 2 compared to women below Action Level 
1. The proportion of job redundancy due to low back pain was significantly higher in 
men with waist circumference above Action Level 2 compaied to men below Action 
Level 1. Those with large waist circumference had lower scores for physical functioning 
(Figure 6.2.3) and the odds ratios (95% confidence interval limits) for ‘poor’ physical 
function health concept were two and half times higher in subjects with waist 
circumference above Action Level 2 compared to those below Action Level 1.
Tables 6.2.6 a & b show the proportions of subjects ‘exposed’ to large waist, with waist 
above Action Level 1 or Action Level 2, and the odds ratios for ill health. These values 
were used to calculate the population attributable risks for symptoms of disease and 
‘poor’ quality of life in those with waist circumference above Action Level 1 or above 
Action Level 2. The difference in population attributable risks between categories above 
Action Level 1 and above Action Level 2 is the population attributable risks for those 
with a waist circumference in between the two Action Levels.
Tables 6.2.6 a & b show the proportions of subjects ‘exposed’ to large waist, with waist 
circumference above Action Level 1 or Action Level 2, and the odds ratios for ill health. 
These values were used to calculate the population attributable risks for symptoms of 
disease and ‘poor’ quality of life in those with waist above Action Level 1 or Action 
Level 2. Table 6.2.7 shows that the excess proportions of subjects with poor health 
attributable to large waist (above Action Level 1) were approximately 10 to 40 percent. 
The difference in population attributable risks from categories of waist circumference 
Action Levels 1 and 2 is the population attributable risk for those with a waist between
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Action Level 1 to Action Level 2. This difference of population attributable risk was as 
high as the values for category above Action Level 2.
DISCUSSION
Body mass index has become the conventional index for classifying adiposity (WHO, 
1995), and we have analysed the present data set using conventional BMI cut-offs 
(Chapter 6.1). On the other hand, BMI is not a perfect index, since it still has some 
relationship with height (Chapter 4.3; Han et al, 1997c) and BMI fails to take account 
of fat distribution in its relationship with ill health. Waist circumference is an alternative 
measure with some advantages. It is now recognised that adverse central fat distribution 
has a separate impact on simiiai* health problems as overweight. The present study 
examined the relationships between several chronic diseases and quality life with waist 
circumference, which reflects both BMI and central fat deposition (Chapter 3.1; Lean et 
al, 1995). We have already shown that those with large waist (i.e. highest tertile) are at 
several times more at risk of symptoms of disease and having difficulty in perform basic 
daily activities, as assessed by quality of life (Chapter 5.6).
The present study has brought together data from analyses, several health associations 
and has applied standardised cut-off of waist circumference which we have previously 
defined as representing Action Levels for health promotion. Using waist circumference 
cut-offs, some 20% of adults exceed Action Level 2, and can be seen to need weight 
management. These include 90% of those with BMI >30 kg/m^ and also those with BMI 
25-30 who also have central fat distribution (Chapter 3.1; Lean et al, 1995). Chan et al 
(1994) have shown that compared to men in the lowest 20% of waist circumference 
(<34.5 inches), men in the top 20% of waist circumference (>40 inches) had age and 
lifestyle adjusted relative risk of 11 (95% confidence interval: 6  to 19) for developing 
NIDDM in a five year follow-up survey. This top quintile cut-off coincides with our 
Action Level 2. Standard cut-offs based on the Action Levels allow comparisons
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between studies, such as population attributable risks (Table 6.2.6) to highlight the 
excessive costs of adverse fat distribution in different populations.
Health Economic evaluations of overweight has been hampered by lack of consistent 
analyses using standai'dised criteria, and particularly criteria for the reference 
population. There is an additional practical problem in the need for accurate, calibrated 
equipment to measure height and weight in siu'veys. Given that waist circumference 
does not vary importantly with height as an index of adiposity (Chapter 4.3; Han et al, 
1997c), there are practical attractions to its use in health surveys.
In the present study, there were 24% men and 18% women with waist circumference 
above Action Level 2, who clearly had increased health problems of all kinds. There was 
also a significant, intermediate element of risk for those with waist circumference 
between Action Level 1 and Action Level 2 for many health problems. In this regard, 
waist circumference cut-offs can be seen to perform at least as well as the corresponding 
BMI cut-offs (25-30, >30 kg/m^). The grades of risk are similar for waist above Action 
Level 2 and BMI above 30 kg/m^ in both men and women for all the outcome measures. 
On the other hand, the range Action Level 1 to Action Level 2 several significant 
impairments of physical function in men, but not women whereas BMI 25-30 kg/m^ was 
associated with significantly impaired physical function in women but not in men. Odds 
ratios are likely to be overestimated if  the prevalence is high (Lee, 1994). Thus the 
results of some items of the physical functioning health concept (Tables 6.2.3a & b) in 
the present study should be interpreted with caution.
It is important that those with waist circumference above Action Level 2 should be 
urged to undergo screening for metabolic risks including hypertension, dislipidaemia 
and particularly NIDDM. It is a common knowledge that most people who have 
NIDDM are unaware of it (Harris et al, 1992), even with complications (UKPDS Group, 
1990). Table 6.2.7 shows the population attributable risks based on waist circumference
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Action Level 1 and Action Level 2, providing standard values for estimating excess 
costs of ill health due to overweight.
CONCLUSIONS
There is no strong a priori reason to prefer BMI or waist circumference for categorising 
adiposity or predict preventable ill health. There are some minor differences in the 
patterns of disease and symptoms associated with intermediate categories of BMI or 
waist circumference, but above Action Level 2 or BMI 30 kg/m^, a wide range of 
problems will have developed in a large population of adults. The greater number above 
Action Level 2 (20% of adults) than above BMI 30 kg/m^ (15%) reflects those with 
central fat distribution which BMI still in the range 25-30 kg/m^. The aims o f health 
promotion and of effective long term treatment should be to prevent progression into the 
highest categories, very substantial reductions in health care costs and social costs are 
likely if that is achieved.
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Table 6.2.1. Characteristics of 5887 men and 7018 women.
Men Women
Mean SD Range Mean SD Range
Age (years) 42.9 10.7 20.3-60.0 42.2 1 1 . 0 20.2-59.9
Weight (kg) 82.0 1 2 . 0 44.4-157.0 68.5 11.5 36.6-153.0
Height (cm) 178.4 7.3 152.0-210.0 165.7 6.7 134.5-190.0
Body mass index (kgW ) 25.8 3.5 15.7-50.1 25.0 4.2 14.9-58.3
Waist circumference (cm) 92.3 1 0 . 8 64.0-155.0 81.0 1 1 . 1 56.5-150.0
Hip circumference (cm) 1 0 1 . 8 6 . 6 69.0-150.0 1 0 2 . 2 8.4 76.4-165.0
Waist to hip ratio 0.905 0.072 0.621-1.369 0.791 0.070 0.567-1.302
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Table 6.2.2. Unadjusted prevalence in total population of 5887 men and 7018 women 
(1885 men and 2156 women had information on quality of life) with chronic disease, 
symptoms and poor quality of life.
Men
% 95% Cl
Women
% 95% Cl
Respiratory symptoms
Wheezing when not having a cold 9.2 8.5, 10.0 8.4 7.7, 9.2
Woken up by shortness o f breath 5.0 4.4, 5.6 6 . 1 5.5, 6.7
Coughing for more than 3 months 7.7 7.0, 8.4 7.5 6 .8 , 8 . 2
Bring up phlegm for more than 3 months 6 . 8 6.2, 7.5 5.0 4.3, 5.6
Shortness of breath when walking uphill/stairs 16.0 15.1, 17.0 24.7 23.7, 25.6
Shortness of breath when walking with others 4.6 4.0, 5.1 7.4 6.9, 7.9
Cardiovascular risk factors
High total cholesterol (>6.5 rmnol/1) 14.6 13.7, 15.5 13.5 12.7, 14.3
Low HDL-cholesterol (<0.9 mmol/1) 21.3 20.3, 22.3 5.1 4.6, 5.6
Hypertension* 10.3 9.5, 11.1 8.3 7.7, 8.9
At least one risk factor 38.0 36.8,39.2 23.5 22.5, 24.5
Diabetes
Non-insulin dependent diabetes mellitus 1 . 6 1.3, 1.9 0.9 0.7, 1.2
Symptoms o f  low back pain
Chr onic low back pain (total >12 weeks/year) 16.6 15.6, 17.6 20.5 19.6,21.4
Symptoms of intervertébral disc hermiation 13.4 12.5, 14.3 17.6 16.7, 18.4
'Poor ’ quality o f  life 
Difficulties in physical functioning
Vigorous activitiest 50.1 47.8, 52.4 54.0 51.7, 56.3
Moderate activities f 13.7 12.1, 15.3 24.1 22.5, 25.7
Lifting/canying groceriesj' 17.5 15.8, 19.3 32.6 30.8, 34.3
Walking several flights of stairsf 15.8 14.1, 17.4 2 2 . 2 20.5,23.9
Walking one flight of stairs')' 6.4 5.2, 7.5 8.9 7.8, 10.0
Bending, kneeling')' 25.4 23.4, 27.4 28.2 26.2, 30.2
Walking more than a mile')' 15.2 13.5, 16.8 18.4 16.7, 20.0
Walking several blocks')' 8 . 0 6 .8 , 9.3 9.4 8.2, 10.7
Walking one blockf 5.5 4.4, 6.5 6.5 5.4, 7.5
Bathing or dressing')' 4.0 3.1, 4.9 3.1 2.2, 4.0
‘Poor’ physical frinctioning concept:); 8.4 7.2, 9.7 1 0 . 8 9.5, 12.0
* Systolic >160 or diastolic blood pressure >95 mmHg or medication for hypertension; { single items of
physical functioning concept; :):<66.7% standardised scores.
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Table 6.2.3a. Unadjusted prevalence of subjects with clironic disease, symptoms and 
poor quality of life in categories of waist circumference Action Levels, in men.
Men Waist circumference (cm)
<94 94-102 > 1 0 2 X
Proportions of subjects (18.0)
Respiratory symptoms
Wheezing when not having a cold 8.5 9.1 11.9 11.3**
Woken up by shortness of breath 4.3 5.7 6.4 9.6**
Coughing for more than 3 months 7.2 8 . 2 8 . 8 3.4
Bring up phlegm for more than 3 months 6.3 7.2 8 . 0 4.1
Shortness of breath when walking uphill/stairs 10.4 17.1 31.5 261***
Shortness of breath when walking with others 2 . 8 4.7 1 0 . 0 97.1***
Cardiovascular risk factors
High total cholesterol (>6.5 mmol/1) 9.5 18.0 26.4 202.5***
Low HDL-cholesterol (<0.9 mmol/1) 15.3 26.5 33.5 192.1***
Hypertension! 4.7 12.3 25.3 382.8***
At least one risk factor 26.0 47.4 64.2 571.4***
Diabetes
Non-insulin dependent diabetes mellitus 0 . 6 1 . 8 4.5 82.8***
Low back pain
Chi'onic low back pain (total >12 weeks/year) 14.1 19.5 2 1 . 1 39.8***
Symptom of intervertébral disc hermiation 1 1 . 1 16.5 16.5 37.3***
'Poor ’ quality o f  life 
Difficulties in physical functioning
Vigorous activities:): 42.2 59.9 62.6 66.4***
Moderate activities:): 1 0 . 2 16.3 21.3 30.7***
Lift/carry groceries{ 13.7 2 0 . 2 2 & 2 31.3***
Walking several flights of stairsj 10.4 17.9 29.9 77.6***
Walking one flight of stairs J 4.7 5.7 1 2 . 6 28.8***
Bending, kneeling:}: 18.7 28.6 42.5 82.1***
Walking more than a mile:): 1 0 . 8 18.1 25.0 45.8***
Walking several blocks:): 4.9 9.3 16.1 46.0***
Walking one block:): 3.8 5.2 10.9 25.8***
Bathing or dressing:): 2.7 4.1 8 . 1 19.2***
‘Poor’ physical functioning § 4.8 1 0 . 2 17.5 57.4***
<0.001, **/* <0.01, *P <0.05; fsystolic >160 or diastolic blood pressure >95 mmHg or medication
for hypertension; :|:single items of physical functioning concept; §<66.7% standardised scores.
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Table 6.2,3b. Unadjusted prevalence of subjects with cluonic disease, symptoms and 
poor quality of life in categories of waist circumference Action Levels, in women.
Women Waist circumference (cm)
<80 80-88 > 8 8 X
Proportions of subjects (2 ^ . 0 (23.9)
Respiratory symptoms
Wheezing when not having a cold 7.1 8.5 11.3 27.2***
Woken up by shortness of breath 4.8 6.9 8 . 2 25.8***
Coughing for more than 3 months 6.3 7.5 10.3 27.2***
Bring up phlegm for more than 3 months 4.3 4.4 6.9 18.0***
Shortness of breath when walking uphill/stairs 17.4 25.5 39.4 300***
Shortness of breath when walking with others 4.5 7.9 14.6 166***
Cardiovascular risk factors
High total cholesterol (>6.5 nunol/1) 8 . 0 16.6 22.4 222.7***
Low HDL-cholesterol (<0.9 mmol/1) 3.2 4.4 9.9 108.7***
Hypertension! 3.2 7.6 19.9 414.8***
At least one risk factor 13.6 26.0 42.5 540.7***
Diabetes
Non-insulin dependent diabetes mellitus 0.4 0.5 2.7 y2
Low back pain
Chronic low back pain (total >12 weeks/yeai’) 16.5 2 2 . 8 26.9 83.3***
Symptom of intervertébral disc hermiation 14.4 18.0 24.1
'Poor ’ quality o f  life 
Difficulties in physical functioning
Vigorous activities! 46.9 55.2 6 8 . 8 6 8 .8 ***
Moderate activities! 17.6 24.9 37.8 79.8***
Lift/carry groceries! 25.2 33.5 48.0 83.5***
Walking several flights of stairs! 16.2 223 35.7 78.1***
Walking one flight of stairs! 5.6 8.4 16.8 54.7***
Bending, loieeling! 19.6 28.3 47.4 135***
Walking more than a mile! 14.0 18.9 27.7 44 5 * * *
Walking several blocks! 6.9 8 . 2 16.2 36.8***
Walking one block! 4.8 5.4 1 1 . 1 24.5***
Bathing or dressing! 2 . 8 3.0 3.9 1.5
‘Poor’ physical functioning § 7.1 1 0 . 0 19.7 59.1***
***/> <0.001, <0.01, <0.05; fsystolic >160 or diastolic blood pressure >95 mmHg or medication
for hypertension; ;j:single items o f  physical functioning concept; §<66.7% standardised scores.
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Table 6.2.4a. Odds ratios for cluonic disease, symptoms and poor quality o f life in 
categories of waist Action Levels, adjusted for age and lifestyle factors (see Appendix
6.2.1), in men.
Men Waist circumference
94-102 > 1 0 2
ORt 95% Cl ORt 95% Cl
1 . 1 0 0.88, 1.40 1.42** 1 . 1 1 , 1.80
1 . 2 2 0.91, 1.64 1.29 0.94, 1.77
1.14 0.89, 1.45 1 . 1 1 0.85, 1.45
1.07 0.83, 1.38 1 . 1 0 0.83, 1.46
1.50*** 1.24, 1.81 3.05*** 2.53, 3.67
1.37 0.98, 1.91 2.67*** 1.96, 3.64
Respiratory symptoms 
Wheezing when not having a cold 
Woken up by shortness of breath 
Coughing for more than 3 months 
Bring up phlegm for more than 3 months 
Shortness of breath when walking uphill/stairs 
Shortness o f breath when walking with others
Cardiovascular risk factors
High total cholesterol (>6.5 mmol/1) 1.55*** 1.28, 1 . 8 6 2.35*** 1.94,2.85
Low HDL-cholesterol (<0.9 mmol/1) 2.29*** 1.95, 2.70 3.28*** 2.75,3.92
Hypertension! 2 .0 0 *** 1.59, 2.52 4.29*** 3.43, 5.36
At least one risk factor 2.24*** 1.95,2.57 4.23*** 3.61,4.95
Diabetes
Non-insulin dependent diabetes mellitus 2.04* 1.11,3.76 q 45*** 2.54, 7.79
Low back pain
Chronic low back pain (total >12 weeks/year) 1.16 0.97, 1.37 1.17 0.97,1.41
Symptom of intervertébral dise hermiation 1 .2 2 * 1.01, 1.37 1 . 1 2 0.91,1.37 ,
'Poor ’ quality o f  life
Difficulties in physical functioning
Vigorous activities § 1.59*** 1.25,2.03 1.59*** 1.21,2.09
Moderate activities § 1.34 0.95, 1.90 1.57* 1.09,2.26
Lift/carry groceries § 1 . 2 0 0.88, 1.65 1.46* 1.05,2.03
Walking several flights of stairs § 1.47* 1.05,2.06 2.60*** 1.85,3.63
Walking one flight of stairs § 0 . 8 8 0.51, 1.49 1.82* 1.23,2.94
Bending, kneeling§ 1.31* 1.00, 1.73 2.26*** 1.69,3.01
Walking more than a mile§ 1 67** 1.20,2.32 2.28*** 1.62,3.22
Walking several blocks § 1.62* 1.03,2.56 2.63*** 1.69,4.11 ;
Walking one block § 1.18 0.67, 2.06 2.31** 1.38,3.86
Bathing or dressing§ 1.24 0.66, 2.33 2 .2 1 ** 1.23,3.99
‘Poor’ physical functioning# 1.75* 1.10,2.78 2.78*** 1.77,4.38
<0.001, <0.01, *P <0.05; fodds ratio with reference to waist circumference <94 cm (below
Action Level 1); Jsystolic >160 or diastolic blood pressure >95 mmHg or medication for hypertension;
§single items of physical functioning concept; #<66.7% standardised scores.
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Table 6.2.4b. Odds ratios for chi'onic disease, symptoms and poor quality of life in 
categories o f waist circumference Action Levels, adjusted for age and lifestyle factors, 
in women (see Appendix 6.2.1).
Women Waist circumference Action Levels
80-88 >88
ORt 95% Cl ORt 95% Cl
Respiratory symptoms 
Wheezing when not having a cold 
Woken up by shortness of breath 
Coughing for more than 3 months 
Bring up phlegm for more than 3 months 
Shortness of breath when walking uphill/stairs 
Shortness of breath when walking with others
Cardiovascular risk factors 
High total cholesterol (>6.5 mmol/1)
Low HDL-cholesterol (<0.9 mmol/1)
HypertensionJ
At least one risk factor
Diabetes
Non-insulin dependent diabetes mellitus
Low back pain 
Chronic low back pain (total >12 weeks/year) 
Symptom of intervertébral disc hermiation
‘Poor ’ quality o f  life 
Difficulties in physical functioning 
Vigorous activities §
Moderate activities §
Lift/carry groceries §
Walking several flights of stairs §
Walking one flight of stairs§
Bending, kneeling §
Walking more than a mile§
Walking several blocks§
Walking one block§
Bathing or dressing§
‘Poor’ physical functioning#
1 .2 3 0 .9 9 ,  1 .5 3 1 .6 4 * * * 1 .3 2 ,  2 .0 4
1 .4 7 * * 1 .1 4 ,  2 .1 5 1 .6 7 * * * 1 .3 0 ,  2 .1 5
1 .1 9 0 .9 4 ,  1 .5 0 1 .5 6 * * * 1 .2 4 ,  1 .9 7
0 .9 7 0 .7 2 ,  1 ,3 0 1 .4 6 * * 1 .1 1 ,  1 .9 2
1 .5 2 * * * 1 .3 1 ,  1 .7 5 2 .6 7 * * * 2 .3 2 ,  3 .0 9
1 .6 2 * * * 1 .2 7 ,  2 .0 6 2 .8 2 * * * 2 .2 5 ,  3 .5 3
1 .5 3 * * * 1 .2 7 ,  1 .8 4 1 .7 5 * 1 . 4 6 , 2 . 1 0
1 .4 6 * 1 .0 7 ,  1 .9 8 3 .3 4 * * * 2 .5 4 ,  4 .4 0
1 .5 7 * * * 1 . 2 1 , 2 . 0 5 3 .9 1 * * * 3 .1 0 ,  4 .9 4
1 .5 9 * * * 1 .3 7 ,  1 .8 6 2 .7 7 * * * 2 . 3 8 , 3 . 2 1
0 .8 4 0 .3 4 ,  2 .0 5 3 .7 6 * * * 1 .9 4 ,  7 .3 1
1 .2 6 * * * 1 .0 9 ,  1 .4 7 1 .4 1 * * * 1 .2 1 ,  1 .6 4
1 .0 9 0 .9 3 ,  1 .2 7 1 .4 1 * * * 1 .2 0 ,  1 .6 5
1 .1 4 0 .9 1 ,  1 .4 3 j y y * * * 1 .3 9 ,  2 .2 6
1 .1 8 0 .9 0 ,  1 .5 6 1 .7 6 * * * 1 . 3 5 , 2 . 3 0
1 .0 8 0 .8 4 ,  1 .3 9 1 .5 4 * * * 1 .2 1 ,  1 .9 8
1 .2 3 0 .9 3 ,  1 .6 3 2 .0 0 * * * 1 . 5 3 , 2 . 6 2
1 .1 9 0 .7 8 ,  1 .8 2 2 .0 3 * * * 1 .3 9 ,  2 .9 6
1 .2 9 * 1 .0 0 ,  1 .6 8 2 .4 3 * * * 1 . 8 9 , 3 . 1 2
1 .3 1 0 .9 8 ,  1 .7 6 1 .8 4 * * * 1 .3 8 ,  2 .4 5
1 .0 5 0 .7 0 ,  1 .5 9 1 .3 2 ,  2 .7 5
0 .9 0 0 .5 5 ,  1 .4 8 1 .5 4 * 1 .0 0 ,  2 .3 8
0 .9 1 0 .4 7 ,  1 .7 6 0 .9 7 0 .5 1 ,  1 .8 4
1 .1 7 0 .7 9 ,  1 .7 4 2 .1 0 * * * 1 . 4 8 , 3 . 0 0
<0.001, <0.01, *P <0.05; fodds ratio with reference to waist circumference <94 cm (below
Action Level 1); f  systolic >160 or diastolic blood pressure >95 inmHg or medication for hypertension;
§single items of physical functioning concept; #<66.7% standardised scores.
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Table 6.2.5. Proportions of subjects whose daily life were affected due to low back pain 
in the past twelve months {n ~ 2467 men, 3448 women) in different categories of waist 
circumference Action Levels, adjusted for age, smoking, and education.
Men Women
Waist circumference (cm) Waist circumference (cm)
<94 94-102 > 1 0 2 <80 80-88 > 8 8  ;
Proportions (%)f (56.6) (24.6) (18,8) (48.8) (25.1) (26.1)
Daily business hindered 28.0 27.4 32.0 25.9 26.8 32.0**
Absence from work 23.8 218 25.3 19.4 21.4 25.0*
Medical consultation 38.6 43.6* 40.6 39.7 41.7 46.3** f
Job redundancy 1 0 . 6 1 2 . 0 16.8** 7.4 8 . 6 1 1 .8 **
Job modification 8 . 2 7.4 1 0 . 8 7.2 6 . 6 6 . 2
Difference from waist <94 cm in men or <80 cm in women; <0.01, ^P <0.05; i'proportions o f
subjects in each waist circumference category.
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Table 6.2.6a. Odds ratios of symptoms of chronic diseases and poor subjective health in 
different categories of waist circumference Action Levels in men, adjusted for age and 
lifestyle factors (see Appendix 6.2.1).
Waist circumference
>94 (Action Level 1) >102 (Action Level 2)
ORt 95% Cl O R tt 95% Cl
Respiratory symptoms P = 0.421$ P = 0.180$
Wheezing when not having a cold 1.24* 1.02, 1.50 1.36** 1.09, 1.70
Woken up by shortness of breath 1.25 0.97, 1.61 1.18 0.89, 1.56
Coughing for more than 3 months 1 . 2 1 0.91, 1.39 1.06 0.82, 1.36
Bring up phlegm for more than 3 months 1.08 0.87, 1.35 1.08 0.83, 1.40
Shortness of breath when walking uphill/stairs 2.09*** 1.79, 2.45 2.57*** 2.18,3.04
Shortness of breath when walking with others 1.92*** 1.46, 2.54 2.33*** 1.79,3.05
Cardiovacular risk factors P = 0.421$ P = 0.180$
High total cholesterol 1 ,8 6 *** 1.59, 2.19 1.64,2.31
Low HDL-cholesterol 2 .6 6 *** 2.31,3.07 2.31*** 1.97,2.71
Hypertension 2.89*** 2.37, 3.52 3.08*** 2.56, 3.71
At least one risk factor 2.89*** 2.56, 3.25 3.06*** 2.65, 3.54
Diabetes P = 0.421$ P = 0.180$
Non-insulin dependent diabetes mellitus 3.10*** 1.83,5.24 3.08*** 2.00,4.72
Symptoms o f  low back pain P = 0.421$ P = 0.180$
Chronic low back pain (total >12 weeks/year) 1.16* 1.00, 1.35 1 . 1 0 0.93, 1.31
Symptom of intervertébral disc hermiation 1.17 1.00, 1.38 1.03 0.85, 1.24
‘Poor ’ quality o f  life P = 0.419$ P = 0.185$
Difficulties in physical functioning
Vigorous activities § 1.59*** 1.29, 1.96 1.34* 1.04, 1.74
Moderate activities § 1.45*** 1.08, 1.97 1.39 1.00, 1.94
Lifting carrying groceries§ 1.32* 1.01,1.73 1.36* 1.00, 1.84
Walking several flights of stairs § 1.92*** 1.44, 2.55 2 .2 0 *** 1.63,2.98
Walking one flight of stairs § 1.29 0.84, 1.96 1.92** 1.25,2.95
Bending, kneeling§ 1 .6 8 *** 1.33,2.12 2.03*** 1.56, 2.64
Walking more than a mile§ 1.91*** 1.44,2.54 1.84*** 1.35,2.50
Walking several blocks§ 2.05*** 1.39,3.01 2 .1 2 *** 1.44,3.13
Walking one block§ 1 .6 6 * 1.06,2.61 2.16*** 1.37,3.14
Bathing or dressing§ 1 . 6 6 0.99, 2.78 2 .0 2 *** 1.20,3.39
‘Poor’ physical functioning^ 2.19*** 1.48,3.25 2.15*** 1.46,3.18
***p <0.001, **P <0.01, *P <0.05; odds ratio with reference to waist fbelow Action Level 1 (<94 cm)
and tfbelow  Action Level 2 (<102 cm); JP = proportion of subjects ‘exposed’ to the risk of large waist
according to Action Levels; §single items of physical functioning concept; ^standardised scores <66.7%.
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Table 6.2.6b. Odds ratios o f symptoms of chronic diseases and poor subjective health in 
different categories of waist circumference Action Levels in women , adjusted for age 
and lifestyle factors (see Appendix 6.2.1).
Waist circumference Action Levels
>80 (Action Level 1) 
ORt 95% Cl
> 8 8  (Action Level 2) 
O R tt 95% Cl
Respiratory symptoms P = 0.483$ p = 0.239$
Wheezing when not having a cold 1.41*** 1.17, 1.70 1.51*** 1.24, 1.84
Woken up by shortness of breath 1.56*** 1.26, 1.94 1.41** 1.13, 1.77
Coughing for more than 3 months 1.36** 1 . 1 2 , 1 . 6 6 1.46*** 1.18, 1.79
Bring up phlegm for more than 3 months 1 .2 0 *** 0.95, 1.52 1.48** 1.15, 1.89
Shortness of breath when walking uphill/stairs 199*** 1.76, 2.25 2.24*** 1.97, 2.55
Shortness of breath when walking with others 2.17*** 1.77, 2.66 2.28*** 1 .8 8 , 2.76
Cardiovacular risk factors P = 0.483$ P = 0.239$
High total cholesterol 1.64*** 1.39, 1.92 2 42*** 1 .2 1 , 1.67
Low HDL-cholesterol 2.28*** 1.78,2.92 2 .8 6 *** 2.25, 3.62
Hypertension 2 .6 6 *** 2.14,3.31 3.12*** 2.60, 3.76
At least one risk factor 2 . 1 0 *** 1.85,2.39 2.24*** 1.97, 2.56
Diabetes p = 0.483$ P = 0.239$
Non-insulin dependent diabetes mellitus 2.34*** 1.24, 4.43 4.07*** Z35, 7.04
Symptoms o f  low back pain P = 0.483$ P =: 0.239$
Clironic low back pain (total >12 weeks/year) 1.33*** 1.17,1.51 1.27*** 1 .1 2 , 1.45
Symptom of intervertébral disc hermiation 1.23** 1.08, 1.41 1.36*** 1.18, 1.57
‘Poor ’ quality o f  life P = 0.469$ p = 0.238$
Difficulties in physical functioning
Vigorous activities§ 1.39*** 1.15, 1.68 1.70*** 1.35, 2.14
Moderate activities§ 1.44** 1.15, 1.80 1 .6 6 *** 1.31, 2 . 1 1
Lifting carrying groceries§ 1.28* 1.04, 1.58 1.51*** 1 .2 1 , 1.90
Walking several flights of stairs § 1.56*** 1.24, 1.96 1 . 8 6 1.46, 2.37
Walking one flight of stairs § 1 61** 1.15,2.27 1.89*** 1.36, 2.64
Bending, kneeling§ 1.43,2.19 2 .2 0 *** 1.75, 2.76
Walking more than a mile§ 1.53*** 1.20, 1.95 1 .6 6 *** 1.28, 2.16
Walking several blocks§ 1.46* 1.06, 2.03 1 .8 8 *** 1.35, 2.61
Walking one block§ 1.23 0.83, 1.81 1.62* 1 .1 0 , 2.39
Bathing or dressing§ 0.94 0.55, 1.62 1 . 0 1 0.56, 1.82
‘Poor’ physical fmictioningTj 1.56** 1.15,2.16 1.97*** 1.44, 2.70
<0.001, **P <0.01, *P <0.05; odds ratio with reference to waist j'below Action Level 1 (<80 cm)
and fl'below Action Level 2 (<88 cm); $P = proportion of subjects ‘exposed’ to the risk o f large waist
according to Action Levels; § single items of physical functioning concept; ^standardised scores <66,7%.
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Table 6.2.6. Population attributable risks of symptoms due to large waist circumference
111 men.
Population attributable risk (%)
Men Women
>94* >1 0 2 ** >80* >8 8 **
Respiratory symptoms
Wlieezing when not having a cold 9.2 6 . 1 16.5 10.9
Woken up by SOB 9.5 3.1 21.3 8.9
Coughing for more than 3 months 8 . 1 1 . 1 14.8 9.9
Bring up phlegm for more than 3 months 3.3 1.42 8 . 8 10.3
SOB when walking uphill/stairs 31.5 2 2 . 0 32.4 22.9
SOB when walking with others 27.9 19.3 36.1 23.4
Cardiovacular risk factors
High total cholesterol 26.6 14.5 23.6 9.1
Low HDL-cholesterol 41.1 19.1 38.2 30.8
Hypertension 44.3 27.3 44.5 33.6
At least one risk factor 44.3 27.1 34.7 22.9
Diabetes
Non-insulin dependent diabetes mellitus 46.9 27.3 39.3 42.3
Symptoms o f  low back pain
Chronic low back pain (total >12 wks/yr) 6.3 1 . 8 13.8 6 . 1
Symptom of intervertébral disc hermiation 6.7 0.5 1 0 . 0 7.9
‘Poor ' quality o f  life 
Difficulties in physical functioning'^
Vigorous activities t 19.8 5.9 15.5 14.3
Moderate activities^ 15.9 6.7 17.1 13.6
Liftingcan-ying groceries! 1 1 . 8 6 . 2 1 1 . 6 1 0 . 8
Walking several flights of stairs! 27.8 18.2 2 0 . 8 17.0
Walking one flight of stairs! 1 0 . 8 14.5 2 2 . 2 17.5
Bending, kneeling! 2 2 . 2 16.0 26.5 2 2 . 2
Walking more than a mile! 27.6 13,5 41.8 28.3
Walking several blocks! 30.6 17,2 17.8 17.3
Walking one block! 21.7 17.7 9.7 12.9
Bathing or dressing! 21.7 15.9 NA 0 . 2
‘Poor’ physical functioning! 33.3 17.5 2 0 . 8 18.8
*NA, not applicable as odds ratio <1; reference group with waist circumference *below Action Level 1 
(<94 cm in men, <80 cm in women) and **below Action Level 2 (<102 cm in men, < 8 8  cm in women); 
'{"single items o f  physical fimctioning concept; $<66.7% standardised scores.
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^  Difference between smokers
cd 3 5 - and non-smokers: <0.001 Smokers
25 -
Non-smokers
15 -
MEN
94-102<94 >102a Waist circumference (em)
Smokers1 Difference between smokers 
~ and non-smokers : * * <0 . 0 0 1
"i Non-smokers
25 -
WOMEN
<80 80-88 >88
b  Waist circumference (cm)
Figure 6.2.1. Age adjusted prevalence of shortness of breath when walking uphill or 
upstairs in smokers and non-smokers in different categories of waist circumference 
based on Action Levels (Lean et al, 1995) in men (a) and in women (b).
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□  W O M EN
^  3 0
% % %
Figure 6.2.2. The proportions of subjects whose daily activities are affected by low back 
pain in the past twelve months.
P hysical functioning
I
'gC/l1
100
M E N W O M EN
< 9 4  9 4 -1 0 2  > 1 0 2 < 8 0  8 0 -8 8  > 8 8
Waist divided by Action Levels (cm)
Figure 6.2.3. Standardised scores of physical functioning concept in men and women in 
different categories of waist circumference based on Action Levels (Lean et al, 1995).
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cd 3 .0  ■Vh
C/l 2.5  '"O 2 .0  '
O 1.5 ’
1 .0  ’
0.5  ■
0 .0  i
a
3.5  '
3 .0  .
o 2 .5  '
cd 2 .0  .
CO
" O 1.5 .o 1 .0  •-
0 .5  '
0 .0  ^
b
Significantly d ifferent from  w aist 
below  A ction  L evel 1 : * * * P  <0.001
Reference
M EN
<94 94-102 >102
Waist circumference (cm)
Sign ifican tly  d ifferent from  w aist 
b elow  A ction  L e v e l 1: < 0.001
*  * *
Reference
W OM EN
<80 80-88 > 8 8  
W aist circumference (cm)
Figure 6.2.4. Odds ratios for poor physical functioning (standardised scores <66.7%) in 
men (a) and women (b) in different categories of waist circumference based on Action 
Levels (Lean et al, 1995). Odds ratios adjusted for age, lifestyle and demographic 
factors.
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Appendix 6,2.1. Age, lifestyle and demographic factors as possible confounders 
considered in analysis of the associations of symptoms of chronic disease and impaired 
quality of life with waist circumference.
Reference group Dummy variables ' :
1 2 3
Age (years) '^ '^ '^ '^^ 20-29 30-39 40-49 50-59
Smoking'*’'^ ’"’^ ’" Non-smokers Ex-smokers Current smokers
Alcohol consumption 
(glasses/day)^’^ ’'^ ’^
Occasional
(< 1 )
None
(0 )
Moderate 
(1 to <3)
Heavy
(>3)
Physical activity Active 
(do sport)
Inactive 
(do no sport)
Educational level Level 3
(higher vocational 
or university)
Level 2 Level 1 
(vocational or (lower than 
higher secondary) secondary)
Marital status^ Single Married or 
cohabiting
Divorced or 
widowed
Employment® Currently
employed
Unemployed Housewives Retired
early
Household
composition®
Living with 
someone
Living with no 
one
Intimate contactf® No one 1 - 2 3-5 > 6
Parity (live births)® None 1 - 2 >3
b 1* * 1 j
“diabetes, ‘‘low back pain, and Equality o f life; f  discussing personal matters with other people.
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7.1
WAIST REDUCTION AND CARDIOVASCULAR BENEFITS 
DURING WEIGHT MANAGEMENT IN WOMEN
This section has been peer reviewed and has been published as
Han TS. Richmond PR, Avenell A, Lean MEJ. Waist circumference reduction 
and cardiovascular benefits during weight management in women. International 
Journal of Obesity 1997; 21:127-34.
Collaboration with Aberdeen Weight Loss study
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ABSTRACT
Objective'. To examine the relationship between waist circumference and cardiovascular 
risk factors duiing weight loss, and to consider possible waist reduction targets for 
weight management.
Design’. Single strand six month weight loss study on food based diets in 110 women 
aged 18-68 years, and body mass index >25 kg/m^ set at an outpatient clinic.
Main outcome measures'. Waist circumference, weight, body mass index (BMI), total 
plasma cholesterol, low (LDL) and high density lipoprotein (HDL) cholesterol, 
triglyceride, and blood pressuie.
Results’. Antliropometric and metabolic measuiements improved with mean weight loss 
of 4.9 (SE ±0.4) kg at tlnee months and 6.2 (SE ±0.4) kg at six months. Weight loss 
closely related to waist reduction (%Weight loss = 0.85 x Waist reduction (cm) - 2.09', r 
= 0.79). The proportion of subjects with waist circumference below 80 cm (Action Level 
1) or above 8 8  cm (Action Level 2) were 9% and 60% at baseline, 29% and 38% at three 
months and 36% and 33% at six months. Waist reduction (adjusted for age, smoking, 
alcohol consumption, diet treatment and baseline dependent and independent variables) 
correlated significantly with falls in total cholesterol (r = 0.31; P <0.01), LDL 
cholesterol (r = 0.35; P <0.01) and diastolic blood pressure (r = 0.32; P <0.01), but not 
significantly with HDL cholesterol, triglyceride or systolic blood pressure. BMI showed 
similar correlations, whereas waist to hip ratio changes were not associated with changes 
in any cardiovascular risk factors. Amongst those whose waist fell by >5 cm, 45 at tlnee 
months and 43 at six months, there were >10% improvements in at least one risk factor 
for 71% and 84% respectively. Amongst those whose waist fell by 5 to 10 cm, 40 
women at three months and 30 at six months, at least one risk factor improved in 70% 
and in 83% respectively.
Conclusions'. Waist reduction of 5 to 10 cm in Caucasian women, across a range of 
baseline BMI 25-50 kgim  or waist circumference 72-133 cm, may be used as guideline 
to encourage overweight women to achieve a realistic target with a high probability of 
health benefits.
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INTRODUCTION
Obesity, a preventable disease with a huge burden of symptoms and secondary health 
problems, is rising in prevalence in Britain (Gregory et al, 1990; Bennett et al, 1995). 
Treatment of obesity is difficult, many people become disillusioned with their 
apparently slow progress and fluctuations in body weight during slimming often in the 
context of unreasonable targets. Maintaining modest weight loss may lead to more 
sustained health benefits and thus a greater overall health improvement than attempting 
the large weight loss required to achieve ideal body weight (Lean et al, 1990; Goldstein 
et al, 1992; Dattilo et al, 1992; Atkinson et al, 1993; Williamson et al, 1995; Wadden et 
al, 1996).
Waist circumference reduction is a rewarding consequence of slimming and has been 
suggested as a better motivator than weight change (Egger et al, 1995). We have 
recently proposed the use o f waist circumference for health promotion as a simple 
method for detecting overweight (body mass index) and central fat distribution (waist to 
hip ratio) (Chapter 4.1; Lean et al, 1995) , and for identifying people with 
cardiovascular risk factors (Chapter 5.2; Han et al, 1995c; Chapter 4.2; Han et al, 
1996c). People with waist circumference between Action Level 1 and Action Level 2, 
(the ‘Alert Zone’, >94-102 cm in men, >80-88 cm in women) have increased 
cardiovascular risks, and above Action Level 2 (the ‘Action Zone’, >102 cm in men, > 8 8  
cm in women), the cardiovascular risks are approximately tripled (Chapter 5.2; Han et 
al, 1995c).
The present study examined the relationships between anthropometric measurements 
and cardiovascular risk factors during six months of weight loss, and considered 
possible targets for weight management based on changes in waist circumference.
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METHODS 
Subjects and dietary advice
Women aged 18 to 6 8  years, body mass index >25 kg/m^, free from active disease or 
drugs known to affect body weight, were recruited for a study of six month weight 
management. Two 1200 kcal/day diets were randomly allocated, after pilot studies to 
determine acceptability, containing 58% energy {n = 57) or 35% energy from 
carbohydrate {n = 53). Dietary advice, given by the same dietitian (PR), employed food 
exchanges supported by appropriate recipes.
Anthropometry
Body weight was measiued to the nearest 0.1 kg in light clothes and height to the nearest 
0.1 cm. Body mass index was calculated as weight (kg) divided by height squared (m^). 
Waist circumference midway between the lowest rib margin and the iliac crest and hip 
circumference level with the greater trochanters were measured to the nearest mm 
(Chapter 3.1; Lean et al, 1996; World Health Organisation, 1989). Body fat (as % body 
weight) was calculated from waist circumference (Chapter 3.1; Lean et al, 1996), 
Skinfold thicknesses were measured (Duinin and Womersley, 1974) but gave identical 
results for body fat, as calculated from waist, so data are not presented.
Risk factor measurements
Total plasma cholesterol, high density lipoprotein cholesterol, and triglyceride were 
measured using standard laboratory methods, and low density lipoprotein cholesterol 
was calculated (Fiedewald et al, 1972). Systolic and diastolic blood pressures (first and 
fouidh Korotkoff sounds) were recorded with subjects lying and rested five minutes. 
Information on alcohol consumption (units/week) and smoking (cigarettes per day) were 
assessed by questiomiaire.
Statistical methods
Subjects were categorised into tlnee groups according to the previously defined cut-offs 
o f waist circumference for women: below Action Level 1 (<80 cm), between Action
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Level 1 and Action Level 2 (>80-88 cm), and above Action Level 2 ( > 8 8  cm) (C hapter 
4.1; Lean et al, 1995). Improvements in risk factors were defined as >10%. Cross 
tabulation was used to determine the proportions of subjects who improved risk factors 
tlnough waist reduction, and to test (Chi square) the differences in improvements 
according to waist circumference.
RESULTS
Seventeen percent (« = 19) of recruits dropped out before three months and 25.5% (M = 
28) by six months. The dropouts were 13 years younger {P <0.001) than those who 
continued. There were no significant differences in body mass index (P = 0.24 at tlnee 
months and P  = 0.38 at six months) or in waist circumference (P = 0.18 at three months 
and P  = 0.25 at six months) between the two diet groups (high carbohydrate or low 
carbohydrate). The numbers and ages o f dropouts were not significantly different 
between the two diet groups tlnoughout the study. Baseline measurements and changes 
in anthropometry and cardiovascular risk factors were not significantly different 
between the two diet groups at three months (Table 7.1.1) or at six months (Table
7.1.2), so all 110 women were analysed together to examine the relationships between 
changes in antlrropometry and changes in cardiovascular risk factors. Characteristics of 
all 110 women are shown in Table 7.1.3.
Anthr opometric rneasrrrernents followed similar patterns with 60-70% of total decreases 
within the first three months, with associated improvements in blood lipid. At six 
months, total cholesterol and triglyceride remained significantly below the baseline 
values, but high density lipoprotein cholesterol retrrrned to the baseline value. Low 
density lipoprotein cholesterol and blood pressures did not change significantly (Table
7.1.4).
At thr'ee months of weight management, the proportion of women with waist 
circmnferences in the ‘Action Zone’ ( > 8 8  cm) was reduced from 59.6 to 38.2% of the
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sample, and those with waist below Action Level 1 (<80 cm) increased from 9.2 to 
29.2%. By six months, women with baseline waist > 8 8  cm decreased to 33.3%, whilst 
those with waist <80 cm increased to 35.8%. The proportion of women with waist >80- 
8 8  cm remained between 29-31% throughout the study (Figure 7.1.1). Amongst those 
whose baseline waist was in the ‘Action Zone’, 26.0% at tlnee months and 29.8% at six 
months moved into the ‘Alert Zone’, and 6 % at three months and 13% at six months fell 
to below Action Level 1. Amongst those whose baseline waist was in the ‘Alert Zone’, 
56.7% at tlnee months and 56.0% at six months dropped to below Action Level 1 of 
waist circumference. The relationship between changes in weight and waist (Table
7.1,5) or changes in cardiovascular risk factors (Table 7.1.6) was not significantly 
influenced by baseline waist circumference.
At tlnee months, decreases in total cholesterol, low density lipoprotein cholesterol and 
triglyceride correlated significantly with decreases in body weight and body mass index. 
At six months, decreases in total cholesterol, low density lipoprotein cholesterol, and 
diastolic blood pressure correlated with body weight, body mass index and waist 
circumference (Table 7.1.7). Changes in waist to hip ratio did not correlate with changes 
in any of the cardiovascular risk factors throughout the study.
Changes in waist circumference related closely to changes in body weight (Figure
7.1.2). Regression analysis showed reduction in waist circumference correlated more 
strongly with percentage change in body weight (r = 0.70 at three months and r  = 0.75 at 
six months) than with changes in the absolute amount of body weight (r = 0.63 at three 
months and r = 0.68 at six months). Reduction of 5 to 10 cm of waist circumference 
predicted 6.3 to 10.6% of weight loss (Equation 1). Weight loss of 5 to 10% predicted 
4.7 to 8.0 cm of waist reduction (Equation 2).
Amongst women who improved risk factors by >10%, plasma triglyceride reduction 
accounted for 54% at tliree months and 56% at six months. Other risk factors improved
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by >10% for 17-27% of women at tlnee months and 27-30% at six months, and about 
three quarters of all subjects improved at least one of the five risk factors considered by 
>10% (Table 7.1.8). In general, amongst women with waist reductions of 5-10 cm, 70% 
improved at least one risk factor by >10% at three months and 83% at six months 
(Table 7.1.9). The improvements with waist reduction were similar for women with 
different categories of waist circumference at baseline (data not shown).
DISCUSSION
There are currently no imiversally accepted standards or criteria defining successful 
weight management. From Table 7.1.7 it can be seen that weight, body mass index and 
waist circumference related to major cardiovascular risk reduction during slimming. The 
results are similar to those studies of weight loss. In our free living subjects, energy 
balance was restored at about 3 months in most subjects. The changes in certain 
measurements reflect the independent effects of acute energy reduction and of weight 
loss, for example the biphasic changes in plasma high density lipoprotein cholesterol 
(Dattilo et al, 1992). Recognising the ease of measurement and motivational value, we 
have focused on waist reduction using cut-offs defined in an earlier study of body mass 
index and waist to hip ratio (Chapter 4.1; Lean et al, 1995). The ‘Gutbuster’ 
programme in Australia using waist circumference to encourage weight management in 
men, with a target of 1% of waist reduction a week, showed 75% of men maintained 
more than 5% of waist reduction at 2 year's (Egger et al, 1995).
Risk factor improvements of 10% probably have major long term benefits (Law et al, 
1994; Verschuren, 1995). Amongst women who achieved waist reduction from 5 to 10 
cm in the present study, over 80% had improved at least one risk factor by > 1 0 %, and 
since weight loss was almost complete by three months, this improvement is likely to 
reflect loss of weight, not acute negative energy balance. Risk factor improvements were 
no greater in those who lost >7.5 or >10 cm of waist (Table 7.1.9), and did not differ 
with baseline waist (Table 7.1.6). Few comparable data exist, by Andersen et al (1995)
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found that a 5.6% reduction of body weight in overweight women improved total 
cholesterol by 2 1 % and triglyceride by 19%, and these improvements in cardiovascular 
risk factors were as great as in those who had achieved 11% weight loss. The same study 
showed similar pattern of weight loss and waist reduction in 6 6  overweight women, 
treated with a diet of 925 kcal/day for 3 months followed by 1500 kcal/day for 15 
months. A 16.4% weight loss at six months was accompanied by 13 cm of waist 
reduction, falls in total cholesterol and triglyceride, and high density lipoprotein 
cholesterol returned to baseline value after a temporary decrease dm'ing the phase of 
negative energy balance (at two months) (Anderson et al, 1995). Colman et al (1995) 
found 9 kg weight loss reduced waist circumference by 7 cm in men, with waist 
circumference being the strongest predictor of improved glucose tolerance.
Using Action Level derived from lai'ge population study (Chapter 4.1; Lean et al, 1995; 
Chapter 5.2; Han et al, 1995c), it is proposed that those with waist circumference below 
Action Level 1, who have relatively little of the intra-abdominal fat (Pouliot et al, 1994), 
do not need to lose weight but should be awai'e of potential health risks when their waist 
approaches this level. In the ‘Alert Zone’ (>94-102 cm in men, ^80-88 cm in women), 
subjects should avoid weight gain, and some self-managed weight loss by lifestyle 
modification such as increasing physical activity level (Blair, 1993; Kempen et al, 1995; 
Racette et al, 1995; Wood, 1993). Patients in this ‘Alert Zone’ of waist range with 
problems like non-insulin dependent diabetes mellitus, hypertension, or angina would 
benefit from more active weight loss (Schuler et al, 1992; Yamanouchi et al, 1995). 
Above this range, termed the ‘Action Zone’ (>102 cm in men, and > 8 8  cm in women), 
professional help should be sought to achieve sustained weight loss and for risk factor 
screening.
CONCLUSIONS
The present study extends the value of waist measurement into management. In 
conclusion, reduction in waist circumference, weight or body mass index produces
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beneficial effects on certain cardiovascular risk factors, whereas waist to hip ratio 
reduction is less powerful predictor o f risk factor improvements. Modest weight loss 
associated with 5 to 10 cm of waist reduction appears a reasonable initial target for 
weight management in overweight Caucasian women irrespective of body mass index or 
baseline waist circumference, and will produce beneficial effects on cardiovascular risk 
factors.
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Table 7.1.1. Changes from baseline values in anthropometric and metabolic 
measurements of women who continued on the study until tlnee months on a high 
carbohydrate (58% of energy) or low carbohydrate (35% of energy).
High carbohydrate diet Low carbohydrate diet
P%n M eant 95% Cl n Mean t 95% Cl
Weight (kg) 48 -5.3, -3.3 43 -5.6*** -6 .8 , -4.3 0.109
BMI (k g W ) 48 - 1  7*** -2.1,-1.3 43 -2 .2 *** -2.6,-1.7 0.104
Waist (cm) 48 -4.2*** -5.4, -3.0 41 -5.0*** -6.3,-3.8 0.331
Hips (cm) 48 -3.5*** -4.5, -2.5 41 -4.0*** -5.1,-3.0 0.503
Waist to hip ratio 48 -0.013** -0.022, -0.004 41 -0.017** -0.028, -0.006 0.512
Percent body fat§ 48 - 1 .8 *** -2.4,-1.3 41 -2 .2 *** -2.8, -1.7 0.331
Cholesterolll 46 -0.33** -0.55,-0.10 38 -0 .2 1 "' -0.43, 0.02 0.446
LDL1 43 -0.23* -0.43, -0.02 36 -0 .0 1 "' -0.20, 0.19 0.114
HDL% 43 -0.05* -0.10, -0.03 36 -0.03"' -0.10, 0.04 0.579
Triglyceride^ 44 -0.15"^ -0.32, 0.03 36 -0.28** -0.48, -0.08 0.323
SBP (mmHg) 40 -2 .0 "' -7.2, 3.2 38 -1.9"' -7.8, 4.1 0.973
DBP (mmHg) 40 -1.3"' -4.7, 2 . 2 38 -2 . 1 "' -6.4, 2.1 0.745
fPaired Mest compared to baseline: ***p  <0.001; <0.01; *P  <0.05; ns, not significant; :|:independent
?-test for differences between groups o f  the changes in anthropometry and cardiovascular risk factors; 
§percent body fat (percent o f  body weight) estimated from waist circumference, adjusted for age (Lean et 
al, 1996); ^unit = o f  measurement = mmol/1; BMI == body mass index; LDL = low density lipoprotein 
cholesterol, HDL = high density lipoprotein cholesterol; SBP = systolic blood pressure; DBP = diastolic 
blood pressure.
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Table 7.1.2. Changes from baseline values in anthi’opometric and metabolic 
measurements of women who continued on the study until six months (completers) on a 
high carbohydrate (58% of energy) or low carbohydrate (35% of energy).
High carbohydrate diet Low carbohydrate diet
P%n M eant 95% Cl n M eant 95% Cl
Weight (kg) 42 -5.6»** -7.1,-4.1 40 -6 .8 *** -8.4, -5.2 0.283
BMI (kg/m^) 42 -2 .2 *** -2.7,-1.6 40 -2 .6 *** -3.3, -2.0 0.257
Waist (cm) 41 -5.7*** -7.2, -4.2 40 -6.5*** -8.1,-4.9 0.470
Hips (cm) 41 -5.2*** -6 .6 , -3.8 40 -5.7*** -7.0, -4.4 0.577
Waist to hip ratio 41 -0.015** -0.026, -0.004 40 -0.019** -0.030, -0.007 0.624
Percent body fat§ 41 -2.5*** -3.2,-1.9 40 -3.5, -2.2 0.470
Cholesterol^ 40 -0.34** -0.56, -0.13 37 -0 . 1 2 "' -0.42,0.17 0.233
LDLf 37 -0.17"' -0.36, 0.02 34 -0.03"' -0.29, 0.24 0.368
HDLIf 37 -0 .0 2 "' -0.08, 0.05 34 +0.05"' -0.03,0.14 0.180
Triglyceride^ 39 -0.27** -0.45,-0.10 34 -0.25* -0.44, -0.06 0.828
SBP (mmHg) 38 - 1 .1 "' -6 .6 , 4.4 36 -0.3"' -6.1, 5.6 0.836
DBP (mmHg) 38 -2.7"' -6.4, 1.1 36 -2.3"' -6.1, 1.5 0.894
tPaired Mest compared to baseline: <0.001; **P <0.01; *P <0.05; ns, not significant; ^Independent
^-test for differences between groups o f  the changes in anthropometry and cardiovascular risk factors; 
§Percent body fat (percent o f body weight) estimated from waist circumference, adjusted for age (Lean et  
al, 1996); ^unit o f  measurement = mmol/1; BMI = body mass index; LDL = low density lipoprotein 
cholesterol, HDL = high density lipoprotein cholesterol; SBP = systolic blood pressure; DBP = diastolic 
blood pressure.
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Table 7.1.3. Baseline physical and metabolic characteristics of 110 women.
Mean SD Range
Age (years) 50.6 13.7 18.0-68.0
Weight (kg) 84.3 15.8 62.9-152.7
Height (m) 1.61 0.06 1.46-1.77
Body mass index (kg/m^) 32.6 5.3 24.5-49.8
Waist circumference (cm) 92.5 11.7 72.0-133.0
Hip circumference (cm) 113.6 11.7 97.5-152.5
Waist to hip ratio 0.814 0.053 0.706-0.948
Body fat (% of body weight)* 42.4 5.3 30.1-55.7
Cholesterol (mmol/1) 6.64 1.35 4.10-11.40
Low density lipoprotein (mmol/1) 4.47 1.05 2.60-7.00
High density lipoprotein (mmol/1) 1.46 0.37 0.80-2.60
Triglyceride (mmol/1) 1.48 0.85 0.40-5.50
Systolic blood pressure (mmHg) 136.2 22.5 92.0-194.0
Diastolic blood pressure (mmHg) 85.1 1 2 . 1 60.0-120.0
Mean arterial blood pressure (mmHg) 1 0 2 . 1 14.8 72.0-141.3
A ll variables were not significantly different between the two diet treatment groups. Note: Recalculations 
o f  body mass index found two subjects whose baseline values were below 25 kg/m^ (24.5 and 24.9); 
*body fat calculated from waist circumference (Lean et al, 1996).
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Table 7.1.4. Changes in antliropometric and metabolic measurements of women who 
had 1 2 0 0  kcal/day diets from baseline to six months.
Baseline to 3 months Baseline to 6  months
n Meant 95% Cl n M eant 95% Cl
Weight (kg) 91 _4 -5.7, -4.1 82 -6 .2 *** -7.3,-5.1
BMI (kg/mh 91 -2 .2 , - 1 . 6 82 -2.4*** -2 .8 , -2 . 0
Waist (cm) 89 -4.6*** -5.4, -3.7 81 -6 . 1 *** -7.2, -5.0
Hips (cm) 89 -3.8*** -4.5, -3.0 81 -5.4* * * -6.4, -4.5
Waist to hip ratio 89 -0.015** -0 .0 2 2 , -0.008 81 -0.017** -0.024, -0.009
Percent body fatj 89 -2 .0 *** -2.4,-1.6 81 -2.7*** -3.1,-2.2
Cholesterol§ 84 -0.27** -0.43, -0.11 77 -0.24* -0.42, -0.06
LDL§ 79 -0.13 -0.27, 0.01 71 -0 . 1 0 -0.26, 0.05
HDL§ 79 -0.04* -0.08, -0 . 0 0 71 0 . 0 2 -0.03, 0.07
Triglyceride § 80 -0 .2 1 ** -0.34, -0.07 73 -0.26*** -0.39, -0.14
SBP (mmHg) 78 -1.9 -5.8, 1.9 74 -0.7 -4.6, 3,3
DBP (mmHg) 78 -1.7 -4.3, 1.0 74 -2.5 -5.1, 0.1
MAP (nrniHg) 78 - 1 . 8 -7.4, 1.6 74 -3.5 -7.9, 0.9
tPaired t-test; <0.001; **P  <0.01; "^ P <0.05; Jbody fat (percentage o f  body weight) fat calculated 
from waist circumference (Lean et al, 1996); §unit o f  measurement = mmol/1; LDL -  low density 
lipoprotein cholesterol, HDL = high density lipoprotein cholesterol; SBP = systolic blood pressure; DBP 
= diastolic blood pressure; MAP = mean arterial blood pressure.
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Table 7.1.5. Changes in waist circumference and body weight in women classified into
groups according to their Action Levels of waist circumference at baseline.
Baseline waist 
(cm)*
Baseline to 3 months Baseline to 6  months
n Mean 95%CI F t  P Mean 95%CI F t P
Waist reduction (cm)
<80 1 1 -3.2 -4.9,-1.5 -5.1 -7.7, -2.4
80-88 34 -4.8 -6 .1, -3.5 0.61 0.55 -6.1 -8.9, -5.4 0.26 0.78
> 8 8 65 -4.7 -5.9, -3.5 -6.3 -8.2, -4.9
Waist reduction (%)
<80 1 1 -4.1 -6.3,-1.8 -6.5 -9.9, -3.1
80-88 34 -5.7 -7.3, -4.2 0.61 0.55 -7.2 -8.9, -5.4 0.14 0.87
> 8 8 65 -4.8 -6.1,-3.5 -6.5 "8.2, -4.9
Weight loss (kg)
<80 1 1 -4.1 -5.8, -2.4 -5.3 -7.6, -2.9
80-88 34 -4.7 -5.7, -3.6 0.42 0.66 -5.9 -7.4, -4.5 0.30 0.74
> 8 8 65 -5.2 -6.4, -4.0 -6.5 -8.2, -4.9
Weight loss (Vo)
<80 1 1 -6 . 1 -8 .8 , -3.4 -7.8 -11.5, -4.1
80-88 34 -6 . 2 -7.6, -4.8 0.12 0.89 -7.7 -9.5, -5.9 0.14 0.87
> 8 8 65 -5.7 -7.3, -4.2 -7.1 -8 .8 , -5.4
* Subject groups classified according to baseline waist circumference Action Levels (Action Level 1 = 80 
cm, Action Level 2 =  8 8  cm (Lean et al, 1995)); fanalysis o f variance to determine whether losses in 
anthropometry were different in women whose baseline waist circumferences were in different groups 
according to Action Levels.
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Table 7.1.6. Changes in cai'diovascular risk factors in women classified into groups
according to their Action Levels of waist circumference at baseline.
Baseline waist Baseline to 3 months Baseline to 6  months
(cm)*
n Mean 95%CI F f  P Mean 95%CI F f P
Total cholesterol
<80 1 1 -0.33 -1.07, 0.41 -0.26 -0.73, 0.22
80-88 34 -0 . 2 1 -0.45, 0.03 0.15 0.86 -0.30 -0.58, -0.03 0.14 0.87
> 8 8 65 -0.30 -0.52, -0.07 -0 . 2 0 -0.47, 0.07
<80 1 1 -0.14
Low density lipoprotein cholesterol 
-1.01,0.73 -0.21 -0.72,0.29
80-88 34 -0.09 -0.27, 0.09 0.07 0.93 -0.16 -0.39, 0.06 0.35 0.71
> 8 8 65 -0.15 -0.34, 0.05 -0.05 -0.28,0.19
<80 1 1 -0.04
High density lipoprotein cholesterol 
-0.17,0.10 -0.02 -0.21,0.16
80-88 34 -0.03 -0.10,0.04 0.14 0.87 0.00 -0.09, 0.08 0.43 0.65
> 8 8 65 -0.05 -0 .1 1 , 0 . 0 0 0.04
Triglyceride
-0.03,0.11
<80 1 1 -0 . 2 0 -0.45, 0.05 -0 . 2 0 -0.40, 0.00
80-88 34 -0.08 -0.26,0.10 0.96 0.39 -0.23 -0.36, -0.09 0.17 0.84
> 8 8 65 -0.28 -049, -0.07 -0.29 -0.50. -0.09
Systolic blood pressure
<80 1 1 -4..3 -15.6, 7.0 1.9 -9.1, 12.9
80-88 34 -2 . 0 -9.2, 5.1 0.11 0.90 -4.2 -11.7,3.2 0.84 0.44
> 8 8 65 -1.4 -6 .8 , 4.0 1 . 0 -4.4, 6.4
<80 1 1 -7.8 -17.6,2.1
Diastolic blood pressure
-2.9 -11.0,5.2
80-88 34 -3.1 -7.1, 0.9 2.17 0.12 -5.1 -9.2, -0.9 1.14 0.32
> 8 8 65 0.5 -3.3,4.3 -0 . 8 -4.6, 3.0
<80 1 1 -6 . 6 -16.2, 2.9
Mean arterial blood pressure
-1.3 -9 .2 ,6 . 6
80-88 34 -2.7 -7.3, 1.8 1.14 0.33 -4.8 -9.6, 0.5 1.18 0.31
> 8 8 65 -0 . 2 -4.1,3.8 -0 . 2 -4.1, 3.7
* Subject groups classified according to baseline waist circumference Action Levels (Action Level 1 = 8 0  
cm, Action Level 2 =  8 8  cm (Lean et al, 1995)); fanalysis o f  variance to determine whether losses in 
cardiovascular risk factors were different in women whose baseline waist circumferences were in 
different groups according to Action Levels.
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Table 7.1.7. Correlation coefficients between changes in antlnopometric measurements 
and changes in risk factors adjusted for age, alcohol consumption, cigarette smoking, 
diet treatments and baseline dependent and independent variables of each corresponding 
pair of correlate.
Weight Body mass index Waistt Waist to hip ratio
Baseline to three months
Total cholesterol 0.365** 0.372** 0.219 -0.039
Low density lipoprotein 0.256** 0.271* 0.166 -0.073
High density lipoprotein 0.125 0.129 0.058 -0.077
Triglyceride 0.372** 0.349** 0.230* 0.126
Systolic blood pressure -0.083 -0.081 -0.067 0.080
Diastolic blood pressuie -0.075 -0.063 -0.039 0.159
Mean blood pressure -0.076 -0.068 -0.049 0.139
Baseline to six months
Total cholesterol 0.336** 0.339** 0.311** 0.183
Low density lipoprotein 0.333** 0.333** 0.347** 0.177
High density lipoprotein 0.029 0.025 0 . 0 1 1 0.042
Triglyceride 0.248* 0.251* 0.199 0 . 2 0 1
Systolic blood pressure 0.092 0.081 0 . 1 1 2 0.123
Diastolic blood pressure 0.287* 0.284* 0.319** 0.025
Mean blood pressure 0.228 0 . 2 2 0 0.259* 0.139
Significance levels: <0.01; <0.05; tbody fat (% o f  body weight) calculated from waist
circumference equation (Lean et al, 1996) gave identical correlation coefficients.
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Table 7.1.8. The percentage of women whose waist reduced by different amounts, and 
those who improved cardiovasculai* risk factors by > 1 0 %, during six months of weight 
management.
Improvement
criterion
At 3 months 
n = 89* 
%*
At 6  months
M = 81*
%:!:
Waist circumference T <5.0 cm 49.4 46.9
Waist circumference 4^ >5.0 cm 50.6 53.1
Waist circumference 'i' >7.5 cm 18.0 39.5
Waist circumference 4^  > 1 0  cm 5.6 16.0
Waist circumference 4^ 5-10 cm 44.9 37.0
Total cholesterol i  > 1 0 % 27.4 28.6
Low density lipoprotein \L>io% 26.6 29.6
High density lipoprotein f  > 1 0 % 16.5 26.8
Triglyceride 4/> 1 0 % 53.8 56.2
Mean blood pressure i  > 1 0 % 23.1 2 1 . 6
At least one risk factor > 1 0 % 73.5 80.0
*The number o f subjects who completed the weight management programme; fpercentage o f subjects 
whose waist were reduced by different amounts, and those who improved cardiovascular risk factors by 
> 10%.
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Table 7.1.9. The numbers of women who underwent waist reduction of different 
amounts and who improved specific cardiovascular risk factors by >10 %, during six 
months of weight management.
<5 cm >5 cm >7.5 cm >10 cm 5-10 cm
in = 44*) in = 45)* (n = 16)* {n = 5)* (n -  40)*
%t %t %t %t %t
Three months
Total cholesterol 17.1 37.2 37.5 50.0 34.2
Low density lipoprotein 15.0 38.5 33.3 33.3 38.2
High density lipoprotein 17.5 15.4 13.3 16.7 14.7
Triglyceride 53.7 53.8 73.3 83.3 50.0
Mean blood pressure 20.5 25.6 33.3 33.3 23.5
At least 1 risk factor 63.6 71.1 87.5 80.0 70.0
Six months
(M = 38)* {n = 43)*' (n ~ 32)* (%=13)* (n = 30)*
Total cholesterol 19.4 36.6 43.8 42.9 32.1
Low density lipoprotein 12.5 43.6 54.8 42.9 42.3
High density lipoprotein 31.4 28^ 25.8 35.7 23.1
Triglyceride 55.9 56.4 61.3 64.3 53.8
Mean blood pressure 11.4 30.8 27.6 16.7 35.7
At least 1 risk factor 65.8 83.7 87.5 84.6 83.3
*The number o f subjects whose waist was reduced by <5, >5, >7.5, >10, or 5-■10 cm; tthe percentage o f
subjects amongst those who improved risk factors by > 1 0 % through different amounts o f  waist reduction; 
improvement o f  at least one risk factor in those who lost 5-10 cm did not differ from that in those who 
lost >10 cm at 3 months (x^ = 0.22, P  =  0.64) and at six months = 0.01, 7* =  0.92).
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Figure 7.1.1. Distribution of waist circumference at baseline, three months and six 
months of weight management in women. Waist circumference: Action Level 1 = 80 
cm, Alert Zone = 80-88 cm, and Action Zone >88 cm.
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Figure 7.1.2. The pattern of change in weight loss and waist circumference reduction 
during six months of weight management in women. Equation I. Predicting % weight 
loss from waist reduction (r^  = 55.0%; SEE = 3.6 %weight): % Weight loss = 0.85 (95% 
confidence interval: 0.68 to 1,01) x Waist reduction (cm) - 2.09 (95% confidence 
interval: -3.40 to -0.77); Equation 2. Predicting waist reduction from % weight loss (r^  
= 55.0%; SEE = 3.2 cm): Waist reduction (cm) = 0.66 (95% confidence interval: 0.52 to 
0.79) X %Weight loss - 1.35 (95% confidence interval: -2.54 to -0.16).
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8.1
SKELETAL PROPORTIONS AND METABOLIC DISORDERS IN ADULTS
This section has been submitted for publication as
Han TS. Hooper J, Morrison CE, Lean MEJ. Skeletal proportions: the influences 
of age and gender with metabolic disorders in adults, (submitted).
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ABSTRACT
Objective: The present study investigated the associations of stature, lower leg length 
(LLL) and demi-arm span (demi-AS) with major predisposing cardiovascular risk 
factors and coronary heart disease.
Study design and subjects: Cross-sectional study set at Glasgow Royal Infirmary of a 
subsample of 543 men and 646 women aged 25-66 years from the random MONICA 
sample.
Outcome measures: Blood pressure, plasma total cholesterol, diabetes mellitus and 
coronary heait disease (angina, angioplasty, heart attack, and coronary artery bypass 
graft).
Results: Results were adjusted for age, social class and smoking. Analysis of variance 
showed that in men, shortness of height, LLL or demi-AS were all associated with 
hypercholesterolaemia. Long LLL, high ratios of LLLiheight or LLL:demi-AS was 
associated with diabetes mellitus. In women, shortness of height or LLL was associated 
with coronary heart disease. High ratio of demi-AS:height or low ratio of LLL:demi-AS 
was associated with coronary heart disease.
Conclusions: Short stature and limb lengths, and also altered skeletal proportions, which 
may reflect interrupted early growth, are associated with several metabolic disorders. 
Skeletal disproportion associates with diabetes in men and coronaiy heart disease in 
women.
Key words: age, coronary heart disease, diabetes mellitus, growth, statuie, limb lengths.
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INTRODUCTION
It has been suggested that growth failure in utero at different periods of pregnancy may 
result in altered body moiphology (Barker, 1994). Early growth is clearly affected by 
under feeding in experimental animals (McCance, 1968). Disproportionate growth, e.g. 
longer or shorter limbs than expected for height occurs with delayed puberty (Tarmer et 
al, 1971), but associations with metabolic disorders ai’e not described. Different body 
proportions exist between adults of different races (Reeves et al, 1996), but improved 
standards of living with adequate nutrition has brought the body proportions of Japanese 
children nearer to the reference standar ds of the British (Tanner et al, 1982). Increase in 
height, or specifically leg length reflects improvement in health and growth (Tamrer et 
al, 1982).
The present study investigated the sex and age differences in limb lengths relative to 
height and the associations of height, limb lengths and their relative proportions with 
hypertension, hypercholesterolaemia, diabetes mellitus and coronaiy heart disease.
METHODS 
Subjects
From the Glasgow MONICA project to monitor cardiovascular disease in the West of 
Scotland (Morrison et al, 1997), a subsample of 543 men and 646 women had additional 
measurements o f limb lengths.
Anthropometry
Weight to the nearest 100 g, height to the nearest 1 mm, waist circumference and hip 
circumference to the nearest 1 mm were measured according to standard protocols 
(WHO, 1995). Lower leg length (LLL) was measured to the nearest mm, as the distance 
from the top of the patellae to the soles lying supine, and demi-arm span (demi-AS) as 
the horizontal distance from the web space between middle and fourth fingers to the 
midpoint of the sternal notch to the nearest mm, in sitting position.
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Physiological and biochemical assessment
A non-fasting venous blood sample was taken to determine plasma cholesterol. Systolic 
blood pressure and diastolic blood pressure, first and fifth Korotkoff sound respectively, 
were measured in sitting position after 15 minute rest. Coronary heart disease and 
known diabetes were assessed from questionnaire, defined as having angina and/or 
angioplasty and/or coronary heart bypass graft and/or heart attack. Diabetes mellitus was 
defined as having been told be doctor to have diabetes.
Statistical analyses
All analyses were performed using SPSS statistical package (Version 6.1, Chicago, 
USA). Analysis of variance (simple factorial) was carried out to determine the 
relationships between body lengths (independent variables) and metabolic disorders 
(dependent variables) with adjustments made for age, social class and smoking as 
possible confounding factors (covariâtes).
RESULTS
Table 8.1.1 shows the characteristics of subjects. Men and women had similar profiles 
of age and body mass index. Men were heavier and taller, with longer limbs and higher 
ratios of LLLdieight, demi-ASiheight and LLL:demi-AS than women. For a given limb 
length, men had lower height than women (Figures 8.1.1a & b), and for a given LLL, 
men had shorter demi-AS than women (Figure 8.1.1c).
Table 8.1.2 shows the proportions of hypertension, hypercholesterolaemia and coronary 
heait disease were significantly greater with shorter height in both sexes. The 
proportions of hypercholesterolaemia in men and coronary heart disease in women were 
elevated in those with shorter LLL.
Analysis of variance with adjustments for age, social class and smoking (Table 8.1.3) 
showed that in men, shortness of height, LLL or demi-AS were all associated with 
hypercholesterolaemia. Long LLL and high ratios of LLL:height and LLL:demi-AS
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were associated with diabetes mellitus. In women, shortness of height or LLL, high ratio 
of demi-AS rheight or low ratio of LLL:demi-AS were all associated with coronary heart 
disease. For a given age, there were no differences in LLL;demi-AS ratio in men with or 
without coronary heart disease (Figure 8.1.2a). Women with coronary heart disease had 
lower ratio of LLL:demi-AS than women of similar age with coronary heart disease 
(Figure 8.1.2b). Compared to men without diabetes mellitus of similar’ age, men with 
diabetes mellitus had an elevated ratio of LLL: height (Figure 8.1.3a). Women with and 
without diabetes mellitus did not differ in the ratio of LLL:height (Figure 8.1.3b). There 
were no associations between other ratios of limb lengths to height with metabolic 
disorders in the present study.
DISCUSSION
In the present study, some body disproportions appear to relate to specific metabolic 
disease differently in each sex group. Men with high ratio of LLL:height or LLL:demi- 
AS (longer LLL than expected of height or demi-AS) were associated with diabetes 
mellitus, and women with a high ratio of demi-AS :height or low ratio of LLL:demi-AS 
(longer demi-AS than expected of height or lower LLL than expected of demi-AS) were 
associated with coronary heart disease. Skeletal growth in children has been monitored 
extensively (Tanner, 1989). It is well established that short stature is related to poor 
standards of living (Floud et al, 1990). Several recent reports have indicated that 
diabetes mellitus and impaired glucose tolerance are associated with short stature 
(Chapter 5.5; Brown et al, 1991; Mooy et al, 1995; Alvai’sson et al, 1994; Williams et 
al, 1991), although McKeigue (1991) found no relationships between height and 
impaired glucose tolerance.
Classie studies of McCance (1968) have shown that protein and energy deficient diets 
have sepai’ate adverse effects on skeletal development in pigs. Low energy intake but 
balanced macronutrients resulted in a proportionally small stature. Adequate energy 
intake but lack of protein resulted in reduced skeletal structure but the size of the skull 
was preserved. It is possible that there may be hierarchical steps to sustain growth of
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vital organs, e.g. the nervous system, visceral organs and musculoskeletal system in that 
order, under conditions of stress or nutritional deprivation. Thus the musculoskeletal 
system, arguably the most expendable organ, may be amongst the first organ to be 
‘sacrificed’. Different limb lengths relative to height or relative to one another’s length 
may reflect growth failure in early life. Under certain environmental conditions, subtle 
alterations in funetion of visceral organs and endocrine systems may become manifest as 
later development of metabolic disorders.
According to the ‘thrifty phenotype’ hypothesis (Hales and Barker, 1992) used to 
explain the relationships between eaiiy growth failure, abnormal organ morphology and 
function, and metabolic disorders, it is possible that musculoskeletal structure might be 
abnormally developed in people who were malnourished at critical times during intra­
uterine development. In such adverse condition, blood (nutrients) may be diverted 
towards the brain at the expense of peripheral organs. This hypothesis is supported by 
several studies of blood distribution. Chr onic hypoxia, produced by embolisation of the 
uteroplacental bed in fetal lamb, led to blood redistributed towards the brain (Reuss et 
al, 1982; Block et al 1984). Blood flow redistributed towards the brain has also been 
shown in asymmetrical growth retarded human foetuses, with large head relative to 
waist circumference (Al-Ghazali et al, 1989). In the most extreme situation, early 
malnutrition or stress will lead to low birth weight (known to relate to later metabolic 
diseases). The present results suggest that subtle alterations in skeletal size might be a 
subclinical indicator. The present study did not have information on subjects’ body 
proportions or body weight at birth.
CONCLUSION
Short stature and limb lengths, and also altered skeletal proportions, which may reflect 
interrupted growth, are associated with several metabolic disorders. Skeletal 
disproportion associates with coronary heart disease in women and diabetes mellitus in 
men.
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Table 8.1.1. Subjects’ characteristics.
Men {n = 543) Women (n = 646)
P fMean SD Range Mean SD Range
Age (years) 46.3 11.4 25.5-65.8 45.2 11.9 25.7-65.4 ns
Weight (kg) 78.8 13.9 42.0-130.7 66.8 13.5 42.7-124.6 4= *  *
Height (cm) 172.2 7.1 140.1-194.7 159.3 6.4 137.5-188.6
BMI (kgW ) 26.6 4.3 16.4-42.1 26.3 5.0 17.3-50.9 ns
LLL (cm) 51.5 2.9 40.5-59.5 47.1 2.7 40.2-57.6 =i= ^
Demi-AS (cm) 79.4 4.0 64.2-90.3 72.9 3.5 63.0-88.5
LLL to height ratio 0.299 0.010 0.269-0.334 0.296 0.010 0.256-0.341 * $  *
Demi-AS'.height ratio 0.461 0.014 0.410-0.510 0.457 0.013 0.405-0.497 *  *  $
LLL to demi-AS ratio 0.650 0.026 0.577-0.747 0.647 0.024 0.557-0.743
Systolic BP (mmHg) 133.1 18.9 82.0-252.0 123.7 19.4 88.8-211.0
Diastolic BP (mmHg) 81.7 11.5 51.0-129.0 73.7 11.3 35.0-121.0 * $
Cholesterol (mmol/1) 5.99 1.12 3.00-9.92 5.94 1.25 3.26-10.17 ns
tIndependent H est for the differences in variables between men and women: *^*p  <0.001; P  <0.05, ns = 
not significant; BMI ~  body mass index; LLL == lower leg length; AS = arm span; BP = blood pressure.
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Table 8.1.2. Regression equations for predicting height from lower leg length and demi- 
arm span, and for predicting demi-arm span from lower leg length in 543 men and 646 
women.
Predicting height from lower leg length (LLL)
Equation la Men Height = 2.050 x LLL + 66.593
Equation lb Women Height = 1.982 x LLL + 65.992
Predicting height ftom demi-arm span (demi-AS)
Equation 2a Men Height = 1.442 x demi-AS + 52.978
Equation 2b Women Height = 1.459 x demi-AS + 57.768
Predicting demi-aim span fi'om lower leg length (LLL)
Equation 3a Men Height = 1.024 x LLL + 26.568
Equation 3b Women Height = 0.982 x LLL + 26.590
SEE
95% confidence interval (%) (cm)
Independent Constant
variable
Equation la Men 1.929 to 2.171 60.334 to 72.851 69.9 3.91
Equation lb Women 1.862 to 2.102 60.342 to 71.642 67.6 3.64
Equation 2a Men 1.353 to 1.530 50.730 to 64.807 65.4 4.17
Equation 2b Women 1.367 to 1.552 46.200 to 59.755 62.4 3.97
Equation 3 a Men 0.940 to 1.108 22.229 to 30.906 54.70 2.7
Equation 3 b Women 0.907 to 1.057 23.051 to 30.128 56.69 2.28
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Figure 8.1.1. Plots and regression lines between height and lower leg length (a), 
between height and demi-arm span (b) and between lower leg length and demi-arm span 
(c) in 543 men (□ , solid line) and 646 women (# , dashed line).
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9.1  —
NATURAL SPORTING ABILITY, BIRTH WEIGHT AND 
PREDISPOSITION TO CARDIOVASCULAR DISORDERS
This section has been submitted for publication as
Lean MEJ, Han TS. Natural sporting ability, birth weight and predisposition to 
cardiovascular disorders, (submitted).
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ABSTRACT
Objective: To test the hypothesis that people with a natural ability in “power sports” (a 
presumed marker for predominanee of type 2, glycolytic muscle fibres) might have 
increased risks of coronary heart disease (CHD) compared to those with a natural ability 
in “endurance sports” (as a marker for predominance of type 1, oxidative muscle fibres), 
and that early growth as reflected by birth weight might influence these relationships. 
Design and subjects: Retrospective self-reported study of 231 male former soldiers, aged 
34-87 years who had undergone a course in physical training in the Army School of 
Physical Training, Aldershot, (UK).
Outcome measures: Subsequent cardiovascular disorders.
Results: The proportions who had CHD, defined as angina and/or coronary angioplasty 
and/or coronary artery bypass graft and/or heart attack were 18.7% in power group 
compared to 9.7% in endurance group (difference: % ~ 3.9, P  = 0.05). The proportions 
with CHD and/or risk factors rose to 39.3% in power group compared to 25.8% in 
endurance group (difference: % = 4.8, P = 0.03). Birth weight related negatively to CHD 
(p = -0.18, P == 0.38), and to CHD and/or risk factors (P = -0.31, P  = 0.03). Men in the 
power group with birth weights below median were more likely to develop CHD and/or 
risk factors (age, current body mass index, and lifestyle factors adjusted odds ratio = 
10.5, 95% confidence interval: 1.9 to 59.5), compared to men in the endumnce group 
with birth weights above median.
Conclusion: Men with a natural ability in power sports are at increased risk of 
developing cardiovascular disorders when compared to men with a natural ability in 
endurance sports. Low birth weight has an independent additive effect. These findings 
suggest the hypothesis that a predominance of type 2, glycolytic muscle fibres, 
presumably of genetic origin, predisposes to cardiovascular disorders.
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INTRODUCTION
In the history of modern medicine, coronary heart disease (CHD) and related disorders 
including hypertension and dyslipidaemia have probably been more intensively studied 
than most other diseases. Recent epidemiological studies have produced compelling 
evidence for associations of growth retardation in early life, using birth weight as the 
marker, with cardiovascular disorders and other metabolic diseases (Barker et al, 1992). 
Barker (1994) has proposed the use of the ‘thrifty phenotype’ and ‘programming’ 
hypotheses as ways to explain these relationships.
Several studies have suggested that features related to metabolic syndrome may be 
associated with a muscle metabolism which tends to rely predominantly on the 
glycolytic pathway (as opposed to oxidative pathway). Type 2b, glycolytic, white 
muscle fibres are less sensitive to insulin action than type 1, oxidative, red muscle fibres 
in rats (Bonen et al, 1981; James et al, 1985; Richter et al, 1984). In a study of non­
diabetic Caucasian {n = 23) and Pima Indian {n = 41) men, Lillioja et al (1987) have 
shown that insulin action correlated positively with the proportion of type 1 fibres (r = 
0.29, P  = 0.02) and negatively with the proportion of type 2b muscle fibres (r = -0.38, P 
= 0.003). In women, Ki'otkiewski et al (1990) found that type 2b muscle fibres 
correlated positively {P <0.05) with fasting insulin and glucose. Men and women with 
NIDDM (Marin et al, 1994) and women with Cushing’s syndrome (Rebuffé-Scrive et al, 
1988) have significantly higher proportions of type 2b muscle fibres than ‘healthy’ 
controls. All the aforementioned studies of muscle fibres and related metabolic disorders 
showed type 2b muscle fibres were associated with another feature related to metabolic 
syndrome, abdominal fat distribution (indicated by high ratio of waist to hip or to thigh 
circumference). Men with intra-abdominal fat accumulation (measured by computerised 
tomography), associated with metabolic disorders including raised insulin concentration 
and blood pressure, have low capacities for endurance (aerobic) exercise (Seidell et al, 
1989a). The range of type 1 fibres varies from 10% to 90% between individuals (Saltin 
and Gollnick, 1983). Men tend to have higher proportion of type 2 muscle fibres than 
women (Simoneau et al, 1989). Athletes who specialise in aerobic sports, such as
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marathon runners, tend to have high proportion of slow twitch (type 1) muscle fibres, 
while those who specialise in anaerobic sports, such as sprinters or jumpers, tend to have 
high proportion of fast twitch (type 2a and 2b) fibres (Âstrand and Rodahl, 1986).
Hypothesis
The present study aimed to test the hypothesis that subjects with a natural ability in 
power sports (a presumed marker for type 2 muscle fibre predominance) might have 
increased risks of developing cardiovascular disorders compared to those with a natural 
ability in endurance sport (as a marker for type 1 muscle fibre predominance), and that 
the relationships may be influenced by birth weight, reflecting early growth.
METHODS 
Subjects and study design
British male former soldiers who had undergone a course in physical training at the 
Army Physical Training School, Aldershot were studied retrospectively on the basis of 
their interest in physical activity and probable relative homogeneity in terms of health, 
fitness, dietary and other lifestyle behaviours. Five hundred names of former ai’my 
soldiers were selected randomly from the computer database, and 231 (response rate = 
46.2%) of these subjects aged 34 to 87 years returned self-completed questionnaires.
Questionnaires
Questionnaires were designed based on the Glasgow MONICA Personal Health 
Questionnaire (Morrison et al, 1997). Lists of events associated with endurance and 
another associated with power sports were presented. Subjects were asked to select only 
one list which best described the events for which they thought they had better natural 
ability when aged between 16-40 years (Table 9.1.1). This information provided two 
separate groups of subjects, ‘endurance’ and ‘power’ (Dirix et al, 1991) for analysis.
Subjects provided self measured anthi'opometric variables, and were asked to provide 
their birth weight if known, confirmed with elder relatives if  possible. The accuiacy of
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reported birth weight could not be validated in the present study, but birth weight self- 
reported by women aged 27-44 years (Troy et al, 1996) or recalled from mothers (Troy 
et al, 1996; Lumey et al, 1994) or both paients (Pless and Pless, 1995) has been found to 
be valid for epidemiological analysis. The questiomiaires contained lists o f medical 
history including angina, coronary angioplasty, coronaiy artery bypass graft, heart 
attack, hypertension, hypercholesterolaemia, diabetes mellitus, and medications for these 
conditions, i.e. aspirin for heart disease, medications for angina, high blood pressure and 
high cholesterol. Lifestyle factors were also reported including smoking, alcohol 
drinking, current physical activity level, education. Recent dietaiy consumption was 
obtained using a short food frequency questionnaire (developed for the Scottish Health 
Survey), including meat, fish, potatoes/rice/pasta, and raw vegetables consumption.
Statistical analyses
Clusters of outcome measures were made for coronary heart disease (CHD) {n ~ 32, 
prevalence = 13.9%), defined as having angina and/or coronary angioplasty and/or 
coronary artery bypass graft and/or heart attack), and for CHD and/or hypertension 
and/or hypercholesterolaemia and/or diabetes mellitus, and/or medications fo r these 
conditions (CHD and/or risk factors) {n = 74, prevalence = 33.0%). Statistical analyses 
were performed using SPSS Version 6 (Chicago, USA). Independent /-tests were used to 
test for the differences between groups’ characteristics, and Chi-square tests for the 
differences in prevalenees of cardiovascular disorders. Linear multiple regression 
analysis was used to determine the relationships between birth weight and CHD or CHD 
and/or risk factors, with age adjustment. Logistic regression was performed to test the 
interaction between sporting ability and birth weight in relation to cardiovascular 
disorders (CHD or CHD and/or risk factors) with age adjustment. The relative risk of 
eardiovascular disorders was estimated by odds ratios in logistic regression analysis, 
adjusted for age, body mass index, lifestyle factors and, and types of food consumed. 
Ninety-five percent confidence interval limits were calculated as the exponential of (p 
±1.96 X standai'd enor) (Kleinbaum et al, 1982).
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RESULTS
Table 9.1.2 shows that for the whole sample {n = 231), age and height did not differ 
significantly between endurance and power groups, and similar numbers of subjects 
reported natural ability for power or endurance events. The power group had higher 
body weight and body mass index when they were in the army and at the time of the 
study. There were 111 subjects who provided a reported birth weight. Ten subjects (6 
endurance and 4 power) reported that they had been born prematurely, and were 
excluded in analyses involving birth weight. In the remaining 101 subjects, there were 
no significant differences in age or any antliroponietric variable between endurance and 
power groups (Table 9.1.2). There were no differences in proportions of current lifestyle 
behaviours between endurance and power groups (Table 9.1.3).
Table 9.1.4 shows that compared to the endurance group, there was a tendency for 
higher prevalences in the power group in all cardiovascular conditions, predisposing risk 
factors, medications for these cardiovascular disorders. There were no age differences 
between endurance and power groups who had CHD (age = 70.3 versus 70.5, P = 0.97) 
or CHD and/or risk factors (age = 66.7 versus 66.0, P = 0.79). Compared to endurance 
group, the power group had higher risk of CHD {P = 0.05) and CHD and/or risk factors 
(P = 0.03) (Table 9.1.5, Figure 9.1.1).
Linear multiple regression analysis with age adjustment, showed that birth weight was 
negatively related to CHD (P = -0.18, P = 0.38), and to CHD and/or risk factors (P = - 
0.31, P = 0.03), supporting previous findings of Barker et al (1992). Birth weight was 
therefore incorporated as a possible confoimder in the analysis of the relationships of 
CHD or CHD and/or risk factors with natural sporting ability. There were no 
interactions (age adjusted) between birth weight and natural sporting ability in relation 
to cardiovascular disorders (results not shown).
Table 9.1,6 shows that compared to the endurance group, with age and birth weight 
adjustments, the power group had significant risks of CHD and/or risk factors (P <0.01).
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The relationships between sporting ability and CHD and/or risk factors were analysed 
separately in two groups of birth weight above and below the median (3402 g) (Table 
9.1.2, Tables 9.1.6 & 9.1.7). Figure 9.1.2 shows that the prevalence of CHD and/or risk 
factors was higher for the power group than the endurance group for any birth weight. 
The lowest prevalence of CHD and/or risk factors was observed in the endurance group 
with large birth weight, and highest in the power group with low birth weight. Those in 
the power group with large birth weight had higher prevalence of CHD and/or risk 
factors than those in endurance group with low birth weight. Similar findings were 
observed for association between sporting ability with existing CHD (data not shown).
Endurance subjects with large birth weight were used as the reference group. After age 
adjustment, power subjects with small birth weight had the highest odds ratio of CHD or 
CHD and/or risk factors (Table 9.1.6). Endurance subjects with small birth weight were 
at lower risk than power subjects with large birth weight. There were slight changes in 
these relationships when adjustments were made for current body mass index and 
lifestyle factors (Table 9.1.7). The additional adjustment for current frequency 
consumption of meat, carbohydrate foods, and raw vegetables changed the odds ratio to 
10.7 (95% confidence interval: 1.8 to 61.4, P  <0.01) for CHD and/or risk factors.
DISCUSSION
The present study has produced novel data to suggest that men with a natural ability in 
power sports, as a presumed marker for type 2 muscle fibre predominance, had increased 
incidence of cai'diovascular disorders in later life. A low birth weight, indicating early 
growth retardation, had an independent additive effect. These findings suggest that 
increased glycolytic, type 2 muscle fibres predispose to the development of 
cardiovascular disorders. This conclusion from the present study is supported by 
previous studies showing associations of increased type 2 muscle fibres with features 
related to the metabolic syndrome including diminished insulin action (Lillioja et a/, 
1987; Krotkiewski et al, 1990), NIDDM (Mâiin et al, 1994), Cushing’s syndrome 
(Rebuffs-Srive et al, 1988), and abdominal fat distribution (Lillioja et al, 1987; Rebuffé-
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Srive et al, 1988; Seidell et al, 1989a; Ki’otkiewski et al, 1990). Although it is also well 
established that physical activity improves most cardiovascular risk factors, and delays 
CHD (Morris et al, 1980; Monis et al, 1990; Paffenbai'ger et al, 1986), it has not been 
possible to sepaiate the effects of training horn underlying physiological factors.
Subjects in the present study were all sports enthusiasts, and mostly homogenous in 
terms of their standard physical training programme, their diet exposure, and other 
lifestyle behaviours when they were in the Army, There was no evidence for differences 
in their current physical activity, cigarette smoking, alcohol drinking, educational level 
or selected dietary components currently consumed (Table 9.1.3). The risks of 
developing cardiovascular disorders in those with natural ability in power sports with 
small birth weight remained significantly higher than those with a natural ability in 
endurance sports with large birth weight, even when other possible confounding factors 
including age, current body mass index, smoking, current leisure activity, alcohol 
drinking and education were made. Additional adjustments for current consumption 
frequencies of meat, carbohydrate foods (potatoes/rice/pasta) and raw vegetables did not 
change the odds ratios significantly.
The results from the present study cannot explain how natural ability in power sports led 
to the increased risk of cardiovascular disorders, but muscle composition and sporting 
ability are probably genetically determined. As Klissouras (1976) put it: “Natural 
tendency inevitably asserts itself’, most of men in the present study (about 95%) who 
considered themselves to have natural ability in one type of sport actually performed 
sport events of that same type. The quote “endurance (or power) athletes are born, not 
made” is fittingly supported by studies of monozygotic and dizygotic twins (Klissouras, 
1971 & 1976; Klissouras et al, 1973; Komi et al, 1977) to determine the heritability 
estimate. Heritability estimate has been found to be 93% for maximum oxygen uptake, 
81% for maximum blood lactate, and 86% for maximum heart rate (Klissouras, 1971). 
Komi et al (1977) have shown that heritability estimate for percentage type 1 muscle 
fibres o f the vastus lateralis muscle was 99.5% in males and 92.8% in females.
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Furthermore, no changes in muscle fibre composition have been observed by either 
endurance (Gollnick et al, 1973) or strength training (Thorstensson et al, 1975).
The measurements of natural sporting ability, cardiovascular disorders and birth weight 
were self-reported. It is possible that some of the answers were unreliable, leading to 
random errors and probably imderestimating the ‘true’ associations between variables 
(bias towards the null hypothesis). It seems unlikely that the answers on natural sporting 
ability and birth weight were influenced by disease state (recall bias).
The observations of the associations of type 2b muscle fibres with abdominal fat 
distribution (Lillioja et al, 1987; Rebuffé-Srive et al, 1988; Krotkiewski et al, 1990) and 
poor endurance with intra-abdominal fat accumulation (Seidell et al, 1989a), and the 
associations o f low birth weight with abdominal fat distribution in men (Law et al, 
1992) and in women (Han et al, 1995a) suggest possible mechanisms linking abnormal 
fat metabolism and type 2 muscle fibres with early growth retardation (Figure 9.1.3). 
The present study found no interactions between birth weight and natural sporting 
ability in relation to cardiovascular disorders. Natural ability in power sports and low 
birth weight had an additive effect on the development of coronary heart disease and 
related disorders. It has been suggested that malnutrition at different period of fetal 
growth has an adverse effect on organs differently, depending on the time when cell 
differentiation for a particular organ is most prolific (Barker, 1994). Thus muscle fibre 
composition may be influenced by growth failure at different time during development 
in utero. The present study did not have this information.
CONCLUSIONS
Men with a natural ability in power sports are at higher risk of developing 
cardiovascular disorders than those with a natural ability in endurance sports, and low 
birth weight has an independent additive effect. The results fi'om the present study 
suggest that muscle fibre composition may play a role in developing cardiovascular 
disorders in later life.
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Table 9.1.1. Question and lists of ‘endurance’ and ‘power’ sport events adapted from 
The Olympic Book of Sports Medicine (Dirix et al, 1991).
Between 16-40 years, was your NATURAL ABILITY highest for endurance sports or 
power sports? please tick ONE BOX ONLY
ENDURANCE SPORTS
Examples of endurance sports
Running 1 mile or more 
Cross country 
Cross-country skiing 
Triathlon 
Road cycling 
Orienteering
Long distance swimming 
Canoeing
Walking long distance
or POWER SPORTS
Examples of power sports 
100 yard dash
Sprint running 100 m, 200 m
Long jump
High jump
Weight lifting
Discuss tlirowing
Shot putting
Javelin throwing
Pole vaulting
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Table 9.1.2. Chai'acteristics of 231 male former soldiers. All antliropometric measures 
were converted to metric units from reported empirical units.
Natural ability in 
‘endurance sports’ {n = 124)
Natural ability in 
‘power sports’ (n = 107)
Mean SE Range Mean SE Range
All subject
Age (years) 59.7 1.2 34.4-86.8 62.4 1.2 37.3-87.3 0.11
Current weight (kg) 75.0 0.7 44.5-103.9 l l A 0.8 60.3-101.6 0.03
Height (cm) 173.9 0.5 158.8-190.5 174.1 0.7 152.4-193.0 0.78
Current BMI (kg/m^) 24.8 0.2 15.8-34.8 25.5 0.2 21.5-31.9 0.04
Weight in army (kg) 69.6 0.6 54.0-82.6 71.3 0.6 54.0-101.6 0.05
BMI in army (kgW ) 23.0 0.2 19.1-27.8 23.5 0.2 19.1-30.7 0.03
Those with reported birth weight, excluding those born prematurely (n - 10)
n == 52 n == 49
Age (years) 58.2 1.8 34.4-83.9 60.8 1.7 37.3-83.8 0.29
Current weight (kg) 76.6 0.9 61.0-95.3 79.0 1.2 60.3-101.6 0.13
Height (cm) 174.6 0.8 163.8-190.5 175.3 1.1 160.0-193.0 0.53
Current BMI (kg/m^) 25.2 0.3 20.8-30.1 25.7 0.4 21.7-31.9 0.24
Weight in army (kg) 70.8 0.8 57.2-82.6 72.0 1.0 54.4-101.6 0.38
BMI in army (kgW ) 23.3 0.2 19.2-26.1 23.5 0.3 19.5-28.8 0.60
Birth weight (kg) 3.39 0.08 1.36-4.59 3.54 0.11 1.42-5.44 0.25
* Independent ^-test for the differences in characteristics between groups; BMI = body mass index.
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Table 9.1.3. Comparison of lifestyle factors and dietary intake between men with 
natural ability in ‘endurance sports’ versus ‘power sports’.
Proportions (%) 
‘Endurance ‘Power 
group’ group’ 
(M = 124) (M = 107) p*
Exercise at least once a week 61.0 61.7 0 . 0 1 0.91
Currently smoking 12.9 1 1 . 2 0.15 0.70
Alcohol drinking >3 units/day 18.5 2 0 . 6 0.15 0.70
Education level at secondary or below 39.0 42.9 0.35 0.56
Meat eaten >2 times a week 79.0 80.4 0.06 0.80
Potatoes, pasta or rice eaten >2 times a week 87.1 8 8 . 8 0.15 0.70
Raw vegetables eaten >2 times a week 70.2 74.8 0.61 0.44
* Chi-square test for the differences in proportions between the two groups.
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Table 9.1.4. Prevalence of coronaiy heart disease, predisposing risk factors and 
medications for these conditions, and family history of heart disease in 124 men with a 
natnial ability in ‘endurance sports’ and 107 men in ‘power sports’.
Prevalence
‘Endurance sports’ 
(N=  124)
‘Power sports’ 
(# = 1 0 7 )
n % n % X * P* 1
List 1: Coronary heart disease
Angina 3 2.4 9 8.4 4.19 0.04 1
Coronary angioplasty 1 0 . 8 2 1.9 0.51 0.48 1
Coronary artery bypass graft 1 0 . 8 5 4.7 3.39 0.07
Heart attack 1 1 8.9 17 15.9 2.65 0 . 1 0
List 2: Predisposing risk factors
Hypercholesterolaemia 9 7.3 14 13.1 2.17 0.14
Hypertension 16 12.9 19 17.8 1.05 0.31
Diabetes mellitus 3 2.4 3 2 . 8 0.03 0 . 8 6
List 3: Medications
Aspirin for the heart disease 1 1 8.9 13 1 2 . 1 0 . 6 6 0.42 ;
Medication for angina 2 1 . 6 5 4.7 1.83 0.18
Medication for hypertension 4 3.2 1 2 1 1 . 2 5.69 0 . 0 2
Medication for hypercholesterolaemia 2 1 . 6 6 5.6 2.74 0 . 1 0
Medication or diet for diabetes 2 1 . 6 2 1.9 0 . 0 2 0 . 8 8
Clusters
CHDf 1 2 9.7 2 0 18.7 3.91 0.05
CHD and/or risks and/or medications:): 32 25.8 42 39.3 4.77 0.03
* Chi-square test for the differences in prevalence between the two groups; f  coronary heart disease = 
angina and/or coronary angioplasty and/or coronary artery bypass graft and/or heart attack (list 1); 
:|:coronary heart disease (list 1) and/or predisposing risks factors (list 2) and/or medications (list 3).
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Table 9.1.5. Odds ratios for coronary heait disease and coronary heart disease and/or 
predisposing risk factors and/or medications for these conditions, in 107 men with a 
natural ability in ‘power sports’ compared to 124 men with a natural ability in 
‘endurance sports’.
Odds ratio 95% Cl P
Dependent variable: coronary heart disease"}" 
Predictors:
‘Endurance group’ (reference)
‘Power group’
1 . 0 0
2.15 1.00, 4.63 0.05
Dependent variable: coronary heart disease and/or 
risks and/or medications:};
Predictors:
‘Endurance group’ (reference) 1 . 0 0
‘Power group’ 1 . 8 6 1.06,3.25 0.03
tCoronary heart disease = angina and/or coronary angioplasty and/or coronary artery bypass graft and/or 
heart attack (Table 9.1.4, list I); fcoronary heart disease and/or predisposing risks factors and/or 
medications (Table 9.1.4, lists 1-3).
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Table 9.1.6. Odds ratios for coronary heart disease and/or predisposing risk factors 
and/or medications for these conditions, in subjects with birth weight reported (49 men
with a natural ability in ‘power sports’ compared to 52 
‘endurance sports’), adjusted for age.
men with a natural ability in
Odds
ratio
95% confidence 
interval
P
Dependent variable: CHD and/or predisposing risk
factors and/or medications'^
Predictors:
‘Endurance group’ (reference) 1 . 0 0
‘Power group’ 4.73 1.75, 12.80 0 . 0 0
Birth weight above mediant (reference) 1 . 0 0
Birth weight below mediant 2.70 1.01,7.17 0.05
Dependent variable: CHD and/or predisposing risk
factors and/or medications*
Predictors (combined terms):
‘Endurance’ and birth weight above median (reference) 1 . 0 0
‘Endurance’ and birth weight below median 2.31 0.52, 10.29 0.27
‘Power’ and birth weight above median 4.08 0.95, 17.59 0.06
‘Power’ and small birth weight below median 12.30 2.40, 63.00 0 . 0 0
* Coronary heart disease and/or predisposing risks factors and/or medications (Table 9.14, lists 1-3); 
fmedian value o f birth weight = 3402 g.
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Table 9.1.7. Odds ratios for coronary heart disease and/or predisposing risk factors 
and/or medications for these conditions, in subjects with birth weight reported (49 men 
with a natural ability in ‘power sports’ compared to 52 men with a natural ability in 
‘endurance sports’), adjusted for age, education, current body mass index, smoking, 
alcohol drinking and physical activity.
Odds
ratio
95% confidence 
interval
P
Dependent variable: CHD and/or predisposing risk
factors and/or medications*
Predictors:
‘Endurance group’ (reference) 1 . 0 0
‘Power group’ 4.31 1.48, 12.55 0 . 0 1
Birth weight above medianj" (reference) 1 . 0 0
Birth weight below medianf 2.65 0.77, 9.17 0.07
Dependent variable: CHD and/or predisposing risk
factors and/or medications*
Predictors (combined terms):
‘Endurance’ and birth weight above median (reference) 1 . 0 0
‘Endurance’ and birth weight below median 1.83 0.38, 8.78 0.45
‘Power’ and birth weight above median 3.01 0.64, 14.21 0.16
‘Power’ and small birth weight below median 10.51 1.86, 59.46 0 . 0 1
* Coronary heart disease and/or predisposing risks factors and/or medications (Table 9.14, lists 1-3); 
jmedian value of birth weight = 3402 g.
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Figure 9.1.1. Proportions of subjects with coronary heart disease and/or predisposing 
risks and/or medications in groups with natural ability in endurance or power sports.
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Figure 9.1.2. Proportions o f subjects with coronary heart disease and/or predisposing 
risks and/or medications in groups with natural ability in endurance or power sports, 
with large or small birth weight.
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10.1
DEVELOPMENT AND EVALUATION OF THE 'WAIST WATCHER' 
TAPE MEASURE FOR ASSESSMENT OF WAIST 
CIRCUMFERENCE IN FREE LIVING SUBJECTS
This section has been submitted for publication as
Han TS Morrison CE, Lean MEJ. ‘Waist Watcher’ tape measure as a screening 
tool to identify people at increased health risk through intra-abdominal fat 
accumulation, (in preparation).
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ABSTRACT
Objective'. To evaluate the accuracy of self-reported and self-measured waist by subjects 
using the ‘Waist Watcher’ tape measure, designed to monitor waist circumference.
Study design and setting: Random sample of 101 men and 62 women aged 28-67 years 
in a cross-sectional study, based at Glasgow Royal Infirmary.
Outcome measures: Self-reported and self-measured waist circumference, and self- 
classification according to the previously defined waist Action Level 1 (94 cm in men, 
80 cm in women) and Action Level 2 (102 cm in men, 8 8  cm in women), and waist 
circumference measured by investigator using the ‘Waist Watcher’ tape measure.
Results: Waist circumference measured by the investigator was used as the reference 
method. The mean errors (95% confidence interval limits of agreement) for self-reported 
waist (se lf reported minus reference) were -7.1 cm (-21.5 to 7.2) in men and -5.2 (-22.2 
to 11.9) in women, and for subjects’ self-measured waist made by the ‘Waist Watcher’ 
(self-measured minus reference) were -0.6 cm (-6.5 to 5.4) in men and -0.6 (-5.3 to 4.5) 
in women. Classifications using waist Action Level 1 or Aetion Level 2 by the 
investigator were used as the reference method. S e lf reported waist circumference of 
men and women, respectively, would be classified correctly in different categories based 
on Action Level 1 with sensitivities of 57.4% and 74.3%, and specificities of 92.5% and 
100%, and Action Level 2 with sensitivities of 32.4% and 27.8%, and specificities of 
98.5% and 93.2%. Using the ‘Waist Watcher’ with different colour bands based on the 
Action Levels to assess waist size, subjects classified themselves into correct categories 
according to Action Level 1 with sensitivities of 100% and 94,3%, and specificities of 
95.0% and 96.3%, and according to Action Level 2 with sensitivities of 97.1% and 
100%, and specificities of 100% for both sexes. Only 2% of the sample misclassified 
themselves into the wrong categories of waist circumference Action Levels.
Conclusions: ‘Waist Watcher’ tape measure offers advantages over self-reported home- 
assessed measui'ement of waist circumference, and may be used as a screening tool for 
self-classifying the risk of ill health through intra-abdominal fat accumulation.
Key words: abdominal fat distribution, health promotion, waist circumference.
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INTRODUCTION
Obesity, a wholly preventable disease, is increasing 2-5% per decade and has now 
reached an epidemic proportion, affecting more than 15% in most Western countries 
(Seidell et al, 1995a; Kuczmai'ski et al 1994). On the basis of current epidemiology and 
trends, targets set by health authorities to reduce the rising prevalence by the year 2 0 0 0  
will inevitably fail.
Health promotion and batlnoom scales have hitherto made no impact on the upward 
trend in overweight and obesity. Obesity is partly explained by genetic predisposition 
but also requires an appropriate environment, e.g. over-provision of food without the 
need for physical activity, to express itself (Bouchard et al, 1990; Stunlcard et al, 1990). 
The recent success in cloning of human obese gene responsible for producing leptin 
(Zhang et al, 1994) has caused great excitement amongst the scientific community and 
the popular press, but the world is still waiting for its successful application in obesity 
treatment. Although genetic predisposition is a logical necessity to explain why only 
some people become obese, mechanisms are not yet clear and ‘gluttony and sloth’ 
(Prentice and Jebb, 1995) are frequent victim-blaming explanations.
Fatter than ever, people in the UK and other urban societies are increasingly suffering 
from a catalogue of symptoms of obesity and secondary diseases, including tiredness, 
sweating, breathlessness, back pain, ailhritis, menstrual and fertility disorders, 
cardiovascular disease, non-insulin-dependent diabetes mellitus and several major 
cancers. These lead to impaired quality of life, depression and premature death. Recent 
estimates o f costs per annum for treating obesity are 195 million pounds in Britain 
(Office of Health and Economics, 1994), and 70 billion dollars in the United States 
(Institute of Medicine, 1995). The limited success in reversing the increasing trends in 
obesity attributable to the lack of public awareness of self-assessment of obesity and a 
sense of medical impotence in management, uiges the development of new strategies. 
Clinical guidelines for improved medical management are available in several countries
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(Institute of Medicine, 1995; Scottish Intercollegiate Guidelines Network, 1996, German 
Society of Obesity Research, 1995).
Given the complex interactions between cosmetic and health impact of body shape and 
size, a waist circumference reduction is a rewarding consequence of slimming and has 
been suggested as a better motivator than weight change (Egger et al, 1995). We have 
recently proposed the use of waist circumference as a simple method for detecting 
overweight (body mass index) and central fat distribution (waist to hip ratio) (Chapter 
4.1; Lean et al, 1995), and for identifying people with cardiovascular risk factors 
(Chapter 4.2; Han et al, 1996c). The figures for waist circumference Action Level 1 (94 
cm in men, 80 cm in women) and Action Level 2 (102 cm in men, 8 8  cm in women) 
were identified for health promotion to alert people to increasing health risks. A patent 
‘Waist Watcher’ tape measure was manufactured specifically for the present study based 
on these Action Levels. The present study was designed to evaluate the ‘Waist Watcher’ 
tape measiu'e (Figure 10.1.1) in s e lf  measurement and self-classification of waist 
circumference categories aceording to the Action Levels.
METHODS 
Subjects
A random sample of subjects who participated in the MONICA 4 project one year 
previously were recalled by letter and telephone. They were selected based on the 
predetermined values according to their previous measui'ed waist circumference and age 
available from the MONICA 4 database. A maximum of 1800 subjects were available 
for recruitment. The response rate was about 50%. From these, quota sampling was used 
in order to assign approximately equal number in each subgroup aiming for 50 men and 
50 women in each of 12 subgroups defined by sex, waist circumference Action Levels 
(below Action Level 1, between Action Level 1 and Action Level 2, and above Action 
Level 2), and age (below and above 50 years) . Subjects were randomised within each 
subgroup. One group received general advice about weight management and were given 
the ‘Waist Watcher’ tape measure with which to monitor their waist circumference and
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guidance in its use. The other group, serving as controls, did not receive advice or the 
tape measure. In the present study, baseline self-reported, self-measured and self­
classified waist circumference according to the Action Levels were compared to those 
made by the investigator, in 94 men and 45 women who were available at the time of 
analyses.
Anthropometry
Reported measurements
Subjects were asked to complete a postal questionnaire about euirent body weight, 
height, waist and hips at home. Additional data to be analysed later includes information 
on subjects’ selection of body shapes based on silhouette photographs of men and 
women with a wide range of body fatness and fat distribution, history of weight 
management, lifestyle habits, family and medical history. Subjects will be recalled to 
measui'e waist circumference and body weight after six months to assess the 
effectiveness of the ‘Waist Watcher’ tape measure in self-weight management, 
compared to the control group. Long term monitoring of weight management is planned.
Self-measurement using the ‘Waist Watcher ‘ tape measure
The ‘Waist Watcher’ tape measure (Figure 10.1.1) was made to help subjects measure 
their waist cireumferenee easily. The tape can be made into a complete loop and fitted 
firmly around the waist by a spring meehanism, controlled by a push-button. This allows 
subjects with free hands for adjusting the tape. The measurement can be conveniently 
read by removing the tape fi’om the waist, which is particulaiiy helpful to overweight 
subjects who find it hard to read bending down. The tape has the conventional numbers 
in centimetres and inches on each side, and tlnee colour bands separated by Action 
Levels: green band to indicate waist below Action Level 1 (<94 cm in men, <80 cm in 
women); amber band between ‘Action Level 1 and ‘Aetion Level 2; (94-102 cm in 
men, 80-88 cm in women); and red band above Action Level 2 (>102 cm in men, > 8 8  
cm in women). The meaning of the band colours aie explained in the handout 
‘'Recommendations fo r  Weight Management^ which includes a set of step-by-step
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photographie instructions to guide subjects how to measure their waist circumference 
without any assistance from the investigator (Figure 10.1.2).
Waist circumference measured by investigator
At the end of the experiments, subjeets were asked to be measured by the investigator, 
thus subjects would not know beforehand that their measui'ement of the waist would be 
checked. Also, the investigator did not see the subjects’ measurement values.
Analysis
The accmacy of self-reported waist circumference, self-measured and self-classification 
of waist circumference into categories according to the Action Levels using the ‘Waist 
Watcher’, were compared to those made by the investigator, which were considered as 
the reference method. Statistical and graphical presentation based on the Bland and 
Altman (1986) methods were used to chaiacterise the bias, errors and limits of 
agreement of measurements in relation to sex, waist size and age. The proportions of 
subjects classified into categories of waist circumference Action Levels based on their 
waist circumference measured by the investigator were used as reference groups for 
large waist, above Action Level 1 (>94 cm in men, >80 cm in women) or above Action 
Level 2 (>102 cm in, and > 8 8  cm in women). Sensitivities and specificities (Bland, 
1987) were calculated to assess subjects’ ability to classify themselves correctly into 
categories according to waist circumference Action Level 1 or Action Level 2.
RESULTS
Table 10.1.1 shows the subjects’ characteristics. The mean values of self-reported 
measurements and those made by the trained investigator were similar. Nearly all 
subjects reported all the measurements, except only 36% men were able to provide their 
hip measurement.
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Waist circumference measurements made by the investigator were used as the reference 
values. The errors of self-reported home-assessed waist circumference from subjects 
(self-reported minus reference) were -7.1 cm (95% confidence interval: -21.5 to 6.5) in 
men and -5.2 cm (95% confidence interval: 22.2 to 11.9) in women (Table 10.1.1, 
Figures 10.1.3a & b). There was a systematic bias in errors of self-reported waist in 
men (r = -0.63, P <0.001) and in women (r = -0.48, P  <0.001) of different waist size 
(Figures 10.1.3a & b), i.e. subjects with smaller waist tended to overestimate and those 
with a larger waist to underestimate their waist size, compared to the reference values.
The errors of waist circumference measured by subjects using the ‘Waist Watcher’ tape 
measure (self-measured minus reference) were -0.6 cm (95% confidence interval: -6.5 to 
5.4) in men and -0.6 cm (95% confidence interval: -5.3 to 4.5) in women (Table 10.1.1, 
Figures 10.1.4a & b). There was a systematic bias in errors of self-measured waist 
circumference (r = -0.36, P = 0.01) in men of different waist size (Figure 10.1.4a), i.e. 
men with smaller waist tended to obtain higher and those with larger waist tended to 
obtain lower waist measurements, compared to the reference values. No bias in the 
errors of self-measured waist circumference was observed (r = 0.02, P  = 0.88) in women 
of different waist size (Figure 10.1.4b). The variability (spread) in the errors of self­
measured waist circumference was similar throughout the range of waist circumference, 
i.e. subjects with larger waist gave the same limits of errors as those with smaller waist 
(Figures 10.1.4a & b).
There were no significant systematic biases in the errors of self-reported waist with age 
in men (r = 0.19, P  = 0.6) and in women (r = -0.23, P  = 0.07) (Figures 10,1.5a & b), or 
in the errors of self-measured waist with age in men (r = 0.11, P  = 0.26) and in women 
(r = -0.01, P = 0.92) (Figures 10.1.6a & b). In younger men and younger women below 
40 years (Figures 10.1.6a & b), the variability (spread) o f eiTors of self-measured waist 
circumference was less than in the older groups.
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Table 10.1.2 shows that the proportions of subjects in each categories of waist 
circumference Action Levels were roughly equal (35%) using reference measurement 
made by investigator. This was expected as quota sampling was employed to ensure 
approximately equal numbers of subjects in each category were recruited, based on their 
waist circumference measured one year previously. Subjects tended to underreport their 
waist, such that there were fewer numbers in the lowest (below Action Level 1) waist 
category based on self-reported waist measurement. The distribution of subjects in each 
category based on waist circumference measured by subject using the ‘Waist Watcher’ 
was almost identical to the reference.
In Table 10.1.3, subjects in categories of waist Action Level 1 or Action Level 2 
identified by the investigator were used as reference. Self-reported waist circumference 
of men and women, respectively, would be classified correctly in different categories 
based on Action Level 1 with sensitivities of 57.4% and 74.3%, and specificities of 
92.5% and 100%, and Action Level 2 with sensitivities of 32.4% and 27.8%, and 
specificities of 98.5% and 93.2%. With the aid of the ‘Waist Watcher’ tape measure and 
photographic instructions, men and women, respectively, self-classified their waist 
circumference correctly according to Action Level 1 with sensitivities of 100% and 
94.3%, and specificities of 95.0% and 96.3%, and according to Action Level 2 with 
sensitivities of 97.1% and 100%, and specificities of 100% (both sexes). There were less 
than 2 % of subjects who misclassified themselves into the vw’ong categories of waist 
based on the Action Levels.
DISCUSSION
We have addressed the public health needs, using a single measurement of waist 
circumference to alert the general public to their risks of ill health, and their need to seek 
professional help based on the Action Levels of waist circumference (Chapter 4.1; Lean 
et at, 1995). Both men and women undeiTeported their waist circumference, thus the 
specificities for classification of subjects into the lower categories of waist Action 
Levels were high (>93%), but the sensitivities for identifying those with larger waist in
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higher categories of waist Action Levels were very low - 57-74% based on Action Level 
1 and about 30% based on Action Level 2. With the aid of the ‘Waist Watcher’ tape 
measure (Figure 10.1.1) and photographic instructions (Figure 10.1.2) which were 
designed specifically for the present study, to help subjects measure their waist easily, 
most subjects could identify themselves correctly in different categories of waist 
circumference according to the Action Levels with sensitivities and specificities above 
94%, thus the ‘Waist Watcher’ tape measure provides a useful screening tool, in health 
promotion, for self-classification of increased health risk through intra-abdominal fat 
accumulation, otherwise would be missed from self-reported waist circumference.
Our previous findings indicate clearly that large waist circumference is associated with 
symptoms of obesity and secondary diseases (Chapter 5) imposing enormous burdens 
of ill health on health services and society (Chapter 6). Waist circumference as an index 
of adiposity is minimally influenced by height (Chapter 4.3; Han et al, 1997c), 
although height does have an influence on health independent of adiposity. Thus, a 
single measurement of waist circumference is a valid and simple indicator of ill health. 
If waist circumference is to be used for health promotion programmes for weight 
management in the general public, it is essential that the subjects should be able to 
measure their waist correctly. Some previous studies have shown waist circumference 
measured by trained observers is reliable (Rimm et al, 1990; Hall and Young, 1989, 
Ferrerio, 1995), but recent study on self-reported weight and height in British teenagers 
(16-17 years) found that shorter and fatter individuals overestimated their height and 
underestimated their weight, while conversely taller and thimier subjects underestimated 
their height (Crawley and Portides, 1995). The agreement between self-reported and 
self-measured values for height and weight were within 1 cm and 1 kg respectively, but 
they varied (95% confidence interval) by 7 cm and 7 kg respectively (Nakatsuka et al, 
1995). In these studies, conventional tape measures were used, and these may be 
problematic for the very obese who camiot see their waist. The ‘Waist Watcher’ allows a 
more reliable ‘blind’ measurement. The present study found that the variability of eiTors 
(spread of errors about the mean error) of self-measui*ed waist circumference was similar
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in subjects o f different of waist size (Figures 10.1.4a & b), and younger people were 
able to measure their waist more accurately than older groups (Figures 10.1.6a & b). In 
the present study, while nearly all subjects were able to report all home-assessed 
measurements, only 36% men offered hip circumference measurement. These results 
provide further support for the use of a single measurement of waist circumference in 
health promotion directed at general public.
The present study is part of a larger prospective study. At baseline, waist size self- 
reported and self-measured by the subjects using the ‘Waist Watcher’ tape measure were 
compared to that measured by the investigator. Subjects will be recalled in six months to 
assess the effectiveness of the ‘Waist Watcher’ tape, used as a motivational tool to 
prevent weight gain in those with waist below Action Level 1, and to encourage weight 
loss in those with waist above Action Level 1. In addition, comparisons between weight 
and height measured by the investigator and those reported by the subjects, and the 
influences of body image perception on the differences between self-reported or self­
measured anthropometry and assessment by an investigator will be evaluated.
The practical value of this research is that a single measurement of waist circumference 
can be adopted confidently both by health professionals and the general public as a tool 
for alerting individuals who need weight management. Health promotion can contribute 
to weight management by alerting people to their level of risk and the need to take 
action. This implies the need to establish specialised obesity clinics to serve these needs. 
Individuals with waist circumference below Action Level 1 do not need to lose weight 
but should be awaie of potential health risks if their waist exceeds this level. In the range 
between Action Level 1 and Action Level 2, people should not further gain weight, with 
lifestyle modification such as increasing physical activity level and some self-weight 
management. Everybody above Action Level 2, should be urged to take action and to 
seek professional help to achieve sustained weight loss. These waist Action Levels have 
already been recognised by epidemiologists in the field of public health (Carey et al, 
1997), and adopted for national health promotion by British Diabetic Association
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(Walker, 1997), Health Education Board for Scotland (1997), and Scottish 
Intercollegiate Guidelines Network (1996). Loss of 5-10 cm in circumferentially 
challenged individuals is a goal warrants major congratulations (Chapter 7; Han et al, 
1997a), and will help health service planners to rest easy!
CONCLUSIONS
A ‘Waist Watcher’ tape measure with photographic instructions offers advantages over 
self-reported measurement of waist in self-classifying waist size, and provides a useful 
tool for screening people at increased health risk tlnough intra-abdominal fat 
accumulation.
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Table 10.1.1. Characteristics of subjects.
Men Women
n Mean SD Range n Mean SD Range
Reported, home-assessed measurements
Age (years) 1 0 1 51.4 10.3 27.9-66.6 62 49.2 1 0 . 1 28.6-67.1
Weight (kg) 1 0 1 83.7 15.1 57.2-120.8 62 70.0 1 2 . 8 50.8-101.7
Height (cm) 1 0 1 172.7 7.4 158.0-190.0 62 159.5 5.8 148.0-173.0
BMI (kg/m^) 1 0 1 28.4 4.5 19.8-39.7 62 27.6 5.5 18.9-45.2
Waist (cm) 1 0 0 91.8 9.7 71.1-119.4 62 78.9 1 0 . 8 58.4-111.8
Hips (cm) 36 97.9 13.1 81.3-137.2 61 100.9 1 0 . 0 76.2-127.0
Waist circumference by subjects using ‘Waist Watcher’ tape measure
Waist (cm) 1 0 1 98.2 11.9 73.0-130.0 62 83.3 11.7 65.0-113.0
Measurements by investigator
Weight (kg) 1 0 1 84.3 15.8 53.9-126.6 62 71.1 1 2 . 8 51.5-103.5
Height (cm) 1 0 1 173.7 7.4 157.9-191.4 62 161.0 5.6 146.8-172.2
BMI (kgW ) 1 0 1 27.9 4.47 18.4-40.9 62 27.5 5.5 19.5-44.9
Waist (cm) 1 0 1 98.7 12.7 71.2-129.3 62 83.8 11.4 65.7-114.5
Hips (cm) 1 0 1 104.8 7.8 89.0-130.0 62 105.1 9.4 87.0-137.2
Waist to hip ratio 1 0 1 0.94 0.07 0.79-1.13 62 0.80 0.06 0.68-0.90
Errors o f  self-reported and self-measured waist circumference (cm)
95% C It 95% C It
SR-reference 1 0 0 -7.14 7.18 -21.50, 6.47 62 -5,16 8.53 -22.2, 11.90
SM-reference 1 0 1 -0.55 2.99 -6.53, 5.43 62 -0.56 2.36 -5.28, 4.46
|95%  confidence interval limits of agreement (±2 SD of the mean error); SR-reference = self-reported 
waist circumference minus reference values measured by investigator; SM-reference = self-measured 
waist circumference using ‘Waist Watcher’ minus reference values measured by investigator.
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Table 10.1.2. Proportions of subjects in different categories of waist circumference 
Action Levels identified from measuiements made by investigator (reference), from self- 
reported, and from subjects self-measmements using the ‘Waist Watcher’ tape measure.
By investigator 
(reference)
Self-reported Self-measured
Waist circumference (cm) n % n % n %
Men {n = 101) 
<94 40 39.6 63 62.4 38 37.6
94-102 27 26.7 26 25.7 30 29.7
> 1 0 2 34 33.7 1 2 11.9 33 32.7
Women (n = 62) 
<80 27 43.5 36 58.1 28 45.2
80-88 17 21A 18 29.0 16 25^
> 8 8 18 29.0 8 12.9 18 29.0
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Table 10.1.3. Sensitivities and specificities of the identification of subjects into different 
waist circumference Action Level categories based on their reported and self-measured 
waist circumference, using groups classified from measurements made by the 
investigator as reference.
Self-reportedf Self-measured:|:
Sensitivity
(%)
Specificity
(%)
Sensitivity
(%)
Specificity
(%)
Men {n = 101)
Action Level 1 (94 cm) 57.4 92.5 1 0 0 95.0
Action Level 2 (102 cm) 32.4 98.5 97.1 1 0 0
Women {n = 62)
Action Level 1 (80 cm) 74.3 1 0 0 94.3 96.3
Action Level 2(88 cm) 27.8 93.2 1 0 0 1 0 0
fWaist circumference was reported by subjects from home-assessment; :|:self-classification into waist 
circumference categories by subjects was aided by ‘Waist Watcher’ tape measure which has three band 
colours separated by Action Levels (Figure 10.1.2).
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iFigure 10.1.1. The ‘Waist Watcher’ tape measure.
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Figure 10.1.3. Plots of errors of self-reported waist circumference (subjects’ self- 
reported values minus reference values measured by investigator) against reference 
values, in 101 men (a) and 62 women (b). Solid line indicates mean eiTor, and dashed 
lines indicate 95% confidence interval limits of agreement (±2 SD of the mean error).
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Figure 10.1.5. Plots of errors of self-reported waist circumference (subjects’ self- 
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indicate 95% confidence interval limits of agreement (±2 SD of the mean eiTor).
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11.1 Overall conclusions of the findings and answers to research 
questions
11.1.1 Development of simple anthropometric methods for assessing body 
morphology
Recognising the limited success in preventing the rising prevalence of overweight in 
Western countries, the studies in the present thesis have focused on the development and 
validation of a simple method for assessing adiposity. Several approaches were taken to 
re-examine, develop and validate a wide range of methods to determine adiposity. The 
research question “ylre existing methods o f  measuring body morphology satisfactory in 
terms o f  accuracy and practica lity^  was answered in Chapter 3.1. It was shown that 
conventional skinfold method ai’e not entirely satisfactory because it underestimated 
body fat in extreme central fatness and older age. Waist circumference method showed 
no bias in these groups. The advantages of the waist circumference method are the 
convenience and ease of measurement. The equations employing waist circumference 
were found to be robust in cross-validation with a Dutch sample. Research question 
“Caw a better novel method be derived to reflect central fa t and total adiposityT" was 
posed. In Chapter 4.1, it is argued that the waist circumference is better by virtue of 
practicality, and also its better reflection of both total fat and central (intra-abdominal) 
fat. Further more, ROC analysis has shown that waist circumference ‘Action Level 1 ’ 
coincided with the ‘optimal’ cut-offs, where sensitivity equals specificity for identifying 
major cardiovascular risk factors.
11.1.2 Relationships between body morphology and metabolic disorders
It is now well accepted that excessive intra-abdominal fat aecumulation is a health 
hazard, and that waist circumference reflects this fat mass. To answer the research 
question “LTow well does waist circumference relate to metabolic disorders compared to 
the existing methods o f  body mass index and waist to hip ra tioT \ A series of cross- 
sectional epidemiological studies in Chapter 5 showed that waist circumference related 
at least as well as other commonly used antlrropometric indices of body mass index and 
waist to hip ratio, to a cluster of symptoms and clironic diseases including
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cardiovascular risk factors, respiratory insufficiency, diabetes mellitus, symptoms of low 
back pain and impairment of quality of life. Analyses in chapter 4 show that there is no 
need to adjust waist circmnference for height.
11.1.3 Some determinants of body morphology and metabolic disorders 
Animal studies have shown imbalance diet during early growth can affect skeletal 
structiue. The research question ''Does disproportionate stature (limb lengths relative to 
height) associate with health hazardsT  was answered in a study of body lengths in 
Chapter 8. Men and women with body disproportions appeared to relate to specific 
metabolic disorders. This was a relatively small study in relation to the prevalence of 
disease, so the apparent difference between men and women should ideally be confirmed 
in larger samples.
Several studies have indicated that increased proportions of type 2b muscle fibres are 
associated with featuies related to metabolic syndrome X. It has previously been 
established that athletes who are specialised in power sports tend to have higher 
proportions of type 2 b muscle fibres, as opposed to type 1 muscle fibre predominance in 
athletes who are specialised in endurance sports. The research questions "Is the 
musculoskeletal system affected by low birth weight, contributing to altered body 
functional capacity in adult lifel and "Do individuals with declared natural ability in 
pow er sports suffer higher rate o f  coronary heart diseaseT  were answered in a 
retrospective self reported study of former soldiers in Chapter 9. The data supported 
Barker et al, in showing a significant relationship between low birth weight and CHD. 
There was an indication that those who reported having a natural ability in power sports 
at the age between 16-40 to have increased risk of coronary heart disease and 
predisposing risk factors, compared to those who considered themselves as having a 
natural endurance sporting ability. There was no interaction between birth weight and 
sporting ability on metabolic disorders. Compaied to men with a natural ability in 
endurance sports and above median birth weight, those with a natui'al ability in power
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sports and below median birth weight were more likely to develop cardiovascular 
disorders later in life.
11.1.4 Implications of altered body morphology on health risks applied towards 
health promotion
Waist circumference has been suggested as a simple method for assessing associated 
health risk, directed at the general public. Research questions posed in the present thesis 
"Is self-reported waist circumference reliableT'' and "Does a patent W aist Watcher' 
tape measure improve self-measurement?'’ was answered by a study of reported home- 
based measurement and waist measurement using the ‘Waist Watcher’ tape measure. 
Results in Chapter 10 showed that the error was reduced with the use of the ‘Waist 
Watcher’ and that more than 95% of subjects were able to self-classify themselves 
con'ectly into different categories according to the waist ‘Action Levels’.
Conclusion
An attempt to synthesise the findings in this thesis, together with evidence collected by 
other, is made in Figure 11.2.1, as a progression from the simple model shown in 
Figure 1.2.1. Some of the new links are firmly established by evidence, others remain 
speculative.
11.2 Validity of conclusions, limitations of the studies in the present 
thesis, and future research directions
In this section, the validity of the conclusions and limitations of the studies in the 
present thesis, and future research direction are discussed. Possible mechanisms linking 
body morphology, early growth and metabolic complications will be formulated to 
postulate further hypotheses for future studies.
11.2.1 Validity and limitations of the studies and further research needs 
The present thesis has drawn on a wide range of studies to explore the importance of 
body morphology in relation to metabolic disorders in adults. The assoeiations of
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overweight and fat distribution with metabolic disorders were obtained mostly from 
cross-sectional studies. To be able to confirm aetiological relationship, a longitudinal 
follow up is necessary, and this is underway in the MORGEN study. The retrospective 
follow up study of natural sporting ability and coronary heart disease in later life used 
indirect markers and reported information rather than actual physical and biological 
measurements. Prospective studies using measured variables should be conducted to 
confirm the findings from this study. This study, and the analysis of limb length and 
disease aie both limited by relatively small size in relation to the prevalences of diseases 
in the samples.
The present thesis has derived a number of anthiopometric methods based on waist 
circumference measurement to identify body fatness. Measurements of waist 
circumference was highly reproducible. Derived predictive equations and standard cut­
offs of waist circumference to define body mass index and waist to hip ratio were found 
to be robust in cross-validation on different populations. The same cut-off points were 
found using different methodological and analytical approaches, e.g. analysis of risk 
factors. Waist circufmerence, strongly reflects intra-abdominal, correlated consistently 
with a variety of symptoms and indices o f ill health. Thus the methods employing waist 
circumference can be applied for assessing health risk associated with obesity and 
abdominal fat accumulation confidently by health professionals, and in health promotion 
directed at the general public.
11.2.2 Future research directions
Extensive research into the aetiology of overweight and body fat distribution as 
indicators of ill health and metabolic disorders has focused on genetic and 
environmental factors and their interactions. However, recent evidence emerged from 
the epidemiological studies of Barker and colleagues has pointed towards early 
malnutrition, reflected by poor growth, as a major determinant of the same metabolic 
diseases in adulthood, including cai’diovascular disease, diabetes and lung disease. These 
authors’ interpretations of the associations between increased risks of diseases in adults
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and their low weight at birth or at one year were based on the ‘tlirifty phenotype’ 
hypothesis which suggests that growth and development of vital organs ar e sacrificed to 
sustain brain growth when mifavourable conditions occur (e.g. malnutrition). If  this 
occm's during the critical period of early growth, the ‘programming’ hypothesis suggests 
vital organs may be permanently damaged; these functional defects can persist into adult 
life, rendering subjects greater susceptibility to ill health.
Does muscle fibre composition have a direct influence on metabolic diseases, or does it 
require the metabolism of the muscle fibres through different metabolic pathways to 
express the metabolic risks exerting on the cardiovascular system and other organs? Is it 
possible that failure in growth at a specific time of pregnancy and/or the severity of the 
insult determines the composition, and thus functional capacity of skeletal muscles? 
According to the ‘tlirifty phenotype’ hypothesis used to explain the relationsliips 
between early growth and metabolic disorders, muscle morphology may also be affected 
by early growth. It would be expected that type 2 muscle fibres are more predominant in 
people who were malnouiished (low birth weight) during intra-uterine development. In 
such adverse condition, blood may be diverted towards the brain at the expense of 
peripheral organs. This hypothesis is supported by several studies of blood distribution. 
Clironic hypoxia, produced by embolisation of the unteroplacental bed in fetal lamb, led 
to blood redistributed towards the brain (Reuss et al, 1982; Block et al 1984). Blood 
flow redistributed towards the brain has also been shown in asymmetrical, relatively 
larger head than waist circumference, growth retaided human foetuses (Al-Ghazali et al, 
1989). Thus in such situation of peripheral blood (nutrient) deprivation, the skeletal 
muscles would probably adapt towai'ds a metabolic system relying less on oxidative, i.e. 
more glycolytic, less vascularised type 2 muscle fibres. The morphology and function of 
the skeletal muscles would then be permanently ‘programmed’ for life, limiting subjects 
to rely on glycolytic metabolism, with a decreased ability to perform physical activities 
involving oxidative metabolism, whereas the ability to perform power activities which 
are not dependent on oxygen would probably not be impaired. Barker (1994) has 
proposed that early growth restraint, including undernutrition at different stages of
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pregnancy may result in disproportionate body size, accompanied by abnormal 
development of organs, reflected by altered organ size, morphology and function, and 
this may persist tlnoughout an individual’s life. It is possible that there may be many 
more hierarchical steps to sustain growth of more vital organs, i.e. the nervous system, 
vital organs and musculoskeletal system in that order. In the present study, we 
hypothesise that the musculoskeletal system may be one of the first body organs to be 
‘sacrificed’. This is in agreement findings from development of pigs reared on different 
diet composition and energy intake (McCance, 1968).
Emerging from the present thesis, several future reseai'ch projects can be proposed.
1. Longitudinal studies of waist circumference and ill health.
2. Physiological measures of muscle function and metabolic status in different clinical 
situations.
3. Follow up study of the effectiveness of the ‘Waist Watcher’ tape measure in self 
weight management in free living subjects.
4. Long term intervention for primary prevention of obesity employing waist 
circumference in high risk individuals.
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Figure 11.2.1. Synthesis of possible links of substrate storage and utilisation with body 
morphology and metabolic disorders, incorporating results from the present thesis and those 
from research elsewhere, described in Chapter 1, as a progression from the simple model 
shown in Figure 1.2.1 The red indicates links strengthened by work in the present thesis.
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